data_1mak_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mak _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 30' ' ' VAL . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 28' ' ' SER . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.411 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.657 0.265 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 55' ' ' LYS . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.524 HH21 ' N ' ' A' ' 65' ' ' ASP . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.524 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CB ' HD12 ' A' ' 21' ' ' ILE . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.459 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.7 t -71.63 124.54 28.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.535 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.92 147.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.38 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.426 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 4.3 mtp -143.42 110.56 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.195 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -101.38 117.13 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.783 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.485 ' OE1' ' HA3' ' A' ' 105' ' ' GLY . 5.7 tt0 -101.21 133.43 45.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.732 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -154.37 163.37 24.39 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.88 179.46 31.25 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.306 -1.539 . . . . 0.0 111.119 -1.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 mt -77.6 -35.97 52.3 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.563 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.98 151.57 46.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -138.26 85.6 18.27 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.797 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 106.75 1.5 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.77 1.647 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.46 -177.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.576 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.6 m -122.27 156.2 34.32 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.1 mt -67.48 86.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.32 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.77 36.3 0.07 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -135.86 166.34 23.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -94.11 137.39 33.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.236 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.67 160.24 16.1 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.57 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -149.04 90.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.628 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 77' ' ' THR . 2.8 mt -86.62 113.61 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' THR . 7.2 t -81.21 156.3 25.72 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.654 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.8 91.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -91.0 166.63 12.91 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.978 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 p -148.39 167.36 25.46 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.996 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -79.62 -69.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -92.14 154.7 18.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.757 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -64.2 132.31 49.98 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.23 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.23 33.43 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.5 127.0 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.008 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.489 1.491 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.419 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . 5.0 m-80 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 m -107.79 99.41 8.88 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 35' ' ' ASN . 21.3 m-85 -83.85 75.78 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -132.58 125.67 31.03 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.244 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 17.2 p-10 -126.06 160.84 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.839 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -108.3 174.92 5.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.498 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 27.9 m-85 -150.2 161.76 41.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.547 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 tp -160.51 111.14 1.82 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.282 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.42 161.07 17.75 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.964 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 tptt . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.855 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.858 0.361 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 63' ' ' VAL . 49.0 mt -108.9 -51.12 2.92 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.759 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mm -127.47 134.85 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.517 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -112.83 -21.95 10.92 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' SER . 19.6 mttp -135.33 106.54 6.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.334 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.667 ' CG1' ' H ' ' A' ' 57' ' ' SER . 6.3 p 29.7 -85.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.15 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.667 ' H ' ' CG1' ' A' ' 56' ' ' VAL . 21.4 t -114.35 48.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.238 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -125.61 108.11 11.25 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 -73.53 144.22 46.2 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -73.41 155.35 39.41 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.984 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.8 p -59.11 98.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.622 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.56 -17.79 4.97 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 52' ' ' LEU . 95.4 t -73.56 120.11 79.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.305 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.75 150.19 86.87 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.107 1.872 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -55.07 -19.88 8.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' ' OE2' ' A' ' 84' ' ' GLU . 61.4 mtt85 -56.01 -14.39 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.497 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -115.1 128.3 56.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.043 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.91 125.43 17.76 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.33 149.46 18.59 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.084 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.46 160.13 39.28 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 175.16 159.97 22.23 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.672 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 p -90.83 -99.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.675 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.78 -37.25 0.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.2 p -121.89 17.61 10.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.71 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 9.3 t70 -152.25 125.13 8.49 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 76' ' ' PHE . 20.9 m-85 -139.09 156.18 47.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.841 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.0 m -150.89 149.28 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.11 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.89 109.51 21.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.772 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -100.77 123.05 44.41 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.752 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mt -108.08 132.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.8 m -64.63 -60.82 2.67 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -135.98 109.61 8.02 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.47 110.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.157 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE2' ' NE ' ' A' ' 66' ' ' ARG . 4.7 mt-10 -95.26 -175.52 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.295 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.17 66.28 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.249 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.24 -32.58 19.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.895 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.11 -12.58 40.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.384 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.81 147.8 49.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.787 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.88 -161.16 28.25 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.557 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.08 117.92 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.97 154.15 19.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.672 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 106' ' ' GLY . 45.6 m-85 -146.39 168.48 21.03 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.42 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.6 p -159.05 151.09 20.98 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.321 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.497 ' HG ' ' N ' ' A' ' 103' ' ' PHE . 13.0 t -152.69 -175.34 5.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.513 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.426 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 1.1 pp0? -135.84 136.38 40.57 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.0 m -110.36 42.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -38.62 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.139 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -109.42 156.21 20.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.393 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 92.3 t -127.1 134.66 26.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.606 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -72.24 163.29 88.16 Favored 'Cis proline' 0 C--N 1.318 -1.045 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.731 -0.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.16 162.08 34.54 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 122.044 1.83 . . . . 0.0 111.389 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 28.5 p -87.43 -92.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.542 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' N ' ' HG ' ' A' ' 94' ' ' SER . 65.8 t80 61.99 116.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.445 0.466 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.92 54.97 0.04 OUTLIER Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.888 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.485 ' HA3' ' OE1' ' A' ' 6' ' ' GLN . . . -114.1 -120.87 3.57 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . 127.23 68.72 0.16 Allowed Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.887 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.3 m -86.01 106.06 16.91 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.204 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -75.53 115.84 15.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.198 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.34 93.47 4.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.619 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -121.93 143.86 49.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.741 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -62.47 152.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.294 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -63.29 123.42 18.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.878 0.37 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.29 116.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.291 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 151.09 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 120.39 11.6 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.1 143.7 47.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.446 ' HG3' ' SG ' ' A' ' 93' ' ' CYS . 1.4 tt0 -118.23 148.2 42.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.819 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.11 154.76 18.48 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.796 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.43 178.61 33.79 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.734 -1.361 . . . . 0.0 111.102 -1.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 mt -77.05 -44.5 30.5 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.911 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.04 152.23 48.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.12 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -142.95 78.71 15.18 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.092 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.85 126.19 14.91 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.757 1.638 . . . . 0.0 109.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.43 -175.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.335 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.76 167.06 11.1 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.599 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.54 89.83 7.15 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.04 48.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 176.47 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.26 148.02 23.54 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -125.38 161.02 27.95 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -160.64 96.54 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.434 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.25 139.65 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.595 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 m -107.22 145.83 32.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.8 t -153.55 118.46 5.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.901 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -123.72 156.18 36.47 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.236 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.8 p -122.03 146.58 47.03 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -58.05 -49.77 75.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -111.22 156.22 21.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -64.62 144.81 56.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.89 30.32 3.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.23 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.72 141.64 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.502 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 . . . . . 0 N--CA 1.488 1.456 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.119 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.888 0.375 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.3 m -115.32 150.34 36.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -132.2 101.44 5.38 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.463 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.03 129.18 12.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.786 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' OH ' ' A' ' 41' ' ' TYR . 12.4 p-10 -130.76 160.29 34.79 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.891 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -112.52 151.79 29.57 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' OH ' ' ND2' ' A' ' 39' ' ' ASN . 22.6 m-85 -129.31 166.59 19.17 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 tp -154.53 126.68 7.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.011 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -124.03 165.83 16.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.014 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tptp . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.26 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.0 mt -113.73 -64.7 1.27 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mm -116.17 140.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.662 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.1 p90 -130.27 158.59 39.37 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.178 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.2 tptm 74.4 -67.07 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.986 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -171.07 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.494 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 p -152.43 -28.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.347 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 30.9 m-80 -51.65 129.0 24.98 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -90.25 139.59 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.44 151.12 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.694 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -59.39 104.07 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.14 -12.85 6.39 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.326 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.01 119.21 75.38 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.39 150.83 78.57 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.874 1.716 . . . . 0.0 111.828 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.51 -15.51 11.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.389 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -57.2 -18.4 15.58 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.75 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -107.43 128.62 54.64 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.0 125.54 17.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.57 144.97 17.05 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -160.44 -177.59 6.33 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.08 169.92 33.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.276 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 m -91.21 -82.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.25 -37.9 0.1 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.599 -1.286 . . . . 0.0 111.12 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -125.13 13.97 8.39 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.98 117.4 12.01 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -132.34 144.54 50.63 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.611 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.2 m -141.37 139.69 33.57 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.783 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -106.14 111.48 24.11 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.765 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 37.8 mttt -107.1 147.74 29.65 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.629 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.3 mt -124.77 134.84 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.435 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.5 m -67.24 -55.47 13.89 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.174 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.14 110.63 8.54 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.25 130.17 35.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.211 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.96 -172.27 2.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.758 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 -29.6 62.06 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.39 -43.09 67.49 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.86 -36.07 16.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.571 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 77.1 mt -45.24 136.34 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.35 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.56 -144.74 10.91 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.409 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.0 141.07 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.004 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -117.83 151.12 37.98 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.619 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -146.64 163.78 34.77 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -137.58 136.03 37.2 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.362 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 p -139.4 155.13 47.84 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.954 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.38 37.9 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -127.83 28.78 5.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.234 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 -57.57 3.19 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.596 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -105.91 159.69 15.83 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 38.3 t -110.0 140.77 22.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.318 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.47 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 7.4 Cg_endo -77.44 163.69 88.1 Favored 'Cis proline' 0 C--N 1.315 -1.193 0 C-N-CA 123.715 -1.369 . . . . 0.0 111.824 -0.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.36 118.9 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.021 1.814 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -89.9 135.32 33.71 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.741 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.38 -179.85 7.03 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.212 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.64 -175.71 41.5 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -82.93 -69.9 1.37 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 136.43 114.31 1.33 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 125.32 53.23 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.299 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.6 128.12 37.31 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.48 90.92 3.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.23 143.46 41.95 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.925 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.66 150.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.961 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -62.61 121.37 13.17 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.649 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.47 106.27 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.44 164.05 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -143.7 110.59 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -77.15 110.54 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.65 131.16 44.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.178 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.89 156.53 13.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.445 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -82.86 175.22 39.49 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.372 -1.512 . . . . 0.0 110.972 -1.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.08 -39.05 21.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.485 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -129.44 143.45 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 tp -137.59 81.05 30.56 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.824 -1.151 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.54 121.74 8.48 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.773 1.649 . . . . 0.0 109.646 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.29 -178.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 118.98 -1.088 . . . . 0.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -108.6 172.92 6.56 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -89.19 89.49 7.96 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.01 28.03 0.34 Allowed Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.49 174.94 6.08 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.852 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -96.51 141.96 29.16 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.76 167.31 10.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.832 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -162.03 79.89 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.048 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.2 mt -75.11 133.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.207 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -105.52 155.69 18.94 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.153 -1.019 . . . . 0.0 113.312 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.41 89.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.464 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -94.42 147.41 23.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.427 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.491 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 1.2 m -111.35 163.99 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.609 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -47.86 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.41 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -119.83 150.93 39.63 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.519 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -55.7 132.02 48.04 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.843 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.28 32.62 0.55 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.121 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.27 143.46 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.379 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.117 0.484 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -108.43 146.29 33.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -129.97 124.29 32.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.38 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -150.74 154.14 36.82 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.315 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.73 160.07 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.981 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.491 ' CZ3' ' HB3' ' A' ' 93' ' ' CYS . 84.0 m95 -129.68 146.72 51.44 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -142.25 138.21 31.24 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.679 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.1 tp -119.87 139.59 52.15 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.568 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -125.75 146.84 49.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.563 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.426 -179.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.9 tp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.778 0.323 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 67' ' ' PHE . 4.9 tp -111.03 -81.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.993 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.83 135.52 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 48.0 p90 -116.46 171.54 7.78 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' LEU . 4.8 mmtp 58.09 -150.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.007 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 4.87 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.802 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -179.57 65.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -155.41 113.57 3.43 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.574 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.8 mtm-85 -76.33 138.51 40.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -76.52 164.01 26.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.543 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.3 m -55.29 130.99 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.161 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.29 35.45 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.73 116.66 52.25 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.347 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.91 148.66 91.81 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.175 1.917 . . . . 0.0 112.697 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.83 -17.71 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -57.85 -14.73 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.755 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD1' HD23 ' A' ' 52' ' ' LEU . 82.2 m-85 -105.56 118.95 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.948 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 p -125.94 123.75 39.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.99 118.68 2.77 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.1 p -163.95 168.71 19.0 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.5 -160.42 33.92 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 p -90.78 -174.73 4.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.3 64.42 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.8 p -122.8 18.38 10.23 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.546 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 72' ' ' SER . 4.1 m-20 -140.16 131.0 25.95 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.949 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.31 127.78 14.06 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.218 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 40.5 m -135.16 131.04 36.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.576 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -93.32 89.65 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.487 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -82.76 141.81 32.08 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.488 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -125.52 141.25 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.152 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.6 m -69.81 -73.19 0.17 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.423 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 106.24 11.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.009 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.5 106.23 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.924 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.36 168.71 11.68 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.975 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.14 -16.85 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.764 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.76 -36.36 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -26.87 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.092 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.4 mt -50.25 138.1 17.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.32 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.01 -151.24 23.49 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.746 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.93 125.51 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.517 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -99.8 156.75 16.94 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.634 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -149.02 160.21 43.53 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -144.04 151.42 39.65 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.952 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 t -150.33 168.78 23.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.831 -1.148 . . . . 0.0 112.129 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.8 171.24 9.79 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.46 20.41 1.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -90.01 -19.2 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.77 126.85 42.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.146 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.476 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 11.9 p -110.27 138.4 20.87 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.382 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.0 Cg_endo -70.09 155.38 94.17 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.691 -1.379 . . . . 0.0 111.562 -0.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.14 156.22 56.53 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 122.157 1.905 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -89.94 -59.53 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.6 t80 65.86 118.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.007 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.72 -171.5 31.05 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.647 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.32 -174.51 15.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.39 47.36 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.079 -1.534 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -77.38 116.55 18.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.074 -1.051 . . . . 0.0 108.979 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -82.06 95.11 7.34 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.93 75.84 7.89 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.761 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.7 142.41 34.38 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.416 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 tt -77.78 159.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -62.87 140.3 58.8 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.861 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.17 147.95 6.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 t -103.64 157.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.4 mtp -142.87 112.84 7.05 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -93.44 111.82 23.57 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.465 ' CG ' ' HA2' ' A' ' 105' ' ' GLY . 11.3 tm0? -104.92 139.93 38.91 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.73 162.67 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.26 178.52 28.12 Favored 'Cis proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.686 -1.381 . . . . 0.0 110.731 -2.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.81 -64.02 1.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.635 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.45 153.48 26.07 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.93 82.49 17.47 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.977 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.79 116.27 4.19 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.807 1.672 . . . . 0.0 110.457 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -140.12 -170.74 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.186 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 t -118.61 176.11 5.41 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 mt -90.64 92.21 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.436 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.94 -7.64 3.25 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.484 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -172.29 4.09 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.232 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -105.72 166.95 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.03 160.59 39.59 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.479 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 p -159.48 89.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.411 HD12 ' CG ' ' A' ' 91' ' ' TYR . 19.8 mt -79.41 133.77 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -97.59 147.95 23.78 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.657 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -154.81 102.72 2.38 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.572 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 25' ' ' SER . 4.1 ttt180 -111.65 147.73 34.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.636 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.453 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 34.5 m -120.39 157.25 29.69 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.6 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.2 t -65.4 -65.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.696 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.443 ' HG2' ' H ' ' A' ' 28' ' ' SER . 8.7 tt0 -99.19 162.79 12.85 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.683 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.3 p -68.61 121.15 15.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.696 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.73 28.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.8 t -89.57 127.49 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.677 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.898 -179.848 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 m -99.99 103.28 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.52 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -84.14 121.47 27.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.919 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -173.89 135.14 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.638 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -137.46 177.31 7.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.05 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -126.07 148.95 49.22 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.407 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 20.2 m-85 -128.91 161.11 30.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 tp -157.61 113.38 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -134.85 156.89 48.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.456 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.934 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.059 0.457 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.08 -73.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mm -100.04 138.49 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CZ ' ' ND2' ' A' ' 58' ' ' ASN . 37.3 p90 -136.19 12.91 3.31 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.411 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -147.7 44.38 1.1 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.178 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 18.8 t 70.08 -27.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.733 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 55' ' ' LYS . 33.1 t -155.16 -45.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.121 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.432 ' ND2' ' CZ ' ' A' ' 54' ' ' TYR . 2.9 t30 -58.93 126.81 29.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.481 HH12 ' CG ' ' A' ' 65' ' ' ASP . 5.8 mtm180 -81.25 169.97 16.66 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CG ' ' N ' ' A' ' 61' ' ' SER . 91.6 t80 -90.07 159.51 16.79 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.295 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.418 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 4.5 m -60.66 114.91 3.25 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -17.72 16.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.36 129.55 74.53 Favored Pre-proline 0 C--N 1.306 -1.314 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.235 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -65.21 165.16 22.89 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.765 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.481 ' CG ' HH12 ' A' ' 59' ' ' ARG . 0.2 OUTLIER -78.08 -14.78 59.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.821 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HD2' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.11 -11.54 31.02 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.09 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.501 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 51.1 m-85 -101.25 121.12 41.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.967 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -126.66 129.62 48.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.054 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.38 144.57 18.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -160.92 150.0 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.44 160.57 24.4 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.514 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 p -91.21 -85.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.93 -32.69 0.1 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.374 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 p -119.42 15.1 12.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.8 135.2 14.2 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.406 ' C ' ' HG1' ' A' ' 77' ' ' THR . 14.2 m-85 -146.18 149.89 34.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.862 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 76' ' ' PHE . 40.3 m -143.96 143.13 31.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.858 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 tt -106.97 101.51 10.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.955 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -96.68 138.36 34.37 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.006 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 57.9 mt -121.3 138.4 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.79 -74.29 0.14 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.985 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.04 103.6 10.06 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.85 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.684 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.29 166.34 16.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.726 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.22 34.01 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.718 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.92 -39.35 34.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.93 -14.46 61.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 85.1 mt -58.21 150.99 20.21 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.531 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.34 -166.67 26.73 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.567 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.45 129.26 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.163 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.411 ' CG ' HD12 ' A' ' 21' ' ' ILE . 17.7 m-85 -103.18 146.31 28.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 93.8 m-85 -138.48 169.52 17.64 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.94 134.9 9.96 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.2 p -142.04 173.2 11.74 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -129.92 157.7 41.57 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.35 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -126.46 10.11 7.26 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.459 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 m -68.76 -32.27 71.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.628 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -114.16 124.22 51.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.3 138.35 19.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.1 159.98 96.42 Favored 'Cis proline' 0 C--N 1.317 -1.113 0 C-N-CA 123.774 -1.344 . . . . 0.0 111.769 -0.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 103' ' ' PHE . 3.3 Cg_exo -60.58 141.25 94.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.137 1.891 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -91.12 -28.72 17.72 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.262 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 101' ' ' PRO . 60.5 m-85 54.46 -159.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.516 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.48 -174.2 15.88 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.465 ' HA2' ' CG ' ' A' ' 6' ' ' GLN . . . 93.74 161.92 35.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.775 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.68 56.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.418 ' OG1' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m -79.36 110.34 14.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -80.61 99.84 8.33 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.775 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.96 84.73 6.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.766 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.1 147.18 32.83 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.084 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -83.32 153.33 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -57.21 131.1 48.95 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.359 -1.782 . . . . 0.0 110.442 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.04 0.448 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.586 HG23 ' CD2' ' A' ' 98' ' ' HIS . 77.0 t -67.42 146.43 13.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.338 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.56 148.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' A' ' 95' ' ' GLN . 3.8 mtt -139.01 107.91 5.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -98.59 97.18 8.5 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.569 ' OE1' ' SG ' ' A' ' 93' ' ' CYS . 2.2 tp60 -78.82 141.95 37.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.438 ' HG1' ' C ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -159.86 158.43 26.85 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.821 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -77.77 178.13 36.23 Favored 'Cis proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.313 -1.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.34 -57.36 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.692 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.0 m -113.95 144.16 43.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.239 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.86 73.05 54.16 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.331 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.97 118.23 5.4 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.661 1.574 . . . . 0.0 110.377 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.63 -178.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.261 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.32 156.85 18.07 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.557 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.5 mt -73.89 88.25 1.82 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.605 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.81 43.95 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 179.89 6.12 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -96.2 148.17 22.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.3 157.6 36.25 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -151.09 82.73 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.75 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.5 ' CD1' ' CG ' ' A' ' 91' ' ' TYR . 5.2 mt -80.27 117.83 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.264 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -86.89 159.34 19.08 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.3 t -157.78 97.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.603 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -104.22 153.56 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.299 -0.96 . . . . 0.0 113.019 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 m -128.28 145.8 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -62.51 -50.98 69.25 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.363 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.97 145.57 38.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.078 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -57.63 139.7 52.95 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.5 mt -93.06 39.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.545 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.08 137.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.723 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.961 0.41 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.46 127.85 49.33 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -116.67 110.5 18.56 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.639 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.73 146.79 26.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -141.03 162.18 36.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.379 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.405 ' CE2' HD11 ' A' ' 78' ' ' LEU . 75.8 m95 -128.98 150.1 50.54 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -145.02 158.01 43.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 tp -138.04 117.78 13.15 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.297 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.65 152.95 43.0 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.736 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.486 1.361 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.261 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.857 0.36 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD21 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -95.93 -70.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.236 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -111.24 141.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.572 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -128.82 8.01 5.7 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.81 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 17.3 tttt -160.65 61.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 15.8 t 71.21 -65.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.007 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 p -124.77 -36.53 2.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.451 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -48.1 115.51 1.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.705 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -85.71 151.54 23.78 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -80.7 164.73 22.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.053 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.75 137.22 54.83 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 -40.01 3.04 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.2 110.2 1.78 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.685 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.35 150.69 86.28 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.94 1.76 . . . . 0.0 111.702 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -12.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.465 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -58.64 -12.57 4.28 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -111.35 120.34 41.89 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.726 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.4 p -133.69 100.36 4.75 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.29 153.35 23.4 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.83 158.13 27.88 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.22 157.25 16.11 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.2 m -90.39 -94.26 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.85 -36.28 0.36 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -120.01 16.17 12.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.176 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -152.43 125.97 8.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.611 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.2 m-85 -142.8 138.85 30.68 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.065 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 78' ' ' LEU . 23.9 m -138.8 144.76 39.48 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.492 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.433 ' N ' HG21 ' A' ' 77' ' ' THR . 4.2 tp -99.62 108.69 21.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -97.53 130.39 44.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.0 140.35 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.834 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -72.82 -62.79 1.33 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.776 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.2 102.65 7.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.672 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.39 110.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.696 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.03 175.66 5.68 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.03 -29.77 58.12 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.413 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -73.14 -28.18 62.09 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.51 -1.45 15.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 111' ' ' ILE . 89.3 mt -76.76 152.4 35.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.79 -154.97 19.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.85 134.33 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.539 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CG ' ' CD1' ' A' ' 21' ' ' ILE . 11.3 m-85 -98.57 152.57 19.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.38 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.08 161.74 36.89 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.569 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 2.4 p -144.28 142.3 30.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.509 ' HG ' ' C ' ' A' ' 93' ' ' CYS . 47.4 m -146.38 156.64 43.46 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.811 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -104.64 152.09 22.88 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.395 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.59 30.09 7.55 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -102.32 -60.89 1.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.586 ' CD2' HG23 ' A' ' 2' ' ' VAL . 16.9 m-70 -80.0 156.01 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.5 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 69.4 t -141.69 139.74 19.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.034 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.9 Cg_endo -70.11 154.74 94.33 Favored 'Cis proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.362 -1.516 . . . . 0.0 111.304 -0.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 149.6 89.72 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.963 1.775 . . . . 0.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.2 p -82.58 -59.77 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.186 -1.005 . . . . 0.0 110.723 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 t80 62.04 125.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.399 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.92 -151.24 10.13 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.75 -173.77 42.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.064 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.16 64.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 118.994 -1.574 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.8 m -79.93 104.4 10.48 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.651 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 121.39 18.63 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.14 78.83 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -105.94 145.69 30.98 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.604 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.438 HD13 HD13 ' A' ' 88' ' ' LEU . 17.7 mt -64.11 131.22 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.49 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -72.19 104.08 3.54 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.468 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 116.389 -1.767 . . . . 0.0 109.829 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 121.008 0.432 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.17 154.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.975 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.79 144.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 96.75 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.516 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -92.74 161.05 14.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.0 162.49 28.92 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.063 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -165.85 156.76 11.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.518 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -88.33 177.98 19.96 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.265 -1.14 . . . . 0.0 110.665 -2.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.25 -48.32 20.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.518 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 t -122.07 153.62 38.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.0 79.87 21.71 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 118.954 -1.099 . . . . 0.0 112.387 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.23 113.32 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.646 1.564 . . . . 0.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.13 -174.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.7 p -118.31 160.07 22.29 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.62 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 mt -78.89 87.41 4.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.33 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.9 35.04 0.11 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.41 -173.36 3.09 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.485 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -106.07 146.08 30.61 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.09 37.08 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -161.63 89.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.628 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' THR . 7.8 mt -73.26 146.23 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.377 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 7' ' ' THR . 22.8 t -117.62 140.58 49.45 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.21 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m -146.3 101.15 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.098 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -109.3 147.81 32.05 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.156 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 p -115.03 139.61 49.72 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -49.88 -59.09 4.18 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -98.85 154.9 17.68 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.78 133.51 47.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.941 -0.703 . . . . 0.0 111.306 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.28 33.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.32 117.96 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.542 -179.944 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.741 0.305 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -99.22 96.99 8.13 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -80.87 104.8 11.63 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -151.4 146.82 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.935 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.468 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -147.56 161.21 41.58 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.011 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -120.09 152.88 36.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.576 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.52 163.18 32.64 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -146.3 100.17 3.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.697 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -97.76 142.82 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.415 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.656 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 39' ' ' ASN . 15.4 tp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.8 0.333 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 mt -118.22 -51.64 2.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.072 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mm -126.41 136.2 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.738 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.3 p90 -121.86 23.33 10.11 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.158 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.2 OUTLIER 175.37 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.093 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.6 t 56.87 -83.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.575 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t -121.16 43.85 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.805 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.5 m-80 -111.13 99.8 8.58 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.525 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 61.9 mtm180 -82.22 137.18 34.96 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' SER . 81.5 t80 -70.61 156.68 39.13 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.8 p -58.43 112.02 1.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.88 -24.55 7.87 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.88 126.86 93.15 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.98 168.49 5.83 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.011 1.808 . . . . 0.0 112.52 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.78 -23.15 45.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.537 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -53.86 -40.9 66.91 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.383 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 46.4 m-85 -80.0 112.25 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.64 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t -130.34 117.29 19.54 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 129.45 9.9 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 155.63 34.3 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 163.06 -172.24 39.02 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.585 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -91.3 -165.8 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.707 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.53 72.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.138 -1.03 . . . . 0.0 111.268 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 p -121.38 17.32 11.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 6.9 t0 -145.77 133.59 21.21 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.08 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 38' ' ' LEU . 25.2 m-85 -143.32 125.96 15.95 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.425 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 m -123.32 130.97 53.47 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.341 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.71 85.32 5.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.139 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -78.18 142.3 38.06 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.33 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.11 125.77 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.039 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 m -61.24 -59.14 5.77 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.332 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -132.37 107.48 8.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.38 138.38 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -117.69 175.47 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.7 -29.85 69.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.701 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.33 -35.22 66.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -56.08 -30.37 61.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.717 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.3 mt -48.88 137.36 12.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.229 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.34 -147.49 16.47 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.292 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -123.64 120.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.41 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.68 151.94 18.89 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.741 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -143.82 175.39 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.477 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 24.7 p -155.49 152.43 28.89 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 p -155.99 152.59 28.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.211 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.73 148.75 30.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.19 40.87 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.746 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.91 -57.2 2.07 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.189 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -96.18 167.84 10.96 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.323 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.4 t -131.65 137.93 31.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.169 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.5 Cg_endo -70.42 151.67 93.33 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.748 -0.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.3 122.1 10.39 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.762 1.642 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 p -91.09 128.17 36.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -89.92 -175.56 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.96 41.43 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.91 -59.99 2.01 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.907 -1.14 . . . . 0.0 111.093 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.99 101.36 0.63 Allowed Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.571 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.0 m -94.13 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -84.97 134.51 34.24 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.462 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 98.07 5.49 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -121.94 142.22 50.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 tt -64.74 146.74 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.238 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 108.82 2.53 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.024 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.484 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.419 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.166 0.508 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.44 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 46.9 t -86.35 124.35 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.193 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.27 137.44 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.656 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 87.0 mmm -122.82 95.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 137.2 37.42 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.907 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 13.3 tt0 -124.34 148.57 47.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.767 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.86 156.53 17.33 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.425 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -78.65 178.52 34.05 Favored 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.664 -1.39 . . . . 0.0 111.274 -1.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -77.7 -34.43 52.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.204 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 p -138.6 158.0 45.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tp -145.9 85.65 7.55 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.781 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.5 109.05 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.644 1.563 . . . . 0.0 110.307 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.93 176.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.011 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -104.71 168.96 8.73 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.412 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 111' ' ' ILE . 65.6 mt -81.88 88.0 6.36 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.64 51.63 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.61 163.45 32.8 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.771 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -85.23 142.28 29.53 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.45 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.97 166.55 14.29 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.079 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 13.5 p -162.58 94.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.173 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.98 118.42 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -83.1 157.03 22.99 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.488 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.2 t -162.17 112.6 1.56 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.196 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -118.53 144.77 45.83 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 1.4 m -104.88 151.29 24.03 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 m -78.06 0.65 23.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 134.14 10.75 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.14 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -55.53 124.48 17.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.5 31.35 1.18 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.415 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.9 t -88.09 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.63 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.466 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.905 0.383 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -103.59 103.39 13.32 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.091 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -81.72 98.29 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.037 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -147.53 138.03 23.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.676 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 6.9 p-10 -140.38 174.75 10.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.295 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -122.48 148.59 44.97 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.264 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.64 164.14 21.24 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.1 tp -158.65 116.57 2.91 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.928 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.9 161.52 32.84 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.535 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.114 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.2 mt -111.86 -89.4 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.6 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.5 mm -99.12 133.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.293 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 26.0 p90 -133.9 174.67 10.22 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER 52.34 34.61 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.519 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG11 ' HG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 75.74 -37.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.117 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' HG ' HG11 ' A' ' 56' ' ' VAL . 21.0 p -144.09 -41.24 0.27 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.698 -1.201 . . . . 0.0 112.918 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 5.3 m-80 -37.52 122.03 0.9 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.138 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' NH1' ' HA ' ' A' ' 65' ' ' ASP . 25.2 mtm180 -91.59 126.5 36.69 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.425 ' N ' HG22 ' A' ' 63' ' ' VAL . 15.4 t80 -54.36 149.86 9.56 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 112.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.898 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.65 -22.82 11.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.714 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 60' ' ' PHE . 88.7 t -56.95 120.12 35.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.051 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -58.4 138.76 87.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.705 1.603 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 9.3 p-10 -54.15 -22.85 12.25 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 mtm-85 -58.6 -18.74 32.57 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -93.23 114.19 26.61 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.586 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.39 90.34 3.31 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 129.38 9.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -164.35 -173.42 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.517 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 150.53 -179.64 27.08 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.043 -1.551 . . . . 0.0 111.83 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -93.2 -140.75 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.79 -35.57 13.01 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.3 p -123.79 13.18 9.22 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.6 m-20 -132.41 130.36 40.52 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -144.44 145.71 32.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.991 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.408 HG21 ' N ' ' A' ' 78' ' ' LEU . 9.5 m -150.28 140.48 22.18 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.634 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 20' ' ' SER . 4.1 tt -98.5 102.8 14.65 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.95 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -93.93 122.08 36.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 31.2 mt -106.15 138.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.692 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -72.03 -70.22 0.35 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.89 105.24 9.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.89 104.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.01 173.86 7.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.15 48.37 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.43 -39.7 62.42 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.329 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.86 -8.34 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.81 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.68 148.89 48.68 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.881 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.13 -159.85 24.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.64 135.7 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.25 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -100.22 151.77 21.05 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.386 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.78 147.94 38.13 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.1 p -128.32 139.92 52.14 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.191 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 103' ' ' PHE . 2.3 t -144.78 164.26 31.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.077 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.449 HE22 ' HB2' ' A' ' 98' ' ' HIS . 1.4 pt20 -117.48 163.19 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.231 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.56 32.75 2.76 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.029 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.8 m -99.69 -34.07 10.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.501 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.449 ' HB2' HE22 ' A' ' 95' ' ' GLN . 16.5 m-70 -107.97 167.45 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.933 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 43.8 t -136.73 135.75 20.71 Favored Pre-proline 0 N--CA 1.49 1.53 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.8 Cg_endo -70.29 151.76 93.09 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.481 -1.466 . . . . 0.0 111.497 -0.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.01 125.84 20.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.759 1.639 . . . . 0.0 110.209 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 1' ' ' ASP . 11.0 p -93.81 118.31 31.27 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.156 -1.017 . . . . 0.0 112.093 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -105.17 -175.13 2.7 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.292 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.4 177.31 18.24 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.397 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.07 175.97 22.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.408 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 169.87 62.05 0.04 OUTLIER Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.054 -1.545 . . . . 0.0 110.801 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.5 m -78.21 105.37 9.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.859 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -74.82 105.43 5.88 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.19 90.62 4.42 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.993 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.4 146.17 45.59 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.401 HD12 HD13 ' A' ' 15' ' ' LEU . 10.5 mt -60.69 127.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.23 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HZ1' ' C ' ' A' ' 113' ' ' ARG . 8.8 tmtt? -54.49 129.16 34.99 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.417 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.444 ' C ' ' HZ1' ' A' ' 112' ' ' LYS . 15.3 mmt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.141 -1.885 . . . . 0.0 110.431 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.938 0.399 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 98' ' ' HIS . 83.8 t -71.33 122.42 23.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.081 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.06 148.22 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.29 119.73 8.45 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -117.16 122.94 45.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.966 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.597 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 2.9 mp0 -95.39 146.73 24.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.09 157.05 21.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.631 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -76.33 175.58 47.53 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.528 -1.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.77 -34.13 52.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.308 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.11 159.32 42.06 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 tp -145.3 75.02 13.94 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.26 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.57 115.32 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.95 1.767 . . . . 0.0 110.424 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.66 -172.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.737 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.3 154.16 32.78 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.021 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.44 87.76 0.2 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.61 47.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -144.15 175.24 10.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -93.99 154.13 17.82 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.55 159.22 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.607 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -160.78 83.51 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.46 HD12 ' CG ' ' A' ' 91' ' ' TYR . 5.7 mt -82.35 125.85 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.801 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -88.64 154.19 20.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.057 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.597 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 9.8 m -157.3 107.41 2.23 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -119.6 164.74 15.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.277 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.3 p -136.52 165.17 26.48 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.269 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 m -78.65 -29.0 45.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.767 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.29 145.04 51.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.375 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' VAL . 49.3 m -58.8 126.83 29.28 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.347 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.6 32.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.0 t -89.81 147.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.032 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.081 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m120 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.997 0.427 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.6 m -109.02 144.78 36.57 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.153 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -125.89 107.65 10.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.04 134.16 19.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.659 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -129.55 162.19 28.78 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.321 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 52.5 m95 -114.99 160.26 19.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -147.69 127.09 13.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.783 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -117.97 109.7 16.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.255 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -121.01 152.09 39.0 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.624 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm . . . . . 0 N--CA 1.486 1.374 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.35 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.31 -60.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -120.26 140.11 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.799 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.9 p90 -121.54 2.12 10.13 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.248 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 56' ' ' VAL . 61.1 tttt -153.79 50.34 0.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.588 ' CG2' ' N ' ' A' ' 57' ' ' SER . 0.9 OUTLIER 65.11 -58.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.141 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -126.64 54.49 1.59 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.328 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -146.61 105.2 3.82 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.862 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 34.2 mtm180 -71.75 147.65 47.12 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.631 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -86.34 169.52 12.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.767 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -59.89 129.34 41.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.355 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.61 -23.92 25.9 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.017 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.63 115.21 18.38 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.23 151.43 82.29 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.922 1.748 . . . . 0.0 111.954 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' PHE . 8.2 p-10 -57.56 -18.31 18.77 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 84' ' ' GLU . 59.8 mtt85 -53.3 -10.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.516 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 93.0 m-85 -116.49 125.31 51.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.961 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.56 119.64 14.5 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.268 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.29 159.9 13.42 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.89 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.9 p -158.32 175.91 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.196 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 164.2 151.78 6.67 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.3 m -93.82 -71.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -49.36 0.04 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.635 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.5 p -115.83 13.35 16.07 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.75 127.82 33.58 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.432 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 87.3 m-85 -144.73 130.5 19.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.4 m -136.03 139.22 42.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.042 -1.063 . . . . 0.0 112.129 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 9.2 tt -98.64 114.81 27.44 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -108.7 140.63 41.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.75 137.07 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.58 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -69.82 -63.93 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.236 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -124.52 104.93 9.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.2 112.68 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -97.01 -149.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.583 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.47 -30.27 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.07 -33.47 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.613 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.59 -15.64 40.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.75 147.75 52.19 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.295 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.6 -153.11 23.42 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.143 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -117.42 123.18 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.46 ' CG ' HD12 ' A' ' 21' ' ' ILE . 18.0 m-85 -91.77 155.3 18.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.982 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -146.65 167.21 24.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.433 ' C ' ' HG ' ' A' ' 94' ' ' SER . 14.2 p -157.25 145.93 19.68 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.76 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 93' ' ' CYS . 16.0 m -144.41 171.39 14.4 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.467 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -115.55 151.66 34.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.303 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.36 18.28 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.033 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.9 m -91.32 -22.99 20.26 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.45 ' CD2' HG23 ' A' ' 2' ' ' VAL . 86.0 m-70 -122.23 132.44 54.43 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.071 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.2 t -114.3 139.28 23.63 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.448 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -71.35 159.37 94.27 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.774 -0.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.33 144.13 94.77 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.933 1.756 . . . . 0.0 110.996 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -81.05 -63.88 1.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.521 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 5.7 t80 61.86 157.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.35 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.01 -157.89 27.47 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.681 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.41 -156.73 22.81 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.408 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.22 63.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.284 -1.436 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.2 m -77.9 107.98 10.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.351 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -76.91 107.61 9.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.169 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 tt -101.71 84.28 2.54 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 147.9 33.04 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.608 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.3 mt -67.05 129.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.413 ' HE3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -66.24 115.94 6.76 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.003 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.413 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 17.4 mtt180 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.504 -1.712 . . . . 0.0 111.044 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 30' ' ' VAL . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 28' ' ' SER . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.411 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.657 0.265 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 55' ' ' LYS . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.524 HH21 ' N ' ' A' ' 65' ' ' ASP . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.524 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CB ' HD12 ' A' ' 21' ' ' ILE . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.459 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.444 HG23 ' CD2' ' A' ' 98' ' ' HIS . 61.0 t -75.55 150.72 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 118.806 -1.158 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 t -96.85 160.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.35 113.25 5.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -101.31 125.16 47.92 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.409 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.617 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -110.92 135.18 51.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.039 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.82 158.11 26.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.826 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.67 176.89 40.84 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.492 -1.461 . . . . 0.0 111.317 -1.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -79.98 -40.51 27.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.538 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -132.08 150.89 52.04 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.15 82.11 12.12 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.814 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.85 107.88 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.586 1.524 . . . . 0.0 110.041 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.66 178.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -109.11 158.14 18.06 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.146 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.83 88.39 1.02 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.678 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.34 -10.77 1.53 Allowed Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -168.11 1.75 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.229 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.66 156.3 22.99 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -113.64 162.69 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 p -162.4 75.3 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.004 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' THR . 11.2 mt -80.21 121.01 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.979 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.2 t -89.0 157.25 18.43 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.617 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.6 m -160.18 108.52 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.311 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -113.27 155.91 24.26 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.096 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -127.71 139.49 52.66 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -53.42 -53.0 57.59 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -106.4 153.35 22.37 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.449 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.4 p -63.4 122.06 15.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.257 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 29.6 mt -75.81 28.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.017 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' A' ' 28' ' ' SER . 51.9 t -90.06 144.38 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.474 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.506 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.874 0.368 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 m -106.03 155.11 19.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.065 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -128.37 138.42 52.35 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.761 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -165.14 166.36 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.847 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -163.41 149.1 11.47 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.118 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -117.72 154.27 31.96 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.296 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -144.94 151.38 38.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 91' ' ' TYR . 17.8 tp -132.25 81.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.406 ' N ' ' CD ' ' A' ' 43' ' ' GLN . 3.1 mp0 -57.05 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.13 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.082 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.7 tp . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.11 -67.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.645 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 mm -128.29 153.42 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 5.1 p90 -136.35 -65.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.48 73.49 5.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.227 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 t 62.57 -74.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.927 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.2 t -117.67 -8.78 10.85 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 1.7 m-80 -60.71 121.27 11.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.4 HH21 ' CG ' ' A' ' 65' ' ' ASP . 5.6 mtt-85 -97.15 161.13 13.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -86.38 152.93 22.31 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -55.52 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.14 -29.98 2.38 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 121.15 74.78 Favored Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.601 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.88 138.51 86.08 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.752 1.635 . . . . 0.0 111.641 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' CG ' HH21 ' A' ' 59' ' ' ARG . 2.6 t70 -54.48 -14.3 1.22 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.416 ' N ' ' HE ' ' A' ' 66' ' ' ARG . 1.1 mmp_? -57.54 -19.15 23.21 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -100.16 130.47 46.3 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.309 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 p -139.82 121.24 15.05 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.295 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.91 133.4 11.37 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.224 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.2 140.94 35.97 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.83 154.36 12.75 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.7 m -91.28 -79.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.276 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.33 -34.72 0.1 OUTLIER Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.671 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.4 p -121.65 19.19 11.16 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -151.74 126.82 9.79 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.624 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -141.21 138.23 33.17 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 50.0 m -135.86 149.9 49.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.239 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 tt -109.27 109.12 19.95 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.391 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 14.2 mttm -110.53 139.36 45.84 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.232 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.93 132.7 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.619 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.5 m -61.73 -56.41 19.87 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.764 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.37 103.34 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.78 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.01 129.66 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -109.23 -171.86 1.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.46 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.4 63.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.51 -32.46 73.39 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -21.36 50.43 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.606 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.54 143.32 50.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.1 -155.59 26.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.18 114.74 47.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD2' HD11 ' A' ' 42' ' ' LEU . 7.2 m-85 -88.56 152.76 21.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.494 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -148.61 165.7 30.52 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.598 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.92 152.96 31.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.829 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -156.34 178.98 9.69 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.028 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -132.53 142.77 49.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.5 p -115.28 22.67 13.09 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.561 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.442 ' HG1' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -73.29 -43.85 60.2 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.985 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 2' ' ' VAL . 90.9 m-70 -111.39 148.84 32.17 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.468 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER -118.85 142.16 31.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.971 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -70.09 162.99 83.88 Favored 'Cis proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.984 -1.257 . . . . 0.0 111.972 -0.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.96 142.41 81.52 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -79.42 -61.62 1.95 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.981 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 88.1 t80 61.93 161.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.13 -165.7 27.71 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 107.9 -149.98 16.85 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.495 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.71 56.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.4 m -78.79 106.49 10.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -71.16 97.49 1.52 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.411 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tp -88.56 83.5 6.79 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.558 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.14 144.9 38.08 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.61 159.38 3.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -55.92 -29.81 60.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 116.483 -1.722 . . . . 0.0 111.107 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.6 140.03 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.949 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.41 155.59 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mtt -145.54 114.1 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.007 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -100.11 129.26 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.7 140.98 37.92 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.51 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 145.16 7.12 Favored Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -81.15 -176.51 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.8 -1.334 . . . . 0.0 111.165 -2.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.19 -46.6 10.92 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.7 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -124.12 158.42 32.33 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.914 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.74 85.0 7.31 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.43 121.62 8.38 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.846 1.698 . . . . 0.0 110.225 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.39 -170.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.06 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -132.15 161.9 32.21 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -71.08 87.9 0.77 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.186 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.21 30.68 0.1 OUTLIER Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -125.58 -176.33 3.57 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.083 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -114.82 138.84 50.29 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.645 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.64 157.86 22.53 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.298 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 2.7 m -155.44 91.24 1.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.836 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.9 mt -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.607 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 145.5 30.13 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.777 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.27 98.45 2.81 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.466 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.43 154.53 19.33 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.409 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 p -129.9 143.05 50.6 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.901 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -53.66 -71.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.482 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -82.08 152.24 26.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.3 p -66.52 131.45 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 26.8 mt -78.58 30.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.236 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.0 t -97.26 133.44 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.9 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 . . . . . 0 N--CA 1.488 1.457 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.153 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.884 0.373 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 m -109.37 157.49 18.85 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -137.46 108.87 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.172 -1.011 . . . . 0.0 112.491 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.81 128.63 8.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.261 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 28.0 m-20 -125.15 167.71 14.44 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.505 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -124.09 152.14 43.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.438 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.34 156.37 49.05 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.282 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 tp -146.51 117.37 7.67 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.241 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -125.58 158.2 35.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.338 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.128 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -102.72 -67.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.231 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -119.4 142.44 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.3 p90 -145.06 167.82 21.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.078 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 60.85 15.37 5.92 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.461 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.41 ' CB ' ' O ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER 78.58 5.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.681 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -44.11 128.39 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.661 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.542 HH21 ' N ' ' A' ' 65' ' ' ASP . 11.7 mtm-85 -97.29 146.31 25.26 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.165 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.81 159.32 34.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.639 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -58.04 122.28 12.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.43 -18.06 45.63 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.35 116.48 53.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.693 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.476 ' C ' HH21 ' A' ' 59' ' ' ARG . 1.1 Cg_endo -65.89 172.66 8.07 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.137 1.891 . . . . 0.0 112.423 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' HH21 ' A' ' 59' ' ' ARG . 1.2 m-20 -78.05 -15.81 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -56.2 -27.15 53.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.169 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -96.66 118.99 34.31 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.286 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -128.03 91.21 3.23 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.924 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.51 127.62 8.8 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 t -160.96 178.37 9.44 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.58 -178.5 42.58 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.541 -1.314 . . . . 0.0 110.836 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -92.88 -85.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.039 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.2 -34.84 0.11 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.57 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.8 p -124.17 6.6 8.5 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.42 118.36 16.31 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -133.61 153.13 51.91 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.477 HG21 ' N ' ' A' ' 78' ' ' LEU . 16.1 m -154.2 145.89 23.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.83 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' HG21 ' A' ' 77' ' ' THR . 1.9 tt -96.71 99.62 11.21 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.587 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -91.1 122.58 33.87 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.247 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.0 mt -112.5 133.04 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m -70.31 -71.86 0.22 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.665 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.81 102.45 9.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.518 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.7 131.47 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -117.05 -173.9 2.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.302 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.24 -25.36 61.59 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.72 -32.11 59.91 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.07 -31.74 70.29 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.74 139.44 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.583 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.29 -150.72 22.8 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.436 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.09 121.38 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.11 151.28 19.95 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -143.23 164.32 30.52 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.192 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.26 151.48 36.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.9 p -157.22 157.3 34.07 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.178 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 146.96 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -126.14 27.9 6.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.504 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.445 ' HG1' ' HB3' ' A' ' 29' ' ' LEU . 1.1 m -77.98 -33.87 51.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.171 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -105.81 -43.56 4.86 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.229 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.562 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER 66.45 140.12 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.574 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 0.9 OUTLIER -66.67 168.65 50.54 Favored 'Cis proline' 0 C--N 1.318 -1.029 0 C-N-CA 123.901 -1.291 . . . . 0.0 111.903 -0.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.24 134.56 46.02 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.172 1.915 . . . . 0.0 111.788 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 p -78.09 -57.39 3.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.715 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 80.2 t80 62.7 164.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.449 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 139.91 -157.57 25.4 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.65 -137.26 19.93 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.18 68.06 0.38 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.418 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 m -78.31 114.89 17.62 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.713 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -77.39 111.33 12.97 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.682 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 89.39 2.98 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.775 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.45 144.55 48.62 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.1 tt -66.41 150.94 10.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -53.43 135.69 39.04 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.966 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 116.39 -1.767 . . . . 0.0 110.945 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.64 142.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.158 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.54 148.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.634 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mmt -134.26 104.97 6.4 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.627 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 m -100.49 129.71 46.47 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.31 147.38 32.77 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.281 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.401 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.24 142.72 7.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.806 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -83.94 171.78 47.36 Favored 'Cis proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.005 -1.248 . . . . 0.0 111.502 -0.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 1.7 mm? -74.41 -42.43 59.23 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.01 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 p -125.96 146.05 50.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.101 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.69 74.6 45.38 Favored Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.37 117.94 5.12 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.536 1.491 . . . . 0.0 109.877 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.4 -174.67 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -113.05 172.16 7.11 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.725 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.75 86.23 7.37 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.828 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.57 33.4 0.06 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.714 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.23 -173.7 3.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.097 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.47 137.28 52.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.984 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 166.77 11.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.641 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 p -162.23 76.83 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' THR . 19.1 mt -79.23 140.03 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.248 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 t -113.35 152.59 29.76 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.741 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.8 m -156.43 99.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.598 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 75' ' ' ASP . 9.9 mtm180 -110.02 152.63 25.67 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.943 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 p -118.64 150.65 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.317 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -58.5 -45.76 88.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.665 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.63 174.66 5.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.861 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.443 ' HA ' HG21 ' A' ' 74' ' ' THR . 5.1 t -74.04 146.66 43.54 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.9 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.09 30.51 4.08 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.541 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.78 131.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.571 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.723 0.297 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 137.22 36.17 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -117.78 105.36 11.89 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.14 143.12 30.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -134.7 154.72 51.43 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.247 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CE3' HD11 ' A' ' 78' ' ' LEU . 82.6 m95 -123.49 147.41 47.24 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -140.77 145.84 36.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.547 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -130.67 115.54 16.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.87 138.05 54.55 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.749 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 tp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.756 0.312 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.8 -52.43 2.76 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.939 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 55' ' ' LYS . 2.0 mm -129.3 134.42 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.507 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -112.27 39.04 2.53 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HG3' ' H ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 179.22 -167.14 0.07 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.632 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' H ' ' HG3' ' A' ' 55' ' ' LYS . 27.5 t -76.82 -13.31 14.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.85 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.462 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.88 107.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.236 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 31.8 mtm180 -74.38 150.22 40.15 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -80.1 163.73 23.91 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.629 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -63.73 89.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.802 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.47 -28.54 2.32 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.4 116.93 50.05 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.061 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' ARG . 6.2 Cg_exo -57.94 148.49 76.01 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.104 1.869 . . . . 0.0 112.874 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 2.9 m-20 -57.8 -8.81 1.03 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -61.78 -20.67 63.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.927 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 94.9 m-85 -105.51 119.67 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.708 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.9 p -125.51 107.4 10.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.68 139.01 14.3 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.198 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.6 p -156.2 146.12 21.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.082 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -173.63 168.71 41.68 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 p -94.44 -105.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.437 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.73 -33.72 1.26 Allowed Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.026 -1.083 . . . . 0.0 110.483 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 28' ' ' SER . 60.6 p -126.87 10.09 7.0 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.964 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 11.9 t0 -136.68 130.65 32.46 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.071 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 70.0 m-85 -145.03 147.9 33.12 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.533 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 53.3 m -149.8 133.14 16.49 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.656 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -93.74 114.8 27.15 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.468 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -113.66 145.21 41.66 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.825 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 67' ' ' PHE . 67.3 mt -123.08 143.22 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.746 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -70.61 -57.76 4.39 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.547 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 8.7 ptm180 -129.48 107.35 9.41 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.659 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.47 105.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.33 -163.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.86 -30.14 50.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.49 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -26.13 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.708 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.1 -21.9 62.16 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.49 137.46 48.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.78 -158.73 27.76 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.25 124.82 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.568 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -94.16 153.4 18.11 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.297 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.07 170.26 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.73 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.6 p -151.72 152.57 32.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 p -154.89 164.38 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 160.72 29.55 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -134.58 24.24 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.814 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 m -79.92 -43.74 21.61 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.752 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.19 141.69 51.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.788 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 3.2 t -95.98 141.47 23.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 9.3 Cg_endo -77.46 163.51 88.42 Favored 'Cis proline' 0 C--N 1.317 -1.102 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.193 -0.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.424 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 2.3 Cg_endo -67.87 117.43 4.89 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.029 1.819 . . . . 0.0 110.347 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.8 p -90.39 104.25 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -86.34 150.39 24.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.18 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.05 170.72 42.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.1 -149.74 18.63 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 40.91 1.29 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -79.23 106.42 11.25 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.47 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -71.86 112.93 8.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.221 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.61 80.25 1.45 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.56 140.84 34.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.582 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.4 tt -71.8 150.48 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -54.92 128.9 35.48 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.111 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.082 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.078 0.466 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.94 110.57 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 26' ' ' SER . 2.5 t -72.96 141.23 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.087 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.521 ' HE3' ' SG ' ' A' ' 23' ' ' CYS . 5.1 mtp -128.21 105.19 8.19 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.09 143.1 37.66 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.11 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -130.59 135.68 48.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.337 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.18 157.3 24.73 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.112 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.66 176.46 42.6 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.563 -1.432 . . . . 0.0 111.362 -1.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 2.2 mm? -78.96 -44.35 22.63 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.161 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -128.09 144.4 51.11 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.627 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 tp -132.31 78.17 68.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.039 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.81 108.32 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.621 1.547 . . . . 0.0 110.231 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.91 -173.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.976 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -119.1 173.18 7.07 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.675 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -88.04 90.12 8.26 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.94 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.35 42.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -170.56 2.94 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.758 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -109.16 140.68 42.43 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.071 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.95 159.24 16.98 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.75 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -157.43 88.56 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mt -81.19 128.71 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.794 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.15 140.42 30.89 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.029 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 4' ' ' MET . 49.8 t -153.88 110.83 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.792 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.23 173.39 6.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.683 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 79.5 p -132.23 166.99 20.62 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.333 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.456 ' HG ' ' N ' ' A' ' 3' ' ' VAL . 1.5 p -72.85 -50.85 21.44 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.455 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.94 161.01 17.5 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.359 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 30' ' ' VAL . 64.4 m -59.98 126.35 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.408 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.6 mt -79.98 29.93 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.9 t -98.85 137.49 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.556 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.802 0.335 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.8 m -113.86 109.44 18.53 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -98.05 109.74 22.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.057 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.433 ' CD1' ' CG ' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -154.07 127.75 8.72 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.615 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 12.9 p-10 -130.67 152.78 49.65 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.436 ' CE3' HD21 ' A' ' 78' ' ' LEU . 53.7 m95 -115.78 158.35 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 16.9 m-85 -137.14 156.01 48.89 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.596 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.6 127.03 19.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -131.64 155.92 46.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.036 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.272 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.7 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.094 0.473 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.4 -49.65 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.81 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -127.54 135.43 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.385 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.62 -11.25 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.567 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.22 88.57 2.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.376 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.658 ' CG1' ' H ' ' A' ' 57' ' ' SER . 1.5 p 45.26 -68.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 124.348 1.03 . . . . 0.0 113.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.658 ' H ' ' CG1' ' A' ' 56' ' ' VAL . 53.9 p -130.32 28.73 4.95 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -103.78 111.55 24.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -75.87 152.23 37.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.649 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CD2' ' N ' ' A' ' 61' ' ' SER . 33.4 t80 -88.78 167.18 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t -59.79 132.69 54.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.692 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.11 -17.46 56.9 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -73.58 117.69 62.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.8 144.42 96.91 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.731 1.621 . . . . 0.0 111.667 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.99 -10.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -62.27 -19.92 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.54 122.69 46.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.254 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.13 121.32 13.83 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.41 147.78 17.49 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.41 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -161.35 161.1 30.33 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.5 173.45 44.65 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -91.21 -87.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.47 -34.76 0.11 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -120.95 17.86 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.572 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -155.01 126.2 7.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.986 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CG ' ' CD1' ' A' ' 38' ' ' LEU . 7.5 m-85 -141.56 153.53 44.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.445 HG21 ' N ' ' A' ' 78' ' ' LEU . 18.8 m -148.34 142.38 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.445 ' N ' HG21 ' A' ' 77' ' ' THR . 4.6 tp -101.83 115.09 29.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.065 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -111.17 151.11 28.58 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.635 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -127.89 134.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.94 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.6 m -67.35 -49.9 62.12 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.84 103.64 5.94 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.09 117.76 10.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.079 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -108.47 -177.93 3.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.95 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.94 -42.93 56.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.68 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.03 -19.66 53.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt -52.67 147.84 8.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.746 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.36 -160.42 25.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.14 151.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.046 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -123.57 148.69 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.565 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -141.66 162.94 34.25 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.3 p -144.86 125.16 13.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.436 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.5 p -120.64 161.85 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.545 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -125.97 150.7 47.83 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.895 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 52.13 1.61 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.634 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -50.08 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.353 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.457 ' H ' HE22 ' A' ' 95' ' ' GLN . 91.0 m-70 -112.51 163.38 14.54 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.269 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 100' ' ' PRO . 11.2 p -117.98 139.78 26.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . 7.0 Cg_endo -75.75 156.68 99.01 Favored 'Cis proline' 0 C--N 1.315 -1.201 0 C-N-CA 123.69 -1.379 . . . . 0.0 111.71 -0.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.04 120.19 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.977 1.784 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.7 p -91.28 136.19 33.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.397 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.67 176.42 8.17 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.6 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.66 -161.95 37.85 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.98 -79.3 1.27 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.307 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.89 95.09 0.15 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.2 m -92.29 117.33 29.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.561 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -85.51 114.53 22.6 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.318 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.4 93.42 4.59 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.802 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.8 139.18 52.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.85 156.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -55.34 152.32 8.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.707 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.02 152.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.981 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.94 166.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.265 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.76 115.45 5.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.516 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -95.85 140.8 30.11 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.012 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.541 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 1.9 mm-40 -129.9 132.14 46.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.538 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.99 158.02 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.932 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.69 175.1 46.49 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.429 -1.488 . . . . 0.0 110.538 -1.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.75 -43.96 29.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.801 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.7 m -126.14 146.05 50.1 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -136.09 78.03 47.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.62 112.27 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.79 1.66 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.34 178.96 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.386 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -110.34 174.58 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.787 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.95 87.73 7.46 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.77 52.72 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.5 179.38 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.75 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -100.49 141.31 33.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.455 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.76 12.13 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -159.55 91.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.591 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.31 152.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.403 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 m -121.48 140.99 51.47 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.188 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -149.25 110.9 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -113.13 163.48 14.7 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.514 -0.874 . . . . 0.0 112.184 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.2 p -133.47 147.73 51.68 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.3 m -62.72 -41.05 98.96 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.94 159.26 22.72 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -70.68 129.58 39.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.53 34.41 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.72 147.74 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 . . . . . 0 N--CA 1.49 1.553 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.464 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 56' ' ' VAL . 2.9 m -79.26 153.42 29.94 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.651 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -124.09 89.03 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.779 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -155.37 134.49 12.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.181 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -129.42 150.15 50.9 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.044 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CE3' HD12 ' A' ' 78' ' ' LEU . 86.5 m95 -103.96 153.32 20.96 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.346 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.54 130.26 9.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 HD12 ' CE1' ' A' ' 91' ' ' TYR . 13.8 tp -109.83 142.81 40.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -125.3 137.64 54.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.822 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.475 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.709 0.29 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tp -99.63 -62.47 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.675 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -126.25 149.46 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.015 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 42.6 p90 -137.99 160.8 38.36 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.358 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.03 -63.69 0.41 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.629 0.58 . . . . 0.0 110.133 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 7.0 p -172.39 -37.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.756 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 49.6 m -150.5 -25.64 0.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.016 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 34.8 m-80 -53.31 120.92 6.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.274 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NH2' ' HA ' ' A' ' 65' ' ' ASP . 13.4 mtm180 -76.55 151.29 36.39 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -90.27 167.82 12.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.731 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 t -62.62 121.69 13.99 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 103.27 -8.96 53.55 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.62 113.8 58.13 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.342 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -66.0 155.39 69.78 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.129 1.886 . . . . 0.0 112.315 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.546 ' HA ' ' NH2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -57.39 -13.21 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.345 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -62.79 -18.29 62.47 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.026 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -106.18 109.59 21.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.547 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 t -116.95 119.36 35.1 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -126.11 130.64 7.19 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.1 t -161.24 168.91 23.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.95 -177.7 48.56 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.398 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.9 t -91.26 -106.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.068 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.8 -35.15 0.86 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.2 p -124.3 16.85 9.06 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.31 120.86 10.4 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.6 144.67 49.42 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.809 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.5 m -141.15 141.48 34.14 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.635 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -98.86 99.69 10.79 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.785 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -89.12 117.06 27.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.633 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.56 138.11 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.935 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -64.25 1.03 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.904 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -124.37 103.46 8.21 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.013 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.52 104.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.207 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.52 167.76 10.4 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . . . -55.29 -25.45 34.15 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.408 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -79.53 -37.39 36.66 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.506 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -5.24 25.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.312 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.504 ' CD1' ' HA ' ' A' ' 85' ' ' ALA . 85.0 mt -74.03 150.07 40.86 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.1 -149.42 21.55 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.202 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.53 118.58 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.466 ' CE1' HD12 ' A' ' 42' ' ' LEU . 22.6 m-85 -92.76 154.15 18.47 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.34 157.4 44.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.634 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.541 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 16.0 p -135.63 147.47 48.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.755 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -150.0 166.35 29.93 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.627 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.405 HE21 HG21 ' A' ' 102' ' ' THR . 1.7 pp0? -127.22 145.08 50.89 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.62 18.02 13.53 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.504 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -71.77 -42.34 67.28 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.536 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.49 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.0 m-70 -111.4 171.81 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.422 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.469 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 98.9 t -138.81 140.85 28.58 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.6 Cg_endo -70.76 168.82 70.1 Favored 'Cis proline' 0 C--N 1.319 -1.025 0 C-N-CA 123.741 -1.358 . . . . 0.0 111.883 -0.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.88 156.99 54.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.935 1.757 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.405 HG21 HE21 ' A' ' 95' ' ' GLN . 26.7 p -89.58 -64.25 1.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.961 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 63.24 171.55 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.04 -156.92 19.82 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.652 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 -172.73 45.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.14 59.81 0.02 OUTLIER Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.1 m -77.28 109.51 11.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.876 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -78.07 132.03 37.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 76.92 1.42 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.964 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -107.0 137.85 44.28 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.96 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.9 mt -63.32 124.71 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.507 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.476 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -64.12 103.14 0.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.729 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 116.597 -1.668 . . . . 0.0 111.499 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 30' ' ' VAL . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 28' ' ' SER . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.405 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 27.7 t-80 -83.93 167.37 17.03 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -58.2 -27.99 64.39 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.737 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 1.3 p30 -79.45 -10.5 59.82 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.31 -0.93 64.08 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.798 -1.191 . . . . 0.0 111.905 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.81 144.42 28.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.928 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.411 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -109.67 -128.9 0.28 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' H ' ' CG ' ' A' ' 44' ' ' LYS . . . -81.51 -53.25 6.43 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.22 42.88 0.34 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.324 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.16 176.98 5.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -62.29 153.35 75.97 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.62 143.21 98.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.774 1.649 . . . . 0.0 111.25 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.34 135.17 54.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.3 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.17 126.33 51.99 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 55' ' ' LYS . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.524 HH21 ' N ' ' A' ' 65' ' ' ASP . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.524 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.46 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CB ' HD12 ' A' ' 21' ' ' ILE . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.459 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.7 t -71.63 124.54 28.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.535 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.92 147.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.38 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.426 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 4.3 mtp -143.42 110.56 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.195 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -101.38 117.13 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.783 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.485 ' OE1' ' HA3' ' A' ' 105' ' ' GLY . 5.7 tt0 -101.21 133.43 45.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.732 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -154.37 163.37 24.39 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.88 179.46 31.25 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.306 -1.539 . . . . 0.0 111.119 -1.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 mt -77.6 -35.97 52.3 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.563 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.98 151.57 46.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -138.26 85.6 18.27 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.797 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 106.75 1.5 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.77 1.647 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.46 -177.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.576 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.6 m -122.27 156.2 34.32 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.1 mt -67.48 86.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.32 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.77 36.3 0.07 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -135.86 166.34 23.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -94.11 137.39 33.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.236 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.67 160.24 16.1 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.57 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -149.04 90.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.628 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 77' ' ' THR . 2.8 mt -86.62 113.61 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' THR . 7.2 t -81.21 156.3 25.72 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.654 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.8 91.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -91.0 166.63 12.91 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.978 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 p -148.39 167.36 25.46 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.996 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -79.62 -69.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -92.14 154.7 18.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.757 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -64.2 132.31 49.98 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.23 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.23 33.43 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.026 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.5 127.0 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.008 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.486 ' CG ' ' H ' ' A' ' 32' ' ' SER . 48.7 t-80 -77.88 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.419 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.486 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 18.2 m -76.36 70.15 2.92 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.324 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p30 34.96 54.62 0.72 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.384 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.73 -56.36 0.07 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 118.783 -1.675 . . . . 0.0 112.078 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . 5.0 m-80 -82.29 122.59 28.14 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.789 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 m -107.79 99.41 8.88 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 35' ' ' ASN . 21.3 m-85 -83.85 75.78 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.6 tt -132.58 125.67 31.03 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.244 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 17.2 p-10 -126.06 160.84 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.839 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -108.3 174.92 5.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.498 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 27.9 m-85 -150.2 161.76 41.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.547 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 tp -160.51 111.14 1.82 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.282 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.42 161.07 17.75 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.964 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -128.36 -169.81 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.01 122.45 27.82 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.23 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.33 35.61 56.03 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -126.25 154.28 43.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.434 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 49.5 m -73.02 151.77 90.61 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.41 127.01 21.49 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.236 1.957 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -108.1 139.73 42.33 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp -104.86 134.31 48.2 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.229 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' O ' HG22 ' A' ' 63' ' ' VAL . 49.0 mt -108.9 -51.12 2.92 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.759 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mm -127.47 134.85 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.517 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -112.83 -21.95 10.92 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' SER . 19.6 mttp -135.33 106.54 6.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.334 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.667 ' CG1' ' H ' ' A' ' 57' ' ' SER . 6.3 p 29.7 -85.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.15 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.667 ' H ' ' CG1' ' A' ' 56' ' ' VAL . 21.4 t -114.35 48.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.238 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -125.61 108.11 11.25 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 -73.53 144.22 46.2 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.465 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -73.41 155.35 39.41 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.984 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.8 p -59.11 98.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.622 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.56 -17.79 4.97 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 52' ' ' LEU . 95.4 t -73.56 120.11 79.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.305 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.75 150.19 86.87 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.107 1.872 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -55.07 -19.88 8.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' ' OE2' ' A' ' 84' ' ' GLU . 61.4 mtt85 -56.01 -14.39 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.497 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -115.1 128.3 56.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.043 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.91 125.43 17.76 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.33 149.46 18.59 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.084 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.46 160.13 39.28 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 175.16 159.97 22.23 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.672 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 p -90.83 -99.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.675 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.78 -37.25 0.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.2 p -121.89 17.61 10.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.71 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 9.3 t70 -152.25 125.13 8.49 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 20.9 m-85 -139.09 156.18 47.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.841 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.0 m -150.89 149.28 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.11 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.89 109.51 21.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.772 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -100.77 123.05 44.41 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.752 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mt -108.08 132.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.8 m -64.63 -60.82 2.67 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -135.98 109.61 8.02 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.47 110.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.157 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE2' ' NE ' ' A' ' 66' ' ' ARG . 4.7 mt-10 -95.26 -175.52 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.295 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.17 66.28 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.249 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.24 -32.58 19.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.895 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -64.11 -12.58 40.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.384 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.81 147.8 49.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.787 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.88 -161.16 28.25 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.557 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.08 117.92 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -90.97 154.15 19.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.672 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.426 ' CZ ' ' HA2' ' A' ' 106' ' ' GLY . 45.6 m-85 -146.39 168.48 21.03 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.42 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.6 p -159.05 151.09 20.98 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.321 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.497 ' HG ' ' N ' ' A' ' 103' ' ' PHE . 13.0 t -152.69 -175.34 5.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.513 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.426 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 1.1 pp0? -135.84 136.38 40.57 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.0 m -110.36 42.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -38.62 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.139 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -109.42 156.21 20.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.393 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.426 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 92.3 t -127.1 134.66 26.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.606 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -72.24 163.29 88.16 Favored 'Cis proline' 0 C--N 1.318 -1.045 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.731 -0.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.16 162.08 34.54 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 122.044 1.83 . . . . 0.0 111.389 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 28.5 p -87.43 -92.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.542 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' N ' ' HG ' ' A' ' 94' ' ' SER . 65.8 t80 61.99 116.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.445 0.466 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.92 54.97 0.04 OUTLIER Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.888 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.485 ' HA3' ' OE1' ' A' ' 6' ' ' GLN . . . -114.1 -120.87 3.57 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . 127.23 68.72 0.16 Allowed Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.887 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.3 m -86.01 106.06 16.91 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.204 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -75.53 115.84 15.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.198 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.34 93.47 4.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.619 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -121.93 143.86 49.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.741 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.2 mt -62.47 152.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.294 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -63.29 123.42 18.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.316 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.878 0.37 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 70.4 t -71.29 116.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.291 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 151.09 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 120.39 11.6 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.1 143.7 47.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.446 ' HG3' ' SG ' ' A' ' 93' ' ' CYS . 1.4 tt0 -118.23 148.2 42.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.819 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.11 154.76 18.48 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.796 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.43 178.61 33.79 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.734 -1.361 . . . . 0.0 111.102 -1.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 mt -77.05 -44.5 30.5 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.911 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.04 152.23 48.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.12 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -142.95 78.71 15.18 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.092 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.85 126.19 14.91 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.757 1.638 . . . . 0.0 109.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.43 -175.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.335 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.76 167.06 11.1 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.599 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.54 89.83 7.15 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.04 48.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 176.47 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.26 148.02 23.54 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -125.38 161.02 27.95 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -160.64 96.54 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.434 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mt -86.25 139.65 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.595 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 m -107.22 145.83 32.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.8 t -153.55 118.46 5.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.901 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -123.72 156.18 36.47 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.236 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.8 p -122.03 146.58 47.03 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -58.05 -49.77 75.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -111.22 156.22 21.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -64.62 144.81 56.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.89 30.32 3.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.23 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.72 141.64 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.502 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -83.43 -124.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.119 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.1 p -53.97 -69.21 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.711 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -170.35 21.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.802 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.22 15.59 0.05 OUTLIER Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.365 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -132.66 112.06 11.7 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.3 m -115.32 150.34 36.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -132.2 101.44 5.38 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.463 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.03 129.18 12.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.786 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' OH ' ' A' ' 41' ' ' TYR . 12.4 p-10 -130.76 160.29 34.79 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.891 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -112.52 151.79 29.57 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' OH ' ' ND2' ' A' ' 39' ' ' ASN . 22.6 m-85 -129.31 166.59 19.17 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 tp -154.53 126.68 7.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.011 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -124.03 165.83 16.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.014 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -113.98 -146.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.26 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.2 -76.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.248 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.86 49.1 0.94 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 -173.9 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.807 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 p -86.19 148.06 46.54 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.787 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.87 151.99 82.73 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.01 1.806 . . . . 0.0 111.398 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 137.34 53.57 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.899 -0.721 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.4 tp -92.42 135.56 33.94 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.666 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.0 mt -113.73 -64.7 1.27 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mm -116.17 140.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.662 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.1 p90 -130.27 158.59 39.37 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.178 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.2 tptm 74.4 -67.07 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.986 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -171.07 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.494 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 p -152.43 -28.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.347 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 30.9 m-80 -51.65 129.0 24.98 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -90.25 139.59 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.44 151.12 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.694 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -59.39 104.07 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.14 -12.85 6.39 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.326 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.01 119.21 75.38 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.39 150.83 78.57 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.874 1.716 . . . . 0.0 111.828 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.51 -15.51 11.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.389 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -57.2 -18.4 15.58 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.75 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -107.43 128.62 54.64 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.0 125.54 17.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.57 144.97 17.05 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -160.44 -177.59 6.33 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.08 169.92 33.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.276 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 m -91.21 -82.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.25 -37.9 0.1 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.599 -1.286 . . . . 0.0 111.12 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.3 p -125.13 13.97 8.39 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.817 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.98 117.4 12.01 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -132.34 144.54 50.63 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.611 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.2 m -141.37 139.69 33.57 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.783 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -106.14 111.48 24.11 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.765 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 37.8 mttt -107.1 147.74 29.65 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.629 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.3 mt -124.77 134.84 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.435 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.5 m -67.24 -55.47 13.89 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.174 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.14 110.63 8.54 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.25 130.17 35.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.211 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.96 -172.27 2.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.758 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 -29.6 62.06 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.39 -43.09 67.49 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.86 -36.07 16.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.571 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 77.1 mt -45.24 136.34 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.35 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.56 -144.74 10.91 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.409 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.0 141.07 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.004 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -117.83 151.12 37.98 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.619 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -146.64 163.78 34.77 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.446 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -137.58 136.03 37.2 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.362 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 p -139.4 155.13 47.84 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.954 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.38 37.9 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -127.83 28.78 5.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.234 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 -57.57 3.19 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.596 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -105.91 159.69 15.83 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 38.3 t -110.0 140.77 22.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.318 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.47 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 7.4 Cg_endo -77.44 163.69 88.1 Favored 'Cis proline' 0 C--N 1.315 -1.193 0 C-N-CA 123.715 -1.369 . . . . 0.0 111.824 -0.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.36 118.9 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.021 1.814 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.6 p -89.9 135.32 33.71 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.741 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.38 -179.85 7.03 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.212 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.64 -175.71 41.5 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.427 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -82.93 -69.9 1.37 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 136.43 114.31 1.33 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 125.32 53.23 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.299 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.6 128.12 37.31 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.48 90.92 3.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.23 143.46 41.95 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.925 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -66.66 150.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.961 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -62.61 121.37 13.17 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.649 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.9 t -74.47 106.27 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.792 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.44 164.05 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.486 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -143.7 110.59 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -77.15 110.54 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.65 131.16 44.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.178 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.89 156.53 13.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.445 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -82.86 175.22 39.49 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.372 -1.512 . . . . 0.0 110.972 -1.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.08 -39.05 21.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.485 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -129.44 143.45 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 tp -137.59 81.05 30.56 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.824 -1.151 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.54 121.74 8.48 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.773 1.649 . . . . 0.0 109.646 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.29 -178.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 118.98 -1.088 . . . . 0.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -108.6 172.92 6.56 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -89.19 89.49 7.96 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.01 28.03 0.34 Allowed Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.49 174.94 6.08 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.852 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -96.51 141.96 29.16 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.76 167.31 10.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.832 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -162.03 79.89 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.048 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.2 mt -75.11 133.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.207 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -105.52 155.69 18.94 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.153 -1.019 . . . . 0.0 113.312 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.41 89.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.464 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -94.42 147.41 23.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.427 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.491 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 1.2 m -111.35 163.99 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.609 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -47.86 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.41 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -119.83 150.93 39.63 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.519 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -55.7 132.02 48.04 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.843 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 43.8 mt -85.28 32.62 0.55 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.121 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.27 143.46 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 32' ' ' SER . 21.7 t-80 -89.6 -130.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.379 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.479 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 16.6 p -56.07 -60.19 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.592 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' CG ' ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -115.08 -86.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.577 ' H ' ' CG ' ' A' ' 33' ' ' ASN . . . -120.56 17.45 9.53 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.551 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.98 93.42 3.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.621 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -108.43 146.29 33.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.992 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -129.97 124.29 32.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.38 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -150.74 154.14 36.82 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.315 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.73 160.07 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.981 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.491 ' CZ3' ' HB3' ' A' ' 93' ' ' CYS . 84.0 m95 -129.68 146.72 51.44 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -142.25 138.21 31.24 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.679 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.1 tp -119.87 139.59 52.15 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.568 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -125.75 146.84 49.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.563 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -114.19 -135.26 0.35 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.19 -59.32 2.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.38 54.46 0.45 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.43 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.96 164.19 13.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.247 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.0 160.87 81.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.329 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.8 108.88 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.0 1.8 . . . . 0.0 111.563 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -115.39 -171.99 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.9 tp -150.02 149.41 30.31 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.586 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.428 HD23 ' CD1' ' A' ' 67' ' ' PHE . 4.9 tp -111.03 -81.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.993 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.83 135.52 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 48.0 p90 -116.46 171.54 7.78 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' LEU . 4.8 mmtp 58.09 -150.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.007 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 4.87 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.802 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -179.57 65.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -155.41 113.57 3.43 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.574 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.8 mtm-85 -76.33 138.51 40.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -76.52 164.01 26.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.543 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.3 m -55.29 130.99 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.161 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.29 35.45 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.73 116.66 52.25 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.347 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.91 148.66 91.81 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.175 1.917 . . . . 0.0 112.697 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.83 -17.71 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -57.85 -14.73 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.755 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.428 ' CD1' HD23 ' A' ' 52' ' ' LEU . 82.2 m-85 -105.56 118.95 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.948 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 p -125.94 123.75 39.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.99 118.68 2.77 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.1 p -163.95 168.71 19.0 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.5 -160.42 33.92 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 p -90.78 -174.73 4.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.3 64.42 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.8 p -122.8 18.38 10.23 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.546 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 72' ' ' SER . 4.1 m-20 -140.16 131.0 25.95 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.949 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.31 127.78 14.06 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.218 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 40.5 m -135.16 131.04 36.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.576 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -93.32 89.65 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.487 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -82.76 141.81 32.08 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.488 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -125.52 141.25 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.152 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.6 m -69.81 -73.19 0.17 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.423 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 106.24 11.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.009 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.5 106.23 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.924 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.36 168.71 11.68 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.975 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.14 -16.85 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.764 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.76 -36.36 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -26.87 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.092 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.4 mt -50.25 138.1 17.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.32 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.01 -151.24 23.49 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.746 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.93 125.51 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.517 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -99.8 156.75 16.94 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.634 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -149.02 160.21 43.53 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -144.04 151.42 39.65 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.952 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 t -150.33 168.78 23.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.831 -1.148 . . . . 0.0 112.129 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -123.8 171.24 9.79 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.46 20.41 1.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -90.01 -19.2 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.77 126.85 42.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.146 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.476 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 11.9 p -110.27 138.4 20.87 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.382 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.0 Cg_endo -70.09 155.38 94.17 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.691 -1.379 . . . . 0.0 111.562 -0.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.14 156.22 56.53 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 122.157 1.905 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -89.94 -59.53 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.6 t80 65.86 118.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.007 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.72 -171.5 31.05 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.647 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.32 -174.51 15.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.39 47.36 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.079 -1.534 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -77.38 116.55 18.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.074 -1.051 . . . . 0.0 108.979 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -82.06 95.11 7.34 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.93 75.84 7.89 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.761 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.7 142.41 34.38 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.416 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 tt -77.78 159.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -62.87 140.3 58.8 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.861 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.17 147.95 6.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 t -103.64 157.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.4 mtp -142.87 112.84 7.05 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -93.44 111.82 23.57 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.465 ' CG ' ' HA2' ' A' ' 105' ' ' GLY . 11.3 tm0? -104.92 139.93 38.91 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.73 162.67 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.26 178.52 28.12 Favored 'Cis proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.686 -1.381 . . . . 0.0 110.731 -2.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.81 -64.02 1.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.635 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.45 153.48 26.07 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.93 82.49 17.47 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.977 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.79 116.27 4.19 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.807 1.672 . . . . 0.0 110.457 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -140.12 -170.74 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.186 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 t -118.61 176.11 5.41 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.6 mt -90.64 92.21 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.436 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.94 -7.64 3.25 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.484 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -172.29 4.09 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.232 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -105.72 166.95 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.03 160.59 39.59 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.479 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 p -159.48 89.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.411 HD12 ' CG ' ' A' ' 91' ' ' TYR . 19.8 mt -79.41 133.77 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -97.59 147.95 23.78 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.657 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -154.81 102.72 2.38 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.572 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 25' ' ' SER . 4.1 ttt180 -111.65 147.73 34.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.636 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.453 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 34.5 m -120.39 157.25 29.69 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.6 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.2 t -65.4 -65.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.696 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.443 ' HG2' ' H ' ' A' ' 28' ' ' SER . 8.7 tt0 -99.19 162.79 12.85 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.683 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.3 p -68.61 121.15 15.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.696 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.73 28.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.8 t -89.57 127.49 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.677 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.85 162.54 25.99 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.898 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -30.51 71.53 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.897 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -73.62 -17.44 61.16 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.307 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.57 25.46 5.99 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.657 -1.259 . . . . 0.0 111.244 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -119.49 123.96 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 m -99.99 103.28 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.52 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -84.14 121.47 27.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.919 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -173.89 135.14 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.638 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -137.46 177.31 7.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.05 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -126.07 148.95 49.22 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.407 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 20.2 m-85 -128.91 161.11 30.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.9 tp -157.61 113.38 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.965 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -134.85 156.89 48.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.456 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.62 -114.97 0.31 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.934 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.57 -36.63 20.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.422 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.07 48.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -80.38 161.08 25.18 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.474 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -71.39 -51.24 10.04 Favored Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.912 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 48' ' ' SER . 2.8 Cg_endo -68.6 122.03 8.97 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.789 1.659 . . . . 0.0 112.508 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.92 10.0 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.411 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -141.59 134.7 29.17 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.409 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.08 -73.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mm -100.04 138.49 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CZ ' ' ND2' ' A' ' 58' ' ' ASN . 37.3 p90 -136.19 12.91 3.31 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.411 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -147.7 44.38 1.1 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.178 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 18.8 t 70.08 -27.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.733 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 55' ' ' LYS . 33.1 t -155.16 -45.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.121 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.432 ' ND2' ' CZ ' ' A' ' 54' ' ' TYR . 2.9 t30 -58.93 126.81 29.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.481 HH12 ' CG ' ' A' ' 65' ' ' ASP . 5.8 mtm180 -81.25 169.97 16.66 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CG ' ' N ' ' A' ' 61' ' ' SER . 91.6 t80 -90.07 159.51 16.79 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.295 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.418 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 4.5 m -60.66 114.91 3.25 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -17.72 16.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.36 129.55 74.53 Favored Pre-proline 0 C--N 1.306 -1.314 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.235 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -65.21 165.16 22.89 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.765 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.481 ' CG ' HH12 ' A' ' 59' ' ' ARG . 0.2 OUTLIER -78.08 -14.78 59.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.821 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HD2' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.11 -11.54 31.02 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.09 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.501 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 51.1 m-85 -101.25 121.12 41.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.967 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -126.66 129.62 48.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.054 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.38 144.57 18.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -160.92 150.0 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.44 160.57 24.4 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.514 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 p -91.21 -85.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.93 -32.69 0.1 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.374 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 p -119.42 15.1 12.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.8 135.2 14.2 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.406 ' C ' ' HG1' ' A' ' 77' ' ' THR . 14.2 m-85 -146.18 149.89 34.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.862 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 76' ' ' PHE . 40.3 m -143.96 143.13 31.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.858 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 tt -106.97 101.51 10.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.955 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -96.68 138.36 34.37 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.006 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 57.9 mt -121.3 138.4 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.79 -74.29 0.14 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.985 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.04 103.6 10.06 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.85 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.684 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.29 166.34 16.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.726 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.22 34.01 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.718 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.92 -39.35 34.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.93 -14.46 61.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 85.1 mt -58.21 150.99 20.21 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.531 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.34 -166.67 26.73 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.567 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.45 129.26 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.163 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.411 ' CG ' HD12 ' A' ' 21' ' ' ILE . 17.7 m-85 -103.18 146.31 28.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 93.8 m-85 -138.48 169.52 17.64 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.94 134.9 9.96 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.2 p -142.04 173.2 11.74 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -129.92 157.7 41.57 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.35 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -126.46 10.11 7.26 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.459 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 m -68.76 -32.27 71.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.628 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -114.16 124.22 51.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.2 t -104.3 138.35 19.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.315 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -73.1 159.98 96.42 Favored 'Cis proline' 0 C--N 1.317 -1.113 0 C-N-CA 123.774 -1.344 . . . . 0.0 111.769 -0.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 103' ' ' PHE . 3.3 Cg_exo -60.58 141.25 94.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.137 1.891 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -91.12 -28.72 17.72 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.262 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 101' ' ' PRO . 60.5 m-85 54.46 -159.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.516 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.48 -174.2 15.88 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.465 ' HA2' ' CG ' ' A' ' 6' ' ' GLN . . . 93.74 161.92 35.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.775 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.68 56.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.418 ' OG1' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m -79.36 110.34 14.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -80.61 99.84 8.33 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.775 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.96 84.73 6.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.766 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.1 147.18 32.83 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.084 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -83.32 153.33 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -57.21 131.1 48.95 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.359 -1.782 . . . . 0.0 110.442 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.04 0.448 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.586 HG23 ' CD2' ' A' ' 98' ' ' HIS . 77.0 t -67.42 146.43 13.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.338 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.56 148.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' A' ' 95' ' ' GLN . 3.8 mtt -139.01 107.91 5.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -98.59 97.18 8.5 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.569 ' OE1' ' SG ' ' A' ' 93' ' ' CYS . 2.2 tp60 -78.82 141.95 37.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.438 ' HG1' ' C ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -159.86 158.43 26.85 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.821 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -77.77 178.13 36.23 Favored 'Cis proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.313 -1.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.34 -57.36 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.692 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.0 m -113.95 144.16 43.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.239 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.86 73.05 54.16 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.331 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.97 118.23 5.4 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.661 1.574 . . . . 0.0 110.377 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.63 -178.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.261 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.32 156.85 18.07 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.557 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.5 mt -73.89 88.25 1.82 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.605 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.81 43.95 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 179.89 6.12 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -96.2 148.17 22.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.3 157.6 36.25 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -151.09 82.73 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.75 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.5 ' CD1' ' CG ' ' A' ' 91' ' ' TYR . 5.2 mt -80.27 117.83 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.264 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -86.89 159.34 19.08 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.3 t -157.78 97.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.603 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -104.22 153.56 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.299 -0.96 . . . . 0.0 113.019 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 m -128.28 145.8 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -62.51 -50.98 69.25 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.363 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.97 145.57 38.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.078 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -57.63 139.7 52.95 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.5 mt -93.06 39.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.545 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.08 137.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 32' ' ' SER . 59.7 t-80 -93.62 158.99 15.42 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.723 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.454 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 5.7 t -60.74 -21.04 62.55 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.361 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 32.5 p-10 -86.32 -6.38 58.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.34 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.65 12.32 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.401 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -116.29 136.39 53.05 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.409 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.46 127.85 49.33 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -116.67 110.5 18.56 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.639 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.73 146.79 26.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -141.03 162.18 36.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.379 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.405 ' CE2' HD11 ' A' ' 78' ' ' LEU . 75.8 m95 -128.98 150.1 50.54 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -145.02 158.01 43.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 37.8 tp -138.04 117.78 13.15 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.297 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.65 152.95 43.0 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.736 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -110.85 -137.18 0.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.261 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.12 -61.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.46 35.29 1.33 Allowed Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.778 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -89.04 168.89 11.98 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.42 161.6 49.31 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.719 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.2 147.96 91.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.067 1.844 . . . . 0.0 111.854 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 34.6 mttp -134.36 125.23 27.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -114.78 120.99 41.91 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.359 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD21 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -95.93 -70.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.236 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.4 mm -111.24 141.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.572 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -128.82 8.01 5.7 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.81 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 17.3 tttt -160.65 61.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 15.8 t 71.21 -65.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.007 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 p -124.77 -36.53 2.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.451 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -48.1 115.51 1.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.705 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -85.71 151.54 23.78 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -80.7 164.73 22.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.053 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.75 137.22 54.83 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 -40.01 3.04 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.2 110.2 1.78 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.685 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.35 150.69 86.28 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.94 1.76 . . . . 0.0 111.702 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -12.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.465 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -58.64 -12.57 4.28 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -111.35 120.34 41.89 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.726 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.4 p -133.69 100.36 4.75 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.29 153.35 23.4 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.83 158.13 27.88 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.22 157.25 16.11 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.2 m -90.39 -94.26 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.85 -36.28 0.36 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -120.01 16.17 12.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.176 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -152.43 125.97 8.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.611 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.2 m-85 -142.8 138.85 30.68 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.065 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 78' ' ' LEU . 23.9 m -138.8 144.76 39.48 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.492 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' N ' HG21 ' A' ' 77' ' ' THR . 4.2 tp -99.62 108.69 21.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -97.53 130.39 44.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.0 140.35 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.834 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -72.82 -62.79 1.33 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.776 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.2 102.65 7.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.672 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.39 110.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.696 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.03 175.66 5.68 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.03 -29.77 58.12 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.413 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -73.14 -28.18 62.09 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.51 -1.45 15.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.438 HD13 HD13 ' A' ' 111' ' ' ILE . 89.3 mt -76.76 152.4 35.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.79 -154.97 19.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.85 134.33 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.539 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.5 ' CG ' ' CD1' ' A' ' 21' ' ' ILE . 11.3 m-85 -98.57 152.57 19.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.38 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.08 161.74 36.89 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.569 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 2.4 p -144.28 142.3 30.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.509 ' HG ' ' C ' ' A' ' 93' ' ' CYS . 47.4 m -146.38 156.64 43.46 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.811 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -104.64 152.09 22.88 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.395 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.59 30.09 7.55 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -102.32 -60.89 1.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.586 ' CD2' HG23 ' A' ' 2' ' ' VAL . 16.9 m-70 -80.0 156.01 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.5 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 69.4 t -141.69 139.74 19.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.034 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.9 Cg_endo -70.11 154.74 94.33 Favored 'Cis proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.362 -1.516 . . . . 0.0 111.304 -0.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 149.6 89.72 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.963 1.775 . . . . 0.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.2 p -82.58 -59.77 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.186 -1.005 . . . . 0.0 110.723 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 t80 62.04 125.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.399 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.92 -151.24 10.13 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.75 -173.77 42.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.064 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.16 64.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 118.994 -1.574 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.8 m -79.93 104.4 10.48 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.651 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 121.39 18.63 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.14 78.83 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -105.94 145.69 30.98 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.604 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.438 HD13 HD13 ' A' ' 88' ' ' LEU . 17.7 mt -64.11 131.22 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.49 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -72.19 104.08 3.54 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.468 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 116.389 -1.767 . . . . 0.0 109.829 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 121.008 0.432 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.17 154.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.975 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.79 144.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 96.75 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.516 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -92.74 161.05 14.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.0 162.49 28.92 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.063 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -165.85 156.76 11.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.518 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -88.33 177.98 19.96 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.265 -1.14 . . . . 0.0 110.665 -2.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.25 -48.32 20.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.518 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 t -122.07 153.62 38.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.0 79.87 21.71 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 118.954 -1.099 . . . . 0.0 112.387 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.23 113.32 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.646 1.564 . . . . 0.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.13 -174.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.7 p -118.31 160.07 22.29 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.62 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 mt -78.89 87.41 4.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.33 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.9 35.04 0.11 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.41 -173.36 3.09 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.485 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -106.07 146.08 30.61 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.09 37.08 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -161.63 89.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.628 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' THR . 7.8 mt -73.26 146.23 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.377 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 7' ' ' THR . 22.8 t -117.62 140.58 49.45 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.21 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m -146.3 101.15 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.098 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -109.3 147.81 32.05 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.156 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 p -115.03 139.61 49.72 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -49.88 -59.09 4.18 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -98.85 154.9 17.68 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.78 133.51 47.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.941 -0.703 . . . . 0.0 111.306 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.28 33.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.32 117.96 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -72.38 161.34 30.95 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -62.24 -23.6 66.77 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -85.43 -7.74 58.77 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.57 35.08 6.04 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.469 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -119.56 121.91 40.43 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -99.22 96.99 8.13 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -80.87 104.8 11.63 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -151.4 146.82 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.935 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.468 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -147.56 161.21 41.58 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.011 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -120.09 152.88 36.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.576 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.52 163.18 32.64 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -146.3 100.17 3.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.697 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -97.76 142.82 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.415 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.68 -147.14 0.31 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.656 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.14 -55.6 5.57 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.212 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.91 39.58 1.32 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -112.18 169.41 8.88 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.021 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.3 t -73.94 137.49 76.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.52 106.72 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.886 1.724 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 144.99 32.2 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.742 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 39' ' ' ASN . 15.4 tp -99.17 138.66 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.753 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 mt -118.22 -51.64 2.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.072 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mm -126.41 136.2 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.738 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.3 p90 -121.86 23.33 10.11 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.158 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.2 OUTLIER 175.37 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.093 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.6 t 56.87 -83.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.575 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t -121.16 43.85 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.805 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.5 m-80 -111.13 99.8 8.58 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.525 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 61.9 mtm180 -82.22 137.18 34.96 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' SER . 81.5 t80 -70.61 156.68 39.13 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.8 p -58.43 112.02 1.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.88 -24.55 7.87 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.88 126.86 93.15 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.98 168.49 5.83 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.011 1.808 . . . . 0.0 112.52 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.78 -23.15 45.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.537 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -53.86 -40.9 66.91 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.383 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 46.4 m-85 -80.0 112.25 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.64 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t -130.34 117.29 19.54 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 129.45 9.9 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 155.63 34.3 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 163.06 -172.24 39.02 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.585 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -91.3 -165.8 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.707 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.53 72.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.138 -1.03 . . . . 0.0 111.268 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 p -121.38 17.32 11.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 6.9 t0 -145.77 133.59 21.21 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.08 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.526 ' CE2' HD11 ' A' ' 38' ' ' LEU . 25.2 m-85 -143.32 125.96 15.95 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.425 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.1 m -123.32 130.97 53.47 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.341 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tp -91.71 85.32 5.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.139 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -78.18 142.3 38.06 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.33 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.11 125.77 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.039 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 m -61.24 -59.14 5.77 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.332 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -132.37 107.48 8.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.38 138.38 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -117.69 175.47 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.7 -29.85 69.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.701 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.33 -35.22 66.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -56.08 -30.37 61.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.717 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.3 mt -48.88 137.36 12.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.229 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.34 -147.49 16.47 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.292 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -123.64 120.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.41 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -94.68 151.94 18.89 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.741 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -143.82 175.39 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.477 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 24.7 p -155.49 152.43 28.89 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 p -155.99 152.59 28.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.211 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -108.73 148.75 30.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.19 40.87 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.746 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.91 -57.2 2.07 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.189 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -96.18 167.84 10.96 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.323 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.4 t -131.65 137.93 31.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.169 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.5 Cg_endo -70.42 151.67 93.33 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.748 -0.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.3 122.1 10.39 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.762 1.642 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 p -91.09 128.17 36.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -89.92 -175.56 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.96 41.43 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.91 -59.99 2.01 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.907 -1.14 . . . . 0.0 111.093 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.99 101.36 0.63 Allowed Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.571 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.0 m -94.13 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -84.97 134.51 34.24 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.462 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 98.07 5.49 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -121.94 142.22 50.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.2 tt -64.74 146.74 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.238 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 108.82 2.53 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.024 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.484 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.419 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.166 0.508 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 46.9 t -86.35 124.35 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.193 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.27 137.44 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.656 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 87.0 mmm -122.82 95.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 137.2 37.42 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.907 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 13.3 tt0 -124.34 148.57 47.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.767 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.86 156.53 17.33 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.425 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -78.65 178.52 34.05 Favored 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.664 -1.39 . . . . 0.0 111.274 -1.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -77.7 -34.43 52.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.204 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 p -138.6 158.0 45.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tp -145.9 85.65 7.55 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.781 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.5 109.05 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.644 1.563 . . . . 0.0 110.307 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.93 176.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.011 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -104.71 168.96 8.73 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.412 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 111' ' ' ILE . 65.6 mt -81.88 88.0 6.36 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.64 51.63 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.61 163.45 32.8 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.771 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -85.23 142.28 29.53 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.45 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -121.97 166.55 14.29 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.079 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 13.5 p -162.58 94.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.173 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.98 118.42 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -83.1 157.03 22.99 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.488 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.2 t -162.17 112.6 1.56 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.196 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -118.53 144.77 45.83 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 1.4 m -104.88 151.29 24.03 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 m -78.06 0.65 23.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 134.14 10.75 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.14 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -55.53 124.48 17.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -91.5 31.35 1.18 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.415 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.9 t -88.09 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.63 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -67.47 154.18 41.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.466 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -60.14 -31.2 69.86 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.443 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -76.02 -1.48 26.01 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.083 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.92 50.1 3.6 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.26 120.95 12.6 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -103.59 103.39 13.32 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.091 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -81.72 98.29 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.037 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -147.53 138.03 23.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.676 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 6.9 p-10 -140.38 174.75 10.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.295 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -122.48 148.59 44.97 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.264 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.64 164.14 21.24 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.1 tp -158.65 116.57 2.91 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.928 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.9 161.52 32.84 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.535 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -102.45 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.114 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.98 61.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.314 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.93 77.44 0.05 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.31 -159.06 0.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.628 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -89.92 161.06 39.48 Favored Pre-proline 0 N--CA 1.488 1.473 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.38 125.47 16.95 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.71 1.607 . . . . 0.0 110.131 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -136.88 136.75 38.98 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.535 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.0 tp -114.19 143.37 44.93 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.7 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.2 mt -111.86 -89.4 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.6 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.5 mm -99.12 133.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.293 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 26.0 p90 -133.9 174.67 10.22 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER 52.34 34.61 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.519 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG11 ' HG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER 75.74 -37.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.117 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HG ' HG11 ' A' ' 56' ' ' VAL . 21.0 p -144.09 -41.24 0.27 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.698 -1.201 . . . . 0.0 112.918 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 5.3 m-80 -37.52 122.03 0.9 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.138 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' NH1' ' HA ' ' A' ' 65' ' ' ASP . 25.2 mtm180 -91.59 126.5 36.69 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.425 ' N ' HG22 ' A' ' 63' ' ' VAL . 15.4 t80 -54.36 149.86 9.56 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 112.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.898 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.65 -22.82 11.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.714 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 60' ' ' PHE . 88.7 t -56.95 120.12 35.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.051 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -58.4 138.76 87.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.705 1.603 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 9.3 p-10 -54.15 -22.85 12.25 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 mtm-85 -58.6 -18.74 32.57 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -93.23 114.19 26.61 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.586 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.39 90.34 3.31 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.03 129.38 9.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -164.35 -173.42 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.517 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 150.53 -179.64 27.08 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.043 -1.551 . . . . 0.0 111.83 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -93.2 -140.75 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.79 -35.57 13.01 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.3 p -123.79 13.18 9.22 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.6 m-20 -132.41 130.36 40.52 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -144.44 145.71 32.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.991 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.408 HG21 ' N ' ' A' ' 78' ' ' LEU . 9.5 m -150.28 140.48 22.18 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.634 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 20' ' ' SER . 4.1 tt -98.5 102.8 14.65 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.95 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -93.93 122.08 36.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 31.2 mt -106.15 138.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.692 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -72.03 -70.22 0.35 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.89 105.24 9.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.89 104.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.01 173.86 7.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.15 48.37 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.43 -39.7 62.42 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.329 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.86 -8.34 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.81 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.68 148.89 48.68 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.881 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.13 -159.85 24.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.64 135.7 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.25 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -100.22 151.77 21.05 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.386 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.78 147.94 38.13 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.1 p -128.32 139.92 52.14 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.191 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 103' ' ' PHE . 2.3 t -144.78 164.26 31.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.077 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.449 HE22 ' HB2' ' A' ' 98' ' ' HIS . 1.4 pt20 -117.48 163.19 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.231 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.56 32.75 2.76 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.029 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.8 m -99.69 -34.07 10.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.501 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.449 ' HB2' HE22 ' A' ' 95' ' ' GLN . 16.5 m-70 -107.97 167.45 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.933 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 43.8 t -136.73 135.75 20.71 Favored Pre-proline 0 N--CA 1.49 1.53 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.8 Cg_endo -70.29 151.76 93.09 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.481 -1.466 . . . . 0.0 111.497 -0.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.01 125.84 20.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.759 1.639 . . . . 0.0 110.209 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.419 ' CG2' ' HB3' ' A' ' 1' ' ' ASP . 11.0 p -93.81 118.31 31.27 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.156 -1.017 . . . . 0.0 112.093 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -105.17 -175.13 2.7 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.292 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.4 177.31 18.24 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.397 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.07 175.97 22.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.408 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 169.87 62.05 0.04 OUTLIER Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.054 -1.545 . . . . 0.0 110.801 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.5 m -78.21 105.37 9.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.859 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -74.82 105.43 5.88 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.19 90.62 4.42 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.993 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.4 146.17 45.59 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.401 HD12 HD13 ' A' ' 15' ' ' LEU . 10.5 mt -60.69 127.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.23 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.444 ' HZ1' ' C ' ' A' ' 113' ' ' ARG . 8.8 tmtt? -54.49 129.16 34.99 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.417 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.444 ' C ' ' HZ1' ' A' ' 112' ' ' LYS . 15.3 mmt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.141 -1.885 . . . . 0.0 110.431 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.938 0.399 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 98' ' ' HIS . 83.8 t -71.33 122.42 23.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.081 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.06 148.22 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.29 119.73 8.45 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -117.16 122.94 45.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.966 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.597 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 2.9 mp0 -95.39 146.73 24.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.09 157.05 21.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.631 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -76.33 175.58 47.53 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.528 -1.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.77 -34.13 52.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.308 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.11 159.32 42.06 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 tp -145.3 75.02 13.94 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.26 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.57 115.32 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.95 1.767 . . . . 0.0 110.424 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.66 -172.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.737 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.3 154.16 32.78 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.021 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.44 87.76 0.2 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.61 47.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -144.15 175.24 10.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -93.99 154.13 17.82 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.55 159.22 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.607 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -160.78 83.51 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.46 HD12 ' CG ' ' A' ' 91' ' ' TYR . 5.7 mt -82.35 125.85 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.801 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -88.64 154.19 20.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.057 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.597 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 9.8 m -157.3 107.41 2.23 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -119.6 164.74 15.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.277 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.3 p -136.52 165.17 26.48 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.269 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 m -78.65 -29.0 45.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.767 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.29 145.04 51.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.375 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' VAL . 49.3 m -58.8 126.83 29.28 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.347 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.6 32.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.0 t -89.81 147.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.032 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -101.23 167.97 9.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.081 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 98.4 p -55.84 -37.27 68.49 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.389 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -68.18 -19.73 64.81 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.88 14.66 24.35 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.23 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -106.13 138.51 42.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.378 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.6 m -109.02 144.78 36.57 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.153 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -125.89 107.65 10.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.04 134.16 19.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.659 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -129.55 162.19 28.78 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.321 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.411 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 52.5 m95 -114.99 160.26 19.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -147.69 127.09 13.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.783 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -117.97 109.7 16.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.255 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -121.01 152.09 39.0 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.624 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -136.15 -109.34 0.2 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.35 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.38 -97.03 0.11 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.253 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.28 49.12 1.71 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -123.58 10.34 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.603 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.48 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -32.23 -57.7 0.44 Allowed Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.277 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 48' ' ' SER . 2.6 Cg_endo -63.66 84.17 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.426 1.418 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -148.81 158.89 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.325 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -164.66 135.89 4.26 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.0 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.31 -60.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -120.26 140.11 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.799 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.9 p90 -121.54 2.12 10.13 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.248 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 56' ' ' VAL . 61.1 tttt -153.79 50.34 0.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.588 ' CG2' ' N ' ' A' ' 57' ' ' SER . 0.9 OUTLIER 65.11 -58.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.141 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -126.64 54.49 1.59 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.328 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -146.61 105.2 3.82 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.862 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 34.2 mtm180 -71.75 147.65 47.12 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.631 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -86.34 169.52 12.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.767 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -59.89 129.34 41.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.355 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.61 -23.92 25.9 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.017 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.63 115.21 18.38 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.23 151.43 82.29 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.922 1.748 . . . . 0.0 111.954 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' PHE . 8.2 p-10 -57.56 -18.31 18.77 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 84' ' ' GLU . 59.8 mtt85 -53.3 -10.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.516 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 93.0 m-85 -116.49 125.31 51.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.961 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.56 119.64 14.5 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.268 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.29 159.9 13.42 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.89 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.9 p -158.32 175.91 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.196 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 164.2 151.78 6.67 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.3 m -93.82 -71.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -49.36 0.04 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.635 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.5 p -115.83 13.35 16.07 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.75 127.82 33.58 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.432 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 87.3 m-85 -144.73 130.5 19.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.4 m -136.03 139.22 42.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.042 -1.063 . . . . 0.0 112.129 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 9.2 tt -98.64 114.81 27.44 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -108.7 140.63 41.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.75 137.07 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.58 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -69.82 -63.93 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.236 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -124.52 104.93 9.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.2 112.68 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -97.01 -149.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.583 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.47 -30.27 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.07 -33.47 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.613 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.59 -15.64 40.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.75 147.75 52.19 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.295 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.6 -153.11 23.42 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.143 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -117.42 123.18 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.46 ' CG ' HD12 ' A' ' 21' ' ' ILE . 18.0 m-85 -91.77 155.3 18.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.982 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -146.65 167.21 24.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.433 ' C ' ' HG ' ' A' ' 94' ' ' SER . 14.2 p -157.25 145.93 19.68 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.76 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 93' ' ' CYS . 16.0 m -144.41 171.39 14.4 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.467 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -115.55 151.66 34.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.303 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.36 18.28 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.033 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.9 m -91.32 -22.99 20.26 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.45 ' CD2' HG23 ' A' ' 2' ' ' VAL . 86.0 m-70 -122.23 132.44 54.43 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.071 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.2 t -114.3 139.28 23.63 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.448 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -71.35 159.37 94.27 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.774 -0.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.33 144.13 94.77 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.933 1.756 . . . . 0.0 110.996 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -81.05 -63.88 1.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.521 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 5.7 t80 61.86 157.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.35 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.01 -157.89 27.47 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.681 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.41 -156.73 22.81 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.408 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.22 63.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.284 -1.436 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.2 m -77.9 107.98 10.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.351 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -76.91 107.61 9.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.169 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 tt -101.71 84.28 2.54 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 147.9 33.04 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.608 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.3 mt -67.05 129.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' HE3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -66.24 115.94 6.76 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.003 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.413 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 17.4 mtt180 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.504 -1.712 . . . . 0.0 111.044 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 30' ' ' VAL . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 28' ' ' SER . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.405 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 27.7 t-80 -83.93 167.37 17.03 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -58.2 -27.99 64.39 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.737 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 1.3 p30 -79.45 -10.5 59.82 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.31 -0.93 64.08 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.798 -1.191 . . . . 0.0 111.905 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.81 144.42 28.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.411 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -109.67 -128.9 0.28 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' H ' ' CG ' ' A' ' 44' ' ' LYS . . . -81.51 -53.25 6.43 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.218 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.22 42.88 0.34 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.324 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.16 176.98 5.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -62.29 153.35 75.97 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.62 143.21 98.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.774 1.649 . . . . 0.0 111.25 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.34 135.17 54.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.3 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.17 126.33 51.99 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.558 HG12 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.642 ' N ' ' O ' ' A' ' 55' ' ' LYS . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.524 HH21 ' N ' ' A' ' 65' ' ' ASP . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.524 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.429 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.46 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CB ' HD12 ' A' ' 21' ' ' ILE . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.459 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.444 HG23 ' CD2' ' A' ' 98' ' ' HIS . 61.0 t -75.55 150.72 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 118.806 -1.158 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.5 t -96.85 160.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -149.35 113.25 5.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.903 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -101.31 125.16 47.92 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.409 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.617 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -110.92 135.18 51.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.039 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.82 158.11 26.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.826 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.67 176.89 40.84 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.492 -1.461 . . . . 0.0 111.317 -1.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -79.98 -40.51 27.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.538 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -132.08 150.89 52.04 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 tp -143.15 82.11 12.12 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.814 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.85 107.88 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.586 1.524 . . . . 0.0 110.041 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.66 178.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.227 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -109.11 158.14 18.06 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.146 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.83 88.39 1.02 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.678 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.34 -10.77 1.53 Allowed Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -168.11 1.75 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.229 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.66 156.3 22.99 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -113.64 162.69 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 p -162.4 75.3 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.004 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' THR . 11.2 mt -80.21 121.01 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.979 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.2 t -89.0 157.25 18.43 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.617 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.6 m -160.18 108.52 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.311 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -113.27 155.91 24.26 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.096 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -127.71 139.49 52.66 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -53.42 -53.0 57.59 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -106.4 153.35 22.37 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.449 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.512 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.4 p -63.4 122.06 15.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.257 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 29.6 mt -75.81 28.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.017 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' A' ' 28' ' ' SER . 51.9 t -90.06 144.38 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.474 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.485 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 28.4 t-80 -96.5 169.2 10.06 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.506 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.403 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 1.4 t -67.22 -29.88 69.66 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.662 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.485 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -75.69 -14.52 60.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.349 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.75 -20.37 34.19 Favored Glycine 0 N--CA 1.497 2.702 0 C-N-CA 119.671 -1.252 . . . . 0.0 111.575 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -79.23 130.64 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 m -106.03 155.11 19.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.065 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -128.37 138.42 52.35 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.761 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -165.14 166.36 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.847 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -163.41 149.1 11.47 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.118 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -117.72 154.27 31.96 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.296 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -144.94 151.38 38.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 91' ' ' TYR . 17.8 tp -132.25 81.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.406 ' N ' ' CD ' ' A' ' 43' ' ' GLN . 3.1 mp0 -57.05 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.13 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -101.51 158.3 16.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.082 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 44' ' ' LYS . . . -60.37 107.55 0.68 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.686 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.79 -43.32 2.87 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' O ' ' C ' ' A' ' 48' ' ' SER . 0.9 OUTLIER -79.6 11.36 3.16 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.88 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.516 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -30.37 -55.61 0.35 Allowed Pre-proline 0 N--CA 1.495 1.823 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.031 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 1.8 Cg_endo -68.43 87.05 0.42 Allowed 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.42 1.413 . . . . 0.0 111.135 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -153.1 156.11 38.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.7 tp -134.28 152.68 51.94 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.806 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.11 -67.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.645 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 mm -128.29 153.42 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 5.1 p90 -136.35 -65.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.48 73.49 5.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.227 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.4 t 62.57 -74.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.927 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.2 t -117.67 -8.78 10.85 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 1.7 m-80 -60.71 121.27 11.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.4 HH21 ' CG ' ' A' ' 65' ' ' ASP . 5.6 mtt-85 -97.15 161.13 13.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -86.38 152.93 22.31 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -55.52 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.14 -29.98 2.38 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 121.15 74.78 Favored Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.601 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.88 138.51 86.08 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.752 1.635 . . . . 0.0 111.641 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' CG ' HH21 ' A' ' 59' ' ' ARG . 2.6 t70 -54.48 -14.3 1.22 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.416 ' HE ' ' N ' ' A' ' 66' ' ' ARG . 1.1 mmp_? -57.54 -19.15 23.21 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -100.16 130.47 46.3 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.309 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 p -139.82 121.24 15.05 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.295 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.91 133.4 11.37 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.224 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.2 140.94 35.97 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.83 154.36 12.75 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.7 m -91.28 -79.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.276 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.33 -34.72 0.1 OUTLIER Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.671 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.4 p -121.65 19.19 11.16 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -151.74 126.82 9.79 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.624 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -141.21 138.23 33.17 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 50.0 m -135.86 149.9 49.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.239 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 tt -109.27 109.12 19.95 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.391 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 14.2 mttm -110.53 139.36 45.84 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.232 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.93 132.7 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.619 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.5 m -61.73 -56.41 19.87 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.764 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.37 103.34 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.78 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.01 129.66 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -109.23 -171.86 1.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.46 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.4 63.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.51 -32.46 73.39 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -21.36 50.43 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.606 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.54 143.32 50.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.1 -155.59 26.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.18 114.74 47.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CD2' HD11 ' A' ' 42' ' ' LEU . 7.2 m-85 -88.56 152.76 21.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.494 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -148.61 165.7 30.52 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.598 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.92 152.96 31.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.829 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -156.34 178.98 9.69 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.028 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -132.53 142.77 49.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.5 p -115.28 22.67 13.09 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.561 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.442 ' HG1' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -73.29 -43.85 60.2 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.985 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.444 ' CD2' HG23 ' A' ' 2' ' ' VAL . 90.9 m-70 -111.39 148.84 32.17 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.468 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER -118.85 142.16 31.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.971 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -70.09 162.99 83.88 Favored 'Cis proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.984 -1.257 . . . . 0.0 111.972 -0.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.96 142.41 81.52 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -79.42 -61.62 1.95 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.981 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 88.1 t80 61.93 161.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.13 -165.7 27.71 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 107.9 -149.98 16.85 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.495 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.71 56.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.4 m -78.79 106.49 10.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -71.16 97.49 1.52 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.411 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tp -88.56 83.5 6.79 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.558 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.14 144.9 38.08 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.61 159.38 3.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -55.92 -29.81 60.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 116.483 -1.722 . . . . 0.0 111.107 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.7 t -71.6 140.03 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.949 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.41 155.59 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mtt -145.54 114.1 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.007 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -100.11 129.26 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.7 140.98 37.92 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.51 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.84 145.16 7.12 Favored Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.16 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -81.15 -176.51 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.8 -1.334 . . . . 0.0 111.165 -2.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.19 -46.6 10.92 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.7 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -124.12 158.42 32.33 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.914 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tp -146.74 85.0 7.31 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.953 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.43 121.62 8.38 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.846 1.698 . . . . 0.0 110.225 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.39 -170.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.06 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -132.15 161.9 32.21 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -71.08 87.9 0.77 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.186 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.21 30.68 0.1 OUTLIER Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -125.58 -176.33 3.57 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.083 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -114.82 138.84 50.29 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.645 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.64 157.86 22.53 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.298 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 2.7 m -155.44 91.24 1.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.836 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.9 mt -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.607 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 145.5 30.13 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.777 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.27 98.45 2.81 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.466 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.43 154.53 19.33 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.409 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 p -129.9 143.05 50.6 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.901 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -53.66 -71.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.482 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -82.08 152.24 26.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.3 p -66.52 131.45 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 26.8 mt -78.58 30.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.236 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.0 t -97.26 133.44 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.9 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -86.32 163.11 17.88 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.153 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -60.7 -24.62 65.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.028 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -76.5 -15.29 59.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.321 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.67 -10.04 41.36 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.634 -1.27 . . . . 0.0 111.499 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 8.8 m120 -89.25 141.21 28.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 m -109.37 157.49 18.85 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -137.46 108.87 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.172 -1.011 . . . . 0.0 112.491 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.81 128.63 8.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.261 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 28.0 m-20 -125.15 167.71 14.44 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.505 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -124.09 152.14 43.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.438 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.34 156.37 49.05 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.282 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 tp -146.51 117.37 7.67 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.241 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -125.58 158.2 35.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.338 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -114.25 -147.28 0.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.42 -56.32 3.41 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.002 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.64 56.43 0.69 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -131.64 162.89 29.32 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.691 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 m -70.96 124.45 91.04 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.04 158.48 29.69 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.87 1.714 . . . . 0.0 111.516 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.98 159.58 44.48 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.322 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.96 134.82 44.56 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.957 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -102.72 -67.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.231 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -119.4 142.44 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.3 p90 -145.06 167.82 21.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.078 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB2' ' CD2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 60.85 15.37 5.92 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.461 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' CB ' ' O ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER 78.58 5.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.681 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -44.11 128.39 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.661 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.542 HH21 ' N ' ' A' ' 65' ' ' ASP . 11.7 mtm-85 -97.29 146.31 25.26 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.165 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.81 159.32 34.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.639 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -58.04 122.28 12.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.43 -18.06 45.63 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.35 116.48 53.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.693 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.476 ' C ' HH21 ' A' ' 59' ' ' ARG . 1.1 Cg_endo -65.89 172.66 8.07 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.137 1.891 . . . . 0.0 112.423 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' HH21 ' A' ' 59' ' ' ARG . 1.2 m-20 -78.05 -15.81 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -56.2 -27.15 53.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.169 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -96.66 118.99 34.31 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.286 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -128.03 91.21 3.23 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.924 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.51 127.62 8.8 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 t -160.96 178.37 9.44 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.58 -178.5 42.58 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.541 -1.314 . . . . 0.0 110.836 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -92.88 -85.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.039 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.2 -34.84 0.11 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.57 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.8 p -124.17 6.6 8.5 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.42 118.36 16.31 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -133.61 153.13 51.91 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.477 HG21 ' N ' ' A' ' 78' ' ' LEU . 16.1 m -154.2 145.89 23.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.83 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' HG21 ' A' ' 77' ' ' THR . 1.9 tt -96.71 99.62 11.21 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.587 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -91.1 122.58 33.87 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.247 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.0 mt -112.5 133.04 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m -70.31 -71.86 0.22 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.665 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.81 102.45 9.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.518 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.7 131.47 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -117.05 -173.9 2.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.302 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.24 -25.36 61.59 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.72 -32.11 59.91 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.07 -31.74 70.29 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.74 139.44 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.583 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.29 -150.72 22.8 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.436 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.09 121.38 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.463 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -93.11 151.28 19.95 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.174 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -143.23 164.32 30.52 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.192 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.26 151.48 36.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.9 p -157.22 157.3 34.07 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.178 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 146.96 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -126.14 27.9 6.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.504 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.445 ' HG1' ' HB3' ' A' ' 29' ' ' LEU . 1.1 m -77.98 -33.87 51.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.171 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -105.81 -43.56 4.86 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.229 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.562 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER 66.45 140.12 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.574 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 0.9 OUTLIER -66.67 168.65 50.54 Favored 'Cis proline' 0 C--N 1.318 -1.029 0 C-N-CA 123.901 -1.291 . . . . 0.0 111.903 -0.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.24 134.56 46.02 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.172 1.915 . . . . 0.0 111.788 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 p -78.09 -57.39 3.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.715 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 80.2 t80 62.7 164.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.449 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 139.91 -157.57 25.4 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.65 -137.26 19.93 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.18 68.06 0.38 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.418 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.1 m -78.31 114.89 17.62 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.713 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -77.39 111.33 12.97 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.682 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 89.39 2.98 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.775 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.45 144.55 48.62 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.1 tt -66.41 150.94 10.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -53.43 135.69 39.04 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.966 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 116.39 -1.767 . . . . 0.0 110.945 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.64 142.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.158 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.54 148.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.634 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mmt -134.26 104.97 6.4 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.627 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 m -100.49 129.71 46.47 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -109.31 147.38 32.77 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.281 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.401 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.24 142.72 7.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.806 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -83.94 171.78 47.36 Favored 'Cis proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.005 -1.248 . . . . 0.0 111.502 -0.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 1.7 mm? -74.41 -42.43 59.23 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.01 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 p -125.96 146.05 50.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.101 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.69 74.6 45.38 Favored Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.37 117.94 5.12 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.536 1.491 . . . . 0.0 109.877 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.4 -174.67 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -113.05 172.16 7.11 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.725 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.75 86.23 7.37 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.828 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.57 33.4 0.06 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.714 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.23 -173.7 3.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.097 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.47 137.28 52.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.984 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 166.77 11.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.641 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 p -162.23 76.83 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' THR . 19.1 mt -79.23 140.03 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.248 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 t -113.35 152.59 29.76 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.741 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.8 m -156.43 99.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.598 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 75' ' ' ASP . 9.9 mtm180 -110.02 152.63 25.67 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.943 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 p -118.64 150.65 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.317 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -58.5 -45.76 88.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.665 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.63 174.66 5.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.861 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.443 ' HA ' HG21 ' A' ' 74' ' ' THR . 5.1 t -74.04 146.66 43.54 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.9 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.0 mt -101.09 30.51 4.08 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.541 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.78 131.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.571 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 152.54 37.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.012 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 t -45.8 -25.94 0.59 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.712 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -155.2 45.24 0.49 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.138 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -136.29 -136.14 3.51 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -176.45 3.95 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.074 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 137.22 36.17 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -117.78 105.36 11.89 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.14 143.12 30.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.346 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -134.7 154.72 51.43 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.247 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CE3' HD11 ' A' ' 78' ' ' LEU . 82.6 m95 -123.49 147.41 47.24 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -140.77 145.84 36.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.547 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -130.67 115.54 16.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.87 138.05 54.55 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.749 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 -122.61 0.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.66 -39.92 12.9 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.316 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.44 68.83 0.1 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.605 -1.284 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -117.04 159.01 23.19 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.13 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.495 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -75.77 -56.43 1.75 Allowed Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.644 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 48' ' ' SER . 5.6 Cg_exo -56.92 113.57 1.53 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.565 1.51 . . . . 0.0 111.511 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.0 24.81 3.59 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.5 tp -143.08 126.52 16.74 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.732 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.8 -52.43 2.76 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.939 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 55' ' ' LYS . 2.0 mm -129.3 134.42 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.507 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -112.27 39.04 2.53 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HG3' ' H ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 179.22 -167.14 0.07 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.632 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' H ' ' HG3' ' A' ' 55' ' ' LYS . 27.5 t -76.82 -13.31 14.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.85 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.462 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.88 107.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.236 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 31.8 mtm180 -74.38 150.22 40.15 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -80.1 163.73 23.91 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.629 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -63.73 89.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.802 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.47 -28.54 2.32 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.4 116.93 50.05 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.061 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' ARG . 6.2 Cg_exo -57.94 148.49 76.01 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.104 1.869 . . . . 0.0 112.874 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 2.9 m-20 -57.8 -8.81 1.03 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -61.78 -20.67 63.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.927 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 94.9 m-85 -105.51 119.67 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.708 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.9 p -125.51 107.4 10.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.68 139.01 14.3 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.198 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.6 p -156.2 146.12 21.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.082 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -173.63 168.71 41.68 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 p -94.44 -105.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.437 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.73 -33.72 1.26 Allowed Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.026 -1.083 . . . . 0.0 110.483 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 28' ' ' SER . 60.6 p -126.87 10.09 7.0 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.964 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 11.9 t0 -136.68 130.65 32.46 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.071 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 70.0 m-85 -145.03 147.9 33.12 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.533 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 53.3 m -149.8 133.14 16.49 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.656 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -93.74 114.8 27.15 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.468 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -113.66 145.21 41.66 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.825 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 67' ' ' PHE . 67.3 mt -123.08 143.22 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.746 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -70.61 -57.76 4.39 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.547 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 8.7 ptm180 -129.48 107.35 9.41 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.659 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.47 105.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.33 -163.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.86 -30.14 50.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.49 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -26.13 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.708 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.1 -21.9 62.16 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.49 137.46 48.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.78 -158.73 27.76 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.25 124.82 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.568 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -94.16 153.4 18.11 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.297 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.07 170.26 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.73 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.6 p -151.72 152.57 32.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 p -154.89 164.38 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 160.72 29.55 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -134.58 24.24 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.814 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 m -79.92 -43.74 21.61 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.752 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.19 141.69 51.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.788 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 3.2 t -95.98 141.47 23.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 9.3 Cg_endo -77.46 163.51 88.42 Favored 'Cis proline' 0 C--N 1.317 -1.102 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.193 -0.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.424 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 2.3 Cg_endo -67.87 117.43 4.89 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.029 1.819 . . . . 0.0 110.347 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.8 p -90.39 104.25 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -86.34 150.39 24.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.18 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.05 170.72 42.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.1 -149.74 18.63 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 40.91 1.29 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -79.23 106.42 11.25 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.47 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -71.86 112.93 8.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.221 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.61 80.25 1.45 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.56 140.84 34.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.582 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.4 tt -71.8 150.48 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -54.92 128.9 35.48 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.111 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.082 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.078 0.466 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.94 110.57 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 26' ' ' SER . 2.5 t -72.96 141.23 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.087 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.521 ' HE3' ' SG ' ' A' ' 23' ' ' CYS . 5.1 mtp -128.21 105.19 8.19 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.09 143.1 37.66 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.11 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -130.59 135.68 48.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.337 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.18 157.3 24.73 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.112 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -78.66 176.46 42.6 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.563 -1.432 . . . . 0.0 111.362 -1.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 2.2 mm? -78.96 -44.35 22.63 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.161 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -128.09 144.4 51.11 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.627 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 tp -132.31 78.17 68.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.039 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.81 108.32 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.621 1.547 . . . . 0.0 110.231 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.91 -173.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.976 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -119.1 173.18 7.07 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.675 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -88.04 90.12 8.26 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.94 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.35 42.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -170.56 2.94 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.758 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -109.16 140.68 42.43 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.071 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.95 159.24 16.98 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.75 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -157.43 88.56 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mt -81.19 128.71 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.794 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.15 140.42 30.89 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.029 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 4' ' ' MET . 49.8 t -153.88 110.83 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.792 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.23 173.39 6.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.683 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 79.5 p -132.23 166.99 20.62 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.333 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.456 ' HG ' ' N ' ' A' ' 3' ' ' VAL . 1.5 p -72.85 -50.85 21.44 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.455 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.94 161.01 17.5 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.359 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 30' ' ' VAL . 64.4 m -59.98 126.35 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.408 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.6 mt -79.98 29.93 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.9 t -98.85 137.49 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.432 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 13.5 t-80 -86.43 171.05 11.43 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.556 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 t -74.0 -24.44 59.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 8.6 p30 -77.97 -29.74 49.91 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.446 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 43.89 0.65 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -130.43 141.54 50.53 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.838 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.8 m -113.86 109.44 18.53 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -98.05 109.74 22.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.057 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.433 ' CD1' ' CG ' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -154.07 127.75 8.72 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.615 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 12.9 p-10 -130.67 152.78 49.65 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.436 ' CE3' HD21 ' A' ' 78' ' ' LEU . 53.7 m95 -115.78 158.35 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 16.9 m-85 -137.14 156.01 48.89 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.596 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.6 127.03 19.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -131.64 155.92 46.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.036 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.0 -118.37 0.3 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.272 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.23 -90.06 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.616 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -124.53 38.62 2.32 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.96 -175.94 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.1 p -84.73 151.08 57.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.545 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.08 125.85 20.28 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.009 1.806 . . . . 0.0 111.836 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -107.38 137.9 44.57 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.383 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.13 133.91 47.44 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.337 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.4 -49.65 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.81 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -127.54 135.43 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.385 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -122.62 -11.25 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.567 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.22 88.57 2.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.376 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.658 ' CG1' ' H ' ' A' ' 57' ' ' SER . 1.5 p 45.26 -68.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 124.348 1.03 . . . . 0.0 113.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.658 ' H ' ' CG1' ' A' ' 56' ' ' VAL . 53.9 p -130.32 28.73 4.95 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -103.78 111.55 24.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -75.87 152.23 37.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.649 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.425 ' CD2' ' N ' ' A' ' 61' ' ' SER . 33.4 t80 -88.78 167.18 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t -59.79 132.69 54.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.692 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.11 -17.46 56.9 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -73.58 117.69 62.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.8 144.42 96.91 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.731 1.621 . . . . 0.0 111.667 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.99 -10.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -62.27 -19.92 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.54 122.69 46.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.254 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.13 121.32 13.83 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.41 147.78 17.49 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.41 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -161.35 161.1 30.33 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.5 173.45 44.65 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -91.21 -87.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.47 -34.76 0.11 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -120.95 17.86 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.572 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -155.01 126.2 7.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.986 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CG ' ' CD1' ' A' ' 38' ' ' LEU . 7.5 m-85 -141.56 153.53 44.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.445 HG21 ' N ' ' A' ' 78' ' ' LEU . 18.8 m -148.34 142.38 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.445 ' N ' HG21 ' A' ' 77' ' ' THR . 4.6 tp -101.83 115.09 29.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.065 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -111.17 151.11 28.58 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.635 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -127.89 134.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.94 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.6 m -67.35 -49.9 62.12 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.84 103.64 5.94 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.09 117.76 10.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.079 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -108.47 -177.93 3.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.95 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.94 -42.93 56.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.68 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.03 -19.66 53.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt -52.67 147.84 8.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.746 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.36 -160.42 25.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.14 151.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.046 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -123.57 148.69 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.565 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -141.66 162.94 34.25 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.3 p -144.86 125.16 13.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.436 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.5 p -120.64 161.85 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.545 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -125.97 150.7 47.83 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.895 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 52.13 1.61 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.634 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -50.08 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.353 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.457 ' H ' HE22 ' A' ' 95' ' ' GLN . 91.0 m-70 -112.51 163.38 14.54 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.269 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 100' ' ' PRO . 11.2 p -117.98 139.78 26.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . 7.0 Cg_endo -75.75 156.68 99.01 Favored 'Cis proline' 0 C--N 1.315 -1.201 0 C-N-CA 123.69 -1.379 . . . . 0.0 111.71 -0.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.04 120.19 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.977 1.784 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.7 p -91.28 136.19 33.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.397 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.67 176.42 8.17 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.6 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.66 -161.95 37.85 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.98 -79.3 1.27 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.307 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.89 95.09 0.15 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.2 m -92.29 117.33 29.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.561 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -85.51 114.53 22.6 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.318 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.4 93.42 4.59 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.802 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.8 139.18 52.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.85 156.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -55.34 152.32 8.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.707 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.02 152.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.981 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 t -96.94 166.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.265 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -148.76 115.45 5.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.516 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -95.85 140.8 30.11 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.012 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.541 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 1.9 mm-40 -129.9 132.14 46.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.538 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.99 158.02 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.932 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -79.69 175.1 46.49 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.429 -1.488 . . . . 0.0 110.538 -1.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -77.75 -43.96 29.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.801 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.7 m -126.14 146.05 50.1 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -136.09 78.03 47.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.62 112.27 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.79 1.66 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.34 178.96 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.386 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -110.34 174.58 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.787 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -85.95 87.73 7.46 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.911 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.77 52.72 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.5 179.38 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.75 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -100.49 141.31 33.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.455 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.37 165.76 12.13 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -159.55 91.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.591 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 25.9 mt -79.31 152.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.403 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 m -121.48 140.99 51.47 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.188 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -149.25 110.9 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -113.13 163.48 14.7 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.514 -0.874 . . . . 0.0 112.184 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.2 p -133.47 147.73 51.68 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.3 m -62.72 -41.05 98.96 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.94 159.26 22.72 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -70.68 129.58 39.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.53 34.41 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.72 147.74 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -97.42 167.22 11.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.464 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 t -75.19 66.39 1.69 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.883 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -174.14 -30.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.837 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 31.55 1.15 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.671 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.43 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 2.6 m-80 -132.47 132.71 43.0 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 56' ' ' VAL . 2.9 m -79.26 153.42 29.94 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.651 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -124.09 89.03 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.779 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -155.37 134.49 12.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.181 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -129.42 150.15 50.9 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.044 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.495 ' CE3' HD12 ' A' ' 78' ' ' LEU . 86.5 m95 -103.96 153.32 20.96 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.346 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.54 130.26 9.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 HD12 ' CE1' ' A' ' 91' ' ' TYR . 13.8 tp -109.83 142.81 40.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -125.3 137.64 54.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.822 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -121.85 170.03 10.19 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.475 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.24 137.45 53.15 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.829 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 40.15 51.26 3.54 Favored Glycine 0 N--CA 1.497 2.726 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.42 158.68 39.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.369 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.76 158.68 77.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.843 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.28 150.35 80.54 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.884 1.723 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 134.6 5.19 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.198 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.5 tp -102.62 139.08 38.68 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.319 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tp -99.63 -62.47 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.675 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -126.25 149.46 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.015 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 42.6 p90 -137.99 160.8 38.36 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.358 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.03 -63.69 0.41 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.629 0.58 . . . . 0.0 110.133 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 7.0 p -172.39 -37.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.756 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 49.6 m -150.5 -25.64 0.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.016 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 34.8 m-80 -53.31 120.92 6.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.274 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NH2' ' HA ' ' A' ' 65' ' ' ASP . 13.4 mtm180 -76.55 151.29 36.39 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -90.27 167.82 12.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.731 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 t -62.62 121.69 13.99 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 103.27 -8.96 53.55 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.62 113.8 58.13 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.342 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -66.0 155.39 69.78 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.129 1.886 . . . . 0.0 112.315 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.546 ' HA ' ' NH2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -57.39 -13.21 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.345 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -62.79 -18.29 62.47 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.026 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -106.18 109.59 21.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.547 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 t -116.95 119.36 35.1 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -126.11 130.64 7.19 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.1 t -161.24 168.91 23.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.95 -177.7 48.56 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.398 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.9 t -91.26 -106.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.068 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.8 -35.15 0.86 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.2 p -124.3 16.85 9.06 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.31 120.86 10.4 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.733 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.6 144.67 49.42 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.809 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.5 m -141.15 141.48 34.14 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.635 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -98.86 99.69 10.79 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.785 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -89.12 117.06 27.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.633 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.56 138.11 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.935 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -64.25 1.03 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.904 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -124.37 103.46 8.21 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.013 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.52 104.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.207 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.52 167.76 10.4 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . . . -55.29 -25.45 34.15 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.408 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -79.53 -37.39 36.66 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.506 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -5.24 25.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.312 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.504 ' CD1' ' HA ' ' A' ' 85' ' ' ALA . 85.0 mt -74.03 150.07 40.86 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.1 -149.42 21.55 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.202 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.53 118.58 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.29 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.466 ' CE1' HD12 ' A' ' 42' ' ' LEU . 22.6 m-85 -92.76 154.15 18.47 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -143.34 157.4 44.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.634 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.541 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 16.0 p -135.63 147.47 48.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.755 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -150.0 166.35 29.93 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.627 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.405 HE21 HG21 ' A' ' 102' ' ' THR . 1.7 pp0? -127.22 145.08 50.89 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.62 18.02 13.53 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.504 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -71.77 -42.34 67.28 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.536 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.49 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.0 m-70 -111.4 171.81 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.422 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.469 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 98.9 t -138.81 140.85 28.58 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.6 Cg_endo -70.76 168.82 70.1 Favored 'Cis proline' 0 C--N 1.319 -1.025 0 C-N-CA 123.741 -1.358 . . . . 0.0 111.883 -0.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.88 156.99 54.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.935 1.757 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.405 HG21 HE21 ' A' ' 95' ' ' GLN . 26.7 p -89.58 -64.25 1.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.961 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 63.24 171.55 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.04 -156.92 19.82 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.652 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 -172.73 45.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.14 59.81 0.02 OUTLIER Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.1 m -77.28 109.51 11.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.876 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -78.07 132.03 37.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.2 76.92 1.42 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.964 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -107.0 137.85 44.28 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.96 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.9 mt -63.32 124.71 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.507 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HE3' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -64.12 103.14 0.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.729 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 116.597 -1.668 . . . . 0.0 111.499 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.657 0.265 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG21 ' ND1' ' A' ' 98' ' ' HIS . 69.7 t -71.63 124.54 28.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.535 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.92 147.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.38 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.446 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 4.3 mtp -143.42 110.56 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.195 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -101.38 117.13 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.783 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' HA3' ' A' ' 105' ' ' GLY . 5.7 tt0 -101.21 133.43 45.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.732 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -154.37 163.37 24.39 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.88 179.46 31.25 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.306 -1.539 . . . . 0.0 111.119 -1.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 mt -77.6 -35.97 52.3 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.563 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.98 151.57 46.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -138.26 85.6 18.27 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.797 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 106.75 1.5 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.77 1.647 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.46 -177.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.576 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.6 m -122.27 156.2 34.32 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.1 mt -67.48 86.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.32 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.77 36.3 0.07 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -135.86 166.34 23.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -94.11 137.39 33.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.236 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.67 160.24 16.1 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.57 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -149.04 90.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.628 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.669 HG23 HG21 ' A' ' 107' ' ' THR . 2.8 mt -86.62 113.61 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' THR . 7.2 t -81.21 156.3 25.72 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.654 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.8 91.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -91.0 166.63 12.91 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.978 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 p -148.39 167.36 25.46 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.996 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -79.62 -69.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -92.14 154.7 18.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.757 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -64.2 132.31 49.98 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.23 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 38' ' ' LEU . 14.3 mt -85.23 33.43 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.5 127.0 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.008 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.489 1.491 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.419 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . 5.0 m-80 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 m -107.79 99.41 8.88 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 35' ' ' ASN . 21.3 m-85 -83.85 75.78 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' A' ' 29' ' ' LEU . 5.6 tt -132.58 125.67 31.03 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.244 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 17.2 p-10 -126.06 160.84 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.839 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -108.3 174.92 5.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.498 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 27.9 m-85 -150.2 161.76 41.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.547 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 tp -160.51 111.14 1.82 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.282 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.42 161.07 17.75 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.964 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 tptt . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.855 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 54' ' ' TYR . 31.6 tp . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.858 0.361 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.536 ' O ' HG21 ' A' ' 63' ' ' VAL . 49.0 mt -108.9 -51.12 2.92 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.759 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.9 mm -127.47 134.85 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.517 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HB3' HD21 ' A' ' 51' ' ' LEU . 35.4 p90 -112.83 -21.95 10.92 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.226 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' SER . 19.6 mttp -135.33 106.54 6.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.334 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.046 HG13 ' H ' ' A' ' 57' ' ' SER . 6.3 p 29.7 -85.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.15 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.046 ' H ' HG13 ' A' ' 56' ' ' VAL . 21.4 t -114.35 48.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.238 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -125.61 108.11 11.25 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 18.9 mtt180 -73.53 144.22 46.2 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.465 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -73.41 155.35 39.41 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.984 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.8 p -59.11 98.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.622 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.56 -17.79 4.97 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 52' ' ' LEU . 95.4 t -73.56 120.11 79.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.305 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.75 150.19 86.87 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.107 1.872 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -55.07 -19.88 8.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' ' OE2' ' A' ' 84' ' ' GLU . 61.4 mtt85 -56.01 -14.39 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.497 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -115.1 128.3 56.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.043 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.91 125.43 17.76 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.33 149.46 18.59 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.084 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.46 160.13 39.28 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 175.16 159.97 22.23 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.672 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 p -90.83 -99.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.675 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.78 -37.25 0.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.2 p -121.89 17.61 10.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.71 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 9.3 t70 -152.25 125.13 8.49 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 20.9 m-85 -139.09 156.18 47.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.841 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.0 m -150.89 149.28 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.11 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.89 109.51 21.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.772 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -100.77 123.05 44.41 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.752 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mt -108.08 132.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.8 m -64.63 -60.82 2.67 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -135.98 109.61 8.02 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.47 110.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.157 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE2' ' NE ' ' A' ' 66' ' ' ARG . 4.7 mt-10 -95.26 -175.52 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.295 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.17 66.28 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.249 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 6.7 pt-20 -87.24 -32.58 19.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 60.5 m-20 -64.11 -12.58 40.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.384 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.575 ' CD1' HD11 ' A' ' 111' ' ' ILE . 20.1 mt -69.81 147.8 49.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.88 -161.16 28.25 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.557 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.2 mp -106.08 117.92 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CB ' HD13 ' A' ' 21' ' ' ILE . 25.8 m-85 -90.97 154.15 19.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.672 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 106' ' ' GLY . 45.6 m-85 -146.39 168.48 21.03 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.42 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.6 p -159.05 151.09 20.98 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.321 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.0 t -152.69 -175.34 5.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.513 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 1.1 pp0? -135.84 136.38 40.57 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.0 m -110.36 42.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -38.62 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.139 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.465 ' ND1' HG21 ' A' ' 2' ' ' VAL . 80.4 m80 -109.42 156.21 20.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.393 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 92.3 t -127.1 134.66 26.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.606 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -72.24 163.29 88.16 Favored 'Cis proline' 0 C--N 1.318 -1.045 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.731 -0.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.16 162.08 34.54 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 122.044 1.83 . . . . 0.0 111.389 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 28.5 p -87.43 -92.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.542 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 102' ' ' THR . 65.8 t80 61.99 116.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.445 0.466 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.92 54.97 0.04 OUTLIER Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.888 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.491 ' HA3' ' OE1' ' A' ' 6' ' ' GLN . . . -114.1 -120.87 3.57 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . 127.23 68.72 0.16 Allowed Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.887 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.669 HG21 HG23 ' A' ' 21' ' ' ILE . 94.3 m -86.01 106.06 16.91 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.204 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -75.53 115.84 15.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.198 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -111.34 93.47 4.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.619 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -121.93 143.86 49.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.741 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.575 HD11 ' CD1' ' A' ' 88' ' ' LEU . 17.2 mt -62.47 152.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.294 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 111' ' ' ILE . 2.0 mtpm? -63.29 123.42 18.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.316 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.878 0.37 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' HG21 ' A' ' 102' ' ' THR . 70.4 t -71.29 116.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.291 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 151.09 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 120.39 11.6 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.1 143.7 47.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.527 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 1.4 tt0 -118.23 148.2 42.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.819 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.11 154.76 18.48 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.796 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.43 178.61 33.79 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.734 -1.361 . . . . 0.0 111.102 -1.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 mt -77.05 -44.5 30.5 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.911 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.04 152.23 48.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.12 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -142.95 78.71 15.18 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.092 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.85 126.19 14.91 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.757 1.638 . . . . 0.0 109.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.43 -175.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.335 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.76 167.06 11.1 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.599 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 111' ' ' ILE . 82.3 mt -83.54 89.83 7.15 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.04 48.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 176.47 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.26 148.02 23.54 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -125.38 161.02 27.95 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -160.64 96.54 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.434 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 77' ' ' THR . 37.2 mt -86.25 139.65 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.595 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 m -107.22 145.83 32.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.8 t -153.55 118.46 5.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.901 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -123.72 156.18 36.47 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.236 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 74' ' ' THR . 65.8 p -122.03 146.58 47.03 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -58.05 -49.77 75.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -111.22 156.22 21.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -64.62 144.81 56.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.89 30.32 3.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.23 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.72 141.64 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.502 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 . . . . . 0 N--CA 1.488 1.456 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.119 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.888 0.375 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.3 m -115.32 150.34 36.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -132.2 101.44 5.38 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.463 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.03 129.18 12.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.786 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' OH ' ' A' ' 41' ' ' TYR . 12.4 p-10 -130.76 160.29 34.79 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.891 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -112.52 151.79 29.57 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' OH ' ' ND2' ' A' ' 39' ' ' ASN . 22.6 m-85 -129.31 166.59 19.17 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 91' ' ' TYR . 14.2 tp -154.53 126.68 7.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.011 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -124.03 165.83 16.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.014 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tptp . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.26 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.0 mt -113.73 -64.7 1.27 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mm -116.17 140.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.662 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.1 p90 -130.27 158.59 39.37 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.178 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.2 tptm 74.4 -67.07 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.986 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -171.07 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.494 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 p -152.43 -28.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.347 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 30.9 m-80 -51.65 129.0 24.98 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -90.25 139.59 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.44 151.12 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.694 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -59.39 104.07 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.14 -12.85 6.39 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.326 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.01 119.21 75.38 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.39 150.83 78.57 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.874 1.716 . . . . 0.0 111.828 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.51 -15.51 11.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.389 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -57.2 -18.4 15.58 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.75 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -107.43 128.62 54.64 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.0 125.54 17.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.57 144.97 17.05 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -160.44 -177.59 6.33 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.08 169.92 33.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.276 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 m -91.21 -82.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.25 -37.9 0.1 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.599 -1.286 . . . . 0.0 111.12 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 25' ' ' SER . 64.3 p -125.13 13.97 8.39 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.98 117.4 12.01 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -132.34 144.54 50.63 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.611 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ILE . 88.2 m -141.37 139.69 33.57 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.783 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -106.14 111.48 24.11 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.765 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 37.8 mttt -107.1 147.74 29.65 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.629 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.3 mt -124.77 134.84 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.435 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.5 m -67.24 -55.47 13.89 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.174 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.14 110.63 8.54 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.25 130.17 35.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.211 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.96 -172.27 2.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.758 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 -29.6 62.06 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.39 -43.09 67.49 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.86 -36.07 16.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.571 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 77.1 mt -45.24 136.34 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.35 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.56 -144.74 10.91 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.409 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.9 mp -125.0 141.07 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.489 ' CE1' HD13 ' A' ' 42' ' ' LEU . 24.6 m-85 -117.83 151.12 37.98 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -146.64 163.78 34.77 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -137.58 136.03 37.2 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.362 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 p -139.4 155.13 47.84 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.954 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.38 37.9 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -127.83 28.78 5.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.234 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 -57.57 3.19 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.596 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -105.91 159.69 15.83 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 100' ' ' PRO . 38.3 t -110.0 140.77 22.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.318 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.479 ' HA ' HG13 ' A' ' 99' ' ' VAL . 7.4 Cg_endo -77.44 163.69 88.1 Favored 'Cis proline' 0 C--N 1.315 -1.193 0 C-N-CA 123.715 -1.369 . . . . 0.0 111.824 -0.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.36 118.9 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.021 1.814 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' VAL . 19.6 p -89.9 135.32 33.71 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.741 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.38 -179.85 7.03 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.212 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.64 -175.71 41.5 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -82.93 -69.9 1.37 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 136.43 114.31 1.33 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 125.32 53.23 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.299 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.6 128.12 37.31 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.48 90.92 3.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.23 143.46 41.95 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.925 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.447 HD12 HD21 ' A' ' 15' ' ' LEU . 15.7 tt -66.66 150.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.961 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -62.61 121.37 13.17 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.649 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 98' ' ' HIS . 41.9 t -74.47 106.27 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.792 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -69.44 164.05 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.486 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -143.7 110.59 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -77.15 110.54 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.65 131.16 44.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.178 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -164.89 156.53 13.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.445 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HA ' HG22 ' A' ' 7' ' ' THR . 11.2 Cg_endo -82.86 175.22 39.49 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.372 -1.512 . . . . 0.0 110.972 -1.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.08 -39.05 21.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.485 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -129.44 143.45 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 tp -137.59 81.05 30.56 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.824 -1.151 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.54 121.74 8.48 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.773 1.649 . . . . 0.0 109.646 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.29 -178.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 118.98 -1.088 . . . . 0.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -108.6 172.92 6.56 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -89.19 89.49 7.96 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.01 28.03 0.34 Allowed Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.49 174.94 6.08 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.852 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -96.51 141.96 29.16 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -108.76 167.31 10.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.832 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -162.03 79.89 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.048 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.2 mt -75.11 133.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.207 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -105.52 155.69 18.94 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.153 -1.019 . . . . 0.0 113.312 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.41 89.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.464 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -94.42 147.41 23.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.427 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 1.2 m -111.35 163.99 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.609 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -47.86 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.41 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.454 ' C ' HG22 ' A' ' 74' ' ' THR . 11.4 tt0 -119.83 150.93 39.63 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -55.7 132.02 48.04 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.843 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.562 HD22 ' OE1' ' A' ' 95' ' ' GLN . 43.8 mt -85.28 32.62 0.55 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.27 143.46 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 21.7 t-80 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.1 m120 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.117 0.484 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' LEU . 3.2 m -108.43 146.29 33.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -129.97 124.29 32.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.38 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -150.74 154.14 36.82 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.315 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.73 160.07 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.981 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.677 ' CD2' HD13 ' A' ' 78' ' ' LEU . 84.0 m95 -129.68 146.72 51.44 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -142.25 138.21 31.24 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.679 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.658 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.1 tp -119.87 139.59 52.15 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.568 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' LEU . 12.1 mm100 -125.75 146.84 49.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.563 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.426 -179.968 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 40' ' ' TRP . 25.9 tp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.778 0.323 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.89 HD21 ' CD1' ' A' ' 67' ' ' PHE . 4.9 tp -111.03 -81.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.993 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.83 135.52 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 48.0 p90 -116.46 171.54 7.78 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' LEU . 4.8 mmtp 58.09 -150.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.007 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' VAL . 8.1 p -109.57 4.87 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.802 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -179.57 65.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -155.41 113.57 3.43 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.574 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.8 mtm-85 -76.33 138.51 40.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -76.52 164.01 26.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.543 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.3 m -55.29 130.99 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.161 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.29 35.45 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.73 116.66 52.25 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.347 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.91 148.66 91.81 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.175 1.917 . . . . 0.0 112.697 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.83 -17.71 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -57.85 -14.73 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.755 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.89 ' CD1' HD21 ' A' ' 52' ' ' LEU . 82.2 m-85 -105.56 118.95 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.948 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 p -125.94 123.75 39.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.99 118.68 2.77 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.1 p -163.95 168.71 19.0 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.5 -160.42 33.92 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.582 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 p -90.78 -174.73 4.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.3 64.42 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 27' ' ' GLN . 67.8 p -122.8 18.38 10.23 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.546 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB2' ' H ' ' A' ' 72' ' ' SER . 4.1 m-20 -140.16 131.0 25.95 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.949 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.31 127.78 14.06 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.218 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 40.5 m -135.16 131.04 36.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.576 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.1 tp -93.32 89.65 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -82.76 141.81 32.08 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.488 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -125.52 141.25 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.6 m -69.81 -73.19 0.17 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.423 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 106.24 11.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.009 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.5 106.23 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.924 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.36 168.71 11.68 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.975 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.14 -16.85 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.764 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.76 -36.36 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -26.87 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.092 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.4 mt -50.25 138.1 17.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.32 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.01 -151.24 23.49 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.746 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.93 125.51 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.517 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.658 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.4 m-85 -99.8 156.75 16.94 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.634 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -149.02 160.21 43.53 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -144.04 151.42 39.65 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.952 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 t -150.33 168.78 23.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.831 -1.148 . . . . 0.0 112.129 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.562 ' OE1' HD22 ' A' ' 29' ' ' LEU . 11.2 pt20 -123.8 171.24 9.79 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.712 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.46 20.41 1.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -90.01 -19.2 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.719 ' CD2' HG21 ' A' ' 2' ' ' VAL . 89.9 m-70 -127.77 126.85 42.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.146 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.493 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 11.9 p -110.27 138.4 20.87 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.382 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.0 Cg_endo -70.09 155.38 94.17 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.691 -1.379 . . . . 0.0 111.562 -0.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.14 156.22 56.53 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 122.157 1.905 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -89.94 -59.53 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.6 t80 65.86 118.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.007 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.72 -171.5 31.05 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.647 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.32 -174.51 15.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.39 47.36 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.079 -1.534 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -77.38 116.55 18.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.074 -1.051 . . . . 0.0 108.979 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -82.06 95.11 7.34 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.93 75.84 7.89 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.761 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.7 142.41 34.38 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.416 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 tt -77.78 159.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -62.87 140.3 58.8 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.861 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.17 147.95 6.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 t -103.64 157.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.4 mtp -142.87 112.84 7.05 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -93.44 111.82 23.57 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.492 ' CG ' ' HA2' ' A' ' 105' ' ' GLY . 1.0 OUTLIER -104.92 139.93 38.91 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.15 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.73 162.67 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.26 178.52 28.12 Favored 'Cis proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.686 -1.381 . . . . 0.0 110.731 -2.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 9' ' ' LEU . 3.6 mm? -74.81 -64.02 1.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.635 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.45 153.48 26.07 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.93 82.49 17.47 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.977 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.79 116.27 4.19 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.807 1.672 . . . . 0.0 110.457 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -140.12 -170.74 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.186 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 t -118.61 176.11 5.41 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 85' ' ' ALA . 33.6 mt -90.64 92.21 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.436 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.94 -7.64 3.25 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.484 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -172.29 4.09 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.232 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -105.72 166.95 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -140.03 160.59 39.59 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.479 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 p -159.48 89.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 91' ' ' TYR . 19.8 mt -79.41 133.77 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -97.59 147.95 23.78 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.657 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -154.81 102.72 2.38 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.572 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 25' ' ' SER . 4.1 ttt180 -111.65 147.73 34.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.636 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 34.5 m -120.39 157.25 29.69 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.6 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.2 t -65.4 -65.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.696 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' A' ' 28' ' ' SER . 8.7 tt0 -99.19 162.79 12.85 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.683 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.3 p -68.61 121.15 15.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.696 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 95' ' ' GLN . 25.2 mt -77.73 28.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.8 t -89.57 127.49 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.677 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.898 -179.848 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 m -99.99 103.28 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.52 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -84.14 121.47 27.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.919 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -173.89 135.14 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.638 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -137.46 177.31 7.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.05 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 51' ' ' LEU . 65.2 m95 -126.07 148.95 49.22 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 20.2 m-85 -128.91 161.11 30.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 7.9 tp -157.61 113.38 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.965 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -134.85 156.89 48.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.456 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.934 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 40' ' ' TRP . 10.9 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.059 0.457 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.08 -73.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mm -100.04 138.49 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.19 12.91 3.31 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.411 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -147.7 44.38 1.1 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.178 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 18.8 t 70.08 -27.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.733 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -155.16 -45.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.121 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -58.93 126.81 29.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.496 HH12 ' CG ' ' A' ' 65' ' ' ASP . 5.8 mtm180 -81.25 169.97 16.66 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CG ' ' N ' ' A' ' 61' ' ' SER . 91.6 t80 -90.07 159.51 16.79 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.295 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.418 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 4.5 m -60.66 114.91 3.25 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -17.72 16.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 99.1 t -78.36 129.55 74.53 Favored Pre-proline 0 C--N 1.306 -1.314 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.235 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -65.21 165.16 22.89 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.765 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.496 ' CG ' HH12 ' A' ' 59' ' ' ARG . 0.2 OUTLIER -78.08 -14.78 59.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.821 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.11 -11.54 31.02 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.09 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 51.1 m-85 -101.25 121.12 41.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.967 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -126.66 129.62 48.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.054 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.38 144.57 18.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -160.92 150.0 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.44 160.57 24.4 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.514 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 p -91.21 -85.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.93 -32.69 0.1 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.374 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 p -119.42 15.1 12.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.8 135.2 14.2 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -146.18 149.89 34.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.862 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 m -143.96 143.13 31.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.858 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 40' ' ' TRP . 9.1 tt -106.97 101.51 10.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.955 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -96.68 138.36 34.37 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.006 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 57.9 mt -121.3 138.4 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.79 -74.29 0.14 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.985 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.04 103.6 10.06 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.85 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.684 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.29 166.34 16.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.726 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.404 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -55.37 -25.22 34.01 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.718 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.92 -39.35 34.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.93 -14.46 61.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 109' ' ' LEU . 85.1 mt -58.21 150.99 20.21 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.531 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.34 -166.67 26.73 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.567 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.45 129.26 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.163 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 17.7 m-85 -103.18 146.31 28.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 93.8 m-85 -138.48 169.52 17.64 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.94 134.9 9.96 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.2 p -142.04 173.2 11.74 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HB3' HD13 ' A' ' 29' ' ' LEU . 4.0 pp0? -129.92 157.7 41.57 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -126.46 10.11 7.26 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.459 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 m -68.76 -32.27 71.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.628 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -114.16 124.22 51.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.2 t -104.3 138.35 19.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.315 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' A' ' 99' ' ' VAL . 4.1 Cg_endo -73.1 159.98 96.42 Favored 'Cis proline' 0 C--N 1.317 -1.113 0 C-N-CA 123.774 -1.344 . . . . 0.0 111.769 -0.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 103' ' ' PHE . 3.3 Cg_exo -60.58 141.25 94.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.137 1.891 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -91.12 -28.72 17.72 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.262 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 101' ' ' PRO . 60.5 m-85 54.46 -159.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.516 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.48 -174.2 15.88 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.492 ' HA2' ' CG ' ' A' ' 6' ' ' GLN . . . 93.74 161.92 35.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.775 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.68 56.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -79.36 110.34 14.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -80.61 99.84 8.33 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.775 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -87.96 84.73 6.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.766 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.1 147.18 32.83 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.084 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -83.32 153.33 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -57.21 131.1 48.95 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.359 -1.782 . . . . 0.0 110.442 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.04 0.448 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 98' ' ' HIS . 77.0 t -67.42 146.43 13.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.338 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.56 148.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' A' ' 95' ' ' GLN . 3.8 mtt -139.01 107.91 5.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -98.59 97.18 8.5 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.569 ' OE1' ' SG ' ' A' ' 93' ' ' CYS . 2.2 tp60 -78.82 141.95 37.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.86 158.43 26.85 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -77.77 178.13 36.23 Favored 'Cis proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.313 -1.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.34 -57.36 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.692 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.0 m -113.95 144.16 43.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.239 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.86 73.05 54.16 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.331 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.97 118.23 5.4 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.661 1.574 . . . . 0.0 110.377 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.63 -178.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.261 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.32 156.85 18.07 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.557 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.5 mt -73.89 88.25 1.82 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.605 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.81 43.95 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 179.89 6.12 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.2 148.17 22.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -125.3 157.6 36.25 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.266 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -151.09 82.73 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.75 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 mt -80.27 117.83 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.264 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -86.89 159.34 19.08 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.3 t -157.78 97.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.603 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -104.22 153.56 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.299 -0.96 . . . . 0.0 113.019 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 m -128.28 145.8 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -62.51 -50.98 69.25 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.363 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.97 145.57 38.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.078 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -57.63 139.7 52.95 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.5 mt -93.06 39.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.545 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.08 137.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.723 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' N ' HD21 ' A' ' 35' ' ' ASN . 1.2 m-80 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.961 0.41 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.46 127.85 49.33 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' OG1' ' A' ' 96' ' ' THR . 96.0 m-85 -116.67 110.5 18.56 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.639 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.73 146.79 26.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -141.03 162.18 36.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.379 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.703 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.8 m95 -128.98 150.1 50.54 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -145.02 158.01 43.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 37.8 tp -138.04 117.78 13.15 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.297 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.65 152.95 43.0 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.736 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.486 1.361 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.261 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 54' ' ' TYR . 39.4 tp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.857 0.36 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -95.93 -70.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.236 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 78' ' ' LEU . 6.4 mm -111.24 141.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.572 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' HB3' HD21 ' A' ' 51' ' ' LEU . 53.8 p90 -128.82 8.01 5.7 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.81 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 17.3 tttt -160.65 61.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 15.8 t 71.21 -65.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.007 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 p -124.77 -36.53 2.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.451 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 31.9 m120 -48.1 115.51 1.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.705 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -85.71 151.54 23.78 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -80.7 164.73 22.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.053 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.75 137.22 54.83 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 -40.01 3.04 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.2 110.2 1.78 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.685 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.35 150.69 86.28 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.94 1.76 . . . . 0.0 111.702 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -12.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.465 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -58.64 -12.57 4.28 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.474 ' HE2' ' HH ' ' A' ' 91' ' ' TYR . 29.9 m-85 -111.35 120.34 41.89 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.726 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.4 p -133.69 100.36 4.75 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.29 153.35 23.4 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.83 158.13 27.88 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.22 157.25 16.11 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.2 m -90.39 -94.26 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.85 -36.28 0.36 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -120.01 16.17 12.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.176 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -152.43 125.97 8.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.611 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.2 m-85 -142.8 138.85 30.68 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.065 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 21' ' ' ILE . 23.9 m -138.8 144.76 39.48 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.492 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.2 tp -99.62 108.69 21.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -97.53 130.39 44.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 74.5 mt -115.0 140.35 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.834 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -72.82 -62.79 1.33 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.776 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.2 102.65 7.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.672 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.39 110.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.696 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.03 175.66 5.68 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.03 -29.77 58.12 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.413 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -73.14 -28.18 62.09 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.51 -1.45 15.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 111' ' ' ILE . 89.3 mt -76.76 152.4 35.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.79 -154.97 19.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.85 134.33 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.539 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.541 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 11.3 m-85 -98.57 152.57 19.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.38 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.08 161.74 36.89 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.569 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 2.4 p -144.28 142.3 30.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -146.38 156.64 43.46 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -104.64 152.09 22.88 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.395 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -116.59 30.09 7.55 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.923 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -102.32 -60.89 1.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CD2' HG21 ' A' ' 2' ' ' VAL . 16.9 m-70 -80.0 156.01 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 100' ' ' PRO . 69.4 t -141.69 139.74 19.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.034 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.9 Cg_endo -70.11 154.74 94.33 Favored 'Cis proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.362 -1.516 . . . . 0.0 111.304 -0.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 149.6 89.72 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.963 1.775 . . . . 0.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 102' ' ' THR . 60.2 p -82.58 -59.77 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.186 -1.005 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 t80 62.04 125.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.399 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.92 -151.24 10.13 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 6' ' ' GLN . . . 88.75 -173.77 42.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.064 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.16 64.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 118.994 -1.574 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 21' ' ' ILE . 75.8 m -79.93 104.4 10.48 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.651 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 121.39 18.63 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.14 78.83 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -105.94 145.69 30.98 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.604 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 88' ' ' LEU . 17.7 mt -64.11 131.22 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.49 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -72.19 104.08 3.54 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.468 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 116.389 -1.767 . . . . 0.0 109.829 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 121.008 0.432 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.17 154.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.975 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.79 144.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 96.75 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.516 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -92.74 161.05 14.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.0 162.49 28.92 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.063 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.564 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -165.85 156.76 11.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.518 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 7' ' ' THR . 17.8 Cg_endo -88.33 177.98 19.96 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.265 -1.14 . . . . 0.0 110.665 -2.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.25 -48.32 20.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.518 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 t -122.07 153.62 38.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.0 79.87 21.71 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 118.954 -1.099 . . . . 0.0 112.387 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.23 113.32 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.646 1.564 . . . . 0.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.13 -174.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.7 p -118.31 160.07 22.29 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.62 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 111' ' ' ILE . 63.5 mt -78.89 87.41 4.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.33 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.9 35.04 0.11 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.41 -173.36 3.09 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.485 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -106.07 146.08 30.61 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.09 37.08 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -161.63 89.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.628 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -73.26 146.23 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.377 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' THR . 22.8 t -117.62 140.58 49.45 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.21 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m -146.3 101.15 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.098 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -109.3 147.81 32.05 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.156 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 p -115.03 139.61 49.72 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -49.88 -59.09 4.18 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -98.85 154.9 17.68 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.78 133.51 47.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.941 -0.703 . . . . 0.0 111.306 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.28 33.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.32 117.96 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.542 -179.944 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.741 0.305 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -99.22 96.99 8.13 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -80.87 104.8 11.63 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -151.4 146.82 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.935 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -147.56 161.21 41.58 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.011 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.704 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.1 m95 -120.09 152.88 36.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.576 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.447 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 15.0 m-85 -138.52 163.18 32.64 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.683 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 27.5 tp -146.3 100.17 3.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.697 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -97.76 142.82 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.415 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.656 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.8 0.333 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 mt -118.22 -51.64 2.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.072 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' LYS . 3.9 mm -126.41 136.2 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.738 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.3 p90 -121.86 23.33 10.11 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.158 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 175.37 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.093 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.6 t 56.87 -83.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.575 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t -121.16 43.85 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.805 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.5 m-80 -111.13 99.8 8.58 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.525 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 61.9 mtm180 -82.22 137.18 34.96 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' SER . 81.5 t80 -70.61 156.68 39.13 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.8 p -58.43 112.02 1.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.88 -24.55 7.87 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.88 126.86 93.15 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.43 ' CB ' ' HE ' ' A' ' 66' ' ' ARG . 3.3 Cg_exo -59.98 168.49 5.83 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.011 1.808 . . . . 0.0 112.52 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.78 -23.15 45.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.537 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' A' ' 64' ' ' PRO . 5.8 mtm-85 -53.86 -40.9 66.91 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.383 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 46.4 m-85 -80.0 112.25 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.64 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t -130.34 117.29 19.54 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 129.45 9.9 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 155.63 34.3 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 163.06 -172.24 39.02 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.585 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -91.3 -165.8 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.707 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.53 72.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.138 -1.03 . . . . 0.0 111.268 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 p -121.38 17.32 11.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 6.9 t0 -145.77 133.59 21.21 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.08 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CE2' HD13 ' A' ' 38' ' ' LEU . 25.2 m-85 -143.32 125.96 15.95 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.425 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -123.32 130.97 53.47 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.341 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.704 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.4 tp -91.71 85.32 5.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.139 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -78.18 142.3 38.06 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.33 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.11 125.77 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.039 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 m -61.24 -59.14 5.77 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.332 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -132.37 107.48 8.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.38 138.38 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -117.69 175.47 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.7 -29.85 69.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.701 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.33 -35.22 66.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -56.08 -30.37 61.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.717 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.3 mt -48.88 137.36 12.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.229 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.34 -147.49 16.47 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.292 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -123.64 120.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.41 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 31.5 m-85 -94.68 151.94 18.89 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.741 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -143.82 175.39 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.477 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 24.7 p -155.49 152.43 28.89 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 p -155.99 152.59 28.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.211 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 98' ' ' HIS . 3.6 pt20 -108.73 148.75 30.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.106 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.19 40.87 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.746 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.91 -57.2 2.07 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.189 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.425 ' HB2' HE22 ' A' ' 95' ' ' GLN . 73.1 m80 -96.18 167.84 10.96 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.323 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.4 t -131.65 137.93 31.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.169 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.5 Cg_endo -70.42 151.67 93.33 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.748 -0.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.3 122.1 10.39 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.762 1.642 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 p -91.09 128.17 36.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -89.92 -175.56 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.96 41.43 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.91 -59.99 2.01 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.907 -1.14 . . . . 0.0 111.093 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.99 101.36 0.63 Allowed Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.571 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.0 m -94.13 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -84.97 134.51 34.24 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.462 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 98.07 5.49 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -121.94 142.22 50.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.43 HD12 HD11 ' A' ' 15' ' ' LEU . 13.2 tt -64.74 146.74 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.238 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 108.82 2.53 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.024 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.484 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.166 0.508 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 46.9 t -86.35 124.35 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.193 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.27 137.44 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.656 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 87.0 mmm -122.82 95.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 137.2 37.42 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.907 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 13.3 tt0 -124.34 148.57 47.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.767 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.86 156.53 17.33 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.425 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HA ' HG22 ' A' ' 7' ' ' THR . 6.9 Cg_endo -78.65 178.52 34.05 Favored 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.664 -1.39 . . . . 0.0 111.274 -1.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -77.7 -34.43 52.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.204 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 p -138.6 158.0 45.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -145.9 85.65 7.55 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.781 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.5 109.05 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.644 1.563 . . . . 0.0 110.307 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.5 m -133.93 176.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.011 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -104.71 168.96 8.73 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.412 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 111' ' ' ILE . 65.6 mt -81.88 88.0 6.36 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.64 51.63 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.61 163.45 32.8 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.771 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -85.23 142.28 29.53 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.45 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -121.97 166.55 14.29 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.079 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 13.5 p -162.58 94.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.173 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.727 HD12 ' HB3' ' A' ' 78' ' ' LEU . 3.2 mt -87.98 118.42 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -83.1 157.03 22.99 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.488 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.2 t -162.17 112.6 1.56 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.196 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -118.53 144.77 45.83 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 1.4 m -104.88 151.29 24.03 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 m -78.06 0.65 23.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -156.65 134.14 10.75 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.14 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -55.53 124.48 17.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 95' ' ' GLN . 6.0 mt -91.5 31.35 1.18 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.415 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.9 t -88.09 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.63 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.466 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.905 0.383 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -103.59 103.39 13.32 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.091 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -81.72 98.29 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.037 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -147.53 138.03 23.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.676 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 6.9 p-10 -140.38 174.75 10.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.295 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 78' ' ' LEU . 67.9 m95 -122.48 148.59 44.97 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.264 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.64 164.14 21.24 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 26.1 tp -158.65 116.57 2.91 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.9 161.52 32.84 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.535 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.114 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 60' ' ' PHE . 18.0 tp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 63' ' ' VAL . 20.2 mt -111.86 -89.4 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.6 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.588 HG21 ' HA3' ' A' ' 69' ' ' GLY . 11.5 mm -99.12 133.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.293 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 26.0 p90 -133.9 174.67 10.22 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER 52.34 34.61 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.519 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 75.74 -37.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.117 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 58' ' ' ASN . 21.0 p -144.09 -41.24 0.27 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.698 -1.201 . . . . 0.0 112.918 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 7.8 m120 -37.52 122.03 0.9 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.138 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 65' ' ' ASP . 25.2 mtm180 -91.59 126.5 36.69 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CD1' HD23 ' A' ' 51' ' ' LEU . 15.4 t80 -54.36 149.86 9.56 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 112.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.898 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.65 -22.82 11.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.714 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 52' ' ' LEU . 88.7 t -56.95 120.12 35.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.051 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -58.4 138.76 87.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.705 1.603 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 9.3 p-10 -54.15 -22.85 12.25 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 mtm-85 -58.6 -18.74 32.57 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -93.23 114.19 26.61 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.586 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.39 90.34 3.31 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA3' HG21 ' A' ' 53' ' ' ILE . . . -94.03 129.38 9.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -164.35 -173.42 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.517 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 150.53 -179.64 27.08 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.043 -1.551 . . . . 0.0 111.83 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -93.2 -140.75 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.79 -35.57 13.01 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.3 p -123.79 13.18 9.22 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.6 m-20 -132.41 130.36 40.52 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -144.44 145.71 32.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.991 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 m -150.28 140.48 22.18 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.634 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.727 ' HB3' HD12 ' A' ' 21' ' ' ILE . 4.1 tt -98.5 102.8 14.65 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.95 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -93.93 122.08 36.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 31.2 mt -106.15 138.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.692 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -72.03 -70.22 0.35 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.89 105.24 9.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.89 104.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.01 173.86 7.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.15 48.37 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.43 -39.7 62.42 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.329 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.86 -8.34 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.81 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 111' ' ' ILE . 94.5 mt -69.68 148.89 48.68 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.881 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.13 -159.85 24.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.64 135.7 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.25 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.425 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 26.8 m-85 -100.22 151.77 21.05 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.386 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.78 147.94 38.13 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.1 p -128.32 139.92 52.14 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.191 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.463 ' HG ' ' HD2' ' A' ' 103' ' ' PHE . 2.3 t -144.78 164.26 31.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.077 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.502 HE22 ' HB2' ' A' ' 98' ' ' HIS . 1.4 pt20 -117.48 163.19 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.231 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.56 32.75 2.76 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.029 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.8 m -99.69 -34.07 10.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.501 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.502 ' HB2' HE22 ' A' ' 95' ' ' GLN . 26.2 m80 -107.97 167.45 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.933 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.485 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 43.8 t -136.73 135.75 20.71 Favored Pre-proline 0 N--CA 1.49 1.53 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.8 Cg_endo -70.29 151.76 93.09 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.481 -1.466 . . . . 0.0 111.497 -0.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.01 125.84 20.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.759 1.639 . . . . 0.0 110.209 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 1' ' ' ASP . 11.0 p -93.81 118.31 31.27 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.156 -1.017 . . . . 0.0 112.093 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HD2' ' HG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -105.17 -175.13 2.7 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.292 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.4 177.31 18.24 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.397 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.07 175.97 22.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.408 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 169.87 62.05 0.04 OUTLIER Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.054 -1.545 . . . . 0.0 110.801 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' PRO . 26.5 m -78.21 105.37 9.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -74.82 105.43 5.88 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.19 90.62 4.42 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.993 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.4 146.17 45.59 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 15' ' ' LEU . 10.5 mt -60.69 127.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.23 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 8.8 tmtt? -54.49 129.16 34.99 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.417 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.141 -1.885 . . . . 0.0 110.431 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.938 0.399 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.493 HG21 ' ND1' ' A' ' 98' ' ' HIS . 83.8 t -71.33 122.42 23.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.081 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.06 148.22 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.29 119.73 8.45 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -117.16 122.94 45.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.966 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.615 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 5.9 mp0 -95.39 146.73 24.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.09 157.05 21.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.631 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 7' ' ' THR . 8.5 Cg_endo -76.33 175.58 47.53 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.528 -1.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.77 -34.13 52.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.308 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.11 159.32 42.06 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 tp -145.3 75.02 13.94 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.26 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.57 115.32 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.95 1.767 . . . . 0.0 110.424 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.66 -172.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.737 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.3 154.16 32.78 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.021 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.44 87.76 0.2 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.61 47.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -144.15 175.24 10.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -93.99 154.13 17.82 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -122.55 159.22 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -160.78 83.51 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 77' ' ' THR . 5.7 mt -82.35 125.85 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.801 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -88.64 154.19 20.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.057 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.615 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 9.8 m -157.3 107.41 2.23 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -119.6 164.74 15.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.277 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.3 p -136.52 165.17 26.48 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.269 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 m -78.65 -29.0 45.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.767 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.29 145.04 51.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.375 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.3 m -58.8 126.83 29.28 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.347 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.6 32.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.81 147.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.032 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.081 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m120 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.997 0.427 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.6 m -109.02 144.78 36.57 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.153 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -125.89 107.65 10.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.04 134.16 19.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.659 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -129.55 162.19 28.78 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.321 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 52.5 m95 -114.99 160.26 19.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -147.69 127.09 13.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.783 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.585 HD13 ' CE1' ' A' ' 91' ' ' TYR . 25.2 tp -117.97 109.7 16.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.255 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -121.01 152.09 39.0 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.624 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm . . . . . 0 N--CA 1.486 1.374 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.35 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.31 -60.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 58' ' ' ASN . 5.3 mm -120.26 140.11 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.799 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.9 p90 -121.54 2.12 10.13 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.248 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.62 ' C ' HG13 ' A' ' 56' ' ' VAL . 61.1 tttt -153.79 50.34 0.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER 65.11 -58.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.141 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -126.64 54.49 1.59 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.328 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -146.61 105.2 3.82 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.862 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 34.2 mtm180 -71.75 147.65 47.12 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.631 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -86.34 169.52 12.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.767 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -59.89 129.34 41.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.355 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.61 -23.92 25.9 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.017 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.63 115.21 18.38 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.23 151.43 82.29 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.922 1.748 . . . . 0.0 111.954 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.56 -18.31 18.77 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' CD ' ' A' ' 84' ' ' GLU . 59.8 mtt85 -53.3 -10.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.516 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 93.0 m-85 -116.49 125.31 51.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.961 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.56 119.64 14.5 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.268 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.29 159.9 13.42 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.89 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.9 p -158.32 175.91 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.196 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 164.2 151.78 6.67 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.3 m -93.82 -71.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -49.36 0.04 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.635 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.5 p -115.83 13.35 16.07 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.75 127.82 33.58 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.442 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 87.3 m-85 -144.73 130.5 19.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 21' ' ' ILE . 55.4 m -136.03 139.22 42.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.042 -1.063 . . . . 0.0 112.129 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 9.2 tt -98.64 114.81 27.44 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -108.7 140.63 41.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 77.9 mt -120.75 137.07 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.58 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -69.82 -63.93 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.236 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -124.52 104.93 9.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.2 112.68 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -97.01 -149.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.583 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.47 -30.27 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.07 -33.47 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.613 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.59 -15.64 40.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD11 HD11 ' A' ' 111' ' ' ILE . 58.4 mt -67.75 147.75 52.19 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.295 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.6 -153.11 23.42 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.143 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -117.42 123.18 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' CE1' HD13 ' A' ' 42' ' ' LEU . 18.0 m-85 -91.77 155.3 18.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.982 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -146.65 167.21 24.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.2 p -157.25 145.93 19.68 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.76 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 m -144.41 171.39 14.4 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.467 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -115.55 151.66 34.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.303 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.36 18.28 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.033 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.9 m -91.32 -22.99 20.26 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.493 ' ND1' HG21 ' A' ' 2' ' ' VAL . 67.0 m80 -122.23 132.44 54.43 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.071 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 100' ' ' PRO . 59.2 t -114.3 139.28 23.63 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.448 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.4 Cg_endo -71.35 159.37 94.27 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.774 -0.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.33 144.13 94.77 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.933 1.756 . . . . 0.0 110.996 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -81.05 -63.88 1.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.521 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 5.7 t80 61.86 157.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.35 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.01 -157.89 27.47 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.681 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 6' ' ' GLN . . . 93.41 -156.73 22.81 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.408 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.22 63.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.284 -1.436 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' PRO . 68.2 m -77.9 107.98 10.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.351 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -76.91 107.61 9.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.169 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 tt -101.71 84.28 2.54 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 147.9 33.04 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.608 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 88' ' ' LEU . 17.3 mt -67.05 129.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -66.24 115.94 6.76 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.003 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.437 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 17.4 mtt180 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.504 -1.712 . . . . 0.0 111.044 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.657 0.265 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.55 150.72 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 118.806 -1.158 . . . . 0.0 110.956 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 4' ' ' MET . 12.5 t -96.85 160.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.149 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.442 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.35 113.25 5.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -101.31 125.16 47.92 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.409 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.621 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -110.92 135.18 51.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.039 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.82 158.11 26.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.826 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.5 Cg_endo -78.67 176.89 40.84 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.492 -1.461 . . . . 0.0 111.317 -1.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -79.98 -40.51 27.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.538 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -132.08 150.89 52.04 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.6 tp -143.15 82.11 12.12 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.814 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.85 107.88 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.586 1.524 . . . . 0.0 110.041 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 11' ' ' LEU . 5.1 m -129.66 178.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.227 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -109.11 158.14 18.06 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.146 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.83 88.39 1.02 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.678 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.34 -10.77 1.53 Allowed Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -168.11 1.75 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.229 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.66 156.3 22.99 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -113.64 162.69 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 p -162.4 75.3 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.004 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 77' ' ' THR . 11.2 mt -80.21 121.01 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.979 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.2 t -89.0 157.25 18.43 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.621 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.6 m -160.18 108.52 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.311 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -113.27 155.91 24.26 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.096 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -127.71 139.49 52.66 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -53.42 -53.0 57.59 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -106.4 153.35 22.37 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.449 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.4 p -63.4 122.06 15.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.257 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 29.6 mt -75.81 28.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.017 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' SER . 51.9 t -90.06 144.38 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.474 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.506 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.874 0.368 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 m -106.03 155.11 19.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.065 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -128.37 138.42 52.35 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.761 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -165.14 166.36 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.847 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -163.41 149.1 11.47 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.118 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.479 ' CD2' HD12 ' A' ' 78' ' ' LEU . 64.1 m95 -117.72 154.27 31.96 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -144.94 151.38 38.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 91' ' ' TYR . 17.8 tp -132.25 81.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.406 ' N ' ' CD ' ' A' ' 43' ' ' GLN . 3.1 mp0 -57.05 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.13 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.082 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 52' ' ' LEU . 15.7 tp . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.1 mp -122.11 -67.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.645 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 56' ' ' VAL . 5.5 mm -128.29 153.42 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.021 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 5.1 p90 -136.35 -65.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.48 73.49 5.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.227 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 53' ' ' ILE . 10.4 t 62.57 -74.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.927 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.2 t -117.67 -8.78 10.85 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.3 m120 -60.71 121.27 11.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' A' ' 65' ' ' ASP . 5.6 mtt-85 -97.15 161.13 13.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -86.38 152.93 22.31 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -55.52 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.14 -29.98 2.38 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 121.15 74.78 Favored Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.601 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.88 138.51 86.08 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.752 1.635 . . . . 0.0 111.641 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' A' ' 59' ' ' ARG . 2.6 t70 -54.48 -14.3 1.22 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HE ' ' N ' ' A' ' 66' ' ' ARG . 1.1 mmp_? -57.54 -19.15 23.21 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -100.16 130.47 46.3 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.309 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 p -139.82 121.24 15.05 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.295 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.91 133.4 11.37 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.224 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.2 140.94 35.97 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.83 154.36 12.75 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.7 m -91.28 -79.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.276 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.33 -34.72 0.1 OUTLIER Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.671 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.4 p -121.65 19.19 11.16 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -151.74 126.82 9.79 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.624 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -141.21 138.23 33.17 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 50.0 m -135.86 149.9 49.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.239 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 40' ' ' TRP . 7.1 tt -109.27 109.12 19.95 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 14.2 mttm -110.53 139.36 45.84 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.232 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.93 132.7 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.619 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.5 m -61.73 -56.41 19.87 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.764 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.37 103.34 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.78 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.01 129.66 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -109.23 -171.86 1.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.46 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.4 63.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.51 -32.46 73.39 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -21.36 50.43 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.606 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.54 143.32 50.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.1 -155.59 26.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 90' ' ' ILE . 4.1 mt -114.18 114.74 47.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 42' ' ' LEU . 7.2 m-85 -88.56 152.76 21.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.494 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -148.61 165.7 30.52 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.598 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.92 152.96 31.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.829 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -156.34 178.98 9.69 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.028 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -132.53 142.77 49.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.5 p -115.28 22.67 13.09 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.561 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.85 60.2 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.985 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -111.39 148.84 32.17 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER -118.85 142.16 31.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.971 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 99' ' ' VAL . 1.0 OUTLIER -70.09 162.99 83.88 Favored 'Cis proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.984 -1.257 . . . . 0.0 111.972 -0.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.96 142.41 81.52 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -79.42 -61.62 1.95 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.981 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 88.1 t80 61.93 161.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.13 -165.7 27.71 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 107.9 -149.98 16.85 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.495 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.71 56.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.4 m -78.79 106.49 10.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -71.16 97.49 1.52 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.411 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tp -88.56 83.5 6.79 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.558 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.14 144.9 38.08 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.61 159.38 3.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -55.92 -29.81 60.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 116.483 -1.722 . . . . 0.0 111.107 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' CE1' ' A' ' 98' ' ' HIS . 57.7 t -71.6 140.03 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.949 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.41 155.59 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mtt -145.54 114.1 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.007 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -100.11 129.26 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.532 HE22 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.7 140.98 37.92 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.51 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -163.84 145.16 7.12 Favored Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.16 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 107' ' ' THR . 9.5 Cg_endo -81.15 -176.51 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.8 -1.334 . . . . 0.0 111.165 -2.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.532 HD23 HE22 ' A' ' 6' ' ' GLN . 14.5 mt -85.19 -46.6 10.92 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.7 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -124.12 158.42 32.33 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.914 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -146.74 85.0 7.31 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.953 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.43 121.62 8.38 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.846 1.698 . . . . 0.0 110.225 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 11' ' ' LEU . 3.6 m -143.39 -170.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.06 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -132.15 161.9 32.21 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -71.08 87.9 0.77 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.186 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.21 30.68 0.1 OUTLIER Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -125.58 -176.33 3.57 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.083 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -114.82 138.84 50.29 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.645 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -114.64 157.86 22.53 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.298 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 2.7 m -155.44 91.24 1.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.836 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.521 HD12 HD22 ' A' ' 78' ' ' LEU . 5.9 mt -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.607 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' THR . 8.0 t -104.25 145.5 30.13 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.777 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.27 98.45 2.81 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.466 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.43 154.53 19.33 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.409 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 p -129.9 143.05 50.6 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.901 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -53.66 -71.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.482 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -82.08 152.24 26.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.3 p -66.52 131.45 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' C ' HG21 ' A' ' 97' ' ' THR . 26.8 mt -78.58 30.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.236 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.0 t -97.26 133.44 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.9 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 . . . . . 0 N--CA 1.488 1.457 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.153 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.884 0.373 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 m -109.37 157.49 18.85 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -137.46 108.87 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.172 -1.011 . . . . 0.0 112.491 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.81 128.63 8.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.261 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 28.0 m-20 -125.15 167.71 14.44 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.505 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.512 ' O ' HD12 ' A' ' 51' ' ' LEU . 57.5 m95 -124.09 152.14 43.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.438 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 29.3 m-85 -135.34 156.37 49.05 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.282 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 15.4 tp -146.51 117.37 7.67 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.241 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -125.58 158.2 35.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.338 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.128 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' TRP . 45.0 tp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -102.72 -67.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.231 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -119.4 142.44 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.3 p90 -145.06 167.82 21.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.078 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER 60.85 15.37 5.92 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.461 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER 78.58 5.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.681 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 4.1 m-20 -44.11 128.39 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.661 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.565 HH21 ' N ' ' A' ' 65' ' ' ASP . 11.7 mtm-85 -97.29 146.31 25.26 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.165 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.81 159.32 34.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.639 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -58.04 122.28 12.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.43 -18.06 45.63 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.35 116.48 53.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.693 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.496 ' C ' HH21 ' A' ' 59' ' ' ARG . 1.1 Cg_endo -65.89 172.66 8.07 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.137 1.891 . . . . 0.0 112.423 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.565 ' N ' HH21 ' A' ' 59' ' ' ARG . 1.2 m-20 -78.05 -15.81 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -56.2 -27.15 53.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.169 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -96.66 118.99 34.31 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.286 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -128.03 91.21 3.23 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.924 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.51 127.62 8.8 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 t -160.96 178.37 9.44 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.58 -178.5 42.58 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.541 -1.314 . . . . 0.0 110.836 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -92.88 -85.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.039 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.2 -34.84 0.11 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.57 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.8 p -124.17 6.6 8.5 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.42 118.36 16.31 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -133.61 153.13 51.91 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 16.1 m -154.2 145.89 23.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.83 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 21' ' ' ILE . 1.9 tt -96.71 99.62 11.21 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.587 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -91.1 122.58 33.87 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.247 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 19' ' ' ALA . 45.0 mt -112.5 133.04 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m -70.31 -71.86 0.22 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.665 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.81 102.45 9.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.518 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.7 131.47 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -117.05 -173.9 2.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.302 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.24 -25.36 61.59 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.72 -32.11 59.91 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.07 -31.74 70.29 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.74 139.44 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.583 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.29 -150.72 22.8 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.436 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.6 mp -122.09 121.38 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.463 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.464 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-85 -93.11 151.28 19.95 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.174 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 46.9 m-85 -143.23 164.32 30.52 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.192 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.26 151.48 36.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.9 p -157.22 157.3 34.07 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.178 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 146.96 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -126.14 27.9 6.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.504 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.479 HG21 ' C ' ' A' ' 29' ' ' LEU . 1.1 m -77.98 -33.87 51.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.171 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.632 ' CE1' HG21 ' A' ' 2' ' ' VAL . 73.1 m80 -105.81 -43.56 4.86 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.581 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER 66.45 140.12 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.574 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.581 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 0.9 OUTLIER -66.67 168.65 50.54 Favored 'Cis proline' 0 C--N 1.318 -1.029 0 C-N-CA 123.901 -1.291 . . . . 0.0 111.903 -0.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.24 134.56 46.02 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.172 1.915 . . . . 0.0 111.788 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 p -78.09 -57.39 3.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.715 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 80.2 t80 62.7 164.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.449 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 139.91 -157.57 25.4 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.65 -137.26 19.93 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.18 68.06 0.38 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.418 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 8' ' ' PRO . 12.1 m -78.31 114.89 17.62 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.713 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -77.39 111.33 12.97 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.682 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 89.39 2.98 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.775 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.45 144.55 48.62 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.1 tt -66.41 150.94 10.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -53.43 135.69 39.04 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.966 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 116.39 -1.767 . . . . 0.0 110.945 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 102' ' ' THR . 7.6 t -76.64 142.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.158 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.54 148.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.634 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mmt -134.26 104.97 6.4 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.627 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 m -100.49 129.71 46.47 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.31 147.38 32.77 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.281 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.72 7.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.806 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 107' ' ' THR . 12.1 Cg_endo -83.94 171.78 47.36 Favored 'Cis proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.005 -1.248 . . . . 0.0 111.502 -0.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.758 HD22 ' H ' ' A' ' 9' ' ' LEU . 1.7 mm? -74.41 -42.43 59.23 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.01 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 p -125.96 146.05 50.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.101 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.3 tp -137.69 74.6 45.38 Favored Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.48 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.37 117.94 5.12 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.536 1.491 . . . . 0.0 109.877 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 11' ' ' LEU . 6.3 m -139.4 -174.67 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -113.05 172.16 7.11 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.725 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.75 86.23 7.37 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.828 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.57 33.4 0.06 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.714 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.23 -173.7 3.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.097 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.47 137.28 52.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.984 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 166.77 11.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.641 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 p -162.23 76.83 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 77' ' ' THR . 19.1 mt -79.23 140.03 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.248 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 t -113.35 152.59 29.76 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.741 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.8 m -156.43 99.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.598 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 75' ' ' ASP . 9.9 mtm180 -110.02 152.63 25.67 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.943 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 p -118.64 150.65 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.317 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -58.5 -45.76 88.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.665 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.63 174.66 5.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.861 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 t -74.04 146.66 43.54 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.9 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.515 ' C ' HG21 ' A' ' 97' ' ' THR . 83.0 mt -101.09 30.51 4.08 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.78 131.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.571 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.723 0.297 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 137.22 36.17 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -117.78 105.36 11.89 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' CD2' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -145.14 143.12 30.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.346 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -134.7 154.72 51.43 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.247 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.522 ' O ' HD12 ' A' ' 51' ' ' LEU . 82.6 m95 -123.49 147.41 47.24 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -140.77 145.84 36.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.547 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.8 tp -130.67 115.54 16.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.87 138.05 54.55 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.749 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 40' ' ' TRP . 22.5 tp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.756 0.312 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.427 ' HA ' HG21 ' A' ' 63' ' ' VAL . 3.8 mp -107.8 -52.43 2.76 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.939 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 55' ' ' LYS . 2.0 mm -129.3 134.42 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.507 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -112.27 39.04 2.53 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 179.22 -167.14 0.07 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.632 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' H ' ' HG3' ' A' ' 55' ' ' LYS . 27.5 t -76.82 -13.31 14.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.85 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.462 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.448 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -170.88 107.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.236 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 31.8 mtm180 -74.38 150.22 40.15 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -80.1 163.73 23.91 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.629 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -63.73 89.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.802 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.47 -28.54 2.32 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' A' ' 52' ' ' LEU . 49.8 t -70.4 116.93 50.05 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.94 148.49 76.01 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.104 1.869 . . . . 0.0 112.874 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 2.9 m-20 -57.8 -8.81 1.03 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -20.67 63.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.927 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.47 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 94.9 m-85 -105.51 119.67 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.708 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.9 p -125.51 107.4 10.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.68 139.01 14.3 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.198 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.6 p -156.2 146.12 21.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.082 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -173.63 168.71 41.68 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 p -94.44 -105.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.437 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.73 -33.72 1.26 Allowed Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.026 -1.083 . . . . 0.0 110.483 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.6 p -126.87 10.09 7.0 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.964 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 11.9 t0 -136.68 130.65 32.46 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.071 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 70.0 m-85 -145.03 147.9 33.12 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.533 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 21' ' ' ILE . 53.3 m -149.8 133.14 16.49 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.656 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -93.74 114.8 27.15 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.468 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -113.66 145.21 41.66 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.825 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.439 HG12 ' CD1' ' A' ' 67' ' ' PHE . 67.3 mt -123.08 143.22 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.746 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -70.61 -57.76 4.39 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.547 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 8.7 ptm180 -129.48 107.35 9.41 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.659 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.47 105.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.33 -163.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.86 -30.14 50.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.49 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -26.13 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.708 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.1 -21.9 62.16 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.49 137.46 48.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.78 -158.73 27.76 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.25 124.82 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.568 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.6 m-85 -94.16 153.4 18.11 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.297 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.07 170.26 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.73 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.6 p -151.72 152.57 32.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 p -154.89 164.38 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 160.72 29.55 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -134.58 24.24 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.814 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.515 HG21 ' C ' ' A' ' 29' ' ' LEU . 17.1 m -79.92 -43.74 21.61 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.752 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.19 141.69 51.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.788 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 3.2 t -95.98 141.47 23.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 9.3 Cg_endo -77.46 163.51 88.42 Favored 'Cis proline' 0 C--N 1.317 -1.102 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.193 -0.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 2.3 Cg_endo -67.87 117.43 4.89 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.029 1.819 . . . . 0.0 110.347 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 2' ' ' VAL . 20.8 p -90.39 104.25 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.992 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -86.34 150.39 24.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.18 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.05 170.72 42.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.1 -149.74 18.63 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 40.91 1.29 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' PRO . 95.8 m -79.23 106.42 11.25 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -71.86 112.93 8.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.221 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.61 80.25 1.45 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.56 140.84 34.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.582 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.4 tt -71.8 150.48 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -54.92 128.9 35.48 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.111 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.082 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.078 0.466 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.94 110.57 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.96 141.23 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 5.1 mtp -128.21 105.19 8.19 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.09 143.1 37.66 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.11 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -130.59 135.68 48.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.337 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.18 157.3 24.73 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.112 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 7' ' ' THR . 10.1 Cg_endo -78.66 176.46 42.6 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.563 -1.432 . . . . 0.0 111.362 -1.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.744 HD22 ' N ' ' A' ' 9' ' ' LEU . 2.2 mm? -78.96 -44.35 22.63 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.161 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -128.09 144.4 51.11 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.627 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 tp -132.31 78.17 68.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.039 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.81 108.32 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.621 1.547 . . . . 0.0 110.231 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.91 -173.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.976 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -119.1 173.18 7.07 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.675 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -88.04 90.12 8.26 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.94 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.35 42.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -170.56 2.94 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.758 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -109.16 140.68 42.43 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.071 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . . . -108.95 159.24 16.98 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.75 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -157.43 88.56 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' THR . 4.0 mt -81.19 128.71 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.794 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.15 140.42 30.89 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.029 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.8 t -153.88 110.83 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.792 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.23 173.39 6.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.683 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 79.5 p -132.23 166.99 20.62 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.333 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -72.85 -50.85 21.44 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.94 161.01 17.5 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.359 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' VAL . 64.4 m -59.98 126.35 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.408 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 29' ' ' LEU . 76.6 mt -79.98 29.93 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.9 t -98.85 137.49 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.556 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.802 0.335 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.8 m -113.86 109.44 18.53 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -98.05 109.74 22.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.057 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -154.07 127.75 8.72 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.615 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.559 ' N ' HD23 ' A' ' 38' ' ' LEU . 12.9 p-10 -130.67 152.78 49.65 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD2' HD13 ' A' ' 78' ' ' LEU . 53.7 m95 -115.78 158.35 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 16.9 m-85 -137.14 156.01 48.89 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.596 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 91' ' ' TYR . 9.1 tp -140.6 127.03 19.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.13 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -131.64 155.92 46.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.036 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.272 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 54' ' ' TYR . 27.7 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.094 0.473 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.4 -49.65 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.81 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.563 HG13 HD11 ' A' ' 78' ' ' LEU . 6.1 mm -127.54 135.43 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.495 ' HB3' HD21 ' A' ' 51' ' ' LEU . 51.1 p90 -122.62 -11.25 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.567 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.22 88.57 2.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.376 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.684 HG13 ' N ' ' A' ' 57' ' ' SER . 1.5 p 45.26 -68.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 124.348 1.03 . . . . 0.0 113.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.684 ' N ' HG13 ' A' ' 56' ' ' VAL . 53.9 p -130.32 28.73 4.95 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.4 m-80 -103.78 111.55 24.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -75.87 152.23 37.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.649 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 33.4 t80 -88.78 167.18 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t -59.79 132.69 54.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.692 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.11 -17.46 56.9 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -73.58 117.69 62.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.8 144.42 96.91 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.731 1.621 . . . . 0.0 111.667 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.99 -10.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -62.27 -19.92 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.54 122.69 46.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.254 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.13 121.32 13.83 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.41 147.78 17.49 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.41 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -161.35 161.1 30.33 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.5 173.45 44.65 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -91.21 -87.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.47 -34.76 0.11 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -120.95 17.86 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.572 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -155.01 126.2 7.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.986 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CG ' ' CD1' ' A' ' 38' ' ' LEU . 7.5 m-85 -141.56 153.53 44.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 21' ' ' ILE . 18.8 m -148.34 142.38 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.733 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.6 tp -101.83 115.09 29.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.065 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -111.17 151.11 28.58 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.635 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -127.89 134.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.94 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.6 m -67.35 -49.9 62.12 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.84 103.64 5.94 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 98.7 t -68.09 117.76 10.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.079 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -108.47 -177.93 3.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.95 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.94 -42.93 56.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.68 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.03 -19.66 53.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 88' ' ' LEU . 73.4 mt -52.67 147.84 8.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.746 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.36 -160.42 25.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.14 151.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.046 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' HD13 ' A' ' 42' ' ' LEU . 13.3 m-85 -123.57 148.69 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.565 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -141.66 162.94 34.25 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.3 p -144.86 125.16 13.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.436 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.5 p -120.64 161.85 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.545 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.532 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -125.97 150.7 47.83 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.895 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 52.13 1.61 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.634 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -50.08 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.353 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' H ' HE22 ' A' ' 95' ' ' GLN . 73.5 m80 -112.51 163.38 14.54 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.269 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 100' ' ' PRO . 11.2 p -117.98 139.78 26.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.519 ' HA ' HG23 ' A' ' 99' ' ' VAL . 7.0 Cg_endo -75.75 156.68 99.01 Favored 'Cis proline' 0 C--N 1.315 -1.201 0 C-N-CA 123.69 -1.379 . . . . 0.0 111.71 -0.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.04 120.19 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.977 1.784 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.7 p -91.28 136.19 33.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.397 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.67 176.42 8.17 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.6 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.66 -161.95 37.85 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 6' ' ' GLN . . . -87.98 -79.3 1.27 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.307 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.89 95.09 0.15 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 21' ' ' ILE . 95.2 m -92.29 117.33 29.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.561 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -85.51 114.53 22.6 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.318 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.4 93.42 4.59 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.802 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.8 139.18 52.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.85 156.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -55.34 152.32 8.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.707 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.697 HG21 ' CE1' ' A' ' 98' ' ' HIS . 47.8 t -67.02 152.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.981 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 4' ' ' MET . 3.8 t -96.94 166.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.265 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -148.76 115.45 5.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.516 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -95.85 140.8 30.11 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.012 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.14 46.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.538 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.99 158.02 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.932 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.8 Cg_endo -79.69 175.1 46.49 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.429 -1.488 . . . . 0.0 110.538 -1.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.6 mm? -77.75 -43.96 29.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.801 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.7 m -126.14 146.05 50.1 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -136.09 78.03 47.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.62 112.27 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.79 1.66 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.34 178.96 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.386 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -110.34 174.58 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.787 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 HD13 ' A' ' 111' ' ' ILE . 15.3 mt -85.95 87.73 7.46 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.77 52.72 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.5 179.38 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.75 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -100.49 141.31 33.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.455 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -113.37 165.76 12.13 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -159.55 91.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.591 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 77' ' ' THR . 25.9 mt -79.31 152.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 m -121.48 140.99 51.47 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.188 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -149.25 110.9 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HE ' ' CG ' ' A' ' 75' ' ' ASP . 58.0 mtp180 -113.13 163.48 14.7 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.514 -0.874 . . . . 0.0 112.184 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.2 p -133.47 147.73 51.68 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.3 m -62.72 -41.05 98.96 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.94 159.26 22.72 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -70.68 129.58 39.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.53 34.41 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.72 147.74 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 . . . . . 0 N--CA 1.49 1.553 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.464 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 56' ' ' VAL . 2.9 m -79.26 153.42 29.94 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.651 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -124.09 89.03 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.779 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 76' ' ' PHE . 1.1 tt -155.37 134.49 12.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.181 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -129.42 150.15 50.9 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.044 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD13 ' A' ' 78' ' ' LEU . 86.5 m95 -103.96 153.32 20.96 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.346 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.54 130.26 9.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.8 tp -109.83 142.81 40.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.569 ' H ' HD12 ' A' ' 42' ' ' LEU . 53.0 tt0 -125.3 137.64 54.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.822 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.475 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 53' ' ' ILE . 13.5 tp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.709 0.29 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 67' ' ' PHE . 1.1 tp -99.63 -62.47 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.586 ' O ' HD11 ' A' ' 51' ' ' LEU . 1.2 mm -126.25 149.46 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.015 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.567 ' HB3' HD21 ' A' ' 51' ' ' LEU . 42.6 p90 -137.99 160.8 38.36 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.358 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.03 -63.69 0.41 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.629 0.58 . . . . 0.0 110.133 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 57' ' ' SER . 7.0 p -172.39 -37.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.756 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 49.6 m -150.5 -25.64 0.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.016 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 34.8 m-80 -53.31 120.92 6.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.274 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' NH2' ' HA ' ' A' ' 65' ' ' ASP . 13.4 mtm180 -76.55 151.29 36.39 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -90.27 167.82 12.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.731 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 t -62.62 121.69 13.99 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 103.27 -8.96 53.55 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.62 113.8 58.13 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.342 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -66.0 155.39 69.78 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.129 1.886 . . . . 0.0 112.315 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' NH2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -57.39 -13.21 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.345 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -62.79 -18.29 62.47 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.026 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.487 ' CD1' HD21 ' A' ' 52' ' ' LEU . 63.9 m-85 -106.18 109.59 21.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.547 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 t -116.95 119.36 35.1 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -126.11 130.64 7.19 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.1 t -161.24 168.91 23.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.95 -177.7 48.56 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.398 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.9 t -91.26 -106.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.068 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.8 -35.15 0.86 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.2 p -124.3 16.85 9.06 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -145.31 120.86 10.4 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.733 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 38' ' ' LEU . 40.2 m-85 -133.6 144.67 49.42 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 21' ' ' ILE . 68.5 m -141.15 141.48 34.14 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.635 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.612 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -98.86 99.69 10.79 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.785 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -89.12 117.06 27.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.633 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 37.5 mt -104.56 138.11 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.935 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -64.25 1.03 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.904 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -124.37 103.46 8.21 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.013 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.52 104.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.207 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.52 167.76 10.4 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . . . -55.29 -25.45 34.15 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.408 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -79.53 -37.39 36.66 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.506 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -5.24 25.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.312 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD11 ' A' ' 111' ' ' ILE . 85.0 mt -74.03 150.07 40.86 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.1 -149.42 21.55 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.202 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 mp -120.53 118.58 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.29 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' CE1' HD13 ' A' ' 42' ' ' LEU . 22.6 m-85 -92.76 154.15 18.47 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CE1' ' HA2' ' A' ' 106' ' ' GLY . 97.5 m-85 -143.34 157.4 44.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.634 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.63 147.47 48.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.755 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -150.0 166.35 29.93 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.627 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.54 HE21 HG23 ' A' ' 102' ' ' THR . 1.7 pp0? -127.22 145.08 50.89 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.62 18.02 13.53 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.504 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.77 -42.34 67.28 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.697 ' CE1' HG21 ' A' ' 2' ' ' VAL . 31.9 m80 -111.4 171.81 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.422 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.9 t -138.81 140.85 28.58 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.574 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.6 Cg_endo -70.76 168.82 70.1 Favored 'Cis proline' 0 C--N 1.319 -1.025 0 C-N-CA 123.741 -1.358 . . . . 0.0 111.883 -0.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.88 156.99 54.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.935 1.757 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.54 HG23 HE21 ' A' ' 95' ' ' GLN . 26.7 p -89.58 -64.25 1.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.961 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 63.24 171.55 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.04 -156.92 19.82 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.652 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 -172.73 45.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 162.14 59.81 0.02 OUTLIER Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.005 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.1 m -77.28 109.51 11.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.876 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -78.07 132.03 37.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.481 HD23 HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -123.2 76.92 1.42 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.964 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -107.0 137.85 44.28 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.96 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 88' ' ' LEU . 18.9 mt -63.32 124.71 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.507 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.489 ' HE3' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -64.12 103.14 0.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.729 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 116.597 -1.668 . . . . 0.0 111.499 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.405 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 27.7 t-80 -83.93 167.37 17.03 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -58.2 -27.99 64.39 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.737 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 1.3 p30 -79.45 -10.5 59.82 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.31 -0.93 64.08 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.798 -1.191 . . . . 0.0 111.905 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.81 144.42 28.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.928 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 -128.9 0.28 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.51 -53.25 6.43 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.22 42.88 0.34 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.324 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.16 176.98 5.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -62.29 153.35 75.97 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.62 143.21 98.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.774 1.649 . . . . 0.0 111.25 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.34 135.17 54.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.3 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.17 126.33 51.99 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG21 ' ND1' ' A' ' 98' ' ' HIS . 69.7 t -71.63 124.54 28.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.535 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.92 147.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.38 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.446 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 4.3 mtp -143.42 110.56 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.195 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -101.38 117.13 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.783 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' HA3' ' A' ' 105' ' ' GLY . 5.7 tt0 -101.21 133.43 45.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.732 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -154.37 163.37 24.39 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.88 179.46 31.25 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.306 -1.539 . . . . 0.0 111.119 -1.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 mt -77.6 -35.97 52.3 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.563 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.98 151.57 46.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -138.26 85.6 18.27 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.797 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 106.75 1.5 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.77 1.647 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.46 -177.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.576 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.6 m -122.27 156.2 34.32 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.1 mt -67.48 86.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.32 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.77 36.3 0.07 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -135.86 166.34 23.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -94.11 137.39 33.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.236 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.67 160.24 16.1 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.57 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -149.04 90.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.628 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.669 HG23 HG21 ' A' ' 107' ' ' THR . 2.8 mt -86.62 113.61 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' THR . 7.2 t -81.21 156.3 25.72 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.654 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.8 91.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -91.0 166.63 12.91 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.978 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 p -148.39 167.36 25.46 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.996 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -79.62 -69.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -92.14 154.7 18.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.757 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -64.2 132.31 49.98 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.23 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 38' ' ' LEU . 14.3 mt -85.23 33.43 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.5 127.0 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.008 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 32' ' ' SER . 48.7 t-80 -77.88 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.419 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.426 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 18.2 m -76.36 70.15 2.92 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.324 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 34.96 54.62 0.72 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.384 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.73 -56.36 0.07 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 118.783 -1.675 . . . . 0.0 112.078 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . 5.0 m-80 -82.29 122.59 28.14 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.789 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 m -107.79 99.41 8.88 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 35' ' ' ASN . 21.3 m-85 -83.85 75.78 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' A' ' 29' ' ' LEU . 5.6 tt -132.58 125.67 31.03 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.244 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 17.2 p-10 -126.06 160.84 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.839 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -108.3 174.92 5.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.498 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 27.9 m-85 -150.2 161.76 41.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.547 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 tp -160.51 111.14 1.82 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.282 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.42 161.07 17.75 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.964 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -128.36 -169.81 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.01 122.45 27.82 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.23 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.33 35.61 56.03 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 48' ' ' SER . 2.7 tp60 -126.25 154.28 43.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.446 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 49.5 m -73.02 151.77 90.61 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.41 127.01 21.49 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.236 1.957 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -108.1 139.73 42.33 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 54' ' ' TYR . 31.6 tp -104.86 134.31 48.2 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.229 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.536 ' O ' HG21 ' A' ' 63' ' ' VAL . 49.0 mt -108.9 -51.12 2.92 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.759 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.9 mm -127.47 134.85 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.517 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HB3' HD21 ' A' ' 51' ' ' LEU . 35.4 p90 -112.83 -21.95 10.92 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.226 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' SER . 19.6 mttp -135.33 106.54 6.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.334 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.046 HG13 ' H ' ' A' ' 57' ' ' SER . 6.3 p 29.7 -85.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.15 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.046 ' H ' HG13 ' A' ' 56' ' ' VAL . 21.4 t -114.35 48.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.238 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -125.61 108.11 11.25 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 18.9 mtt180 -73.53 144.22 46.2 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.465 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -73.41 155.35 39.41 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.984 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.8 p -59.11 98.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.622 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.56 -17.79 4.97 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 52' ' ' LEU . 95.4 t -73.56 120.11 79.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.305 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.75 150.19 86.87 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.107 1.872 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -55.07 -19.88 8.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' ' OE2' ' A' ' 84' ' ' GLU . 61.4 mtt85 -56.01 -14.39 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.497 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -115.1 128.3 56.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.043 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.91 125.43 17.76 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.33 149.46 18.59 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.084 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.46 160.13 39.28 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 175.16 159.97 22.23 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.672 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 p -90.83 -99.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.675 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.78 -37.25 0.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.2 p -121.89 17.61 10.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.71 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 9.3 t70 -152.25 125.13 8.49 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 20.9 m-85 -139.09 156.18 47.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.841 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.0 m -150.89 149.28 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.11 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.89 109.51 21.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.772 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -100.77 123.05 44.41 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.752 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mt -108.08 132.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.8 m -64.63 -60.82 2.67 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -135.98 109.61 8.02 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.47 110.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.157 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE2' ' NE ' ' A' ' 66' ' ' ARG . 4.7 mt-10 -95.26 -175.52 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.295 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.17 66.28 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.249 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 6.7 pt-20 -87.24 -32.58 19.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 60.5 m-20 -64.11 -12.58 40.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.384 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.575 ' CD1' HD11 ' A' ' 111' ' ' ILE . 20.1 mt -69.81 147.8 49.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.88 -161.16 28.25 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.557 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.2 mp -106.08 117.92 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CB ' HD13 ' A' ' 21' ' ' ILE . 25.8 m-85 -90.97 154.15 19.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.672 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 106' ' ' GLY . 45.6 m-85 -146.39 168.48 21.03 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.42 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.6 p -159.05 151.09 20.98 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.321 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.0 t -152.69 -175.34 5.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.513 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 1.1 pp0? -135.84 136.38 40.57 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.0 m -110.36 42.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -38.62 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.139 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.465 ' ND1' HG21 ' A' ' 2' ' ' VAL . 80.4 m80 -109.42 156.21 20.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.393 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 92.3 t -127.1 134.66 26.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.606 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -72.24 163.29 88.16 Favored 'Cis proline' 0 C--N 1.318 -1.045 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.731 -0.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.16 162.08 34.54 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 122.044 1.83 . . . . 0.0 111.389 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 28.5 p -87.43 -92.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.542 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 102' ' ' THR . 65.8 t80 61.99 116.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.445 0.466 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.92 54.97 0.04 OUTLIER Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.888 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.491 ' HA3' ' OE1' ' A' ' 6' ' ' GLN . . . -114.1 -120.87 3.57 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . 127.23 68.72 0.16 Allowed Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.887 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.669 HG21 HG23 ' A' ' 21' ' ' ILE . 94.3 m -86.01 106.06 16.91 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.204 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -75.53 115.84 15.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.198 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -111.34 93.47 4.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.619 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -121.93 143.86 49.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.741 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.575 HD11 ' CD1' ' A' ' 88' ' ' LEU . 17.2 mt -62.47 152.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.294 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 111' ' ' ILE . 2.0 mtpm? -63.29 123.42 18.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.316 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.878 0.37 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' HG21 ' A' ' 102' ' ' THR . 70.4 t -71.29 116.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.291 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 151.09 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 120.39 11.6 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.1 143.7 47.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.527 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 1.4 tt0 -118.23 148.2 42.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.819 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.11 154.76 18.48 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.796 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.43 178.61 33.79 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.734 -1.361 . . . . 0.0 111.102 -1.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 mt -77.05 -44.5 30.5 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.911 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.04 152.23 48.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.12 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -142.95 78.71 15.18 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.092 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.85 126.19 14.91 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.757 1.638 . . . . 0.0 109.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.43 -175.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.335 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.76 167.06 11.1 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.599 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 111' ' ' ILE . 82.3 mt -83.54 89.83 7.15 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.04 48.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 176.47 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.26 148.02 23.54 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -125.38 161.02 27.95 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -160.64 96.54 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.434 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 77' ' ' THR . 37.2 mt -86.25 139.65 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.595 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 m -107.22 145.83 32.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.8 t -153.55 118.46 5.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.901 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -123.72 156.18 36.47 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.236 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 74' ' ' THR . 65.8 p -122.03 146.58 47.03 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -58.05 -49.77 75.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -111.22 156.22 21.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -64.62 144.81 56.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.89 30.32 3.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.23 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.72 141.64 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.502 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -83.43 -124.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.119 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.1 p -53.97 -69.21 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.711 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -170.35 21.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.802 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.22 15.59 0.05 OUTLIER Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.365 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -132.66 112.06 11.7 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.3 m -115.32 150.34 36.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -132.2 101.44 5.38 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.463 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.03 129.18 12.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.786 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' OH ' ' A' ' 41' ' ' TYR . 12.4 p-10 -130.76 160.29 34.79 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.891 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -112.52 151.79 29.57 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' OH ' ' ND2' ' A' ' 39' ' ' ASN . 22.6 m-85 -129.31 166.59 19.17 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 91' ' ' TYR . 14.2 tp -154.53 126.68 7.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.011 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -124.03 165.83 16.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.014 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -113.98 -146.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.26 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.2 -76.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.248 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.86 49.1 0.94 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 -173.9 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.807 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 p -86.19 148.06 46.54 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.787 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.87 151.99 82.73 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.01 1.806 . . . . 0.0 111.398 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 137.34 53.57 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.899 -0.721 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.4 tp -92.42 135.56 33.94 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.666 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.0 mt -113.73 -64.7 1.27 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mm -116.17 140.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.662 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.1 p90 -130.27 158.59 39.37 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.178 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.2 tptm 74.4 -67.07 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.986 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -171.07 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.494 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 p -152.43 -28.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.347 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 30.9 m-80 -51.65 129.0 24.98 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -90.25 139.59 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.44 151.12 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.694 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -59.39 104.07 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.14 -12.85 6.39 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.326 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.01 119.21 75.38 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.39 150.83 78.57 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.874 1.716 . . . . 0.0 111.828 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.51 -15.51 11.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.389 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -57.2 -18.4 15.58 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.75 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -107.43 128.62 54.64 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.0 125.54 17.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.57 144.97 17.05 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -160.44 -177.59 6.33 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.08 169.92 33.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.276 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 m -91.21 -82.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.25 -37.9 0.1 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.599 -1.286 . . . . 0.0 111.12 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 25' ' ' SER . 64.3 p -125.13 13.97 8.39 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.98 117.4 12.01 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -132.34 144.54 50.63 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.611 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ILE . 88.2 m -141.37 139.69 33.57 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.783 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -106.14 111.48 24.11 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.765 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 37.8 mttt -107.1 147.74 29.65 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.629 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.3 mt -124.77 134.84 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.435 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.5 m -67.24 -55.47 13.89 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.174 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.14 110.63 8.54 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.25 130.17 35.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.211 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.96 -172.27 2.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.758 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 -29.6 62.06 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.39 -43.09 67.49 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.86 -36.07 16.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.571 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 77.1 mt -45.24 136.34 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.35 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.56 -144.74 10.91 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.409 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.9 mp -125.0 141.07 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.489 ' CE1' HD13 ' A' ' 42' ' ' LEU . 24.6 m-85 -117.83 151.12 37.98 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -146.64 163.78 34.77 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -137.58 136.03 37.2 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.362 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 p -139.4 155.13 47.84 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.954 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.38 37.9 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -127.83 28.78 5.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.234 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 -57.57 3.19 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.596 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -105.91 159.69 15.83 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 100' ' ' PRO . 38.3 t -110.0 140.77 22.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.318 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.479 ' HA ' HG13 ' A' ' 99' ' ' VAL . 7.4 Cg_endo -77.44 163.69 88.1 Favored 'Cis proline' 0 C--N 1.315 -1.193 0 C-N-CA 123.715 -1.369 . . . . 0.0 111.824 -0.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.36 118.9 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.021 1.814 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' VAL . 19.6 p -89.9 135.32 33.71 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.741 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.38 -179.85 7.03 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.212 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.64 -175.71 41.5 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -82.93 -69.9 1.37 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 136.43 114.31 1.33 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 125.32 53.23 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.299 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.6 128.12 37.31 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.48 90.92 3.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.23 143.46 41.95 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.925 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.447 HD12 HD21 ' A' ' 15' ' ' LEU . 15.7 tt -66.66 150.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.961 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -62.61 121.37 13.17 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.649 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 98' ' ' HIS . 41.9 t -74.47 106.27 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.792 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -69.44 164.05 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.486 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -143.7 110.59 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -77.15 110.54 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.65 131.16 44.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.178 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -164.89 156.53 13.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.445 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HA ' HG22 ' A' ' 7' ' ' THR . 11.2 Cg_endo -82.86 175.22 39.49 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.372 -1.512 . . . . 0.0 110.972 -1.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.08 -39.05 21.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.485 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -129.44 143.45 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 tp -137.59 81.05 30.56 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.824 -1.151 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.54 121.74 8.48 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.773 1.649 . . . . 0.0 109.646 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.29 -178.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 118.98 -1.088 . . . . 0.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -108.6 172.92 6.56 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -89.19 89.49 7.96 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.01 28.03 0.34 Allowed Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.49 174.94 6.08 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.852 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -96.51 141.96 29.16 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -108.76 167.31 10.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.832 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -162.03 79.89 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.048 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.2 mt -75.11 133.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.207 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -105.52 155.69 18.94 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.153 -1.019 . . . . 0.0 113.312 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.41 89.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.464 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -94.42 147.41 23.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.427 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 1.2 m -111.35 163.99 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.609 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -47.86 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.41 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.454 ' C ' HG22 ' A' ' 74' ' ' THR . 11.4 tt0 -119.83 150.93 39.63 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -55.7 132.02 48.04 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.843 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.562 HD22 ' OE1' ' A' ' 95' ' ' GLN . 43.8 mt -85.28 32.62 0.55 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.27 143.46 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 21.7 t-80 -89.6 -130.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.379 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.423 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 16.6 p -56.07 -60.19 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.592 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 34' ' ' GLY . 6.4 p-10 -115.08 -86.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.28 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.708 ' H ' ' ND2' ' A' ' 33' ' ' ASN . . . -120.56 17.45 9.53 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.551 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 9.8 m-80 -76.98 93.42 3.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.621 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' LEU . 3.2 m -108.43 146.29 33.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -129.97 124.29 32.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.38 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -150.74 154.14 36.82 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.315 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.73 160.07 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.981 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.677 ' CD2' HD13 ' A' ' 78' ' ' LEU . 84.0 m95 -129.68 146.72 51.44 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -142.25 138.21 31.24 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.679 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.658 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.1 tp -119.87 139.59 52.15 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.568 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' LEU . 12.1 mm100 -125.75 146.84 49.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.563 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -114.19 -135.26 0.35 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.19 -59.32 2.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.38 54.46 0.45 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.43 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.96 164.19 13.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.247 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.0 160.87 81.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.329 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.8 108.88 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.0 1.8 . . . . 0.0 111.563 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -115.39 -171.99 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 40' ' ' TRP . 25.9 tp -150.02 149.41 30.31 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.586 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.89 HD21 ' CD1' ' A' ' 67' ' ' PHE . 4.9 tp -111.03 -81.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.993 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.83 135.52 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 48.0 p90 -116.46 171.54 7.78 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' LEU . 4.8 mmtp 58.09 -150.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.007 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' VAL . 8.1 p -109.57 4.87 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.802 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -179.57 65.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -155.41 113.57 3.43 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.574 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.8 mtm-85 -76.33 138.51 40.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -76.52 164.01 26.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.543 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.3 m -55.29 130.99 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.161 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.29 35.45 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.73 116.66 52.25 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.347 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.91 148.66 91.81 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.175 1.917 . . . . 0.0 112.697 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.83 -17.71 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -57.85 -14.73 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.755 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.89 ' CD1' HD21 ' A' ' 52' ' ' LEU . 82.2 m-85 -105.56 118.95 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.948 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 p -125.94 123.75 39.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.99 118.68 2.77 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.1 p -163.95 168.71 19.0 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.5 -160.42 33.92 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.582 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 p -90.78 -174.73 4.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.3 64.42 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 27' ' ' GLN . 67.8 p -122.8 18.38 10.23 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.546 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB2' ' H ' ' A' ' 72' ' ' SER . 4.1 m-20 -140.16 131.0 25.95 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.949 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.31 127.78 14.06 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.218 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 40.5 m -135.16 131.04 36.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.576 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.1 tp -93.32 89.65 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -82.76 141.81 32.08 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.488 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -125.52 141.25 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.6 m -69.81 -73.19 0.17 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.423 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 106.24 11.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.009 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.5 106.23 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.924 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.36 168.71 11.68 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.975 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.14 -16.85 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.764 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.76 -36.36 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -26.87 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.092 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.4 mt -50.25 138.1 17.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.32 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.01 -151.24 23.49 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.746 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.93 125.51 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.517 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.658 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.4 m-85 -99.8 156.75 16.94 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.634 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -149.02 160.21 43.53 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -144.04 151.42 39.65 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.952 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 t -150.33 168.78 23.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.831 -1.148 . . . . 0.0 112.129 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.562 ' OE1' HD22 ' A' ' 29' ' ' LEU . 11.2 pt20 -123.8 171.24 9.79 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.712 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.46 20.41 1.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -90.01 -19.2 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.719 ' CD2' HG21 ' A' ' 2' ' ' VAL . 89.9 m-70 -127.77 126.85 42.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.146 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.493 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 11.9 p -110.27 138.4 20.87 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.382 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.0 Cg_endo -70.09 155.38 94.17 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.691 -1.379 . . . . 0.0 111.562 -0.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.14 156.22 56.53 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 122.157 1.905 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -89.94 -59.53 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.6 t80 65.86 118.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.007 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.72 -171.5 31.05 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.647 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.32 -174.51 15.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.39 47.36 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.079 -1.534 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -77.38 116.55 18.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.074 -1.051 . . . . 0.0 108.979 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -82.06 95.11 7.34 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.93 75.84 7.89 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.761 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.7 142.41 34.38 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.416 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 tt -77.78 159.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -62.87 140.3 58.8 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.861 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.17 147.95 6.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.157 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 t -103.64 157.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.4 mtp -142.87 112.84 7.05 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -93.44 111.82 23.57 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.492 ' CG ' ' HA2' ' A' ' 105' ' ' GLY . 1.0 OUTLIER -104.92 139.93 38.91 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.15 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.73 162.67 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.26 178.52 28.12 Favored 'Cis proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.686 -1.381 . . . . 0.0 110.731 -2.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 9' ' ' LEU . 3.6 mm? -74.81 -64.02 1.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.635 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.45 153.48 26.07 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.93 82.49 17.47 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.977 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.79 116.27 4.19 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.807 1.672 . . . . 0.0 110.457 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -140.12 -170.74 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.186 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 t -118.61 176.11 5.41 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 85' ' ' ALA . 33.6 mt -90.64 92.21 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.436 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.94 -7.64 3.25 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.484 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -172.29 4.09 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.232 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -105.72 166.95 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -140.03 160.59 39.59 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.479 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 p -159.48 89.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 91' ' ' TYR . 19.8 mt -79.41 133.77 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -97.59 147.95 23.78 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.657 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -154.81 102.72 2.38 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.572 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 25' ' ' SER . 4.1 ttt180 -111.65 147.73 34.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.636 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 34.5 m -120.39 157.25 29.69 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.6 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.2 t -65.4 -65.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.696 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' A' ' 28' ' ' SER . 8.7 tt0 -99.19 162.79 12.85 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.683 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.3 p -68.61 121.15 15.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.696 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 95' ' ' GLN . 25.2 mt -77.73 28.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.8 t -89.57 127.49 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.677 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.85 162.54 25.99 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.898 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -30.51 71.53 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.897 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -73.62 -17.44 61.16 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.307 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.57 25.46 5.99 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.657 -1.259 . . . . 0.0 111.244 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -119.49 123.96 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 m -99.99 103.28 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.52 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -84.14 121.47 27.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.919 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -173.89 135.14 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.638 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -137.46 177.31 7.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.05 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 51' ' ' LEU . 65.2 m95 -126.07 148.95 49.22 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 20.2 m-85 -128.91 161.11 30.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 7.9 tp -157.61 113.38 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.965 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -134.85 156.89 48.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.456 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.62 -114.97 0.31 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.934 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.57 -36.63 20.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.422 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.07 48.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -80.38 161.08 25.18 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -71.39 -51.24 10.04 Favored Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.912 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 48' ' ' SER . 2.8 Cg_endo -68.6 122.03 8.97 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.789 1.659 . . . . 0.0 112.508 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.92 10.0 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.411 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 40' ' ' TRP . 10.9 tp -141.59 134.7 29.17 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.409 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.08 -73.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mm -100.04 138.49 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -136.19 12.91 3.31 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.411 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -147.7 44.38 1.1 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.178 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 18.8 t 70.08 -27.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.733 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -155.16 -45.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.121 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -58.93 126.81 29.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.217 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.496 HH12 ' CG ' ' A' ' 65' ' ' ASP . 5.8 mtm180 -81.25 169.97 16.66 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CG ' ' N ' ' A' ' 61' ' ' SER . 91.6 t80 -90.07 159.51 16.79 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.295 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.418 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 4.5 m -60.66 114.91 3.25 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -17.72 16.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 99.1 t -78.36 129.55 74.53 Favored Pre-proline 0 C--N 1.306 -1.314 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.235 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -65.21 165.16 22.89 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.765 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' CG ' HH12 ' A' ' 59' ' ' ARG . 0.2 OUTLIER -78.08 -14.78 59.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.821 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.11 -11.54 31.02 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.09 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 51.1 m-85 -101.25 121.12 41.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.967 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -126.66 129.62 48.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.054 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.38 144.57 18.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -160.92 150.0 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.44 160.57 24.4 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.514 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 p -91.21 -85.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.93 -32.69 0.1 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.374 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 p -119.42 15.1 12.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.8 135.2 14.2 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -146.18 149.89 34.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.862 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 m -143.96 143.13 31.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.858 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 40' ' ' TRP . 9.1 tt -106.97 101.51 10.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.955 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -96.68 138.36 34.37 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.006 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 57.9 mt -121.3 138.4 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.79 -74.29 0.14 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.985 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.04 103.6 10.06 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.85 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.684 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.29 166.34 16.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.726 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.404 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -55.37 -25.22 34.01 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.718 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.92 -39.35 34.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.93 -14.46 61.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 109' ' ' LEU . 85.1 mt -58.21 150.99 20.21 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.531 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.34 -166.67 26.73 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.567 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.45 129.26 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.163 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 17.7 m-85 -103.18 146.31 28.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 93.8 m-85 -138.48 169.52 17.64 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.94 134.9 9.96 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.2 p -142.04 173.2 11.74 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HB3' HD13 ' A' ' 29' ' ' LEU . 4.0 pp0? -129.92 157.7 41.57 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -126.46 10.11 7.26 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.459 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 m -68.76 -32.27 71.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.628 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -114.16 124.22 51.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.2 t -104.3 138.35 19.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.315 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' A' ' 99' ' ' VAL . 4.1 Cg_endo -73.1 159.98 96.42 Favored 'Cis proline' 0 C--N 1.317 -1.113 0 C-N-CA 123.774 -1.344 . . . . 0.0 111.769 -0.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 103' ' ' PHE . 3.3 Cg_exo -60.58 141.25 94.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.137 1.891 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -91.12 -28.72 17.72 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.262 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 101' ' ' PRO . 60.5 m-85 54.46 -159.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.516 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.48 -174.2 15.88 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.492 ' HA2' ' CG ' ' A' ' 6' ' ' GLN . . . 93.74 161.92 35.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.775 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.68 56.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -79.36 110.34 14.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.521 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -80.61 99.84 8.33 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.775 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -87.96 84.73 6.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.766 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.1 147.18 32.83 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.084 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -83.32 153.33 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -57.21 131.1 48.95 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.359 -1.782 . . . . 0.0 110.442 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.04 0.448 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 98' ' ' HIS . 77.0 t -67.42 146.43 13.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.338 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.56 148.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' A' ' 95' ' ' GLN . 3.8 mtt -139.01 107.91 5.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -98.59 97.18 8.5 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.569 ' OE1' ' SG ' ' A' ' 93' ' ' CYS . 2.2 tp60 -78.82 141.95 37.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.86 158.43 26.85 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -77.77 178.13 36.23 Favored 'Cis proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.313 -1.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.34 -57.36 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.692 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.0 m -113.95 144.16 43.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.239 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.86 73.05 54.16 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.331 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.97 118.23 5.4 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.661 1.574 . . . . 0.0 110.377 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.63 -178.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.261 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.32 156.85 18.07 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.557 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.5 mt -73.89 88.25 1.82 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.605 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.81 43.95 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 179.89 6.12 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.2 148.17 22.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -125.3 157.6 36.25 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.266 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -151.09 82.73 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.75 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 mt -80.27 117.83 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.264 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -86.89 159.34 19.08 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.3 t -157.78 97.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.603 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -104.22 153.56 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.299 -0.96 . . . . 0.0 113.019 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 m -128.28 145.8 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -62.51 -50.98 69.25 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.363 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.97 145.57 38.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.078 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -57.63 139.7 52.95 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.5 mt -93.06 39.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.545 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.08 137.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 32' ' ' SER . 59.7 t-80 -93.62 158.99 15.42 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.723 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.454 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 5.7 t -60.74 -21.04 62.55 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.361 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 32.5 p-10 -86.32 -6.38 58.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.34 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.65 12.32 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.401 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -116.29 136.39 53.05 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.409 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.46 127.85 49.33 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' OG1' ' A' ' 96' ' ' THR . 96.0 m-85 -116.67 110.5 18.56 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.639 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.73 146.79 26.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -141.03 162.18 36.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.379 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.703 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.8 m95 -128.98 150.1 50.54 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -145.02 158.01 43.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 37.8 tp -138.04 117.78 13.15 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.297 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.65 152.95 43.0 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.736 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -110.85 -137.18 0.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.261 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.12 -61.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.46 35.29 1.33 Allowed Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.778 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -89.04 168.89 11.98 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.42 161.6 49.31 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.719 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.2 147.96 91.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.067 1.844 . . . . 0.0 111.854 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 34.6 mttp -134.36 125.23 27.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 54' ' ' TYR . 39.4 tp -114.78 120.99 41.91 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.359 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -95.93 -70.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.236 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 78' ' ' LEU . 6.4 mm -111.24 141.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.572 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' HB3' HD21 ' A' ' 51' ' ' LEU . 53.8 p90 -128.82 8.01 5.7 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.81 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 17.3 tttt -160.65 61.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 15.8 t 71.21 -65.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.007 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 p -124.77 -36.53 2.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.451 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 31.9 m120 -48.1 115.51 1.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.705 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -85.71 151.54 23.78 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -80.7 164.73 22.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.053 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.75 137.22 54.83 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 -40.01 3.04 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.2 110.2 1.78 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.685 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.35 150.69 86.28 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.94 1.76 . . . . 0.0 111.702 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -12.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.465 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -58.64 -12.57 4.28 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.474 ' HE2' ' HH ' ' A' ' 91' ' ' TYR . 29.9 m-85 -111.35 120.34 41.89 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.726 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.4 p -133.69 100.36 4.75 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.29 153.35 23.4 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.83 158.13 27.88 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.22 157.25 16.11 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.2 m -90.39 -94.26 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.85 -36.28 0.36 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -120.01 16.17 12.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.176 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -152.43 125.97 8.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.611 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.2 m-85 -142.8 138.85 30.68 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.065 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 21' ' ' ILE . 23.9 m -138.8 144.76 39.48 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.492 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.2 tp -99.62 108.69 21.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -97.53 130.39 44.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 74.5 mt -115.0 140.35 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.834 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -72.82 -62.79 1.33 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.776 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.2 102.65 7.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.672 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.39 110.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.696 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.03 175.66 5.68 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.03 -29.77 58.12 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.413 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -73.14 -28.18 62.09 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.51 -1.45 15.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 111' ' ' ILE . 89.3 mt -76.76 152.4 35.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.79 -154.97 19.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.85 134.33 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.539 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.541 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 11.3 m-85 -98.57 152.57 19.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.38 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.08 161.74 36.89 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.569 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 2.4 p -144.28 142.3 30.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -146.38 156.64 43.46 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -104.64 152.09 22.88 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.395 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -116.59 30.09 7.55 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.923 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -102.32 -60.89 1.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CD2' HG21 ' A' ' 2' ' ' VAL . 16.9 m-70 -80.0 156.01 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 100' ' ' PRO . 69.4 t -141.69 139.74 19.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.034 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.9 Cg_endo -70.11 154.74 94.33 Favored 'Cis proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.362 -1.516 . . . . 0.0 111.304 -0.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 149.6 89.72 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.963 1.775 . . . . 0.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 102' ' ' THR . 60.2 p -82.58 -59.77 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.186 -1.005 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 t80 62.04 125.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.399 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.92 -151.24 10.13 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 6' ' ' GLN . . . 88.75 -173.77 42.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.064 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.16 64.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 118.994 -1.574 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 21' ' ' ILE . 75.8 m -79.93 104.4 10.48 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.651 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 121.39 18.63 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.14 78.83 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -105.94 145.69 30.98 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.604 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 88' ' ' LEU . 17.7 mt -64.11 131.22 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.49 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -72.19 104.08 3.54 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.468 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 116.389 -1.767 . . . . 0.0 109.829 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 121.008 0.432 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.17 154.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.975 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.79 144.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 96.75 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.516 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -92.74 161.05 14.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.0 162.49 28.92 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.063 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.564 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -165.85 156.76 11.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.518 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 7' ' ' THR . 17.8 Cg_endo -88.33 177.98 19.96 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.265 -1.14 . . . . 0.0 110.665 -2.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.25 -48.32 20.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.518 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 t -122.07 153.62 38.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.0 79.87 21.71 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 118.954 -1.099 . . . . 0.0 112.387 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.23 113.32 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.646 1.564 . . . . 0.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.13 -174.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.7 p -118.31 160.07 22.29 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.62 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 111' ' ' ILE . 63.5 mt -78.89 87.41 4.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.33 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.9 35.04 0.11 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.41 -173.36 3.09 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.485 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -106.07 146.08 30.61 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.09 37.08 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -161.63 89.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.628 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -73.26 146.23 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.377 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' THR . 22.8 t -117.62 140.58 49.45 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.21 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m -146.3 101.15 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.098 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -109.3 147.81 32.05 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.156 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 p -115.03 139.61 49.72 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -49.88 -59.09 4.18 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -98.85 154.9 17.68 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.78 133.51 47.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.941 -0.703 . . . . 0.0 111.306 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.28 33.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.32 117.96 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -72.38 161.34 30.95 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -62.24 -23.6 66.77 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -85.43 -7.74 58.77 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.57 35.08 6.04 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.469 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -119.56 121.91 40.43 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -99.22 96.99 8.13 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -80.87 104.8 11.63 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -151.4 146.82 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.935 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -147.56 161.21 41.58 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.011 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.704 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.1 m95 -120.09 152.88 36.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.576 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.447 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 15.0 m-85 -138.52 163.18 32.64 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.683 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 27.5 tp -146.3 100.17 3.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.697 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -97.76 142.82 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.415 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.68 -147.14 0.31 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.656 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.14 -55.6 5.57 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.212 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.91 39.58 1.32 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -112.18 169.41 8.88 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.021 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.3 t -73.94 137.49 76.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.52 106.72 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.886 1.724 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 144.99 32.2 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.742 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp -99.17 138.66 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.753 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 mt -118.22 -51.64 2.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.072 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' LYS . 3.9 mm -126.41 136.2 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.738 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.3 p90 -121.86 23.33 10.11 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.158 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 175.37 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.093 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.6 t 56.87 -83.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.575 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t -121.16 43.85 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.805 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.5 m-80 -111.13 99.8 8.58 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.525 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 61.9 mtm180 -82.22 137.18 34.96 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' SER . 81.5 t80 -70.61 156.68 39.13 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.8 p -58.43 112.02 1.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.88 -24.55 7.87 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.88 126.86 93.15 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.43 ' CB ' ' HE ' ' A' ' 66' ' ' ARG . 3.3 Cg_exo -59.98 168.49 5.83 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.011 1.808 . . . . 0.0 112.52 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.78 -23.15 45.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.537 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' A' ' 64' ' ' PRO . 5.8 mtm-85 -53.86 -40.9 66.91 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.383 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 46.4 m-85 -80.0 112.25 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.64 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t -130.34 117.29 19.54 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 129.45 9.9 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 155.63 34.3 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 163.06 -172.24 39.02 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.585 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -91.3 -165.8 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.707 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.53 72.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.138 -1.03 . . . . 0.0 111.268 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 p -121.38 17.32 11.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 6.9 t0 -145.77 133.59 21.21 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.08 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CE2' HD13 ' A' ' 38' ' ' LEU . 25.2 m-85 -143.32 125.96 15.95 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.425 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -123.32 130.97 53.47 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.341 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.704 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.4 tp -91.71 85.32 5.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.139 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -78.18 142.3 38.06 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.33 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.11 125.77 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.039 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 m -61.24 -59.14 5.77 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.332 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -132.37 107.48 8.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.38 138.38 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -117.69 175.47 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.7 -29.85 69.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.701 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.33 -35.22 66.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -56.08 -30.37 61.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.717 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.3 mt -48.88 137.36 12.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.229 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.34 -147.49 16.47 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.292 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -123.64 120.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.41 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 31.5 m-85 -94.68 151.94 18.89 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.741 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -143.82 175.39 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.477 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 24.7 p -155.49 152.43 28.89 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 p -155.99 152.59 28.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.211 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 98' ' ' HIS . 3.6 pt20 -108.73 148.75 30.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.106 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.19 40.87 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.746 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.91 -57.2 2.07 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.189 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.425 ' HB2' HE22 ' A' ' 95' ' ' GLN . 73.1 m80 -96.18 167.84 10.96 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.323 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.4 t -131.65 137.93 31.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.169 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.5 Cg_endo -70.42 151.67 93.33 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.748 -0.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.3 122.1 10.39 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.762 1.642 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 p -91.09 128.17 36.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -89.92 -175.56 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.96 41.43 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.91 -59.99 2.01 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.907 -1.14 . . . . 0.0 111.093 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.99 101.36 0.63 Allowed Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.571 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.0 m -94.13 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -84.97 134.51 34.24 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.462 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 98.07 5.49 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -121.94 142.22 50.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.43 HD12 HD11 ' A' ' 15' ' ' LEU . 13.2 tt -64.74 146.74 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.238 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 108.82 2.53 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.024 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.484 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.166 0.508 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 46.9 t -86.35 124.35 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.193 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.27 137.44 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.656 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 87.0 mmm -122.82 95.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 137.2 37.42 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.907 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 13.3 tt0 -124.34 148.57 47.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.767 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.86 156.53 17.33 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.425 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HA ' HG22 ' A' ' 7' ' ' THR . 6.9 Cg_endo -78.65 178.52 34.05 Favored 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.664 -1.39 . . . . 0.0 111.274 -1.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -77.7 -34.43 52.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.204 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 p -138.6 158.0 45.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -145.9 85.65 7.55 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.781 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.5 109.05 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.644 1.563 . . . . 0.0 110.307 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.5 m -133.93 176.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.011 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -104.71 168.96 8.73 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.412 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 111' ' ' ILE . 65.6 mt -81.88 88.0 6.36 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.64 51.63 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.61 163.45 32.8 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.771 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -85.23 142.28 29.53 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.45 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -121.97 166.55 14.29 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.079 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 13.5 p -162.58 94.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.173 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.727 HD12 ' HB3' ' A' ' 78' ' ' LEU . 3.2 mt -87.98 118.42 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -83.1 157.03 22.99 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.488 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.2 t -162.17 112.6 1.56 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.196 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -118.53 144.77 45.83 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 1.4 m -104.88 151.29 24.03 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 m -78.06 0.65 23.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -156.65 134.14 10.75 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.14 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -55.53 124.48 17.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 95' ' ' GLN . 6.0 mt -91.5 31.35 1.18 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.415 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.9 t -88.09 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.63 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.413 ' CG ' HD21 ' A' ' 33' ' ' ASN . 47.3 t-80 -67.47 154.18 41.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.466 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -60.14 -31.2 69.86 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.443 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.671 HD22 ' HB2' ' A' ' 35' ' ' ASN . 5.0 p30 -76.02 -1.48 26.01 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.92 50.1 3.6 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.671 ' HB2' HD22 ' A' ' 33' ' ' ASN . 1.5 m120 -142.26 120.95 12.6 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -103.59 103.39 13.32 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.091 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -81.72 98.29 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.037 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -147.53 138.03 23.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.676 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 6.9 p-10 -140.38 174.75 10.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.295 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 78' ' ' LEU . 67.9 m95 -122.48 148.59 44.97 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.264 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.64 164.14 21.24 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 26.1 tp -158.65 116.57 2.91 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.9 161.52 32.84 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.535 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -102.45 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.114 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.98 61.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.314 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.93 77.44 0.05 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.31 -159.06 0.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.628 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -89.92 161.06 39.48 Favored Pre-proline 0 N--CA 1.488 1.473 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.38 125.47 16.95 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.71 1.607 . . . . 0.0 110.131 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -136.88 136.75 38.98 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.535 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 60' ' ' PHE . 18.0 tp -114.19 143.37 44.93 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.7 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 63' ' ' VAL . 20.2 mt -111.86 -89.4 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.6 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.588 HG21 ' HA3' ' A' ' 69' ' ' GLY . 11.5 mm -99.12 133.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.293 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 26.0 p90 -133.9 174.67 10.22 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER 52.34 34.61 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.519 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 75.74 -37.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.117 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 58' ' ' ASN . 21.0 p -144.09 -41.24 0.27 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.698 -1.201 . . . . 0.0 112.918 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 7.8 m120 -37.52 122.03 0.9 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.138 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 65' ' ' ASP . 25.2 mtm180 -91.59 126.5 36.69 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CD1' HD23 ' A' ' 51' ' ' LEU . 15.4 t80 -54.36 149.86 9.56 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 112.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.898 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.65 -22.82 11.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.714 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 52' ' ' LEU . 88.7 t -56.95 120.12 35.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.051 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -58.4 138.76 87.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.705 1.603 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 9.3 p-10 -54.15 -22.85 12.25 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 mtm-85 -58.6 -18.74 32.57 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -93.23 114.19 26.61 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.586 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.39 90.34 3.31 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA3' HG21 ' A' ' 53' ' ' ILE . . . -94.03 129.38 9.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -164.35 -173.42 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.517 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 150.53 -179.64 27.08 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.043 -1.551 . . . . 0.0 111.83 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -93.2 -140.75 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.79 -35.57 13.01 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.3 p -123.79 13.18 9.22 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.6 m-20 -132.41 130.36 40.52 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -144.44 145.71 32.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.991 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 m -150.28 140.48 22.18 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.634 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.727 ' HB3' HD12 ' A' ' 21' ' ' ILE . 4.1 tt -98.5 102.8 14.65 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.95 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -93.93 122.08 36.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 31.2 mt -106.15 138.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.692 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -72.03 -70.22 0.35 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.89 105.24 9.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.89 104.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.01 173.86 7.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.15 48.37 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.43 -39.7 62.42 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.329 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.86 -8.34 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.81 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 111' ' ' ILE . 94.5 mt -69.68 148.89 48.68 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.881 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.13 -159.85 24.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.64 135.7 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.25 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.425 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 26.8 m-85 -100.22 151.77 21.05 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.386 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.78 147.94 38.13 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.1 p -128.32 139.92 52.14 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.191 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.463 ' HG ' ' HD2' ' A' ' 103' ' ' PHE . 2.3 t -144.78 164.26 31.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.077 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.502 HE22 ' HB2' ' A' ' 98' ' ' HIS . 1.4 pt20 -117.48 163.19 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.231 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.56 32.75 2.76 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.029 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.8 m -99.69 -34.07 10.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.501 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.502 ' HB2' HE22 ' A' ' 95' ' ' GLN . 26.2 m80 -107.97 167.45 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.933 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.485 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 43.8 t -136.73 135.75 20.71 Favored Pre-proline 0 N--CA 1.49 1.53 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.8 Cg_endo -70.29 151.76 93.09 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.481 -1.466 . . . . 0.0 111.497 -0.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.01 125.84 20.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.759 1.639 . . . . 0.0 110.209 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 1' ' ' ASP . 11.0 p -93.81 118.31 31.27 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.156 -1.017 . . . . 0.0 112.093 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HD2' ' HG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -105.17 -175.13 2.7 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.292 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.4 177.31 18.24 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.397 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.07 175.97 22.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.408 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 169.87 62.05 0.04 OUTLIER Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.054 -1.545 . . . . 0.0 110.801 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' PRO . 26.5 m -78.21 105.37 9.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -74.82 105.43 5.88 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.19 90.62 4.42 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.993 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.4 146.17 45.59 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 15' ' ' LEU . 10.5 mt -60.69 127.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.23 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 112' ' ' LYS . 8.8 tmtt? -54.49 129.16 34.99 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.417 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.141 -1.885 . . . . 0.0 110.431 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.938 0.399 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG21 ' ND1' ' A' ' 98' ' ' HIS . 83.8 t -71.33 122.42 23.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.081 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.06 148.22 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.29 119.73 8.45 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -117.16 122.94 45.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.966 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.615 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 5.9 mp0 -95.39 146.73 24.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.09 157.05 21.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.631 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 7' ' ' THR . 8.5 Cg_endo -76.33 175.58 47.53 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.528 -1.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.77 -34.13 52.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.308 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.11 159.32 42.06 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 tp -145.3 75.02 13.94 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.26 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.57 115.32 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.95 1.767 . . . . 0.0 110.424 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.66 -172.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.737 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.3 154.16 32.78 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.021 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.44 87.76 0.2 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.61 47.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -144.15 175.24 10.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -93.99 154.13 17.82 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -122.55 159.22 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -160.78 83.51 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 77' ' ' THR . 5.7 mt -82.35 125.85 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.801 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -88.64 154.19 20.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.057 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.615 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 9.8 m -157.3 107.41 2.23 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -119.6 164.74 15.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.277 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.3 p -136.52 165.17 26.48 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.269 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 m -78.65 -29.0 45.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.767 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.29 145.04 51.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.375 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.3 m -58.8 126.83 29.28 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.347 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.6 32.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.81 147.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.032 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -101.23 167.97 9.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.081 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 98.4 p -55.84 -37.27 68.49 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.389 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -68.18 -19.73 64.81 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.88 14.66 24.35 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.23 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -106.13 138.51 42.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.378 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.6 m -109.02 144.78 36.57 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.153 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -125.89 107.65 10.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.04 134.16 19.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.659 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -129.55 162.19 28.78 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.321 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 52.5 m95 -114.99 160.26 19.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -147.69 127.09 13.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.783 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.585 HD13 ' CE1' ' A' ' 91' ' ' TYR . 25.2 tp -117.97 109.7 16.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.255 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -121.01 152.09 39.0 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.624 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -136.15 -109.34 0.2 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.35 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.38 -97.03 0.11 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.253 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.28 49.12 1.71 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -123.58 10.34 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.603 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.493 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -32.23 -57.7 0.44 Allowed Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.277 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 48' ' ' SER . 2.6 Cg_endo -63.66 84.17 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.426 1.418 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -148.81 158.89 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.325 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -164.66 135.89 4.26 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.0 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.31 -60.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 58' ' ' ASN . 5.3 mm -120.26 140.11 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.799 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.9 p90 -121.54 2.12 10.13 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.248 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.62 ' C ' HG13 ' A' ' 56' ' ' VAL . 61.1 tttt -153.79 50.34 0.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER 65.11 -58.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.141 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -126.64 54.49 1.59 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.328 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -146.61 105.2 3.82 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.862 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 34.2 mtm180 -71.75 147.65 47.12 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.631 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -86.34 169.52 12.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.767 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -59.89 129.34 41.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.355 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.61 -23.92 25.9 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.017 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.63 115.21 18.38 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.23 151.43 82.29 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.922 1.748 . . . . 0.0 111.954 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.56 -18.31 18.77 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' CD ' ' A' ' 84' ' ' GLU . 59.8 mtt85 -53.3 -10.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.516 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 93.0 m-85 -116.49 125.31 51.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.961 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.56 119.64 14.5 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.268 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.29 159.9 13.42 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.89 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.9 p -158.32 175.91 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.196 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 164.2 151.78 6.67 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.3 m -93.82 -71.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -49.36 0.04 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.635 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.5 p -115.83 13.35 16.07 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.75 127.82 33.58 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.442 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 87.3 m-85 -144.73 130.5 19.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 21' ' ' ILE . 55.4 m -136.03 139.22 42.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.042 -1.063 . . . . 0.0 112.129 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 9.2 tt -98.64 114.81 27.44 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -108.7 140.63 41.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 77.9 mt -120.75 137.07 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.58 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -69.82 -63.93 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.236 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -124.52 104.93 9.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.2 112.68 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -97.01 -149.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.583 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.47 -30.27 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.07 -33.47 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.613 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.59 -15.64 40.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD11 HD11 ' A' ' 111' ' ' ILE . 58.4 mt -67.75 147.75 52.19 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.295 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.6 -153.11 23.42 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.143 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -117.42 123.18 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' CE1' HD13 ' A' ' 42' ' ' LEU . 18.0 m-85 -91.77 155.3 18.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.982 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -146.65 167.21 24.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.2 p -157.25 145.93 19.68 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.76 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 m -144.41 171.39 14.4 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.467 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -115.55 151.66 34.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.303 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.36 18.28 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.033 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.9 m -91.32 -22.99 20.26 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.493 ' ND1' HG21 ' A' ' 2' ' ' VAL . 67.0 m80 -122.23 132.44 54.43 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.071 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 100' ' ' PRO . 59.2 t -114.3 139.28 23.63 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.448 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.4 Cg_endo -71.35 159.37 94.27 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.774 -0.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.33 144.13 94.77 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.933 1.756 . . . . 0.0 110.996 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -81.05 -63.88 1.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.521 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 5.7 t80 61.86 157.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.35 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.01 -157.89 27.47 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.681 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 6' ' ' GLN . . . 93.41 -156.73 22.81 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.408 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.22 63.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.284 -1.436 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' PRO . 68.2 m -77.9 107.98 10.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.351 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -76.91 107.61 9.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.169 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 tt -101.71 84.28 2.54 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 147.9 33.04 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.608 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 88' ' ' LEU . 17.3 mt -67.05 129.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -66.24 115.94 6.76 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.003 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.437 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 17.4 mtt180 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.504 -1.712 . . . . 0.0 111.044 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.405 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 27.7 t-80 -83.93 167.37 17.03 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -58.2 -27.99 64.39 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.737 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 1.3 p30 -79.45 -10.5 59.82 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.31 -0.93 64.08 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.798 -1.191 . . . . 0.0 111.905 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.81 144.42 28.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 -128.9 0.28 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.51 -53.25 6.43 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.22 42.88 0.34 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.324 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.16 176.98 5.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -62.29 153.35 75.97 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.62 143.21 98.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.774 1.649 . . . . 0.0 111.25 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.34 135.17 54.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.3 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.17 126.33 51.99 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.55 150.72 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 118.806 -1.158 . . . . 0.0 110.956 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 4' ' ' MET . 12.5 t -96.85 160.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.149 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.442 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.35 113.25 5.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -101.31 125.16 47.92 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.409 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.621 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -110.92 135.18 51.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.039 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.82 158.11 26.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.826 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.5 Cg_endo -78.67 176.89 40.84 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.492 -1.461 . . . . 0.0 111.317 -1.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -79.98 -40.51 27.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.538 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -132.08 150.89 52.04 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.6 tp -143.15 82.11 12.12 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.814 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.85 107.88 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.586 1.524 . . . . 0.0 110.041 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 11' ' ' LEU . 5.1 m -129.66 178.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.227 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -109.11 158.14 18.06 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.146 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.83 88.39 1.02 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.678 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.34 -10.77 1.53 Allowed Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -168.11 1.75 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.229 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.66 156.3 22.99 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -113.64 162.69 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 p -162.4 75.3 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.004 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 77' ' ' THR . 11.2 mt -80.21 121.01 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.979 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.2 t -89.0 157.25 18.43 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.621 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.6 m -160.18 108.52 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.311 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -113.27 155.91 24.26 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.096 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -127.71 139.49 52.66 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -53.42 -53.0 57.59 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -106.4 153.35 22.37 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.449 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.4 p -63.4 122.06 15.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.257 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 29.6 mt -75.81 28.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.017 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' SER . 51.9 t -90.06 144.38 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.474 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.485 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 28.4 t-80 -96.5 169.2 10.06 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.506 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.41 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 1.4 t -67.22 -29.88 69.66 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.662 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.485 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -75.69 -14.52 60.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.349 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.75 -20.37 34.19 Favored Glycine 0 N--CA 1.497 2.702 0 C-N-CA 119.671 -1.252 . . . . 0.0 111.575 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -79.23 130.64 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 m -106.03 155.11 19.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.065 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -128.37 138.42 52.35 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.761 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -165.14 166.36 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.847 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -163.41 149.1 11.47 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.118 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.479 ' CD2' HD12 ' A' ' 78' ' ' LEU . 64.1 m95 -117.72 154.27 31.96 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -144.94 151.38 38.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 91' ' ' TYR . 17.8 tp -132.25 81.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.406 ' N ' ' CD ' ' A' ' 43' ' ' GLN . 3.1 mp0 -57.05 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.13 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HD3' ' N ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -101.51 158.3 16.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.082 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 44' ' ' LYS . . . -60.37 107.55 0.68 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.686 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.79 -43.32 2.87 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' O ' ' C ' ' A' ' 48' ' ' SER . 0.9 OUTLIER -79.6 11.36 3.16 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.88 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.531 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -30.37 -55.61 0.35 Allowed Pre-proline 0 N--CA 1.495 1.823 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.031 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 1.8 Cg_endo -68.43 87.05 0.42 Allowed 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.42 1.413 . . . . 0.0 111.135 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -153.1 156.11 38.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 52' ' ' LEU . 15.7 tp -134.28 152.68 51.94 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.806 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.1 mp -122.11 -67.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.645 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 56' ' ' VAL . 5.5 mm -128.29 153.42 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.021 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 5.1 p90 -136.35 -65.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.48 73.49 5.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.227 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 53' ' ' ILE . 10.4 t 62.57 -74.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.927 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.2 t -117.67 -8.78 10.85 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.3 m120 -60.71 121.27 11.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' A' ' 65' ' ' ASP . 5.6 mtt-85 -97.15 161.13 13.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -86.38 152.93 22.31 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -55.52 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.14 -29.98 2.38 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 121.15 74.78 Favored Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.601 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.88 138.51 86.08 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.752 1.635 . . . . 0.0 111.641 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' A' ' 59' ' ' ARG . 2.6 t70 -54.48 -14.3 1.22 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HE ' ' N ' ' A' ' 66' ' ' ARG . 1.1 mmp_? -57.54 -19.15 23.21 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -100.16 130.47 46.3 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.309 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 p -139.82 121.24 15.05 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.295 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.91 133.4 11.37 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.224 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.2 140.94 35.97 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.83 154.36 12.75 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.7 m -91.28 -79.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.276 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.33 -34.72 0.1 OUTLIER Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.671 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.4 p -121.65 19.19 11.16 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -151.74 126.82 9.79 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.624 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -141.21 138.23 33.17 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 50.0 m -135.86 149.9 49.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.239 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 40' ' ' TRP . 7.1 tt -109.27 109.12 19.95 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 14.2 mttm -110.53 139.36 45.84 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.232 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.93 132.7 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.619 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.5 m -61.73 -56.41 19.87 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.764 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.37 103.34 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.78 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.01 129.66 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -109.23 -171.86 1.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.46 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.4 63.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.51 -32.46 73.39 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -21.36 50.43 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.606 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.54 143.32 50.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.1 -155.59 26.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 90' ' ' ILE . 4.1 mt -114.18 114.74 47.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 42' ' ' LEU . 7.2 m-85 -88.56 152.76 21.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.494 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -148.61 165.7 30.52 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.598 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.92 152.96 31.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.829 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -156.34 178.98 9.69 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.028 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -132.53 142.77 49.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.5 p -115.28 22.67 13.09 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.561 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.85 60.2 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.985 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -111.39 148.84 32.17 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER -118.85 142.16 31.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.971 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 99' ' ' VAL . 1.0 OUTLIER -70.09 162.99 83.88 Favored 'Cis proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.984 -1.257 . . . . 0.0 111.972 -0.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.96 142.41 81.52 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -79.42 -61.62 1.95 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.981 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 88.1 t80 61.93 161.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.13 -165.7 27.71 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 107.9 -149.98 16.85 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.495 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.71 56.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.4 m -78.79 106.49 10.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -71.16 97.49 1.52 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.411 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tp -88.56 83.5 6.79 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.558 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.14 144.9 38.08 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.61 159.38 3.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -55.92 -29.81 60.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 116.483 -1.722 . . . . 0.0 111.107 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.632 HG21 ' CE1' ' A' ' 98' ' ' HIS . 57.7 t -71.6 140.03 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.949 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.41 155.59 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mtt -145.54 114.1 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.007 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -100.11 129.26 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.532 HE22 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.7 140.98 37.92 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.51 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -163.84 145.16 7.12 Favored Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.16 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 107' ' ' THR . 9.5 Cg_endo -81.15 -176.51 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.8 -1.334 . . . . 0.0 111.165 -2.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.532 HD23 HE22 ' A' ' 6' ' ' GLN . 14.5 mt -85.19 -46.6 10.92 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.7 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -124.12 158.42 32.33 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.914 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -146.74 85.0 7.31 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.953 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.43 121.62 8.38 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.846 1.698 . . . . 0.0 110.225 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 11' ' ' LEU . 3.6 m -143.39 -170.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.06 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -132.15 161.9 32.21 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -71.08 87.9 0.77 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.186 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.21 30.68 0.1 OUTLIER Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -125.58 -176.33 3.57 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.083 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -114.82 138.84 50.29 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.645 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -114.64 157.86 22.53 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.298 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 2.7 m -155.44 91.24 1.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.836 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.521 HD12 HD22 ' A' ' 78' ' ' LEU . 5.9 mt -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.607 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' THR . 8.0 t -104.25 145.5 30.13 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.777 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.27 98.45 2.81 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.466 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.43 154.53 19.33 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.409 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 p -129.9 143.05 50.6 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.901 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -53.66 -71.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.482 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -82.08 152.24 26.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.3 p -66.52 131.45 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' C ' HG21 ' A' ' 97' ' ' THR . 26.8 mt -78.58 30.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.236 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.0 t -97.26 133.44 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.9 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -86.32 163.11 17.88 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.153 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -60.7 -24.62 65.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.028 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -76.5 -15.29 59.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.321 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.67 -10.04 41.36 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.634 -1.27 . . . . 0.0 111.499 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 8.8 m120 -89.25 141.21 28.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 m -109.37 157.49 18.85 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -137.46 108.87 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.172 -1.011 . . . . 0.0 112.491 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.81 128.63 8.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.261 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 28.0 m-20 -125.15 167.71 14.44 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.505 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.512 ' O ' HD12 ' A' ' 51' ' ' LEU . 57.5 m95 -124.09 152.14 43.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.438 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 29.3 m-85 -135.34 156.37 49.05 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.282 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 15.4 tp -146.51 117.37 7.67 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.241 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -125.58 158.2 35.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.338 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -114.25 -147.28 0.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.42 -56.32 3.41 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.002 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.64 56.43 0.69 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -131.64 162.89 29.32 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.691 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 m -70.96 124.45 91.04 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.04 158.48 29.69 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.87 1.714 . . . . 0.0 111.516 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.98 159.58 44.48 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.322 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' TRP . 45.0 tp -101.96 134.82 44.56 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.957 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -102.72 -67.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.231 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -119.4 142.44 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.3 p90 -145.06 167.82 21.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.078 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER 60.85 15.37 5.92 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.461 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER 78.58 5.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.681 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 4.1 m-20 -44.11 128.39 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.661 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.565 HH21 ' N ' ' A' ' 65' ' ' ASP . 11.7 mtm-85 -97.29 146.31 25.26 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.165 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.81 159.32 34.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.639 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -58.04 122.28 12.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.43 -18.06 45.63 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.35 116.48 53.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.693 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.496 ' C ' HH21 ' A' ' 59' ' ' ARG . 1.1 Cg_endo -65.89 172.66 8.07 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.137 1.891 . . . . 0.0 112.423 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.565 ' N ' HH21 ' A' ' 59' ' ' ARG . 1.2 m-20 -78.05 -15.81 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -56.2 -27.15 53.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.169 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -96.66 118.99 34.31 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.286 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -128.03 91.21 3.23 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.924 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.51 127.62 8.8 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 t -160.96 178.37 9.44 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.58 -178.5 42.58 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.541 -1.314 . . . . 0.0 110.836 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -92.88 -85.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.039 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.2 -34.84 0.11 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.57 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.8 p -124.17 6.6 8.5 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.42 118.36 16.31 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -133.61 153.13 51.91 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 16.1 m -154.2 145.89 23.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.83 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 21' ' ' ILE . 1.9 tt -96.71 99.62 11.21 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.587 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -91.1 122.58 33.87 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.247 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 19' ' ' ALA . 45.0 mt -112.5 133.04 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m -70.31 -71.86 0.22 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.665 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.81 102.45 9.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.518 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.7 131.47 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -117.05 -173.9 2.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.302 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.24 -25.36 61.59 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.72 -32.11 59.91 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.07 -31.74 70.29 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.74 139.44 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.583 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.29 -150.72 22.8 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.436 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.6 mp -122.09 121.38 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.463 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.464 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-85 -93.11 151.28 19.95 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.174 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 46.9 m-85 -143.23 164.32 30.52 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.192 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.26 151.48 36.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.9 p -157.22 157.3 34.07 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.178 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 146.96 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -126.14 27.9 6.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.504 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.479 HG21 ' C ' ' A' ' 29' ' ' LEU . 1.1 m -77.98 -33.87 51.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.171 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.632 ' CE1' HG21 ' A' ' 2' ' ' VAL . 73.1 m80 -105.81 -43.56 4.86 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.581 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER 66.45 140.12 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.574 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.581 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 0.9 OUTLIER -66.67 168.65 50.54 Favored 'Cis proline' 0 C--N 1.318 -1.029 0 C-N-CA 123.901 -1.291 . . . . 0.0 111.903 -0.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.24 134.56 46.02 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.172 1.915 . . . . 0.0 111.788 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 p -78.09 -57.39 3.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.715 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 80.2 t80 62.7 164.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.449 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 139.91 -157.57 25.4 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.65 -137.26 19.93 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.18 68.06 0.38 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.418 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 8' ' ' PRO . 12.1 m -78.31 114.89 17.62 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.713 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -77.39 111.33 12.97 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.682 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 89.39 2.98 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.775 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.45 144.55 48.62 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.1 tt -66.41 150.94 10.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -53.43 135.69 39.04 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.966 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 116.39 -1.767 . . . . 0.0 110.945 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 102' ' ' THR . 7.6 t -76.64 142.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.158 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.54 148.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.634 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mmt -134.26 104.97 6.4 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.627 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 m -100.49 129.71 46.47 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.31 147.38 32.77 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.281 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.72 7.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.806 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 107' ' ' THR . 12.1 Cg_endo -83.94 171.78 47.36 Favored 'Cis proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.005 -1.248 . . . . 0.0 111.502 -0.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.758 HD22 ' H ' ' A' ' 9' ' ' LEU . 1.7 mm? -74.41 -42.43 59.23 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.01 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 p -125.96 146.05 50.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.101 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.3 tp -137.69 74.6 45.38 Favored Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.48 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.37 117.94 5.12 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.536 1.491 . . . . 0.0 109.877 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 11' ' ' LEU . 6.3 m -139.4 -174.67 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -113.05 172.16 7.11 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.725 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.75 86.23 7.37 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.828 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.57 33.4 0.06 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.714 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.23 -173.7 3.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.097 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.47 137.28 52.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.984 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 166.77 11.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.641 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 p -162.23 76.83 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 77' ' ' THR . 19.1 mt -79.23 140.03 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.248 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 t -113.35 152.59 29.76 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.741 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.8 m -156.43 99.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.598 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 75' ' ' ASP . 9.9 mtm180 -110.02 152.63 25.67 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.943 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 p -118.64 150.65 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.317 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -58.5 -45.76 88.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.665 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.63 174.66 5.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.861 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 t -74.04 146.66 43.54 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.9 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.515 ' C ' HG21 ' A' ' 97' ' ' THR . 83.0 mt -101.09 30.51 4.08 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.78 131.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.571 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 152.54 37.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.012 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 t -45.8 -25.94 0.59 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.712 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -155.2 45.24 0.49 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.138 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -136.29 -136.14 3.51 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -176.45 3.95 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.074 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 137.22 36.17 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -117.78 105.36 11.89 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' CD2' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -145.14 143.12 30.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.346 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -134.7 154.72 51.43 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.247 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.522 ' O ' HD12 ' A' ' 51' ' ' LEU . 82.6 m95 -123.49 147.41 47.24 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -140.77 145.84 36.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.547 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.8 tp -130.67 115.54 16.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.87 138.05 54.55 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.749 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 -122.61 0.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.66 -39.92 12.9 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.316 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.44 68.83 0.1 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.605 -1.284 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.437 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -117.04 159.01 23.19 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.13 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -75.77 -56.43 1.75 Allowed Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.644 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 48' ' ' SER . 5.6 Cg_exo -56.92 113.57 1.53 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.565 1.51 . . . . 0.0 111.511 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.0 24.81 3.59 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 40' ' ' TRP . 22.5 tp -143.08 126.52 16.74 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.732 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.427 ' HA ' HG21 ' A' ' 63' ' ' VAL . 3.8 mp -107.8 -52.43 2.76 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.939 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 55' ' ' LYS . 2.0 mm -129.3 134.42 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.507 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -112.27 39.04 2.53 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 179.22 -167.14 0.07 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.632 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' H ' ' HG3' ' A' ' 55' ' ' LYS . 27.5 t -76.82 -13.31 14.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.85 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.462 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.448 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -170.88 107.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.236 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 31.8 mtm180 -74.38 150.22 40.15 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -80.1 163.73 23.91 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.629 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -63.73 89.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.802 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.47 -28.54 2.32 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' A' ' 52' ' ' LEU . 49.8 t -70.4 116.93 50.05 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.94 148.49 76.01 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.104 1.869 . . . . 0.0 112.874 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 2.9 m-20 -57.8 -8.81 1.03 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -20.67 63.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.927 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.47 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 94.9 m-85 -105.51 119.67 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.708 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.9 p -125.51 107.4 10.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.68 139.01 14.3 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.198 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.6 p -156.2 146.12 21.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.082 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -173.63 168.71 41.68 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 p -94.44 -105.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.437 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.73 -33.72 1.26 Allowed Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.026 -1.083 . . . . 0.0 110.483 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.6 p -126.87 10.09 7.0 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.964 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 11.9 t0 -136.68 130.65 32.46 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.071 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 70.0 m-85 -145.03 147.9 33.12 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.533 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 21' ' ' ILE . 53.3 m -149.8 133.14 16.49 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.656 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -93.74 114.8 27.15 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.468 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -113.66 145.21 41.66 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.825 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.439 HG12 ' CD1' ' A' ' 67' ' ' PHE . 67.3 mt -123.08 143.22 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.746 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -70.61 -57.76 4.39 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.547 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 8.7 ptm180 -129.48 107.35 9.41 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.659 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.47 105.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.33 -163.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.86 -30.14 50.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.49 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -26.13 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.708 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.1 -21.9 62.16 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.49 137.46 48.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.78 -158.73 27.76 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.25 124.82 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.568 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.6 m-85 -94.16 153.4 18.11 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.297 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.07 170.26 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.73 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.6 p -151.72 152.57 32.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 p -154.89 164.38 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 160.72 29.55 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -134.58 24.24 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.814 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.515 HG21 ' C ' ' A' ' 29' ' ' LEU . 17.1 m -79.92 -43.74 21.61 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.752 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.19 141.69 51.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.788 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 3.2 t -95.98 141.47 23.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 9.3 Cg_endo -77.46 163.51 88.42 Favored 'Cis proline' 0 C--N 1.317 -1.102 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.193 -0.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 2.3 Cg_endo -67.87 117.43 4.89 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.029 1.819 . . . . 0.0 110.347 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 2' ' ' VAL . 20.8 p -90.39 104.25 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.992 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -86.34 150.39 24.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.18 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.05 170.72 42.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.1 -149.74 18.63 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 40.91 1.29 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' PRO . 95.8 m -79.23 106.42 11.25 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -71.86 112.93 8.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.221 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.61 80.25 1.45 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.56 140.84 34.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.582 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.4 tt -71.8 150.48 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -54.92 128.9 35.48 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.111 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.082 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.078 0.466 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.5 t -68.94 110.57 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.138 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.96 141.23 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 5.1 mtp -128.21 105.19 8.19 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.09 143.1 37.66 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.11 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -130.59 135.68 48.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.337 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.18 157.3 24.73 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.112 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 7' ' ' THR . 10.1 Cg_endo -78.66 176.46 42.6 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.563 -1.432 . . . . 0.0 111.362 -1.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.744 HD22 ' N ' ' A' ' 9' ' ' LEU . 2.2 mm? -78.96 -44.35 22.63 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.161 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -128.09 144.4 51.11 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.627 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 tp -132.31 78.17 68.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.039 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.81 108.32 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.621 1.547 . . . . 0.0 110.231 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.91 -173.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.976 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -119.1 173.18 7.07 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.675 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -88.04 90.12 8.26 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.94 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.35 42.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -170.56 2.94 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.758 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -109.16 140.68 42.43 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.071 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . . . -108.95 159.24 16.98 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.75 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -157.43 88.56 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' THR . 4.0 mt -81.19 128.71 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.794 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.15 140.42 30.89 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.029 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.8 t -153.88 110.83 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.792 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.23 173.39 6.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.683 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 79.5 p -132.23 166.99 20.62 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.333 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -72.85 -50.85 21.44 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.94 161.01 17.5 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.359 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' VAL . 64.4 m -59.98 126.35 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.408 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 29' ' ' LEU . 76.6 mt -79.98 29.93 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.9 t -98.85 137.49 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.432 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 13.5 t-80 -86.43 171.05 11.43 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.556 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 t -74.0 -24.44 59.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 8.6 p30 -77.97 -29.74 49.91 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.446 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 43.89 0.65 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -130.43 141.54 50.53 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.838 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.8 m -113.86 109.44 18.53 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -98.05 109.74 22.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.057 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -154.07 127.75 8.72 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.615 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.559 ' N ' HD23 ' A' ' 38' ' ' LEU . 12.9 p-10 -130.67 152.78 49.65 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD2' HD13 ' A' ' 78' ' ' LEU . 53.7 m95 -115.78 158.35 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 16.9 m-85 -137.14 156.01 48.89 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.596 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 91' ' ' TYR . 9.1 tp -140.6 127.03 19.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.13 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -131.64 155.92 46.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.036 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.0 -118.37 0.3 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.272 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.23 -90.06 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.616 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -124.53 38.62 2.32 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.96 -175.94 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.1 p -84.73 151.08 57.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.545 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.08 125.85 20.28 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.009 1.806 . . . . 0.0 111.836 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -107.38 137.9 44.57 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.383 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 54' ' ' TYR . 27.7 tp -103.13 133.91 47.44 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.337 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.4 -49.65 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.81 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.563 HG13 HD11 ' A' ' 78' ' ' LEU . 6.1 mm -127.54 135.43 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.495 ' HB3' HD21 ' A' ' 51' ' ' LEU . 51.1 p90 -122.62 -11.25 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.567 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.22 88.57 2.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.376 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.684 HG13 ' N ' ' A' ' 57' ' ' SER . 1.5 p 45.26 -68.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 124.348 1.03 . . . . 0.0 113.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.684 ' N ' HG13 ' A' ' 56' ' ' VAL . 53.9 p -130.32 28.73 4.95 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.4 m-80 -103.78 111.55 24.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -75.87 152.23 37.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.649 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 33.4 t80 -88.78 167.18 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t -59.79 132.69 54.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.692 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.11 -17.46 56.9 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -73.58 117.69 62.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.8 144.42 96.91 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.731 1.621 . . . . 0.0 111.667 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.99 -10.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -62.27 -19.92 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.54 122.69 46.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.254 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.13 121.32 13.83 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.41 147.78 17.49 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.41 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -161.35 161.1 30.33 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.5 173.45 44.65 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -91.21 -87.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.47 -34.76 0.11 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -120.95 17.86 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.572 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -155.01 126.2 7.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.986 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CG ' ' CD1' ' A' ' 38' ' ' LEU . 7.5 m-85 -141.56 153.53 44.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 21' ' ' ILE . 18.8 m -148.34 142.38 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.733 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.6 tp -101.83 115.09 29.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.065 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -111.17 151.11 28.58 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.635 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -127.89 134.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.94 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.6 m -67.35 -49.9 62.12 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.84 103.64 5.94 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 98.7 t -68.09 117.76 10.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.079 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -108.47 -177.93 3.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.95 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.94 -42.93 56.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.68 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.03 -19.66 53.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 88' ' ' LEU . 73.4 mt -52.67 147.84 8.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.746 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.36 -160.42 25.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.14 151.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.046 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' HD13 ' A' ' 42' ' ' LEU . 13.3 m-85 -123.57 148.69 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.565 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -141.66 162.94 34.25 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.3 p -144.86 125.16 13.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.436 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.5 p -120.64 161.85 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.545 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.532 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -125.97 150.7 47.83 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.895 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 52.13 1.61 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.634 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -50.08 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.353 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' H ' HE22 ' A' ' 95' ' ' GLN . 73.5 m80 -112.51 163.38 14.54 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.269 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 100' ' ' PRO . 11.2 p -117.98 139.78 26.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.519 ' HA ' HG23 ' A' ' 99' ' ' VAL . 7.0 Cg_endo -75.75 156.68 99.01 Favored 'Cis proline' 0 C--N 1.315 -1.201 0 C-N-CA 123.69 -1.379 . . . . 0.0 111.71 -0.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.04 120.19 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.977 1.784 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.7 p -91.28 136.19 33.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.397 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.67 176.42 8.17 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.6 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.66 -161.95 37.85 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 6' ' ' GLN . . . -87.98 -79.3 1.27 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.307 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.89 95.09 0.15 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 21' ' ' ILE . 95.2 m -92.29 117.33 29.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.561 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -85.51 114.53 22.6 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.318 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.4 93.42 4.59 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.802 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.8 139.18 52.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.85 156.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -55.34 152.32 8.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.707 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.697 HG21 ' CE1' ' A' ' 98' ' ' HIS . 47.8 t -67.02 152.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.981 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 4' ' ' MET . 3.8 t -96.94 166.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.265 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -148.76 115.45 5.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.516 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -95.85 140.8 30.11 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.012 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 132.14 46.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.538 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.99 158.02 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.932 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.8 Cg_endo -79.69 175.1 46.49 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.429 -1.488 . . . . 0.0 110.538 -1.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.6 mm? -77.75 -43.96 29.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.801 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.7 m -126.14 146.05 50.1 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -136.09 78.03 47.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.62 112.27 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.79 1.66 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.34 178.96 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.386 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -110.34 174.58 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.787 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 HD13 ' A' ' 111' ' ' ILE . 15.3 mt -85.95 87.73 7.46 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.77 52.72 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.5 179.38 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.75 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -100.49 141.31 33.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.455 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -113.37 165.76 12.13 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -159.55 91.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.591 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 77' ' ' THR . 25.9 mt -79.31 152.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 m -121.48 140.99 51.47 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.188 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -149.25 110.9 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HE ' ' CG ' ' A' ' 75' ' ' ASP . 58.0 mtp180 -113.13 163.48 14.7 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.514 -0.874 . . . . 0.0 112.184 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.2 p -133.47 147.73 51.68 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.3 m -62.72 -41.05 98.96 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.94 159.26 22.72 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -70.68 129.58 39.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.53 34.41 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.72 147.74 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.44 ' HB3' HD22 ' A' ' 33' ' ' ASN . 3.6 t-80 -97.42 167.22 11.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.464 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 t -75.19 66.39 1.69 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.883 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.44 HD22 ' HB3' ' A' ' 31' ' ' HIS . 0.7 OUTLIER -174.14 -30.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.837 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 31.55 1.15 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.671 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -132.47 132.71 43.0 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 56' ' ' VAL . 2.9 m -79.26 153.42 29.94 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.651 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -124.09 89.03 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.779 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 76' ' ' PHE . 1.1 tt -155.37 134.49 12.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.181 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -129.42 150.15 50.9 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.044 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD13 ' A' ' 78' ' ' LEU . 86.5 m95 -103.96 153.32 20.96 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.346 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.54 130.26 9.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.8 tp -109.83 142.81 40.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.569 ' H ' HD12 ' A' ' 42' ' ' LEU . 53.0 tt0 -125.3 137.64 54.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.822 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -121.85 170.03 10.19 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.475 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.24 137.45 53.15 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.829 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 40.15 51.26 3.54 Favored Glycine 0 N--CA 1.497 2.726 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.42 158.68 39.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.369 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.76 158.68 77.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.843 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.28 150.35 80.54 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.884 1.723 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 134.6 5.19 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.198 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 53' ' ' ILE . 13.5 tp -102.62 139.08 38.68 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.319 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 67' ' ' PHE . 1.1 tp -99.63 -62.47 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.586 ' O ' HD11 ' A' ' 51' ' ' LEU . 1.2 mm -126.25 149.46 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.015 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.567 ' HB3' HD21 ' A' ' 51' ' ' LEU . 42.6 p90 -137.99 160.8 38.36 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.358 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.03 -63.69 0.41 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.629 0.58 . . . . 0.0 110.133 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 57' ' ' SER . 7.0 p -172.39 -37.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.756 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 49.6 m -150.5 -25.64 0.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.016 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 34.8 m-80 -53.31 120.92 6.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.274 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' NH2' ' HA ' ' A' ' 65' ' ' ASP . 13.4 mtm180 -76.55 151.29 36.39 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -90.27 167.82 12.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.731 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 t -62.62 121.69 13.99 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 103.27 -8.96 53.55 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.62 113.8 58.13 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.342 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -66.0 155.39 69.78 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.129 1.886 . . . . 0.0 112.315 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' NH2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -57.39 -13.21 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.345 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -62.79 -18.29 62.47 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.026 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.487 ' CD1' HD21 ' A' ' 52' ' ' LEU . 63.9 m-85 -106.18 109.59 21.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.547 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 t -116.95 119.36 35.1 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -126.11 130.64 7.19 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.1 t -161.24 168.91 23.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.95 -177.7 48.56 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.398 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.9 t -91.26 -106.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.068 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.8 -35.15 0.86 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.2 p -124.3 16.85 9.06 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -145.31 120.86 10.4 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.733 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 38' ' ' LEU . 40.2 m-85 -133.6 144.67 49.42 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 21' ' ' ILE . 68.5 m -141.15 141.48 34.14 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.635 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.612 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -98.86 99.69 10.79 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.785 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -89.12 117.06 27.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.633 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 37.5 mt -104.56 138.11 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.935 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -64.25 1.03 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.904 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -124.37 103.46 8.21 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.013 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.52 104.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.207 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.52 167.76 10.4 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . . . -55.29 -25.45 34.15 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.408 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -79.53 -37.39 36.66 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.506 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -5.24 25.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.312 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD11 ' A' ' 111' ' ' ILE . 85.0 mt -74.03 150.07 40.86 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.1 -149.42 21.55 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.202 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 mp -120.53 118.58 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.29 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' CE1' HD13 ' A' ' 42' ' ' LEU . 22.6 m-85 -92.76 154.15 18.47 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CE1' ' HA2' ' A' ' 106' ' ' GLY . 97.5 m-85 -143.34 157.4 44.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.634 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 16.0 p -135.63 147.47 48.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.755 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -150.0 166.35 29.93 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.627 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.54 HE21 HG23 ' A' ' 102' ' ' THR . 1.7 pp0? -127.22 145.08 50.89 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.62 18.02 13.53 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.504 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.77 -42.34 67.28 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.697 ' CE1' HG21 ' A' ' 2' ' ' VAL . 31.9 m80 -111.4 171.81 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.422 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.9 t -138.81 140.85 28.58 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.574 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.6 Cg_endo -70.76 168.82 70.1 Favored 'Cis proline' 0 C--N 1.319 -1.025 0 C-N-CA 123.741 -1.358 . . . . 0.0 111.883 -0.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.88 156.99 54.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.935 1.757 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.54 HG23 HE21 ' A' ' 95' ' ' GLN . 26.7 p -89.58 -64.25 1.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.961 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 63.24 171.55 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.04 -156.92 19.82 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.652 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 -172.73 45.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 162.14 59.81 0.02 OUTLIER Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.005 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.1 m -77.28 109.51 11.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.876 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -78.07 132.03 37.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.481 HD23 HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -123.2 76.92 1.42 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.964 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -107.0 137.85 44.28 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.96 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 88' ' ' LEU . 18.9 mt -63.32 124.71 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.507 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.489 ' HE3' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -64.12 103.14 0.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.729 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 116.597 -1.668 . . . . 0.0 111.499 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 98' ' ' HIS . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.657 0.265 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 2' ' ' VAL . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.665 HG21 ' CD2' ' A' ' 98' ' ' HIS . 69.7 t -71.63 124.54 28.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.535 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.92 147.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.38 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.446 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 4.3 mtp -143.42 110.56 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.195 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -101.38 117.13 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.783 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' HA3' ' A' ' 105' ' ' GLY . 5.7 tt0 -101.21 133.43 45.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.732 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -154.37 163.37 24.39 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.88 179.46 31.25 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.306 -1.539 . . . . 0.0 111.119 -1.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 mt -77.6 -35.97 52.3 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.563 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.98 151.57 46.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -138.26 85.6 18.27 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.797 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 106.75 1.5 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.77 1.647 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.46 -177.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.576 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.6 m -122.27 156.2 34.32 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.1 mt -67.48 86.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.32 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.77 36.3 0.07 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -135.86 166.34 23.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -94.11 137.39 33.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.236 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.67 160.24 16.1 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.57 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -149.04 90.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.628 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.669 HG23 HG21 ' A' ' 107' ' ' THR . 2.8 mt -86.62 113.61 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' THR . 7.2 t -81.21 156.3 25.72 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.654 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.8 91.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -91.0 166.63 12.91 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.978 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 p -148.39 167.36 25.46 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.996 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -79.62 -69.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -92.14 154.7 18.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.757 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -64.2 132.31 49.98 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.23 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 38' ' ' LEU . 14.3 mt -85.23 33.43 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.5 127.0 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.008 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.489 1.491 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.419 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . 5.0 m-80 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 m -107.79 99.41 8.88 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 35' ' ' ASN . 21.3 m-85 -83.85 75.78 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' A' ' 29' ' ' LEU . 5.6 tt -132.58 125.67 31.03 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.244 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 17.2 p-10 -126.06 160.84 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.839 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -108.3 174.92 5.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.498 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 27.9 m-85 -150.2 161.76 41.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.547 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 tp -160.51 111.14 1.82 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.282 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.42 161.07 17.75 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.964 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 tptt . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.855 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 54' ' ' TYR . 31.6 tp . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.858 0.361 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.536 ' O ' HG21 ' A' ' 63' ' ' VAL . 49.0 mt -108.9 -51.12 2.92 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.759 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.9 mm -127.47 134.85 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.517 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HB3' HD21 ' A' ' 51' ' ' LEU . 35.4 p90 -112.83 -21.95 10.92 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.226 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' SER . 19.6 mttp -135.33 106.54 6.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.334 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.046 HG13 ' H ' ' A' ' 57' ' ' SER . 6.3 p 29.7 -85.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.15 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.046 ' H ' HG13 ' A' ' 56' ' ' VAL . 21.4 t -114.35 48.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.238 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -125.61 108.11 11.25 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 18.9 mtt180 -73.53 144.22 46.2 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.465 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -73.41 155.35 39.41 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.984 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.8 p -59.11 98.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.622 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.56 -17.79 4.97 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 52' ' ' LEU . 95.4 t -73.56 120.11 79.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.305 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.75 150.19 86.87 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.107 1.872 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -55.07 -19.88 8.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' ' OE2' ' A' ' 84' ' ' GLU . 61.4 mtt85 -56.01 -14.39 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.497 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -115.1 128.3 56.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.043 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.91 125.43 17.76 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.33 149.46 18.59 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.084 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.46 160.13 39.28 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 175.16 159.97 22.23 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.672 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 p -90.83 -99.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.675 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.78 -37.25 0.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.2 p -121.89 17.61 10.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.71 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 9.3 t70 -152.25 125.13 8.49 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 20.9 m-85 -139.09 156.18 47.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.841 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.0 m -150.89 149.28 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.11 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.89 109.51 21.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.772 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -100.77 123.05 44.41 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.752 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mt -108.08 132.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.8 m -64.63 -60.82 2.67 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -135.98 109.61 8.02 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.47 110.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.157 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE2' ' NE ' ' A' ' 66' ' ' ARG . 4.7 mt-10 -95.26 -175.52 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.295 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.17 66.28 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.249 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 6.7 pt-20 -87.24 -32.58 19.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 60.5 m-20 -64.11 -12.58 40.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.384 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.575 ' CD1' HD11 ' A' ' 111' ' ' ILE . 20.1 mt -69.81 147.8 49.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.88 -161.16 28.25 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.557 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.2 mp -106.08 117.92 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CB ' HD13 ' A' ' 21' ' ' ILE . 25.8 m-85 -90.97 154.15 19.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.672 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 106' ' ' GLY . 45.6 m-85 -146.39 168.48 21.03 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.42 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.6 p -159.05 151.09 20.98 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.321 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.0 t -152.69 -175.34 5.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.513 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 1.1 pp0? -135.84 136.38 40.57 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.0 m -110.36 42.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -38.62 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.139 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.665 ' CD2' HG21 ' A' ' 2' ' ' VAL . 82.7 m-70 -109.42 156.21 20.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.393 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 92.3 t -127.1 134.66 26.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.606 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -72.24 163.29 88.16 Favored 'Cis proline' 0 C--N 1.318 -1.045 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.731 -0.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.16 162.08 34.54 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 122.044 1.83 . . . . 0.0 111.389 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 28.5 p -87.43 -92.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.542 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 102' ' ' THR . 65.8 t80 61.99 116.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.445 0.466 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.92 54.97 0.04 OUTLIER Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.888 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.491 ' HA3' ' OE1' ' A' ' 6' ' ' GLN . . . -114.1 -120.87 3.57 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . 127.23 68.72 0.16 Allowed Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.887 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.669 HG21 HG23 ' A' ' 21' ' ' ILE . 94.3 m -86.01 106.06 16.91 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.204 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -75.53 115.84 15.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.198 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -111.34 93.47 4.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.619 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -121.93 143.86 49.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.741 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.575 HD11 ' CD1' ' A' ' 88' ' ' LEU . 17.2 mt -62.47 152.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.294 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 111' ' ' ILE . 2.0 mtpm? -63.29 123.42 18.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.316 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.878 0.37 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' HG21 ' A' ' 102' ' ' THR . 70.4 t -71.29 116.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.291 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 151.09 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 120.39 11.6 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.1 143.7 47.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.527 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 1.4 tt0 -118.23 148.2 42.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.819 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.11 154.76 18.48 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.796 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.43 178.61 33.79 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.734 -1.361 . . . . 0.0 111.102 -1.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 mt -77.05 -44.5 30.5 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.911 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.04 152.23 48.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.12 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -142.95 78.71 15.18 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.092 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.85 126.19 14.91 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.757 1.638 . . . . 0.0 109.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.43 -175.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.335 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.76 167.06 11.1 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.599 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 111' ' ' ILE . 82.3 mt -83.54 89.83 7.15 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.04 48.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 176.47 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.26 148.02 23.54 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -125.38 161.02 27.95 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -160.64 96.54 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.434 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 77' ' ' THR . 37.2 mt -86.25 139.65 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.595 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 m -107.22 145.83 32.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.8 t -153.55 118.46 5.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.901 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -123.72 156.18 36.47 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.236 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 74' ' ' THR . 65.8 p -122.03 146.58 47.03 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -58.05 -49.77 75.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -111.22 156.22 21.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -64.62 144.81 56.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.89 30.32 3.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.23 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.72 141.64 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.502 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 . . . . . 0 N--CA 1.488 1.456 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.119 -179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.888 0.375 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.3 m -115.32 150.34 36.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -132.2 101.44 5.38 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.463 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.03 129.18 12.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.786 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' OH ' ' A' ' 41' ' ' TYR . 12.4 p-10 -130.76 160.29 34.79 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.891 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -112.52 151.79 29.57 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' OH ' ' ND2' ' A' ' 39' ' ' ASN . 22.6 m-85 -129.31 166.59 19.17 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 91' ' ' TYR . 14.2 tp -154.53 126.68 7.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.011 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -124.03 165.83 16.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.014 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tptp . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.26 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.4 tp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.883 0.373 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.0 mt -113.73 -64.7 1.27 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mm -116.17 140.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.662 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.1 p90 -130.27 158.59 39.37 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.178 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.2 tptm 74.4 -67.07 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.986 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -171.07 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.494 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 p -152.43 -28.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.347 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 30.9 m-80 -51.65 129.0 24.98 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -90.25 139.59 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.44 151.12 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.694 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -59.39 104.07 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.14 -12.85 6.39 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.326 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.01 119.21 75.38 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.39 150.83 78.57 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.874 1.716 . . . . 0.0 111.828 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.51 -15.51 11.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.389 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -57.2 -18.4 15.58 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.75 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -107.43 128.62 54.64 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.0 125.54 17.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.57 144.97 17.05 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -160.44 -177.59 6.33 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.08 169.92 33.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.276 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 m -91.21 -82.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.25 -37.9 0.1 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.599 -1.286 . . . . 0.0 111.12 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 25' ' ' SER . 64.3 p -125.13 13.97 8.39 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.98 117.4 12.01 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -132.34 144.54 50.63 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.611 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ILE . 88.2 m -141.37 139.69 33.57 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.783 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -106.14 111.48 24.11 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.765 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 37.8 mttt -107.1 147.74 29.65 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.629 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.3 mt -124.77 134.84 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.435 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.5 m -67.24 -55.47 13.89 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.174 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.14 110.63 8.54 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.25 130.17 35.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.211 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.96 -172.27 2.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.758 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 -29.6 62.06 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.39 -43.09 67.49 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.86 -36.07 16.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.571 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 77.1 mt -45.24 136.34 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.35 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.56 -144.74 10.91 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.409 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.9 mp -125.0 141.07 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.489 ' CE1' HD13 ' A' ' 42' ' ' LEU . 24.6 m-85 -117.83 151.12 37.98 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -146.64 163.78 34.77 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -137.58 136.03 37.2 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.362 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 p -139.4 155.13 47.84 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.954 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.38 37.9 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -127.83 28.78 5.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.234 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 -57.57 3.19 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.596 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -105.91 159.69 15.83 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 100' ' ' PRO . 38.3 t -110.0 140.77 22.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.318 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.479 ' HA ' HG13 ' A' ' 99' ' ' VAL . 7.4 Cg_endo -77.44 163.69 88.1 Favored 'Cis proline' 0 C--N 1.315 -1.193 0 C-N-CA 123.715 -1.369 . . . . 0.0 111.824 -0.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.36 118.9 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.021 1.814 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' VAL . 19.6 p -89.9 135.32 33.71 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.741 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.38 -179.85 7.03 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.212 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.64 -175.71 41.5 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -82.93 -69.9 1.37 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 136.43 114.31 1.33 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 125.32 53.23 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.299 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.6 128.12 37.31 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.48 90.92 3.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.23 143.46 41.95 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.925 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.447 HD12 HD21 ' A' ' 15' ' ' LEU . 15.7 tt -66.66 150.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.961 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -62.61 121.37 13.17 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.649 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 98' ' ' HIS . 41.9 t -74.47 106.27 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.792 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -69.44 164.05 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.486 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -143.7 110.59 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -77.15 110.54 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.65 131.16 44.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.178 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -164.89 156.53 13.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.445 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HA ' HG22 ' A' ' 7' ' ' THR . 11.2 Cg_endo -82.86 175.22 39.49 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.372 -1.512 . . . . 0.0 110.972 -1.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.08 -39.05 21.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.485 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -129.44 143.45 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 tp -137.59 81.05 30.56 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.824 -1.151 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.54 121.74 8.48 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.773 1.649 . . . . 0.0 109.646 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.29 -178.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 118.98 -1.088 . . . . 0.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -108.6 172.92 6.56 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -89.19 89.49 7.96 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.01 28.03 0.34 Allowed Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.49 174.94 6.08 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.852 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -96.51 141.96 29.16 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -108.76 167.31 10.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.832 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -162.03 79.89 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.048 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.2 mt -75.11 133.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.207 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -105.52 155.69 18.94 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.153 -1.019 . . . . 0.0 113.312 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.41 89.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.464 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -94.42 147.41 23.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.427 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 1.2 m -111.35 163.99 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.609 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -47.86 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.41 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.454 ' C ' HG22 ' A' ' 74' ' ' THR . 11.4 tt0 -119.83 150.93 39.63 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -55.7 132.02 48.04 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.843 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.562 HD22 ' OE1' ' A' ' 95' ' ' GLN . 43.8 mt -85.28 32.62 0.55 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.27 143.46 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 21.7 t-80 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.1 m120 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.117 0.484 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' LEU . 3.2 m -108.43 146.29 33.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -129.97 124.29 32.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.38 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -150.74 154.14 36.82 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.315 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.73 160.07 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.981 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.677 ' CD2' HD13 ' A' ' 78' ' ' LEU . 84.0 m95 -129.68 146.72 51.44 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -142.25 138.21 31.24 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.679 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.658 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.1 tp -119.87 139.59 52.15 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.568 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' LEU . 14.4 mm-40 -125.75 146.84 49.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.563 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.426 -179.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 40' ' ' TRP . 25.9 tp . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.778 0.323 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.89 HD21 ' CD1' ' A' ' 67' ' ' PHE . 4.9 tp -111.03 -81.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.993 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.83 135.52 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 48.0 p90 -116.46 171.54 7.78 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' LEU . 4.8 mmtp 58.09 -150.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.007 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 56' ' ' VAL . 8.1 p -109.57 4.87 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.802 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -179.57 65.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -155.41 113.57 3.43 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.574 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.8 mtm-85 -76.33 138.51 40.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -76.52 164.01 26.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.543 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.3 m -55.29 130.99 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.161 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.29 35.45 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.73 116.66 52.25 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.347 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.91 148.66 91.81 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.175 1.917 . . . . 0.0 112.697 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.83 -17.71 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -57.85 -14.73 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.755 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.89 ' CD1' HD21 ' A' ' 52' ' ' LEU . 82.2 m-85 -105.56 118.95 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.948 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 p -125.94 123.75 39.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.99 118.68 2.77 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.1 p -163.95 168.71 19.0 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.5 -160.42 33.92 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.582 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 p -90.78 -174.73 4.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.3 64.42 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 27' ' ' GLN . 67.8 p -122.8 18.38 10.23 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.546 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB2' ' H ' ' A' ' 72' ' ' SER . 4.1 m-20 -140.16 131.0 25.95 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.949 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.31 127.78 14.06 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.218 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 40.5 m -135.16 131.04 36.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.576 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.1 tp -93.32 89.65 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -82.76 141.81 32.08 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.488 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -125.52 141.25 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.6 m -69.81 -73.19 0.17 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.423 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 106.24 11.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.009 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.5 106.23 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.924 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.36 168.71 11.68 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.975 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.14 -16.85 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.764 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.76 -36.36 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -26.87 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.092 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.4 mt -50.25 138.1 17.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.32 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.01 -151.24 23.49 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.746 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.93 125.51 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.517 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.658 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.4 m-85 -99.8 156.75 16.94 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.634 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -149.02 160.21 43.53 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -144.04 151.42 39.65 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.952 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 t -150.33 168.78 23.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.831 -1.148 . . . . 0.0 112.129 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.562 ' OE1' HD22 ' A' ' 29' ' ' LEU . 11.2 pt20 -123.8 171.24 9.79 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.712 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.46 20.41 1.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -90.01 -19.2 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.719 ' CD2' HG21 ' A' ' 2' ' ' VAL . 89.9 m-70 -127.77 126.85 42.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.146 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.493 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 11.9 p -110.27 138.4 20.87 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.382 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.0 Cg_endo -70.09 155.38 94.17 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.691 -1.379 . . . . 0.0 111.562 -0.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.14 156.22 56.53 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 122.157 1.905 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -89.94 -59.53 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.6 t80 65.86 118.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.007 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.72 -171.5 31.05 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.647 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.32 -174.51 15.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.39 47.36 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.079 -1.534 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -77.38 116.55 18.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.074 -1.051 . . . . 0.0 108.979 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -82.06 95.11 7.34 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.93 75.84 7.89 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.761 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.7 142.41 34.38 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.416 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 tt -77.78 159.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -62.87 140.3 58.8 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.861 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.467 HG21 ' CD2' ' A' ' 98' ' ' HIS . 54.1 t -79.17 147.95 6.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.157 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 t -103.64 157.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.4 mtp -142.87 112.84 7.05 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -93.44 111.82 23.57 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.492 ' CG ' ' HA2' ' A' ' 105' ' ' GLY . 11.3 tm0? -104.92 139.93 38.91 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.73 162.67 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.26 178.52 28.12 Favored 'Cis proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.686 -1.381 . . . . 0.0 110.731 -2.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 9' ' ' LEU . 3.6 mm? -74.81 -64.02 1.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.635 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.45 153.48 26.07 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.93 82.49 17.47 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.977 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.79 116.27 4.19 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.807 1.672 . . . . 0.0 110.457 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -140.12 -170.74 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.186 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 t -118.61 176.11 5.41 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 85' ' ' ALA . 33.6 mt -90.64 92.21 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.436 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.94 -7.64 3.25 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.484 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -172.29 4.09 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.232 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -105.72 166.95 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -140.03 160.59 39.59 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.479 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 p -159.48 89.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 91' ' ' TYR . 19.8 mt -79.41 133.77 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -97.59 147.95 23.78 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.657 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -154.81 102.72 2.38 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.572 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 25' ' ' SER . 4.1 ttt180 -111.65 147.73 34.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.636 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 34.5 m -120.39 157.25 29.69 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.6 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.2 t -65.4 -65.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.696 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' A' ' 28' ' ' SER . 8.7 tt0 -99.19 162.79 12.85 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.683 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.3 p -68.61 121.15 15.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.696 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 95' ' ' GLN . 25.2 mt -77.73 28.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.8 t -89.57 127.49 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.677 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.898 -179.848 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 m -99.99 103.28 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.52 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -84.14 121.47 27.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.919 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -173.89 135.14 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.638 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -137.46 177.31 7.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.05 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 51' ' ' LEU . 65.2 m95 -126.07 148.95 49.22 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 20.2 m-85 -128.91 161.11 30.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 7.9 tp -157.61 113.38 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.965 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -134.85 156.89 48.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.456 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.934 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 40' ' ' TRP . 10.9 tp . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.059 0.457 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.08 -73.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mm -100.04 138.49 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CZ ' ' ND2' ' A' ' 58' ' ' ASN . 37.3 p90 -136.19 12.91 3.31 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.411 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -147.7 44.38 1.1 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.178 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 18.8 t 70.08 -27.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.733 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -155.16 -45.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.121 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.432 ' ND2' ' CZ ' ' A' ' 54' ' ' TYR . 2.9 t30 -58.93 126.81 29.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.496 HH12 ' CG ' ' A' ' 65' ' ' ASP . 5.8 mtm180 -81.25 169.97 16.66 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CG ' ' N ' ' A' ' 61' ' ' SER . 91.6 t80 -90.07 159.51 16.79 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.295 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.418 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 4.5 m -60.66 114.91 3.25 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -17.72 16.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 99.1 t -78.36 129.55 74.53 Favored Pre-proline 0 C--N 1.306 -1.314 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.235 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -65.21 165.16 22.89 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.765 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.496 ' CG ' HH12 ' A' ' 59' ' ' ARG . 0.2 OUTLIER -78.08 -14.78 59.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.821 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.11 -11.54 31.02 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.09 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 51.1 m-85 -101.25 121.12 41.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.967 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -126.66 129.62 48.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.054 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.38 144.57 18.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -160.92 150.0 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.44 160.57 24.4 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.514 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 p -91.21 -85.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.93 -32.69 0.1 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.374 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 p -119.42 15.1 12.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.8 135.2 14.2 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -146.18 149.89 34.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.862 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 m -143.96 143.13 31.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.858 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 40' ' ' TRP . 9.1 tt -106.97 101.51 10.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.955 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -96.68 138.36 34.37 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.006 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 57.9 mt -121.3 138.4 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.79 -74.29 0.14 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.985 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.04 103.6 10.06 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.85 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.684 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.29 166.34 16.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.726 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.404 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -55.37 -25.22 34.01 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.718 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.92 -39.35 34.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.93 -14.46 61.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 109' ' ' LEU . 85.1 mt -58.21 150.99 20.21 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.531 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.34 -166.67 26.73 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.567 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.45 129.26 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.163 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 17.7 m-85 -103.18 146.31 28.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 93.8 m-85 -138.48 169.52 17.64 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.94 134.9 9.96 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.2 p -142.04 173.2 11.74 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HB3' HD13 ' A' ' 29' ' ' LEU . 4.0 pp0? -129.92 157.7 41.57 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -126.46 10.11 7.26 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.459 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 m -68.76 -32.27 71.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.628 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.467 ' CD2' HG21 ' A' ' 2' ' ' VAL . 4.9 m-70 -114.16 124.22 51.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.2 t -104.3 138.35 19.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.315 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' A' ' 99' ' ' VAL . 4.1 Cg_endo -73.1 159.98 96.42 Favored 'Cis proline' 0 C--N 1.317 -1.113 0 C-N-CA 123.774 -1.344 . . . . 0.0 111.769 -0.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 103' ' ' PHE . 3.3 Cg_exo -60.58 141.25 94.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.137 1.891 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -91.12 -28.72 17.72 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.262 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 101' ' ' PRO . 60.5 m-85 54.46 -159.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.516 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.48 -174.2 15.88 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.492 ' HA2' ' CG ' ' A' ' 6' ' ' GLN . . . 93.74 161.92 35.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.775 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.68 56.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.418 ' OG1' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m -79.36 110.34 14.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -80.61 99.84 8.33 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.775 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -87.96 84.73 6.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.766 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.1 147.18 32.83 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.084 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -83.32 153.33 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -57.21 131.1 48.95 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.359 -1.782 . . . . 0.0 110.442 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.04 0.448 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 98' ' ' HIS . 77.0 t -67.42 146.43 13.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.338 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.56 148.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' A' ' 95' ' ' GLN . 3.8 mtt -139.01 107.91 5.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -98.59 97.18 8.5 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.569 ' OE1' ' SG ' ' A' ' 93' ' ' CYS . 2.2 tp60 -78.82 141.95 37.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.86 158.43 26.85 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -77.77 178.13 36.23 Favored 'Cis proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.313 -1.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.34 -57.36 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.692 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.0 m -113.95 144.16 43.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.239 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.86 73.05 54.16 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.331 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.97 118.23 5.4 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.661 1.574 . . . . 0.0 110.377 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.63 -178.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.261 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.32 156.85 18.07 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.557 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.5 mt -73.89 88.25 1.82 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.605 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.81 43.95 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 179.89 6.12 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -96.2 148.17 22.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -125.3 157.6 36.25 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.266 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -151.09 82.73 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.75 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 mt -80.27 117.83 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.264 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -86.89 159.34 19.08 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.3 t -157.78 97.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.603 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -104.22 153.56 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.299 -0.96 . . . . 0.0 113.019 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 m -128.28 145.8 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -62.51 -50.98 69.25 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.363 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.97 145.57 38.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.078 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -57.63 139.7 52.95 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.5 mt -93.06 39.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.545 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.08 137.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.723 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.961 0.41 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.46 127.85 49.33 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' OG1' ' A' ' 96' ' ' THR . 96.0 m-85 -116.67 110.5 18.56 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.639 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.73 146.79 26.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -141.03 162.18 36.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.379 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.703 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.8 m95 -128.98 150.1 50.54 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -145.02 158.01 43.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 37.8 tp -138.04 117.78 13.15 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.297 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.65 152.95 43.0 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.736 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 N--CA 1.486 1.361 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.261 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 54' ' ' TYR . 39.4 tp . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.857 0.36 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -95.93 -70.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.236 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 78' ' ' LEU . 6.4 mm -111.24 141.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.572 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' HB3' HD21 ' A' ' 51' ' ' LEU . 53.8 p90 -128.82 8.01 5.7 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.81 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HB3' HD22 ' A' ' 58' ' ' ASN . 17.3 tttt -160.65 61.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 15.8 t 71.21 -65.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.007 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 p -124.77 -36.53 2.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.451 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.424 HD22 ' HB3' ' A' ' 55' ' ' LYS . 77.8 m-20 -48.1 115.51 1.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.705 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -85.71 151.54 23.78 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -80.7 164.73 22.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.053 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.75 137.22 54.83 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 -40.01 3.04 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.2 110.2 1.78 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.685 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.35 150.69 86.28 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.94 1.76 . . . . 0.0 111.702 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -12.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.465 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -58.64 -12.57 4.28 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.474 ' HE2' ' HH ' ' A' ' 91' ' ' TYR . 29.9 m-85 -111.35 120.34 41.89 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.726 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.4 p -133.69 100.36 4.75 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.29 153.35 23.4 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.83 158.13 27.88 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.22 157.25 16.11 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.2 m -90.39 -94.26 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.85 -36.28 0.36 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -120.01 16.17 12.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.176 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -152.43 125.97 8.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.611 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.2 m-85 -142.8 138.85 30.68 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.065 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 21' ' ' ILE . 23.9 m -138.8 144.76 39.48 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.492 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.2 tp -99.62 108.69 21.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -97.53 130.39 44.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 74.5 mt -115.0 140.35 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.834 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -72.82 -62.79 1.33 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.776 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.2 102.65 7.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.672 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.39 110.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.696 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.03 175.66 5.68 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.03 -29.77 58.12 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.413 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -73.14 -28.18 62.09 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.51 -1.45 15.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 111' ' ' ILE . 89.3 mt -76.76 152.4 35.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.79 -154.97 19.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.85 134.33 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.539 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.541 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 11.3 m-85 -98.57 152.57 19.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.38 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.08 161.74 36.89 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.569 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 2.4 p -144.28 142.3 30.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -146.38 156.64 43.46 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -104.64 152.09 22.88 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.395 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -116.59 30.09 7.55 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.923 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -102.32 -60.89 1.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CD2' HG21 ' A' ' 2' ' ' VAL . 16.9 m-70 -80.0 156.01 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 100' ' ' PRO . 69.4 t -141.69 139.74 19.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.034 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.9 Cg_endo -70.11 154.74 94.33 Favored 'Cis proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.362 -1.516 . . . . 0.0 111.304 -0.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 149.6 89.72 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.963 1.775 . . . . 0.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 102' ' ' THR . 60.2 p -82.58 -59.77 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.186 -1.005 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 t80 62.04 125.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.399 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.92 -151.24 10.13 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 6' ' ' GLN . . . 88.75 -173.77 42.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.064 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.16 64.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 118.994 -1.574 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 21' ' ' ILE . 75.8 m -79.93 104.4 10.48 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.651 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 121.39 18.63 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.14 78.83 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -105.94 145.69 30.98 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.604 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 88' ' ' LEU . 17.7 mt -64.11 131.22 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.49 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -72.19 104.08 3.54 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.468 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 116.389 -1.767 . . . . 0.0 109.829 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 121.008 0.432 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 98' ' ' HIS . 87.1 t -63.17 154.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.975 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.79 144.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 96.75 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.516 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -92.74 161.05 14.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.0 162.49 28.92 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.063 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.564 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -165.85 156.76 11.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.518 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 7' ' ' THR . 17.8 Cg_endo -88.33 177.98 19.96 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.265 -1.14 . . . . 0.0 110.665 -2.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.25 -48.32 20.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.518 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 t -122.07 153.62 38.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.0 79.87 21.71 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 118.954 -1.099 . . . . 0.0 112.387 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.23 113.32 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.646 1.564 . . . . 0.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.13 -174.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.7 p -118.31 160.07 22.29 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.62 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 111' ' ' ILE . 63.5 mt -78.89 87.41 4.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.33 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.9 35.04 0.11 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.41 -173.36 3.09 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.485 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -106.07 146.08 30.61 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.09 37.08 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -161.63 89.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.628 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -73.26 146.23 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.377 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' THR . 22.8 t -117.62 140.58 49.45 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.21 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m -146.3 101.15 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.098 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -109.3 147.81 32.05 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.156 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 p -115.03 139.61 49.72 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -49.88 -59.09 4.18 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -98.85 154.9 17.68 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.78 133.51 47.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.941 -0.703 . . . . 0.0 111.306 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.28 33.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.32 117.96 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 . . . . . 0 N--CA 1.49 1.53 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.542 -179.944 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.741 0.305 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -99.22 96.99 8.13 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -80.87 104.8 11.63 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -151.4 146.82 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.935 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -147.56 161.21 41.58 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.011 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.704 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.1 m95 -120.09 152.88 36.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.576 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.52 163.18 32.64 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 27.5 tp -146.3 100.17 3.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.697 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -97.76 142.82 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.415 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.656 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.437 ' CD1' HD22 ' A' ' 39' ' ' ASN . 15.4 tp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.8 0.333 . . . . 0.0 110.753 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 mt -118.22 -51.64 2.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.072 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' LYS . 3.9 mm -126.41 136.2 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.738 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.3 p90 -121.86 23.33 10.11 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.158 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 175.37 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.093 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.6 t 56.87 -83.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.575 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t -121.16 43.85 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.805 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.5 m-80 -111.13 99.8 8.58 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.525 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 61.9 mtm180 -82.22 137.18 34.96 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' SER . 81.5 t80 -70.61 156.68 39.13 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.8 p -58.43 112.02 1.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.88 -24.55 7.87 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.88 126.86 93.15 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.43 ' CB ' ' HE ' ' A' ' 66' ' ' ARG . 3.3 Cg_exo -59.98 168.49 5.83 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.011 1.808 . . . . 0.0 112.52 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.78 -23.15 45.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.537 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' A' ' 64' ' ' PRO . 5.8 mtm-85 -53.86 -40.9 66.91 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.383 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 46.4 m-85 -80.0 112.25 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.64 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t -130.34 117.29 19.54 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 129.45 9.9 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 155.63 34.3 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 163.06 -172.24 39.02 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.585 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -91.3 -165.8 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.707 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.53 72.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.138 -1.03 . . . . 0.0 111.268 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 p -121.38 17.32 11.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 6.9 t0 -145.77 133.59 21.21 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.08 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CE2' HD13 ' A' ' 38' ' ' LEU . 25.2 m-85 -143.32 125.96 15.95 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.425 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -123.32 130.97 53.47 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.341 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.704 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.4 tp -91.71 85.32 5.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.139 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -78.18 142.3 38.06 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.33 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.11 125.77 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.039 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 m -61.24 -59.14 5.77 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.332 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -132.37 107.48 8.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.38 138.38 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -117.69 175.47 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.7 -29.85 69.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.701 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.33 -35.22 66.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -56.08 -30.37 61.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.717 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.3 mt -48.88 137.36 12.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.229 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.34 -147.49 16.47 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.292 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -123.64 120.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.41 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 31.5 m-85 -94.68 151.94 18.89 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.741 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -143.82 175.39 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.477 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 24.7 p -155.49 152.43 28.89 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 p -155.99 152.59 28.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.211 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 98' ' ' HIS . 3.6 pt20 -108.73 148.75 30.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.106 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.19 40.87 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.746 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.91 -57.2 2.07 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.189 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 2' ' ' VAL . 63.6 m-70 -96.18 167.84 10.96 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.323 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.4 t -131.65 137.93 31.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.169 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.5 Cg_endo -70.42 151.67 93.33 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.748 -0.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.3 122.1 10.39 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.762 1.642 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 p -91.09 128.17 36.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -89.92 -175.56 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.96 41.43 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.91 -59.99 2.01 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.907 -1.14 . . . . 0.0 111.093 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.99 101.36 0.63 Allowed Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.571 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.0 m -94.13 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -84.97 134.51 34.24 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.462 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 98.07 5.49 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -121.94 142.22 50.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.43 HD12 HD11 ' A' ' 15' ' ' LEU . 13.2 tt -64.74 146.74 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.238 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 108.82 2.53 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.024 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.484 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.166 0.508 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 46.9 t -86.35 124.35 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.193 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.27 137.44 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.656 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 87.0 mmm -122.82 95.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 137.2 37.42 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.907 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 13.3 tt0 -124.34 148.57 47.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.767 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.86 156.53 17.33 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.425 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HA ' HG22 ' A' ' 7' ' ' THR . 6.9 Cg_endo -78.65 178.52 34.05 Favored 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.664 -1.39 . . . . 0.0 111.274 -1.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -77.7 -34.43 52.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.204 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 p -138.6 158.0 45.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -145.9 85.65 7.55 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.781 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.5 109.05 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.644 1.563 . . . . 0.0 110.307 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.5 m -133.93 176.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.011 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -104.71 168.96 8.73 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.412 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 111' ' ' ILE . 65.6 mt -81.88 88.0 6.36 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.64 51.63 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.61 163.45 32.8 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.771 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -85.23 142.28 29.53 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.45 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -121.97 166.55 14.29 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.079 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 13.5 p -162.58 94.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.173 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.727 HD12 ' HB3' ' A' ' 78' ' ' LEU . 3.2 mt -87.98 118.42 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -83.1 157.03 22.99 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.488 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.2 t -162.17 112.6 1.56 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.196 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -118.53 144.77 45.83 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 1.4 m -104.88 151.29 24.03 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 m -78.06 0.65 23.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -156.65 134.14 10.75 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.14 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -55.53 124.48 17.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 95' ' ' GLN . 6.0 mt -91.5 31.35 1.18 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.415 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.9 t -88.09 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.63 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.466 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.905 0.383 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -103.59 103.39 13.32 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.091 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -81.72 98.29 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.037 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -147.53 138.03 23.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.676 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 6.9 p-10 -140.38 174.75 10.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.295 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 78' ' ' LEU . 67.9 m95 -122.48 148.59 44.97 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.264 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.64 164.14 21.24 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 26.1 tp -158.65 116.57 2.91 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.9 161.52 32.84 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.535 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.114 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 60' ' ' PHE . 18.0 tp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 63' ' ' VAL . 20.2 mt -111.86 -89.4 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.6 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.588 HG21 ' HA3' ' A' ' 69' ' ' GLY . 11.5 mm -99.12 133.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.293 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 26.0 p90 -133.9 174.67 10.22 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER 52.34 34.61 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.519 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 75.74 -37.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.117 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 58' ' ' ASN . 21.0 p -144.09 -41.24 0.27 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.698 -1.201 . . . . 0.0 112.918 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 5.3 m-80 -37.52 122.03 0.9 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.138 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 65' ' ' ASP . 25.2 mtm180 -91.59 126.5 36.69 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CD1' HD23 ' A' ' 51' ' ' LEU . 15.4 t80 -54.36 149.86 9.56 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 112.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.898 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.65 -22.82 11.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.714 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 52' ' ' LEU . 88.7 t -56.95 120.12 35.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.051 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -58.4 138.76 87.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.705 1.603 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 9.3 p-10 -54.15 -22.85 12.25 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 mtm-85 -58.6 -18.74 32.57 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -93.23 114.19 26.61 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.586 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.39 90.34 3.31 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA3' HG21 ' A' ' 53' ' ' ILE . . . -94.03 129.38 9.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -164.35 -173.42 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.517 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 150.53 -179.64 27.08 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.043 -1.551 . . . . 0.0 111.83 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -93.2 -140.75 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.79 -35.57 13.01 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.3 p -123.79 13.18 9.22 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.6 m-20 -132.41 130.36 40.52 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -144.44 145.71 32.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.991 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 m -150.28 140.48 22.18 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.634 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.727 ' HB3' HD12 ' A' ' 21' ' ' ILE . 4.1 tt -98.5 102.8 14.65 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.95 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -93.93 122.08 36.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 31.2 mt -106.15 138.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.692 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -72.03 -70.22 0.35 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.89 105.24 9.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.89 104.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.01 173.86 7.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.15 48.37 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.43 -39.7 62.42 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.329 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.86 -8.34 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.81 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 111' ' ' ILE . 94.5 mt -69.68 148.89 48.68 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.881 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.13 -159.85 24.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.64 135.7 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.25 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.425 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 26.8 m-85 -100.22 151.77 21.05 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.386 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.78 147.94 38.13 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.1 p -128.32 139.92 52.14 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.191 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.463 ' HG ' ' HD2' ' A' ' 103' ' ' PHE . 2.3 t -144.78 164.26 31.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.077 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.502 HE22 ' HB2' ' A' ' 98' ' ' HIS . 1.4 pt20 -117.48 163.19 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.231 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.56 32.75 2.76 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.029 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.8 m -99.69 -34.07 10.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.501 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.502 ' HB2' HE22 ' A' ' 95' ' ' GLN . 16.5 m-70 -107.97 167.45 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.933 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.485 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 43.8 t -136.73 135.75 20.71 Favored Pre-proline 0 N--CA 1.49 1.53 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.8 Cg_endo -70.29 151.76 93.09 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.481 -1.466 . . . . 0.0 111.497 -0.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.01 125.84 20.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.759 1.639 . . . . 0.0 110.209 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 1' ' ' ASP . 11.0 p -93.81 118.31 31.27 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.156 -1.017 . . . . 0.0 112.093 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HD2' ' HG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -105.17 -175.13 2.7 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.292 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.4 177.31 18.24 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.397 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.07 175.97 22.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.408 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 169.87 62.05 0.04 OUTLIER Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.054 -1.545 . . . . 0.0 110.801 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' PRO . 26.5 m -78.21 105.37 9.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -74.82 105.43 5.88 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.19 90.62 4.42 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.993 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.4 146.17 45.59 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 15' ' ' LEU . 10.5 mt -60.69 127.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.23 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 8.8 tmtt? -54.49 129.16 34.99 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.417 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.141 -1.885 . . . . 0.0 110.431 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.938 0.399 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.705 HG21 ' CD2' ' A' ' 98' ' ' HIS . 83.8 t -71.33 122.42 23.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.081 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.06 148.22 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.29 119.73 8.45 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -117.16 122.94 45.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.966 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.615 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 2.9 mp0 -95.39 146.73 24.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.09 157.05 21.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.631 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 7' ' ' THR . 8.5 Cg_endo -76.33 175.58 47.53 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.528 -1.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.77 -34.13 52.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.308 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.11 159.32 42.06 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 tp -145.3 75.02 13.94 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.26 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.57 115.32 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.95 1.767 . . . . 0.0 110.424 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.66 -172.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.737 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.3 154.16 32.78 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.021 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.44 87.76 0.2 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.61 47.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -144.15 175.24 10.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -93.99 154.13 17.82 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -122.55 159.22 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -160.78 83.51 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 77' ' ' THR . 5.7 mt -82.35 125.85 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.801 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -88.64 154.19 20.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.057 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.615 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 9.8 m -157.3 107.41 2.23 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -119.6 164.74 15.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.277 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.3 p -136.52 165.17 26.48 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.269 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 m -78.65 -29.0 45.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.767 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.29 145.04 51.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.375 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.3 m -58.8 126.83 29.28 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.347 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.6 32.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.81 147.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.032 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 . . . . . 0 N--CA 1.49 1.564 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.081 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m120 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.997 0.427 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.6 m -109.02 144.78 36.57 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.153 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -125.89 107.65 10.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.04 134.16 19.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.659 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -129.55 162.19 28.78 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.321 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 52.5 m95 -114.99 160.26 19.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -147.69 127.09 13.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.783 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.585 HD13 ' CE1' ' A' ' 91' ' ' TYR . 25.2 tp -117.97 109.7 16.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.255 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -121.01 152.09 39.0 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.624 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm . . . . . 0 N--CA 1.486 1.374 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.35 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.31 -60.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 58' ' ' ASN . 5.3 mm -120.26 140.11 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.799 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.9 p90 -121.54 2.12 10.13 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.248 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.62 ' C ' HG13 ' A' ' 56' ' ' VAL . 61.1 tttt -153.79 50.34 0.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER 65.11 -58.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.141 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -126.64 54.49 1.59 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.328 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -146.61 105.2 3.82 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.862 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 34.2 mtm180 -71.75 147.65 47.12 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.631 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -86.34 169.52 12.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.767 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -59.89 129.34 41.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.355 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.61 -23.92 25.9 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.017 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.63 115.21 18.38 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.23 151.43 82.29 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.922 1.748 . . . . 0.0 111.954 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.56 -18.31 18.77 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' CD ' ' A' ' 84' ' ' GLU . 59.8 mtt85 -53.3 -10.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.516 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 93.0 m-85 -116.49 125.31 51.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.961 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.56 119.64 14.5 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.268 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.29 159.9 13.42 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.89 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.9 p -158.32 175.91 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.196 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 164.2 151.78 6.67 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.3 m -93.82 -71.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -49.36 0.04 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.635 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.5 p -115.83 13.35 16.07 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.75 127.82 33.58 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.442 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 87.3 m-85 -144.73 130.5 19.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 21' ' ' ILE . 55.4 m -136.03 139.22 42.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.042 -1.063 . . . . 0.0 112.129 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 9.2 tt -98.64 114.81 27.44 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -108.7 140.63 41.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 77.9 mt -120.75 137.07 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.58 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -69.82 -63.93 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.236 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -124.52 104.93 9.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.2 112.68 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -97.01 -149.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.583 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.47 -30.27 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.07 -33.47 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.613 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.59 -15.64 40.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD11 HD11 ' A' ' 111' ' ' ILE . 58.4 mt -67.75 147.75 52.19 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.295 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.6 -153.11 23.42 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.143 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -117.42 123.18 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' CE1' HD13 ' A' ' 42' ' ' LEU . 18.0 m-85 -91.77 155.3 18.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.982 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -146.65 167.21 24.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.2 p -157.25 145.93 19.68 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.76 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 m -144.41 171.39 14.4 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.467 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -115.55 151.66 34.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.303 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.36 18.28 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.033 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.9 m -91.32 -22.99 20.26 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.705 ' CD2' HG21 ' A' ' 2' ' ' VAL . 86.0 m-70 -122.23 132.44 54.43 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.071 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 100' ' ' PRO . 59.2 t -114.3 139.28 23.63 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.448 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.4 Cg_endo -71.35 159.37 94.27 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.774 -0.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.33 144.13 94.77 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.933 1.756 . . . . 0.0 110.996 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -81.05 -63.88 1.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.521 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 5.7 t80 61.86 157.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.35 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.01 -157.89 27.47 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.681 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' CA ' HE21 ' A' ' 6' ' ' GLN . . . 93.41 -156.73 22.81 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.408 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.22 63.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.284 -1.436 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' PRO . 68.2 m -77.9 107.98 10.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.351 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -76.91 107.61 9.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.169 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 tt -101.71 84.28 2.54 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 147.9 33.04 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.608 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 88' ' ' LEU . 17.3 mt -67.05 129.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -66.24 115.94 6.76 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.003 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.437 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 17.4 mtt180 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.504 -1.712 . . . . 0.0 111.044 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 98' ' ' HIS . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.892 0.377 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.657 0.265 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 2' ' ' VAL . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 98' ' ' HIS . 61.0 t -75.55 150.72 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 118.806 -1.158 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 4' ' ' MET . 12.5 t -96.85 160.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.149 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.442 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.35 113.25 5.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -101.31 125.16 47.92 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.409 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.621 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -110.92 135.18 51.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.039 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.82 158.11 26.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.826 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.5 Cg_endo -78.67 176.89 40.84 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.492 -1.461 . . . . 0.0 111.317 -1.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -79.98 -40.51 27.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.538 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -132.08 150.89 52.04 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.6 tp -143.15 82.11 12.12 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.814 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.85 107.88 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.586 1.524 . . . . 0.0 110.041 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 11' ' ' LEU . 5.1 m -129.66 178.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.227 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -109.11 158.14 18.06 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.146 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.83 88.39 1.02 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.678 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.34 -10.77 1.53 Allowed Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -168.11 1.75 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.229 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.66 156.3 22.99 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -113.64 162.69 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 p -162.4 75.3 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.004 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 77' ' ' THR . 11.2 mt -80.21 121.01 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.979 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.2 t -89.0 157.25 18.43 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.621 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.6 m -160.18 108.52 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.311 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -113.27 155.91 24.26 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.096 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -127.71 139.49 52.66 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -53.42 -53.0 57.59 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -106.4 153.35 22.37 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.449 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.4 p -63.4 122.06 15.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.257 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 29.6 mt -75.81 28.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.017 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' SER . 51.9 t -90.06 144.38 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.474 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.491 1.619 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.506 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.874 0.368 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 m -106.03 155.11 19.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.065 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -128.37 138.42 52.35 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.761 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -165.14 166.36 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.847 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -163.41 149.1 11.47 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.118 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.479 ' CD2' HD12 ' A' ' 78' ' ' LEU . 64.1 m95 -117.72 154.27 31.96 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -144.94 151.38 38.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 91' ' ' TYR . 17.8 tp -132.25 81.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.406 ' N ' ' CD ' ' A' ' 43' ' ' GLN . 3.1 mp0 -57.05 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.13 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.082 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 52' ' ' LEU . 15.7 tp . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.1 mp -122.11 -67.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.645 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 56' ' ' VAL . 5.5 mm -128.29 153.42 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.021 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 5.1 p90 -136.35 -65.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.48 73.49 5.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.227 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 53' ' ' ILE . 10.4 t 62.57 -74.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.927 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.2 t -117.67 -8.78 10.85 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 1.7 m-80 -60.71 121.27 11.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' A' ' 65' ' ' ASP . 5.6 mtt-85 -97.15 161.13 13.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -86.38 152.93 22.31 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -55.52 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.14 -29.98 2.38 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 121.15 74.78 Favored Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.601 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.88 138.51 86.08 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.752 1.635 . . . . 0.0 111.641 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' A' ' 59' ' ' ARG . 2.6 t70 -54.48 -14.3 1.22 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HE ' ' N ' ' A' ' 66' ' ' ARG . 1.1 mmp_? -57.54 -19.15 23.21 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -100.16 130.47 46.3 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.309 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 p -139.82 121.24 15.05 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.295 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.91 133.4 11.37 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.224 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.2 140.94 35.97 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.83 154.36 12.75 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.7 m -91.28 -79.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.276 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.33 -34.72 0.1 OUTLIER Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.671 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.4 p -121.65 19.19 11.16 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -151.74 126.82 9.79 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.624 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -141.21 138.23 33.17 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 50.0 m -135.86 149.9 49.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.239 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 40' ' ' TRP . 7.1 tt -109.27 109.12 19.95 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 14.2 mttm -110.53 139.36 45.84 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.232 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.93 132.7 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.619 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.5 m -61.73 -56.41 19.87 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.764 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.37 103.34 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.78 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.01 129.66 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -109.23 -171.86 1.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.46 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.4 63.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.51 -32.46 73.39 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -21.36 50.43 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.606 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.54 143.32 50.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.1 -155.59 26.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 90' ' ' ILE . 4.1 mt -114.18 114.74 47.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 42' ' ' LEU . 7.2 m-85 -88.56 152.76 21.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.494 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -148.61 165.7 30.52 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.598 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.92 152.96 31.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.829 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -156.34 178.98 9.69 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.028 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -132.53 142.77 49.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.5 p -115.28 22.67 13.09 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.561 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.85 60.2 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.985 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.472 ' CD2' HG21 ' A' ' 2' ' ' VAL . 90.9 m-70 -111.39 148.84 32.17 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER -118.85 142.16 31.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.971 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 99' ' ' VAL . 1.0 OUTLIER -70.09 162.99 83.88 Favored 'Cis proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.984 -1.257 . . . . 0.0 111.972 -0.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.96 142.41 81.52 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -79.42 -61.62 1.95 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.981 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 88.1 t80 61.93 161.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.13 -165.7 27.71 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 107.9 -149.98 16.85 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.495 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.71 56.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.4 m -78.79 106.49 10.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -71.16 97.49 1.52 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.411 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tp -88.56 83.5 6.79 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.558 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.14 144.9 38.08 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.61 159.38 3.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -55.92 -29.81 60.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 116.483 -1.722 . . . . 0.0 111.107 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.701 HG21 ' CD2' ' A' ' 98' ' ' HIS . 57.7 t -71.6 140.03 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.949 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.41 155.59 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mtt -145.54 114.1 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.007 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -100.11 129.26 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.532 HE22 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.7 140.98 37.92 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.51 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -163.84 145.16 7.12 Favored Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.16 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 107' ' ' THR . 9.5 Cg_endo -81.15 -176.51 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.8 -1.334 . . . . 0.0 111.165 -2.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.532 HD23 HE22 ' A' ' 6' ' ' GLN . 14.5 mt -85.19 -46.6 10.92 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.7 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -124.12 158.42 32.33 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.914 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -146.74 85.0 7.31 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.953 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.43 121.62 8.38 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.846 1.698 . . . . 0.0 110.225 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 11' ' ' LEU . 3.6 m -143.39 -170.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.06 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -132.15 161.9 32.21 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -71.08 87.9 0.77 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.186 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.21 30.68 0.1 OUTLIER Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -125.58 -176.33 3.57 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.083 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -114.82 138.84 50.29 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.645 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -114.64 157.86 22.53 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.298 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 2.7 m -155.44 91.24 1.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.836 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.521 HD12 HD22 ' A' ' 78' ' ' LEU . 5.9 mt -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.607 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' THR . 8.0 t -104.25 145.5 30.13 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.777 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.27 98.45 2.81 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.466 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.43 154.53 19.33 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.409 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 p -129.9 143.05 50.6 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.901 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -53.66 -71.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.482 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -82.08 152.24 26.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.3 p -66.52 131.45 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' C ' HG21 ' A' ' 97' ' ' THR . 26.8 mt -78.58 30.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.236 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.0 t -97.26 133.44 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.9 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 . . . . . 0 N--CA 1.488 1.457 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.153 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.884 0.373 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 m -109.37 157.49 18.85 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -137.46 108.87 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.172 -1.011 . . . . 0.0 112.491 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.81 128.63 8.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.261 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 28.0 m-20 -125.15 167.71 14.44 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.505 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.512 ' O ' HD12 ' A' ' 51' ' ' LEU . 57.5 m95 -124.09 152.14 43.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.438 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 29.3 m-85 -135.34 156.37 49.05 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.282 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 15.4 tp -146.51 117.37 7.67 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.241 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -125.58 158.2 35.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.338 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 C--N 1.306 -1.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.128 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' TRP . 45.0 tp . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -102.72 -67.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.231 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -119.4 142.44 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.3 p90 -145.06 167.82 21.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.078 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER 60.85 15.37 5.92 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.461 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER 78.58 5.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.681 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -44.11 128.39 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.661 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.565 HH21 ' N ' ' A' ' 65' ' ' ASP . 11.7 mtm-85 -97.29 146.31 25.26 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.165 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.81 159.32 34.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.639 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -58.04 122.28 12.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.43 -18.06 45.63 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.35 116.48 53.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.693 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.496 ' C ' HH21 ' A' ' 59' ' ' ARG . 1.1 Cg_endo -65.89 172.66 8.07 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.137 1.891 . . . . 0.0 112.423 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.565 ' N ' HH21 ' A' ' 59' ' ' ARG . 1.2 m-20 -78.05 -15.81 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -56.2 -27.15 53.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.169 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -96.66 118.99 34.31 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.286 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -128.03 91.21 3.23 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.924 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.51 127.62 8.8 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 t -160.96 178.37 9.44 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.58 -178.5 42.58 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.541 -1.314 . . . . 0.0 110.836 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -92.88 -85.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.039 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.2 -34.84 0.11 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.57 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.8 p -124.17 6.6 8.5 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.42 118.36 16.31 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -133.61 153.13 51.91 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 16.1 m -154.2 145.89 23.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.83 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 21' ' ' ILE . 1.9 tt -96.71 99.62 11.21 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.587 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -91.1 122.58 33.87 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.247 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 19' ' ' ALA . 45.0 mt -112.5 133.04 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m -70.31 -71.86 0.22 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.665 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.81 102.45 9.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.518 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.7 131.47 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -117.05 -173.9 2.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.302 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.24 -25.36 61.59 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.72 -32.11 59.91 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.07 -31.74 70.29 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.74 139.44 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.583 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.29 -150.72 22.8 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.436 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.6 mp -122.09 121.38 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.463 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.464 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-85 -93.11 151.28 19.95 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.174 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 46.9 m-85 -143.23 164.32 30.52 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.192 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.26 151.48 36.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.9 p -157.22 157.3 34.07 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.178 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 146.96 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -126.14 27.9 6.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.504 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.479 HG21 ' C ' ' A' ' 29' ' ' LEU . 1.1 m -77.98 -33.87 51.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.171 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.701 ' CD2' HG21 ' A' ' 2' ' ' VAL . 74.0 m-70 -105.81 -43.56 4.86 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.581 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER 66.45 140.12 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.574 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.581 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 0.9 OUTLIER -66.67 168.65 50.54 Favored 'Cis proline' 0 C--N 1.318 -1.029 0 C-N-CA 123.901 -1.291 . . . . 0.0 111.903 -0.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.24 134.56 46.02 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.172 1.915 . . . . 0.0 111.788 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 p -78.09 -57.39 3.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.715 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 80.2 t80 62.7 164.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.449 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 139.91 -157.57 25.4 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.65 -137.26 19.93 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.18 68.06 0.38 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.418 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 8' ' ' PRO . 12.1 m -78.31 114.89 17.62 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.713 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -77.39 111.33 12.97 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.682 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 89.39 2.98 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.775 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.45 144.55 48.62 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.1 tt -66.41 150.94 10.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -53.43 135.69 39.04 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.966 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 116.39 -1.767 . . . . 0.0 110.945 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 102' ' ' THR . 7.6 t -76.64 142.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.158 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.54 148.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.634 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mmt -134.26 104.97 6.4 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.627 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 m -100.49 129.71 46.47 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.31 147.38 32.77 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.281 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.72 7.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.806 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 107' ' ' THR . 12.1 Cg_endo -83.94 171.78 47.36 Favored 'Cis proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.005 -1.248 . . . . 0.0 111.502 -0.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.758 ' H ' HD22 ' A' ' 9' ' ' LEU . 1.7 mm? -74.41 -42.43 59.23 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.01 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 p -125.96 146.05 50.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.101 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.3 tp -137.69 74.6 45.38 Favored Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.48 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.37 117.94 5.12 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.536 1.491 . . . . 0.0 109.877 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 11' ' ' LEU . 6.3 m -139.4 -174.67 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -113.05 172.16 7.11 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.725 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.75 86.23 7.37 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.828 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.57 33.4 0.06 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.714 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.23 -173.7 3.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.097 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.47 137.28 52.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.984 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 166.77 11.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.641 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 p -162.23 76.83 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 77' ' ' THR . 19.1 mt -79.23 140.03 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.248 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 t -113.35 152.59 29.76 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.741 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.8 m -156.43 99.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.598 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 75' ' ' ASP . 9.9 mtm180 -110.02 152.63 25.67 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.943 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 p -118.64 150.65 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.317 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -58.5 -45.76 88.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.665 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.63 174.66 5.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.861 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 t -74.04 146.66 43.54 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.9 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.515 ' C ' HG21 ' A' ' 97' ' ' THR . 83.0 mt -101.09 30.51 4.08 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.78 131.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.571 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.723 0.297 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 137.22 36.17 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -117.78 105.36 11.89 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' CD2' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -145.14 143.12 30.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.346 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -134.7 154.72 51.43 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.247 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.522 ' O ' HD12 ' A' ' 51' ' ' LEU . 82.6 m95 -123.49 147.41 47.24 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -140.77 145.84 36.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.547 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.8 tp -130.67 115.54 16.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.87 138.05 54.55 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.749 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 40' ' ' TRP . 22.5 tp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.756 0.312 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.427 ' HA ' HG21 ' A' ' 63' ' ' VAL . 3.8 mp -107.8 -52.43 2.76 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.939 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 55' ' ' LYS . 2.0 mm -129.3 134.42 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.507 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -112.27 39.04 2.53 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 179.22 -167.14 0.07 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.632 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' H ' ' HG3' ' A' ' 55' ' ' LYS . 27.5 t -76.82 -13.31 14.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.85 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.462 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.448 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -170.88 107.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.236 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 31.8 mtm180 -74.38 150.22 40.15 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -80.1 163.73 23.91 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.629 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -63.73 89.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.802 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.47 -28.54 2.32 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' A' ' 52' ' ' LEU . 49.8 t -70.4 116.93 50.05 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.94 148.49 76.01 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.104 1.869 . . . . 0.0 112.874 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 2.9 m-20 -57.8 -8.81 1.03 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -20.67 63.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.927 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.47 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 94.9 m-85 -105.51 119.67 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.708 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.9 p -125.51 107.4 10.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.68 139.01 14.3 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.198 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.6 p -156.2 146.12 21.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.082 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -173.63 168.71 41.68 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 p -94.44 -105.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.437 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.73 -33.72 1.26 Allowed Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.026 -1.083 . . . . 0.0 110.483 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.6 p -126.87 10.09 7.0 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.964 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 11.9 t0 -136.68 130.65 32.46 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.071 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 70.0 m-85 -145.03 147.9 33.12 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.533 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 21' ' ' ILE . 53.3 m -149.8 133.14 16.49 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.656 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -93.74 114.8 27.15 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.468 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -113.66 145.21 41.66 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.825 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.439 HG12 ' CD1' ' A' ' 67' ' ' PHE . 67.3 mt -123.08 143.22 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.746 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -70.61 -57.76 4.39 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.547 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 8.7 ptm180 -129.48 107.35 9.41 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.659 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.47 105.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.33 -163.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.86 -30.14 50.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.49 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -26.13 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.708 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.1 -21.9 62.16 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.49 137.46 48.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.78 -158.73 27.76 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.25 124.82 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.568 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.6 m-85 -94.16 153.4 18.11 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.297 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.07 170.26 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.73 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.6 p -151.72 152.57 32.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 p -154.89 164.38 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 160.72 29.55 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -134.58 24.24 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.814 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.515 HG21 ' C ' ' A' ' 29' ' ' LEU . 17.1 m -79.92 -43.74 21.61 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.752 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.19 141.69 51.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.788 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 3.2 t -95.98 141.47 23.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 9.3 Cg_endo -77.46 163.51 88.42 Favored 'Cis proline' 0 C--N 1.317 -1.102 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.193 -0.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 2.3 Cg_endo -67.87 117.43 4.89 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.029 1.819 . . . . 0.0 110.347 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 2' ' ' VAL . 20.8 p -90.39 104.25 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.992 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -86.34 150.39 24.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.18 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.05 170.72 42.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.1 -149.74 18.63 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 40.91 1.29 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' PRO . 95.8 m -79.23 106.42 11.25 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -71.86 112.93 8.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.221 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.61 80.25 1.45 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.56 140.84 34.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.582 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.4 tt -71.8 150.48 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -54.92 128.9 35.48 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.111 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.082 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.078 0.466 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 98' ' ' HIS . 43.5 t -68.94 110.57 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.96 141.23 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 5.1 mtp -128.21 105.19 8.19 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.09 143.1 37.66 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.11 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -130.59 135.68 48.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.337 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.18 157.3 24.73 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.112 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 7' ' ' THR . 10.1 Cg_endo -78.66 176.46 42.6 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.563 -1.432 . . . . 0.0 111.362 -1.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.744 HD22 ' N ' ' A' ' 9' ' ' LEU . 2.2 mm? -78.96 -44.35 22.63 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.161 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -128.09 144.4 51.11 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.627 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 tp -132.31 78.17 68.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.039 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.81 108.32 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.621 1.547 . . . . 0.0 110.231 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.91 -173.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.976 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -119.1 173.18 7.07 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.675 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -88.04 90.12 8.26 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.94 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.35 42.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -170.56 2.94 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.758 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -109.16 140.68 42.43 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.071 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . . . -108.95 159.24 16.98 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.75 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -157.43 88.56 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' THR . 4.0 mt -81.19 128.71 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.794 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.15 140.42 30.89 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.029 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.8 t -153.88 110.83 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.792 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.23 173.39 6.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.683 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 79.5 p -132.23 166.99 20.62 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.333 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -72.85 -50.85 21.44 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.94 161.01 17.5 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.359 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' VAL . 64.4 m -59.98 126.35 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.408 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 29' ' ' LEU . 76.6 mt -79.98 29.93 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.9 t -98.85 137.49 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.556 -179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.802 0.335 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.8 m -113.86 109.44 18.53 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -98.05 109.74 22.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.057 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -154.07 127.75 8.72 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.615 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.559 ' N ' HD23 ' A' ' 38' ' ' LEU . 12.9 p-10 -130.67 152.78 49.65 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD2' HD13 ' A' ' 78' ' ' LEU . 53.7 m95 -115.78 158.35 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 16.9 m-85 -137.14 156.01 48.89 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.596 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 91' ' ' TYR . 9.1 tp -140.6 127.03 19.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.13 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -131.64 155.92 46.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.036 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.272 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 54' ' ' TYR . 27.7 tp . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.094 0.473 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.4 -49.65 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.81 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.563 HG13 HD11 ' A' ' 78' ' ' LEU . 6.1 mm -127.54 135.43 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.495 ' HB3' HD21 ' A' ' 51' ' ' LEU . 51.1 p90 -122.62 -11.25 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.567 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.22 88.57 2.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.376 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.684 HG13 ' N ' ' A' ' 57' ' ' SER . 1.5 p 45.26 -68.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 124.348 1.03 . . . . 0.0 113.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.684 ' N ' HG13 ' A' ' 56' ' ' VAL . 53.9 p -130.32 28.73 4.95 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.4 m-80 -103.78 111.55 24.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -75.87 152.23 37.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.649 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 33.4 t80 -88.78 167.18 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t -59.79 132.69 54.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.692 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.11 -17.46 56.9 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -73.58 117.69 62.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.8 144.42 96.91 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.731 1.621 . . . . 0.0 111.667 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.99 -10.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -62.27 -19.92 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.54 122.69 46.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.254 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.13 121.32 13.83 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.41 147.78 17.49 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.41 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -161.35 161.1 30.33 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.5 173.45 44.65 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -91.21 -87.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.47 -34.76 0.11 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -120.95 17.86 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.572 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -155.01 126.2 7.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.986 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CG ' ' CD1' ' A' ' 38' ' ' LEU . 7.5 m-85 -141.56 153.53 44.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 21' ' ' ILE . 18.8 m -148.34 142.38 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.733 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.6 tp -101.83 115.09 29.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.065 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -111.17 151.11 28.58 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.635 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -127.89 134.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.94 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.6 m -67.35 -49.9 62.12 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.84 103.64 5.94 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 98.7 t -68.09 117.76 10.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.079 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -108.47 -177.93 3.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.95 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.94 -42.93 56.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.68 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.03 -19.66 53.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 88' ' ' LEU . 73.4 mt -52.67 147.84 8.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.746 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.36 -160.42 25.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.14 151.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.046 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' HD13 ' A' ' 42' ' ' LEU . 13.3 m-85 -123.57 148.69 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.565 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -141.66 162.94 34.25 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.3 p -144.86 125.16 13.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.436 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.5 p -120.64 161.85 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.545 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.532 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -125.97 150.7 47.83 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.895 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 52.13 1.61 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.634 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -50.08 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.353 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' H ' HE22 ' A' ' 95' ' ' GLN . 91.0 m-70 -112.51 163.38 14.54 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.269 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 100' ' ' PRO . 11.2 p -117.98 139.78 26.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.519 ' HA ' HG23 ' A' ' 99' ' ' VAL . 7.0 Cg_endo -75.75 156.68 99.01 Favored 'Cis proline' 0 C--N 1.315 -1.201 0 C-N-CA 123.69 -1.379 . . . . 0.0 111.71 -0.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.04 120.19 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.977 1.784 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.7 p -91.28 136.19 33.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.397 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.67 176.42 8.17 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.6 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.66 -161.95 37.85 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 6' ' ' GLN . . . -87.98 -79.3 1.27 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.307 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.89 95.09 0.15 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 21' ' ' ILE . 95.2 m -92.29 117.33 29.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.561 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -85.51 114.53 22.6 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.318 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.4 93.42 4.59 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.802 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.8 139.18 52.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.85 156.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -55.34 152.32 8.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.707 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.64 HG21 ' CD2' ' A' ' 98' ' ' HIS . 47.8 t -67.02 152.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.981 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 4' ' ' MET . 3.8 t -96.94 166.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.265 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -148.76 115.45 5.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.516 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -95.85 140.8 30.11 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.012 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.541 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 1.9 mm-40 -129.9 132.14 46.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.538 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.99 158.02 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.932 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.8 Cg_endo -79.69 175.1 46.49 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.429 -1.488 . . . . 0.0 110.538 -1.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.6 mm? -77.75 -43.96 29.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.801 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.7 m -126.14 146.05 50.1 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -136.09 78.03 47.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.62 112.27 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.79 1.66 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.34 178.96 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.386 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -110.34 174.58 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.787 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 HD13 ' A' ' 111' ' ' ILE . 15.3 mt -85.95 87.73 7.46 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.77 52.72 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.5 179.38 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.75 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -100.49 141.31 33.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.455 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -113.37 165.76 12.13 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -159.55 91.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.591 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 77' ' ' THR . 25.9 mt -79.31 152.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 m -121.48 140.99 51.47 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.188 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -149.25 110.9 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HE ' ' CG ' ' A' ' 75' ' ' ASP . 58.0 mtp180 -113.13 163.48 14.7 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.514 -0.874 . . . . 0.0 112.184 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.2 p -133.47 147.73 51.68 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.3 m -62.72 -41.05 98.96 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.94 159.26 22.72 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -70.68 129.58 39.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.53 34.41 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.72 147.74 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 . . . . . 0 N--CA 1.49 1.553 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.464 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 56' ' ' VAL . 2.9 m -79.26 153.42 29.94 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.651 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -124.09 89.03 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.779 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 76' ' ' PHE . 1.1 tt -155.37 134.49 12.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.181 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -129.42 150.15 50.9 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.044 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD13 ' A' ' 78' ' ' LEU . 86.5 m95 -103.96 153.32 20.96 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.346 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.54 130.26 9.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.8 tp -109.83 142.81 40.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.569 ' H ' HD12 ' A' ' 42' ' ' LEU . 8.1 tt0 -125.3 137.64 54.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.822 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 tttm . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.475 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 53' ' ' ILE . 13.5 tp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.709 0.29 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 67' ' ' PHE . 1.1 tp -99.63 -62.47 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.586 ' O ' HD11 ' A' ' 51' ' ' LEU . 1.2 mm -126.25 149.46 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.015 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.567 ' HB3' HD21 ' A' ' 51' ' ' LEU . 42.6 p90 -137.99 160.8 38.36 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.358 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.03 -63.69 0.41 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.629 0.58 . . . . 0.0 110.133 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 57' ' ' SER . 7.0 p -172.39 -37.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.756 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 49.6 m -150.5 -25.64 0.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.016 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 34.8 m-80 -53.31 120.92 6.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.274 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' NH2' ' HA ' ' A' ' 65' ' ' ASP . 13.4 mtm180 -76.55 151.29 36.39 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -90.27 167.82 12.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.731 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 t -62.62 121.69 13.99 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 103.27 -8.96 53.55 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.62 113.8 58.13 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.342 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -66.0 155.39 69.78 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.129 1.886 . . . . 0.0 112.315 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' NH2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -57.39 -13.21 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.345 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -62.79 -18.29 62.47 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.026 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.487 ' CD1' HD21 ' A' ' 52' ' ' LEU . 63.9 m-85 -106.18 109.59 21.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.547 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 t -116.95 119.36 35.1 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -126.11 130.64 7.19 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.1 t -161.24 168.91 23.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.95 -177.7 48.56 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.398 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.9 t -91.26 -106.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.068 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.8 -35.15 0.86 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.2 p -124.3 16.85 9.06 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -145.31 120.86 10.4 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.733 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 38' ' ' LEU . 40.2 m-85 -133.6 144.67 49.42 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 21' ' ' ILE . 68.5 m -141.15 141.48 34.14 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.635 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.612 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -98.86 99.69 10.79 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.785 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -89.12 117.06 27.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.633 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 37.5 mt -104.56 138.11 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.935 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -64.25 1.03 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.904 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -124.37 103.46 8.21 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.013 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.52 104.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.207 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.52 167.76 10.4 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . . . -55.29 -25.45 34.15 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.408 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -79.53 -37.39 36.66 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.506 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -5.24 25.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.312 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD11 ' A' ' 111' ' ' ILE . 85.0 mt -74.03 150.07 40.86 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.1 -149.42 21.55 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.202 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 mp -120.53 118.58 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.29 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.571 ' CE1' HD13 ' A' ' 42' ' ' LEU . 22.6 m-85 -92.76 154.15 18.47 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CE1' ' HA2' ' A' ' 106' ' ' GLY . 97.5 m-85 -143.34 157.4 44.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.634 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.541 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 16.0 p -135.63 147.47 48.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.755 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -150.0 166.35 29.93 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.627 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.54 HE21 HG23 ' A' ' 102' ' ' THR . 1.7 pp0? -127.22 145.08 50.89 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.62 18.02 13.53 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.504 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.505 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -71.77 -42.34 67.28 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.536 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.64 ' CD2' HG21 ' A' ' 2' ' ' VAL . 44.0 m-70 -111.4 171.81 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.422 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.9 t -138.81 140.85 28.58 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.574 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.6 Cg_endo -70.76 168.82 70.1 Favored 'Cis proline' 0 C--N 1.319 -1.025 0 C-N-CA 123.741 -1.358 . . . . 0.0 111.883 -0.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.88 156.99 54.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.935 1.757 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.54 HG23 HE21 ' A' ' 95' ' ' GLN . 26.7 p -89.58 -64.25 1.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.961 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 63.24 171.55 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.04 -156.92 19.82 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.652 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 -172.73 45.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 162.14 59.81 0.02 OUTLIER Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.005 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.1 m -77.28 109.51 11.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.876 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -78.07 132.03 37.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.481 HD23 HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -123.2 76.92 1.42 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.964 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -107.0 137.85 44.28 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.96 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 88' ' ' LEU . 18.9 mt -63.32 124.71 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.507 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.489 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -64.12 103.14 0.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.729 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 116.597 -1.668 . . . . 0.0 111.499 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 98' ' ' HIS . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.405 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 27.7 t-80 -83.93 167.37 17.03 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -58.2 -27.99 64.39 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.737 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 1.3 p30 -79.45 -10.5 59.82 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.31 -0.93 64.08 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.798 -1.191 . . . . 0.0 111.905 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.81 144.42 28.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.928 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 -128.9 0.28 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.51 -53.25 6.43 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.22 42.88 0.34 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.324 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.16 176.98 5.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -62.29 153.35 75.97 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.62 143.21 98.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.774 1.649 . . . . 0.0 111.25 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.34 135.17 54.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.3 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.17 126.33 51.99 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 2' ' ' VAL . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 121.156 0.503 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.665 HG21 ' CD2' ' A' ' 98' ' ' HIS . 69.7 t -71.63 124.54 28.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.535 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.92 147.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.38 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.446 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 4.3 mtp -143.42 110.56 5.71 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.195 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.7 m -101.38 117.13 34.33 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.783 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' HA3' ' A' ' 105' ' ' GLY . 5.7 tt0 -101.21 133.43 45.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.732 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -154.37 163.37 24.39 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -76.88 179.46 31.25 Favored 'Cis proline' 0 C--N 1.312 -1.371 0 C-N-CA 123.306 -1.539 . . . . 0.0 111.119 -1.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 mt -77.6 -35.97 52.3 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.563 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.98 151.57 46.96 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -138.26 85.6 18.27 Favored Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.797 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 106.75 1.5 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.77 1.647 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.46 -177.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.576 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.6 m -122.27 156.2 34.32 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.383 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.1 mt -67.48 86.36 0.19 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.32 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.77 36.3 0.07 OUTLIER Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -135.86 166.34 23.54 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -94.11 137.39 33.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.236 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.67 160.24 16.1 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.57 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -149.04 90.54 1.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.628 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.669 HG23 HG21 ' A' ' 107' ' ' THR . 2.8 mt -86.62 113.61 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.589 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 7' ' ' THR . 7.2 t -81.21 156.3 25.72 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.654 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.8 91.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -91.0 166.63 12.91 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.978 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 p -148.39 167.36 25.46 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.996 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -79.62 -69.43 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -92.14 154.7 18.53 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.757 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -64.2 132.31 49.98 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.23 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 38' ' ' LEU . 14.3 mt -85.23 33.43 0.55 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.026 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.5 127.0 44.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.008 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 32' ' ' SER . 48.7 t-80 -77.88 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.634 -0.827 . . . . 0.0 110.419 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.426 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 18.2 m -76.36 70.15 2.92 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.324 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p30 34.96 54.62 0.72 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.384 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.73 -56.36 0.07 OUTLIER Glycine 0 N--CA 1.494 2.515 0 C-N-CA 118.783 -1.675 . . . . 0.0 112.078 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 37' ' ' TYR . 5.0 m-80 -82.29 122.59 28.14 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.559 -0.856 . . . . 0.0 112.789 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 m -107.79 99.41 8.88 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.475 ' CZ ' ' HB3' ' A' ' 35' ' ' ASN . 21.3 m-85 -83.85 75.78 10.07 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' A' ' 29' ' ' LEU . 5.6 tt -132.58 125.67 31.03 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.244 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 17.2 p-10 -126.06 160.84 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.839 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -108.3 174.92 5.66 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.498 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 27.9 m-85 -150.2 161.76 41.79 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.547 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.5 tp -160.51 111.14 1.82 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.282 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -113.42 161.07 17.75 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.964 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -128.36 -169.81 2.14 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.855 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.01 122.45 27.82 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.23 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 54.33 35.61 56.03 Favored Glycine 0 N--CA 1.497 2.706 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -126.25 154.28 43.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.053 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.446 ' N ' ' HG3' ' A' ' 47' ' ' GLN . 49.5 m -73.02 151.77 90.61 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.382 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.41 127.01 21.49 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.236 1.957 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -108.1 139.73 42.33 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 54' ' ' TYR . 31.6 tp -104.86 134.31 48.2 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.229 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.536 ' O ' HG21 ' A' ' 63' ' ' VAL . 49.0 mt -108.9 -51.12 2.92 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.759 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 59' ' ' ARG . 2.9 mm -127.47 134.85 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.517 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' HB3' HD21 ' A' ' 51' ' ' LEU . 35.4 p90 -112.83 -21.95 10.92 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.226 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 57' ' ' SER . 19.6 mttp -135.33 106.54 6.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.334 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.046 HG13 ' H ' ' A' ' 57' ' ' SER . 6.3 p 29.7 -85.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.15 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.046 ' H ' HG13 ' A' ' 56' ' ' VAL . 21.4 t -114.35 48.0 1.16 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.238 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -125.61 108.11 11.25 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 18.9 mtt180 -73.53 144.22 46.2 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.465 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -73.41 155.35 39.41 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.984 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.8 p -59.11 98.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.622 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.56 -17.79 4.97 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.774 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 52' ' ' LEU . 95.4 t -73.56 120.11 79.47 Favored Pre-proline 0 N--CA 1.489 1.51 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.305 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.75 150.19 86.87 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 122.107 1.872 . . . . 0.0 112.469 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -55.07 -19.88 8.31 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.756 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' NE ' ' OE2' ' A' ' 84' ' ' GLU . 61.4 mtt85 -56.01 -14.39 2.53 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.497 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -115.1 128.3 56.14 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.783 -0.767 . . . . 0.0 112.043 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.91 125.43 17.76 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.896 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.33 149.46 18.59 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.084 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.46 160.13 39.28 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 175.16 159.97 22.23 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.672 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.3 p -90.83 -99.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.675 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.78 -37.25 0.55 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.2 p -121.89 17.61 10.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.71 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' C ' ' CD1' ' A' ' 76' ' ' PHE . 9.3 t70 -152.25 125.13 8.49 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 20.9 m-85 -139.09 156.18 47.36 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.841 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 4.0 m -150.89 149.28 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.11 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tt -101.89 109.51 21.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.772 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -100.77 123.05 44.41 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.752 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 24.2 mt -108.08 132.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.278 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.8 m -64.63 -60.82 2.67 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.485 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -135.98 109.61 8.02 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.7 t -62.47 110.47 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.157 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' OE2' ' NE ' ' A' ' 66' ' ' ARG . 4.7 mt-10 -95.26 -175.52 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.295 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.17 66.28 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.249 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 6.7 pt-20 -87.24 -32.58 19.67 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.895 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 86' ' ' GLU . 60.5 m-20 -64.11 -12.58 40.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.269 -0.972 . . . . 0.0 111.384 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.575 ' CD1' HD11 ' A' ' 111' ' ' ILE . 20.1 mt -69.81 147.8 49.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.88 -161.16 28.25 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.557 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 90' ' ' ILE . 1.2 mp -106.08 117.92 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CB ' HD13 ' A' ' 21' ' ' ILE . 25.8 m-85 -90.97 154.15 19.65 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.672 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 106' ' ' GLY . 45.6 m-85 -146.39 168.48 21.03 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.42 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.6 p -159.05 151.09 20.98 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.321 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.0 t -152.69 -175.34 5.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.513 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.446 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 1.1 pp0? -135.84 136.38 40.57 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.0 m -110.36 42.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -38.62 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.139 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.665 ' CD2' HG21 ' A' ' 2' ' ' VAL . 82.7 m-70 -109.42 156.21 20.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.393 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 92.3 t -127.1 134.66 26.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.606 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -72.24 163.29 88.16 Favored 'Cis proline' 0 C--N 1.318 -1.045 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.731 -0.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.16 162.08 34.54 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 122.044 1.83 . . . . 0.0 111.389 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 28.5 p -87.43 -92.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.542 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 102' ' ' THR . 65.8 t80 61.99 116.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 123.445 0.466 . . . . 0.0 111.242 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.92 54.97 0.04 OUTLIER Glycine 0 N--CA 1.498 2.825 0 C-N-CA 118.74 -1.695 . . . . 0.0 111.888 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.491 ' HA3' ' OE1' ' A' ' 6' ' ' GLN . . . -114.1 -120.87 3.57 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 92' ' ' PHE . . . 127.23 68.72 0.16 Allowed Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.887 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.669 HG21 HG23 ' A' ' 21' ' ' ILE . 94.3 m -86.01 106.06 16.91 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.204 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 108' ' ' LYS . 0.0 OUTLIER -75.53 115.84 15.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.198 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.537 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -111.34 93.47 4.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.619 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -121.93 143.86 49.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.741 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.575 HD11 ' CD1' ' A' ' 88' ' ' LEU . 17.2 mt -62.47 152.65 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.294 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' N ' HG22 ' A' ' 111' ' ' ILE . 2.0 mtpm? -63.29 123.42 18.64 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.316 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.878 0.37 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' HG21 ' A' ' 102' ' ' THR . 70.4 t -71.29 116.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 118.755 -1.178 . . . . 0.0 110.291 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -68.36 151.09 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.424 -0.911 . . . . 0.0 111.022 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.04 120.39 11.6 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.234 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.1 143.7 47.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.527 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 1.4 tt0 -118.23 148.2 42.64 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.819 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.11 154.76 18.48 Favored Pre-proline 0 N--CA 1.492 1.652 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.796 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -78.43 178.61 33.79 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 123.734 -1.361 . . . . 0.0 111.102 -1.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.0 mt -77.05 -44.5 30.5 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.911 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 p -129.04 152.23 48.87 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.12 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -142.95 78.71 15.18 Favored Pre-proline 0 N--CA 1.489 1.523 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.092 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.85 126.19 14.91 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.757 1.638 . . . . 0.0 109.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.1 m -146.43 -175.06 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.335 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.76 167.06 11.1 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.599 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 111' ' ' ILE . 82.3 mt -83.54 89.83 7.15 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.784 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.04 48.52 0.07 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.81 176.47 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -97.26 148.02 23.54 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -125.38 161.02 27.95 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.816 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -160.64 96.54 1.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.434 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 77' ' ' THR . 37.2 mt -86.25 139.65 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.595 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 m -107.22 145.83 32.17 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.8 t -153.55 118.46 5.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.901 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -123.72 156.18 36.47 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.236 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 74' ' ' THR . 65.8 p -122.03 146.58 47.03 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.549 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -58.05 -49.77 75.75 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -111.22 156.22 21.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -64.62 144.81 56.95 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.912 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.89 30.32 3.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.539 -0.865 . . . . 0.0 111.23 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.72 141.64 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.502 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -83.43 -124.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.119 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.1 p -53.97 -69.21 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.711 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -170.35 21.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.802 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.22 15.59 0.05 OUTLIER Glycine 0 N--CA 1.495 2.618 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.365 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -132.66 112.06 11.7 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.3 m -115.32 150.34 36.43 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.226 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -132.2 101.44 5.38 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.463 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.03 129.18 12.74 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.786 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' ND2' ' OH ' ' A' ' 41' ' ' TYR . 12.4 p-10 -130.76 160.29 34.79 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.891 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -112.52 151.79 29.57 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' OH ' ' ND2' ' A' ' 39' ' ' ASN . 22.6 m-85 -129.31 166.59 19.17 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.374 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.489 HD13 ' CE1' ' A' ' 91' ' ' TYR . 14.2 tp -154.53 126.68 7.78 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.011 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -124.03 165.83 16.8 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.014 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -113.98 -146.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.26 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.2 -76.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.248 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.86 49.1 0.94 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.37 -173.9 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.807 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 p -86.19 148.06 46.54 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.787 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.87 151.99 82.73 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.01 1.806 . . . . 0.0 111.398 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.16 137.34 53.57 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.899 -0.721 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.4 tp -92.42 135.56 33.94 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.666 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.0 mt -113.73 -64.7 1.27 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.621 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mm -116.17 140.21 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.662 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.1 p90 -130.27 158.59 39.37 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.178 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.2 tptm 74.4 -67.07 0.27 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.986 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -171.07 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.494 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.0 p -152.43 -28.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.347 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 30.9 m-80 -51.65 129.0 24.98 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.193 -1.003 . . . . 0.0 111.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 -90.25 139.59 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.44 151.12 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.694 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -59.39 104.07 0.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.14 -12.85 6.39 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.326 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -81.01 119.21 75.38 Favored Pre-proline 0 N--CA 1.488 1.444 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.39 150.83 78.57 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 121.874 1.716 . . . . 0.0 111.828 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -58.51 -15.51 11.46 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.389 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -57.2 -18.4 15.58 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.75 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -107.43 128.62 54.64 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.0 125.54 17.75 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.162 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.57 144.97 17.05 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -160.44 -177.59 6.33 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.08 169.92 33.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.276 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.5 m -91.21 -82.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.25 -37.9 0.1 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.599 -1.286 . . . . 0.0 111.12 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 25' ' ' SER . 64.3 p -125.13 13.97 8.39 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.817 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -138.98 117.4 12.01 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -132.34 144.54 50.63 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.611 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' ILE . 88.2 m -141.37 139.69 33.57 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.596 -0.841 . . . . 0.0 111.783 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -106.14 111.48 24.11 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.765 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 37.8 mttt -107.1 147.74 29.65 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.629 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.3 mt -124.77 134.84 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.435 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 59.5 m -67.24 -55.47 13.89 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.766 -1.174 . . . . 0.0 112.174 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.14 110.63 8.54 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -71.25 130.17 35.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.211 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.96 -172.27 2.01 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.758 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.98 -29.6 62.06 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.39 -43.09 67.49 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -48.86 -36.07 16.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.571 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 77.1 mt -45.24 136.34 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.821 -0.751 . . . . 0.0 111.35 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.56 -144.74 10.91 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.409 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.9 mp -125.0 141.07 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.489 ' CE1' HD13 ' A' ' 42' ' ' LEU . 24.6 m-85 -117.83 151.12 37.98 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -146.64 163.78 34.77 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -137.58 136.03 37.2 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.362 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 p -139.4 155.13 47.84 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.954 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.31 152.38 37.9 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.0 p -127.83 28.78 5.54 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.234 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 -57.57 3.19 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.596 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -105.91 159.69 15.83 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.612 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 100' ' ' PRO . 38.3 t -110.0 140.77 22.64 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.318 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.479 ' HA ' HG13 ' A' ' 99' ' ' VAL . 7.4 Cg_endo -77.44 163.69 88.1 Favored 'Cis proline' 0 C--N 1.315 -1.193 0 C-N-CA 123.715 -1.369 . . . . 0.0 111.824 -0.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.36 118.9 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.021 1.814 . . . . 0.0 110.661 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' VAL . 19.6 p -89.9 135.32 33.71 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.741 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.38 -179.85 7.03 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.212 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.64 -175.71 41.5 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.787 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -82.93 -69.9 1.37 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.928 -1.13 . . . . 0.0 110.884 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 136.43 114.31 1.33 Allowed Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.574 -1.298 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.9 m -115.21 125.32 53.23 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.299 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -91.6 128.12 37.31 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.511 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.48 90.92 3.43 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.23 143.46 41.95 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.925 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.447 HD12 HD21 ' A' ' 15' ' ' LEU . 15.7 tt -66.66 150.07 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.961 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -62.61 121.37 13.17 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.023 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.399 -1.762 . . . . 0.0 110.649 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.12 0.486 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.719 HG21 ' CD2' ' A' ' 98' ' ' HIS . 41.9 t -74.47 106.27 4.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.792 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -69.44 164.05 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 111.486 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 mtt -143.7 110.59 5.65 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -77.15 110.54 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.65 131.16 44.47 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.178 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -164.89 156.53 13.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.445 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HA ' HG22 ' A' ' 7' ' ' THR . 11.2 Cg_endo -82.86 175.22 39.49 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.372 -1.512 . . . . 0.0 110.972 -1.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -83.08 -39.05 21.68 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.485 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.6 m -129.44 143.45 50.84 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.3 tp -137.59 81.05 30.56 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.824 -1.151 . . . . 0.0 112.492 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.54 121.74 8.48 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.773 1.649 . . . . 0.0 109.646 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.29 -178.08 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 118.98 -1.088 . . . . 0.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.1 t -108.6 172.92 6.56 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.553 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -89.19 89.49 7.96 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.01 28.03 0.34 Allowed Glycine 0 N--CA 1.496 2.686 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.659 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.49 174.94 6.08 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.852 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -96.51 141.96 29.16 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -108.76 167.31 10.16 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.832 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 p -162.03 79.89 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.048 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' THR . 5.2 mt -75.11 133.9 30.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.207 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.9 t -105.52 155.69 18.94 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.153 -1.019 . . . . 0.0 113.312 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.41 89.31 0.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.464 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -94.42 147.41 23.26 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.427 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 1.2 m -111.35 163.99 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.609 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.12 -47.86 17.27 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.41 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.454 ' C ' HG22 ' A' ' 74' ' ' THR . 11.4 tt0 -119.83 150.93 39.63 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -55.7 132.02 48.04 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.843 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.562 HD22 ' OE1' ' A' ' 95' ' ' GLN . 43.8 mt -85.28 32.62 0.55 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.121 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 t -88.27 143.46 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 21.7 t-80 -89.6 -130.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.379 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.423 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 16.6 p -56.07 -60.19 3.84 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.592 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -115.08 -86.28 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.28 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.547 ' H ' ' CG ' ' A' ' 33' ' ' ASN . . . -120.56 17.45 9.53 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.551 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 4.1 m120 -76.98 93.42 3.81 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.621 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 29' ' ' LEU . 3.2 m -108.43 146.29 33.32 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -129.97 124.29 32.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.38 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.5 OUTLIER -150.74 154.14 36.82 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.315 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.73 160.07 43.83 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.981 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.677 ' CD2' HD13 ' A' ' 78' ' ' LEU . 84.0 m95 -129.68 146.72 51.44 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.96 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -142.25 138.21 31.24 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.679 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.658 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.1 tp -119.87 139.59 52.15 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.568 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' LEU . 14.4 mm-40 -125.75 146.84 49.6 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.563 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -114.19 -135.26 0.35 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.19 -59.32 2.81 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -153.38 54.46 0.45 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.43 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -93.96 164.19 13.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.247 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.0 160.87 81.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.329 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -58.8 108.88 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.0 1.8 . . . . 0.0 111.563 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -115.39 -171.99 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 40' ' ' TRP . 25.9 tp -150.02 149.41 30.31 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.586 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.89 HD21 ' CD1' ' A' ' 67' ' ' PHE . 4.9 tp -111.03 -81.13 0.58 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.993 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mm -116.83 135.52 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 48.0 p90 -116.46 171.54 7.78 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' LEU . 4.8 mmtp 58.09 -150.87 0.43 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.007 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 56' ' ' VAL . 8.1 p -109.57 4.87 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.802 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.1 t -179.57 65.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -155.41 113.57 3.43 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.574 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.8 mtm-85 -76.33 138.51 40.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.549 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -76.52 164.01 26.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.543 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.3 m -55.29 130.99 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.161 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.29 35.45 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.982 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.73 116.66 52.25 Favored Pre-proline 0 N--CA 1.492 1.627 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.347 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.91 148.66 91.81 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.175 1.917 . . . . 0.0 112.697 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.83 -17.71 10.27 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -57.85 -14.73 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.755 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.89 ' CD1' HD21 ' A' ' 52' ' ' LEU . 82.2 m-85 -105.56 118.95 37.88 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.479 -0.889 . . . . 0.0 111.948 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 p -125.94 123.75 39.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -128.99 118.68 2.77 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.86 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.1 p -163.95 168.71 19.0 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.609 -0.837 . . . . 0.0 110.863 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.5 -160.42 33.92 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.582 ' H ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 p -90.78 -174.73 4.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.84 -24.3 64.42 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.151 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 27' ' ' GLN . 67.8 p -122.8 18.38 10.23 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.546 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.582 ' HB2' ' H ' ' A' ' 72' ' ' SER . 4.1 m-20 -140.16 131.0 25.95 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.949 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.31 127.78 14.06 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.218 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 40.5 m -135.16 131.04 36.3 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.576 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.1 tp -93.32 89.65 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -82.76 141.81 32.08 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.488 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 32.1 mt -125.52 141.25 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.152 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.6 m -69.81 -73.19 0.17 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.423 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 106.24 11.83 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.009 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.5 106.23 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.924 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.36 168.71 11.68 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.975 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.14 -16.85 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.764 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.76 -36.36 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.67 -26.87 65.91 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.092 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.4 mt -50.25 138.1 17.05 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.32 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.01 -151.24 23.49 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.746 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.93 125.51 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.517 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.658 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.4 m-85 -99.8 156.75 16.94 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.634 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -149.02 160.21 43.53 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.066 -0.653 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -144.04 151.42 39.65 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.952 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 t -150.33 168.78 23.09 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.831 -1.148 . . . . 0.0 112.129 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.562 ' OE1' HD22 ' A' ' 29' ' ' LEU . 11.2 pt20 -123.8 171.24 9.79 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.712 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.46 20.41 1.7 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 89.8 m -90.01 -19.2 24.71 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.719 ' CD2' HG21 ' A' ' 2' ' ' VAL . 89.9 m-70 -127.77 126.85 42.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.146 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.493 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 11.9 p -110.27 138.4 20.87 Favored Pre-proline 0 N--CA 1.488 1.426 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.382 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.0 Cg_endo -70.09 155.38 94.17 Favored 'Cis proline' 0 C--N 1.317 -1.103 0 C-N-CA 123.691 -1.379 . . . . 0.0 111.562 -0.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.14 156.22 56.53 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 122.157 1.905 . . . . 0.0 111.243 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.7 p -89.94 -59.53 2.17 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.584 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.6 t80 65.86 118.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.007 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -164.72 -171.5 31.05 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.647 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.32 -174.51 15.29 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.39 47.36 0.03 OUTLIER Glycine 0 N--CA 1.489 2.204 0 C-N-CA 119.079 -1.534 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -77.38 116.55 18.07 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.074 -1.051 . . . . 0.0 108.979 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -82.06 95.11 7.34 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.398 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.93 75.84 7.89 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.761 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.7 142.41 34.38 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.416 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.9 tt -77.78 159.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.141 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -62.87 140.3 58.8 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.861 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 HG21 ' CD2' ' A' ' 98' ' ' HIS . 54.1 t -79.17 147.95 6.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.157 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 t -103.64 157.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.4 mtp -142.87 112.84 7.05 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -93.44 111.82 23.57 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.492 ' CG ' ' HA2' ' A' ' 105' ' ' GLY . 11.3 tm0? -104.92 139.93 38.91 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.73 162.67 20.57 Favored Pre-proline 0 N--CA 1.489 1.49 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.737 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.26 178.52 28.12 Favored 'Cis proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.686 -1.381 . . . . 0.0 110.731 -2.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 9' ' ' LEU . 3.6 mm? -74.81 -64.02 1.13 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.321 -0.952 . . . . 0.0 109.635 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.45 153.48 26.07 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.655 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -139.93 82.49 17.47 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.977 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.79 116.27 4.19 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.807 1.672 . . . . 0.0 110.457 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.5 m -140.12 -170.74 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.186 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 t -118.61 176.11 5.41 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 85' ' ' ALA . 33.6 mt -90.64 92.21 8.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.436 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.94 -7.64 3.25 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.484 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.74 -172.29 4.09 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.232 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -105.72 166.95 10.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -140.03 160.59 39.59 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.479 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 p -159.48 89.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.433 HD13 ' CB ' ' A' ' 91' ' ' TYR . 19.8 mt -79.41 133.77 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.308 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 m -97.59 147.95 23.78 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.657 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -154.81 102.72 2.38 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.572 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 25' ' ' SER . 4.1 ttt180 -111.65 147.73 34.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.636 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 24' ' ' ARG . 34.5 m -120.39 157.25 29.69 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.6 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.2 t -65.4 -65.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.696 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.441 ' HG2' ' H ' ' A' ' 28' ' ' SER . 8.7 tt0 -99.19 162.79 12.85 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.683 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.3 p -68.61 121.15 15.83 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.696 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 95' ' ' GLN . 25.2 mt -77.73 28.47 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 28' ' ' SER . 46.8 t -89.57 127.49 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.677 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.85 162.54 25.99 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.898 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -30.51 71.53 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.897 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -73.62 -17.44 61.16 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.307 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.57 25.46 5.99 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.657 -1.259 . . . . 0.0 111.244 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -119.49 123.96 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.072 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 m -99.99 103.28 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.52 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -84.14 121.47 27.5 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.919 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -173.89 135.14 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.638 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 p30 -137.46 177.31 7.97 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.05 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.442 ' O ' HD12 ' A' ' 51' ' ' LEU . 65.2 m95 -126.07 148.95 49.22 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 20.2 m-85 -128.91 161.11 30.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.538 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 7.9 tp -157.61 113.38 2.82 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.965 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -134.85 156.89 48.13 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.456 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.62 -114.97 0.31 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.934 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.57 -36.63 20.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.422 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.07 48.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -80.38 161.08 25.18 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -71.39 -51.24 10.04 Favored Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.907 -0.717 . . . . 0.0 112.912 -179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 48' ' ' SER . 2.8 Cg_endo -68.6 122.03 8.97 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.789 1.659 . . . . 0.0 112.508 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.92 10.0 3.9 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.411 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 40' ' ' TRP . 10.9 tp -141.59 134.7 29.17 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.409 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -116.08 -73.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.6 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mm -100.04 138.49 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CZ ' ' ND2' ' A' ' 58' ' ' ASN . 37.3 p90 -136.19 12.91 3.31 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.411 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -147.7 44.38 1.1 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.178 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 18.8 t 70.08 -27.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.733 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -155.16 -45.67 0.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.514 -1.274 . . . . 0.0 112.121 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.432 ' ND2' ' CZ ' ' A' ' 54' ' ' TYR . 2.9 t30 -58.93 126.81 29.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.217 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.496 HH12 ' CG ' ' A' ' 65' ' ' ASP . 5.8 mtm180 -81.25 169.97 16.66 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.112 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.418 ' CG ' ' N ' ' A' ' 61' ' ' SER . 91.6 t80 -90.07 159.51 16.79 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.295 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.418 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 4.5 m -60.66 114.91 3.25 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -17.72 16.18 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 99.1 t -78.36 129.55 74.53 Favored Pre-proline 0 C--N 1.306 -1.314 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.235 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -65.21 165.16 22.89 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.843 1.695 . . . . 0.0 111.765 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' CG ' HH12 ' A' ' 59' ' ' ARG . 0.2 OUTLIER -78.08 -14.78 59.36 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.821 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HD2' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.11 -11.54 31.02 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.09 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 51.1 m-85 -101.25 121.12 41.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.967 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -126.66 129.62 48.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.054 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -116.38 144.57 18.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -160.92 150.0 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.611 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.44 160.57 24.4 Favored Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.514 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 p -91.21 -85.31 0.23 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.735 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.93 -32.69 0.1 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.374 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.0 p -119.42 15.1 12.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.821 -0.751 . . . . 0.0 110.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -153.8 135.2 14.2 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -146.18 149.89 34.81 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.862 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 m -143.96 143.13 31.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.858 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' A' ' 40' ' ' TRP . 9.1 tt -106.97 101.51 10.93 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.955 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -96.68 138.36 34.37 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.006 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 57.9 mt -121.3 138.4 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.865 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.79 -74.29 0.14 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.985 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.04 103.6 10.06 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.85 135.85 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.684 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.29 166.34 16.08 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.726 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.404 ' N ' HD22 ' A' ' 15' ' ' LEU . . . -55.37 -25.22 34.01 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.718 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.92 -39.35 34.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.171 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.93 -14.46 61.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.051 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 109' ' ' LEU . 85.1 mt -58.21 150.99 20.21 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.531 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.34 -166.67 26.73 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.567 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.45 129.26 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.163 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 17.7 m-85 -103.18 146.31 28.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 93.8 m-85 -138.48 169.52 17.64 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 6.2 p -157.94 134.9 9.96 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 86.2 p -142.04 173.2 11.74 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.894 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HB3' HD13 ' A' ' 29' ' ' LEU . 4.0 pp0? -129.92 157.7 41.57 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -126.46 10.11 7.26 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.459 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 m -68.76 -32.27 71.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.628 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.467 ' CD2' HG21 ' A' ' 2' ' ' VAL . 4.9 m-70 -114.16 124.22 51.54 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.2 t -104.3 138.35 19.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.315 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' A' ' 99' ' ' VAL . 4.1 Cg_endo -73.1 159.98 96.42 Favored 'Cis proline' 0 C--N 1.317 -1.113 0 C-N-CA 123.774 -1.344 . . . . 0.0 111.769 -0.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HB2' ' CE2' ' A' ' 103' ' ' PHE . 3.3 Cg_exo -60.58 141.25 94.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 122.137 1.891 . . . . 0.0 111.02 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -91.12 -28.72 17.72 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.262 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 101' ' ' PRO . 60.5 m-85 54.46 -159.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.516 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.48 -174.2 15.88 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.075 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.492 ' HA2' ' CG ' ' A' ' 6' ' ' GLN . . . 93.74 161.92 35.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.033 -1.079 . . . . 0.0 110.775 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.68 56.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.675 -1.25 . . . . 0.0 110.397 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.418 ' OG1' ' NE2' ' A' ' 6' ' ' GLN . 53.3 m -79.36 110.34 14.56 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.521 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -80.61 99.84 8.33 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.775 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HD23 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -87.96 84.73 6.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.766 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.1 147.18 32.83 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.084 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -83.32 153.33 3.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -57.21 131.1 48.95 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 116.359 -1.782 . . . . 0.0 110.442 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.04 0.448 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CD2' ' A' ' 98' ' ' HIS . 77.0 t -67.42 146.43 13.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.191 -1.004 . . . . 0.0 111.338 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.56 148.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.905 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.482 ' SD ' ' NE2' ' A' ' 95' ' ' GLN . 3.8 mtt -139.01 107.91 5.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.132 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m -98.59 97.18 8.5 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.835 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.569 ' OE1' ' SG ' ' A' ' 93' ' ' CYS . 2.2 tp60 -78.82 141.95 37.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.288 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.86 158.43 26.85 Favored Pre-proline 0 N--CA 1.493 1.68 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.821 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -77.77 178.13 36.23 Favored 'Cis proline' 0 C--N 1.311 -1.431 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.313 -1.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -78.34 -57.36 3.82 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.692 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 72.0 m -113.95 144.16 43.53 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.239 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 tp -136.86 73.05 54.16 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.331 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.97 118.23 5.4 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.661 1.574 . . . . 0.0 110.377 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.63 -178.64 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 119.299 -0.961 . . . . 0.0 112.261 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.32 156.85 18.07 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.557 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.5 mt -73.89 88.25 1.82 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.605 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.81 43.95 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.13 179.89 6.12 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -96.2 148.17 22.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -125.3 157.6 36.25 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.266 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -151.09 82.73 1.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.75 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 mt -80.27 117.83 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.264 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.0 t -86.89 159.34 19.08 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 18.3 t -157.78 97.63 1.58 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.343 -1.298 . . . . 0.0 108.603 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -104.22 153.56 20.83 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.299 -0.96 . . . . 0.0 113.019 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.2 m -128.28 145.8 50.94 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.806 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -62.51 -50.98 69.25 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.363 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -110.97 145.57 38.16 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.078 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -57.63 139.7 52.95 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.5 mt -93.06 39.86 1.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.545 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.08 137.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.743 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 32' ' ' SER . 59.7 t-80 -93.62 158.99 15.42 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.723 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.454 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 5.7 t -60.74 -21.04 62.55 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.361 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.425 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 32.5 p-10 -86.32 -6.38 58.96 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.34 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.5 28.65 12.32 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.72 -1.229 . . . . 0.0 111.401 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -116.29 136.39 53.05 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.409 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 m -102.46 127.85 49.33 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' OG1' ' A' ' 96' ' ' THR . 96.0 m-85 -116.67 110.5 18.56 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.032 -1.067 . . . . 0.0 112.639 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.73 146.79 26.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.345 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -141.03 162.18 36.1 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.918 -1.113 . . . . 0.0 112.379 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.703 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.8 m95 -128.98 150.1 50.54 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.037 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -145.02 158.01 43.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 37.8 tp -138.04 117.78 13.15 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.297 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -124.65 152.95 43.0 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.736 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -110.85 -137.18 0.37 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.261 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.12 -61.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.424 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.46 35.29 1.33 Allowed Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.548 -1.31 . . . . 0.0 110.778 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -89.04 168.89 11.98 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.42 161.6 49.31 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.719 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.2 147.96 91.53 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.067 1.844 . . . . 0.0 111.854 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 34.6 mttp -134.36 125.23 27.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 54' ' ' TYR . 39.4 tp -114.78 120.99 41.91 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.359 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -95.93 -70.89 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.236 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 78' ' ' LEU . 6.4 mm -111.24 141.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.572 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' HB3' HD21 ' A' ' 51' ' ' LEU . 53.8 p90 -128.82 8.01 5.7 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.001 -1.08 . . . . 0.0 111.81 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HB3' HD22 ' A' ' 58' ' ' ASN . 17.3 tttt -160.65 61.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 15.8 t 71.21 -65.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.007 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 p -124.77 -36.53 2.57 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.359 -0.936 . . . . 0.0 112.451 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.424 HD22 ' HB3' ' A' ' 55' ' ' LYS . 77.8 m-20 -48.1 115.51 1.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.705 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -85.71 151.54 23.78 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -80.7 164.73 22.59 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.053 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.75 137.22 54.83 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.53 -40.01 3.04 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -52.2 110.2 1.78 Allowed Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.685 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.35 150.69 86.28 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 121.94 1.76 . . . . 0.0 111.702 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.11 -12.93 1.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.465 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -58.64 -12.57 4.28 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.259 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.474 ' HE2' ' HH ' ' A' ' 91' ' ' TYR . 29.9 m-85 -111.35 120.34 41.89 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.726 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 37.4 p -133.69 100.36 4.75 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.29 153.35 23.4 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.438 -1.363 . . . . 0.0 110.579 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.9 p -160.83 158.13 27.88 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.879 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.22 157.25 16.11 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 118.995 -1.574 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.2 m -90.39 -94.26 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.85 -36.28 0.36 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.84 -1.171 . . . . 0.0 110.322 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -120.01 16.17 12.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.176 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -152.43 125.97 8.83 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.611 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 76' ' ' PHE . 4.2 m-85 -142.8 138.85 30.68 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.065 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 21' ' ' ILE . 23.9 m -138.8 144.76 39.48 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.492 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.703 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.2 tp -99.62 108.69 21.13 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.982 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -97.53 130.39 44.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 74.5 mt -115.0 140.35 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.834 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.5 m -72.82 -62.79 1.33 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.776 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.2 102.65 7.3 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.672 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.39 110.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.696 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -100.03 175.66 5.68 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.03 -29.77 58.12 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.413 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -73.14 -28.18 62.09 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.953 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.51 -1.45 15.94 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.993 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 111' ' ' ILE . 89.3 mt -76.76 152.4 35.63 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.79 -154.97 19.94 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.85 134.33 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.539 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.541 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 11.3 m-85 -98.57 152.57 19.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.893 . . . . 0.0 111.38 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -140.08 161.74 36.89 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.569 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 2.4 p -144.28 142.3 30.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.307 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -146.38 156.64 43.46 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.482 ' NE2' ' SD ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -104.64 152.09 22.88 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.395 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -116.59 30.09 7.55 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.923 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.0 m -102.32 -60.89 1.46 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CD2' HG21 ' A' ' 2' ' ' VAL . 16.9 m-70 -80.0 156.01 27.37 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.555 HG13 ' HA ' ' A' ' 100' ' ' PRO . 69.4 t -141.69 139.74 19.0 Favored Pre-proline 0 N--CA 1.489 1.514 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.034 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.555 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.9 Cg_endo -70.11 154.74 94.33 Favored 'Cis proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.362 -1.516 . . . . 0.0 111.304 -0.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.02 149.6 89.72 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.963 1.775 . . . . 0.0 111.078 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 102' ' ' THR . 60.2 p -82.58 -59.77 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.186 -1.005 . . . . 0.0 110.723 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 t80 62.04 125.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.399 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.92 -151.24 10.13 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 6' ' ' GLN . . . 88.75 -173.77 42.08 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.064 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 162.16 64.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 118.994 -1.574 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 21' ' ' ILE . 75.8 m -79.93 104.4 10.48 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.651 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 121.39 18.63 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.14 78.83 1.18 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.871 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -105.94 145.69 30.98 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.604 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.507 HD11 HD11 ' A' ' 88' ' ' LEU . 17.7 mt -64.11 131.22 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.49 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -72.19 104.08 3.54 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.468 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 116.389 -1.767 . . . . 0.0 109.829 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 121.008 0.432 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 98' ' ' HIS . 87.1 t -63.17 154.35 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.975 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.79 144.06 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.006 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -122.73 96.75 5.15 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.516 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.3 m -92.74 161.05 14.69 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.139 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.0 162.49 28.92 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.063 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.564 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -165.85 156.76 11.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.518 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 7' ' ' THR . 17.8 Cg_endo -88.33 177.98 19.96 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 124.265 -1.14 . . . . 0.0 110.665 -2.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.25 -48.32 20.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.518 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.2 t -122.07 153.62 38.39 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.1 tp -140.0 79.87 21.71 Favored Pre-proline 0 N--CA 1.489 1.487 0 C-N-CA 118.954 -1.099 . . . . 0.0 112.387 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.23 113.32 3.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 121.646 1.564 . . . . 0.0 109.639 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.13 -174.44 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.306 -0.958 . . . . 0.0 112.52 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.7 p -118.31 160.07 22.29 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.62 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 111' ' ' ILE . 63.5 mt -78.89 87.41 4.74 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.33 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.9 35.04 0.11 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.41 -173.36 3.09 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.485 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -106.07 146.08 30.61 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.203 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.09 37.08 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.093 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.8 p -161.63 89.15 0.73 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.937 -1.105 . . . . 0.0 111.628 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -73.26 146.23 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.377 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' THR . 22.8 t -117.62 140.58 49.45 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.21 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.2 m -146.3 101.15 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.098 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -109.3 147.81 32.05 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.156 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.7 p -115.03 139.61 49.72 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.603 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -49.88 -59.09 4.18 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.177 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -98.85 154.9 17.68 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.493 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -69.78 133.51 47.52 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.941 -0.703 . . . . 0.0 111.306 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.28 33.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.068 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -92.32 117.96 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -72.38 161.34 30.95 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.542 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -62.24 -23.6 66.77 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.199 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -85.43 -7.74 58.77 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.57 35.08 6.04 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.469 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -119.56 121.91 40.43 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.5 m -99.22 96.99 8.13 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.176 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -80.87 104.8 11.63 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD13 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -151.4 146.82 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.935 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -147.56 161.21 41.58 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.011 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.704 ' CD2' HD13 ' A' ' 78' ' ' LEU . 75.1 m95 -120.09 152.88 36.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.576 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -138.52 163.18 32.64 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.683 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 27.5 tp -146.3 100.17 3.33 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.697 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -97.76 142.82 29.07 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.415 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.68 -147.14 0.31 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.656 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.14 -55.6 5.57 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.212 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.91 39.58 1.32 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -112.18 169.41 8.88 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.021 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.3 t -73.94 137.49 76.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.84 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.52 106.72 0.22 Allowed 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.886 1.724 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 144.99 32.2 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.624 -0.83 . . . . 0.0 111.742 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.437 ' CD1' HD22 ' A' ' 39' ' ' ASN . 15.4 tp -99.17 138.66 35.95 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.753 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.9 mt -118.22 -51.64 2.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.072 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 55' ' ' LYS . 3.9 mm -126.41 136.2 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.738 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 40.3 p90 -121.86 23.33 10.11 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.188 -1.005 . . . . 0.0 112.158 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 175.37 80.53 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.093 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.6 t 56.87 -83.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.575 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t -121.16 43.85 2.69 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.805 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.5 m-80 -111.13 99.8 8.58 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.525 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 61.9 mtm180 -82.22 137.18 34.96 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' SER . 81.5 t80 -70.61 156.68 39.13 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.791 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.8 p -58.43 112.02 1.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.808 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 119.88 -24.55 7.87 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.88 126.86 93.15 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.43 ' CB ' ' HE ' ' A' ' 66' ' ' ARG . 3.3 Cg_exo -59.98 168.49 5.83 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.011 1.808 . . . . 0.0 112.52 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.78 -23.15 45.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.537 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' A' ' 64' ' ' PRO . 5.8 mtm-85 -53.86 -40.9 66.91 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.383 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.43 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 46.4 m-85 -80.0 112.25 17.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.64 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t -130.34 117.29 19.54 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.244 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 129.45 9.9 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.2 t -155.15 155.63 34.3 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.104 -1.038 . . . . 0.0 111.207 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 163.06 -172.24 39.02 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.585 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.5 t -91.3 -165.8 1.43 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.694 -0.803 . . . . 0.0 111.707 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.53 72.38 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.138 -1.03 . . . . 0.0 111.268 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 p -121.38 17.32 11.4 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 6.9 t0 -145.77 133.59 21.21 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.08 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.541 ' CE2' HD13 ' A' ' 38' ' ' LEU . 25.2 m-85 -143.32 125.96 15.95 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.425 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 m -123.32 130.97 53.47 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.341 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.704 HD13 ' CD2' ' A' ' 40' ' ' TRP . 5.4 tp -91.71 85.32 5.62 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.139 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -78.18 142.3 38.06 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.33 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.11 125.77 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.039 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.4 m -61.24 -59.14 5.77 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.004 -1.078 . . . . 0.0 112.332 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -132.37 107.48 8.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.9 t -63.38 138.38 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -117.69 175.47 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.7 -29.85 69.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.701 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -73.33 -35.22 66.0 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.726 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -56.08 -30.37 61.91 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.717 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.3 mt -48.88 137.36 12.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.229 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.34 -147.49 16.47 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.292 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 mt -123.64 120.25 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.41 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 31.5 m-85 -94.68 151.94 18.89 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.741 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -143.82 175.39 10.04 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.477 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 24.7 p -155.49 152.43 28.89 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.525 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 p -155.99 152.59 28.34 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.054 -1.059 . . . . 0.0 111.211 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 98' ' ' HIS . 3.6 pt20 -108.73 148.75 30.01 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.106 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.19 40.87 3.47 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.746 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.91 -57.2 2.07 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.189 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.43 ' CD2' HG21 ' A' ' 2' ' ' VAL . 63.6 m-70 -96.18 167.84 10.96 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.323 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 59.4 t -131.65 137.93 31.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.169 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.5 Cg_endo -70.42 151.67 93.33 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.696 -1.377 . . . . 0.0 111.748 -0.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.3 122.1 10.39 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.762 1.642 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 p -91.09 128.17 36.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.106 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -89.92 -175.56 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.68 -175.96 41.43 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.435 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.91 -59.99 2.01 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.907 -1.14 . . . . 0.0 111.093 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 135.99 101.36 0.63 Allowed Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.571 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.0 m -94.13 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.427 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -84.97 134.51 34.24 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.462 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.24 98.07 5.49 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.154 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -121.94 142.22 50.51 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.117 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.43 HD12 HD11 ' A' ' 15' ' ' LEU . 13.2 tt -64.74 146.74 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.238 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.49 108.82 2.53 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.024 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.484 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.418 ' HB3' ' CG2' ' A' ' 102' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 121.166 0.508 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 46.9 t -86.35 124.35 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 119.013 -1.075 . . . . 0.0 111.193 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.27 137.44 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.656 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 87.0 mmm -122.82 95.27 4.56 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -79.07 137.2 37.42 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.907 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 13.3 tt0 -124.34 148.57 47.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.767 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.86 156.53 17.33 Favored Pre-proline 0 N--CA 1.492 1.649 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.425 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HA ' HG22 ' A' ' 7' ' ' THR . 6.9 Cg_endo -78.65 178.52 34.05 Favored 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.664 -1.39 . . . . 0.0 111.274 -1.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mp -77.7 -34.43 52.8 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.204 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.1 p -138.6 158.0 45.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.195 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -145.9 85.65 7.55 Favored Pre-proline 0 N--CA 1.487 1.387 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.781 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -68.5 109.05 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.644 1.563 . . . . 0.0 110.307 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.5 m -133.93 176.46 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.011 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -104.71 168.96 8.73 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.412 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD21 HG12 ' A' ' 111' ' ' ILE . 65.6 mt -81.88 88.0 6.36 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.64 51.63 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -142.61 163.45 32.8 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.771 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -85.23 142.28 29.53 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.45 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -121.97 166.55 14.29 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.079 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 13.5 p -162.58 94.83 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.173 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.727 HD12 ' HB3' ' A' ' 78' ' ' LEU . 3.2 mt -87.98 118.42 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.714 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -83.1 157.03 22.99 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.488 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 51.2 t -162.17 112.6 1.56 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.196 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -118.53 144.77 45.83 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 1.4 m -104.88 151.29 24.03 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.168 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 m -78.06 0.65 23.79 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -156.65 134.14 10.75 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.14 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.8 t -55.53 124.48 17.42 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.007 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 95' ' ' GLN . 6.0 mt -91.5 31.35 1.18 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.415 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.9 t -88.09 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.63 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -67.47 154.18 41.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.466 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -60.14 -31.2 69.86 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.443 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.431 HD21 ' ND2' ' A' ' 35' ' ' ASN . 1.2 p-10 -76.02 -1.48 26.01 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.92 50.1 3.6 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.835 -1.174 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' ND2' HD21 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -142.26 120.95 12.6 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.576 -0.849 . . . . 0.0 111.119 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -103.59 103.39 13.32 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.091 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -81.72 98.29 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.037 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tt -147.53 138.03 23.26 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.676 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 6.9 p-10 -140.38 174.75 10.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.295 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 78' ' ' LEU . 67.9 m95 -122.48 148.59 44.97 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.264 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -125.64 164.14 21.24 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.145 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 26.1 tp -158.65 116.57 2.91 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.9 161.52 32.84 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.535 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -102.45 -141.02 0.35 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.114 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.98 61.53 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.314 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.93 77.44 0.05 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.31 -159.06 0.71 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.628 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -89.92 161.06 39.48 Favored Pre-proline 0 N--CA 1.488 1.473 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.223 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -61.38 125.47 16.95 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 121.71 1.607 . . . . 0.0 110.131 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -136.88 136.75 38.98 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.535 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD23 ' CD1' ' A' ' 60' ' ' PHE . 18.0 tp -114.19 143.37 44.93 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.7 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.515 ' O ' HG21 ' A' ' 63' ' ' VAL . 20.2 mt -111.86 -89.4 0.51 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.6 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.588 HG21 ' HA3' ' A' ' 69' ' ' GLY . 11.5 mm -99.12 133.05 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.293 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 26.0 p90 -133.9 174.67 10.22 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.252 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER 52.34 34.61 15.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.519 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 75.74 -37.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.117 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 58' ' ' ASN . 21.0 p -144.09 -41.24 0.27 Allowed 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.698 -1.201 . . . . 0.0 112.918 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 5.3 m-80 -37.52 122.03 0.9 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.138 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 65' ' ' ASP . 25.2 mtm180 -91.59 126.5 36.69 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.086 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.459 ' CD1' HD23 ' A' ' 51' ' ' LEU . 15.4 t80 -54.36 149.86 9.56 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 112.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.898 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.65 -22.82 11.48 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.714 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 52' ' ' LEU . 88.7 t -56.95 120.12 35.83 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.051 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -58.4 138.76 87.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.705 1.603 . . . . 0.0 111.333 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HA ' ' NH1' ' A' ' 59' ' ' ARG . 9.3 p-10 -54.15 -22.85 12.25 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.0 mtm-85 -58.6 -18.74 32.57 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -93.23 114.19 26.61 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.586 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.39 90.34 3.31 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.588 ' HA3' HG21 ' A' ' 53' ' ' ILE . . . -94.03 129.38 9.87 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 t -164.35 -173.42 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.517 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 150.53 -179.64 27.08 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.043 -1.551 . . . . 0.0 111.83 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -93.2 -140.75 0.21 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.405 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.79 -35.57 13.01 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.3 p -123.79 13.18 9.22 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.167 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 4.6 m-20 -132.41 130.36 40.52 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -144.44 145.71 32.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.991 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.5 m -150.28 140.48 22.18 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.634 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.727 ' HB3' HD12 ' A' ' 21' ' ' ILE . 4.1 tt -98.5 102.8 14.65 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.95 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -93.93 122.08 36.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.965 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 31.2 mt -106.15 138.75 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.692 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 m -72.03 -70.22 0.35 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.89 105.24 9.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.42 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.89 104.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.235 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -93.01 173.86 7.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.66 -27.15 48.37 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.972 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.43 -39.7 62.42 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.329 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.86 -8.34 2.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.81 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 111' ' ' ILE . 94.5 mt -69.68 148.89 48.68 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.881 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.13 -159.85 24.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.64 135.7 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.25 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.425 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 26.8 m-85 -100.22 151.77 21.05 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.386 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.78 147.94 38.13 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.1 p -128.32 139.92 52.14 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.191 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.463 ' HG ' ' HD2' ' A' ' 103' ' ' PHE . 2.3 t -144.78 164.26 31.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.136 -1.026 . . . . 0.0 111.077 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.502 HE22 ' HB2' ' A' ' 98' ' ' HIS . 1.4 pt20 -117.48 163.19 16.77 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.231 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.56 32.75 2.76 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.029 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.8 m -99.69 -34.07 10.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.501 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.502 ' HB2' HE22 ' A' ' 95' ' ' GLN . 16.5 m-70 -107.97 167.45 9.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.933 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.485 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 43.8 t -136.73 135.75 20.71 Favored Pre-proline 0 N--CA 1.49 1.53 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.331 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 4.8 Cg_endo -70.29 151.76 93.09 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.481 -1.466 . . . . 0.0 111.497 -0.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.01 125.84 20.27 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.759 1.639 . . . . 0.0 110.209 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 1' ' ' ASP . 11.0 p -93.81 118.31 31.27 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.156 -1.017 . . . . 0.0 112.093 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' HD2' ' HG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -105.17 -175.13 2.7 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.292 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.4 177.31 18.24 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.867 -1.635 . . . . 0.0 111.397 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.07 175.97 22.8 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.408 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 169.87 62.05 0.04 OUTLIER Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.054 -1.545 . . . . 0.0 110.801 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 8' ' ' PRO . 26.5 m -78.21 105.37 9.4 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.859 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -74.82 105.43 5.88 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.339 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.19 90.62 4.42 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.993 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.4 146.17 45.59 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.535 HG12 HD21 ' A' ' 15' ' ' LEU . 10.5 mt -60.69 127.23 19.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.23 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 112' ' ' LYS . 8.8 tmtt? -54.49 129.16 34.99 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.417 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 116.141 -1.885 . . . . 0.0 110.431 179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.938 0.399 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.705 HG21 ' CD2' ' A' ' 98' ' ' HIS . 83.8 t -71.33 122.42 23.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.081 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.06 148.22 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -147.29 119.73 8.45 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -117.16 122.94 45.47 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.966 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.615 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 2.9 mp0 -95.39 146.73 24.18 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.09 157.05 21.91 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.631 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HA ' HG22 ' A' ' 7' ' ' THR . 8.5 Cg_endo -76.33 175.58 47.53 Favored 'Cis proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.528 -1.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.77 -34.13 52.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.308 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.11 159.32 42.06 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.458 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 tp -145.3 75.02 13.94 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.26 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.57 115.32 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.95 1.767 . . . . 0.0 110.424 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 m -143.66 -172.19 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.737 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.3 154.16 32.78 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.021 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.4 mt -67.44 87.76 0.2 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.61 47.62 0.04 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -144.15 175.24 10.21 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.871 -0.731 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -93.99 154.13 17.82 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.303 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -122.55 159.22 28.19 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.607 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.0 p -160.78 83.51 0.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 77' ' ' THR . 5.7 mt -82.35 125.85 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.801 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER -88.64 154.19 20.51 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 115.471 -0.786 . . . . 0.0 113.057 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.615 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 9.8 m -157.3 107.41 2.23 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -119.6 164.74 15.39 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.277 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.3 p -136.52 165.17 26.48 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.269 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 m -78.65 -29.0 45.54 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.767 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.29 145.04 51.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.375 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.3 m -58.8 126.83 29.28 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.347 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.6 32.2 0.3 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.0 t -89.81 147.85 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.032 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -101.23 167.97 9.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.081 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 98.4 p -55.84 -37.27 68.49 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.389 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -68.18 -19.73 64.81 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.108 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.88 14.66 24.35 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.871 -1.157 . . . . 0.0 111.23 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -106.13 138.51 42.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.378 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.6 m -109.02 144.78 36.57 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.153 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -125.89 107.65 10.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.04 134.16 19.32 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.659 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -129.55 162.19 28.78 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.321 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 52.5 m95 -114.99 160.26 19.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.893 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -147.69 127.09 13.12 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.783 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.585 HD13 ' CE1' ' A' ' 91' ' ' TYR . 25.2 tp -117.97 109.7 16.81 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.255 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -121.01 152.09 39.0 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.624 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -136.15 -109.34 0.2 Allowed 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.35 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.38 -97.03 0.11 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.253 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.28 49.12 1.71 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -123.58 10.34 9.08 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.603 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.493 ' HB3' ' HD3' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -32.23 -57.7 0.44 Allowed Pre-proline 0 N--CA 1.498 1.938 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.277 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 48' ' ' SER . 2.6 Cg_endo -63.66 84.17 0.13 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.426 1.418 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -148.81 158.89 44.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.325 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -164.66 135.89 4.26 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.0 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.6 mt -110.31 -60.04 1.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 58' ' ' ASN . 5.3 mm -120.26 140.11 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.799 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.9 p90 -121.54 2.12 10.13 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.248 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.62 ' C ' HG13 ' A' ' 56' ' ' VAL . 61.1 tttt -153.79 50.34 0.67 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.718 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.62 HG13 ' C ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER 65.11 -58.77 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.141 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -126.64 54.49 1.59 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.328 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.9 OUTLIER -146.61 105.2 3.82 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.862 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 34.2 mtm180 -71.75 147.65 47.12 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.631 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -86.34 169.52 12.88 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.767 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 m -59.89 129.34 41.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.355 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.61 -23.92 25.9 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.017 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.63 115.21 18.38 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.23 151.43 82.29 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.922 1.748 . . . . 0.0 111.954 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.56 -18.31 18.77 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.476 HH21 ' CD ' ' A' ' 84' ' ' GLU . 59.8 mtt85 -53.3 -10.91 0.25 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.516 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 93.0 m-85 -116.49 125.31 51.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.961 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.56 119.64 14.5 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.268 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.29 159.9 13.42 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.817 -1.183 . . . . 0.0 110.89 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.9 p -158.32 175.91 13.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.196 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 164.2 151.78 6.67 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.131 -1.509 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.3 m -93.82 -71.95 0.63 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.41 -49.36 0.04 OUTLIER Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.635 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.5 p -115.83 13.35 16.07 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -133.75 127.82 33.58 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.043 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.442 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 87.3 m-85 -144.73 130.5 19.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 21' ' ' ILE . 55.4 m -136.03 139.22 42.94 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.042 -1.063 . . . . 0.0 112.129 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 9.2 tt -98.64 114.81 27.44 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -108.7 140.63 41.83 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.436 -0.905 . . . . 0.0 112.466 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 77.9 mt -120.75 137.07 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.58 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.2 m -69.82 -63.93 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.236 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -124.52 104.93 9.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.2 112.68 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -97.01 -149.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.583 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.47 -30.27 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.07 -33.47 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.613 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.59 -15.64 40.91 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.846 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD11 HD11 ' A' ' 111' ' ' ILE . 58.4 mt -67.75 147.75 52.19 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.295 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.6 -153.11 23.42 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.143 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -117.42 123.18 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' CE1' HD13 ' A' ' 42' ' ' LEU . 18.0 m-85 -91.77 155.3 18.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.982 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -146.65 167.21 24.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.815 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.2 p -157.25 145.93 19.68 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.76 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 m -144.41 171.39 14.4 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.467 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -115.55 151.66 34.49 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.303 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.36 18.28 9.78 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.033 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.9 m -91.32 -22.99 20.26 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.705 ' CD2' HG21 ' A' ' 2' ' ' VAL . 86.0 m-70 -122.23 132.44 54.43 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.071 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.501 HG13 ' HA ' ' A' ' 100' ' ' PRO . 59.2 t -114.3 139.28 23.63 Favored Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.448 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.4 Cg_endo -71.35 159.37 94.27 Favored 'Cis proline' 0 C--N 1.317 -1.114 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.774 -0.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.33 144.13 94.77 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.933 1.756 . . . . 0.0 110.996 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -81.05 -63.88 1.31 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.216 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.521 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 5.7 t80 61.86 157.31 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.35 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.01 -157.89 27.47 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.681 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' CA ' HE21 ' A' ' 6' ' ' GLN . . . 93.41 -156.73 22.81 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.905 -1.14 . . . . 0.0 110.408 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.22 63.79 0.02 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.284 -1.436 . . . . 0.0 111.219 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 8' ' ' PRO . 68.2 m -77.9 107.98 10.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.351 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -76.91 107.61 9.37 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.79 -0.764 . . . . 0.0 112.169 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.7 tt -101.71 84.28 2.54 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.675 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.36 147.9 33.04 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.608 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 88' ' ' LEU . 17.3 mt -67.05 129.69 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -66.24 115.94 6.76 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.003 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.437 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 17.4 mtt180 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 116.504 -1.712 . . . . 0.0 111.044 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.94 0.4 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 98' ' ' HIS . 20.1 t -75.01 130.68 35.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.694 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -90.78 158.66 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.635 -0.826 . . . . 0.0 110.884 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.1 mmm -140.44 112.49 7.69 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.015 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -80.69 110.63 16.37 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.361 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 7' ' ' THR . 2.2 mt-30 -96.42 127.9 42.84 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.665 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -162.33 155.94 17.76 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.131 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -81.59 177.44 34.67 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.742 -1.357 . . . . 0.0 110.716 -2.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.6 -35.6 24.54 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.315 -0.954 . . . . 0.0 109.736 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.6 p -132.97 156.93 46.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.283 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.5 tp -143.56 76.58 15.82 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.597 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -70.42 93.74 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.657 1.571 . . . . 0.0 109.845 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 11' ' ' LEU . 4.3 m -114.71 -177.09 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.093 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -112.42 152.13 29.03 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.378 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.13 89.24 0.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 143.83 -11.59 2.14 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.994 -1.098 . . . . 0.0 110.78 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.83 -168.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.279 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -109.59 166.42 10.91 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.471 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -129.09 162.57 27.39 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.4 p -162.35 76.18 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.986 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 77' ' ' THR . 15.3 mt -73.14 133.81 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.783 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.6 t -104.51 142.29 34.87 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.541 -0.864 . . . . 0.0 112.741 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 15.4 m -146.35 82.32 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.636 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -81.0 167.79 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.9 m -135.87 154.87 51.02 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.807 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.4 t -67.58 -50.54 57.85 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.86 167.58 11.58 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.084 -0.647 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.9 m -66.19 123.14 19.09 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.739 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.68 32.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.05 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.9 t -97.3 131.07 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.631 -0.827 . . . . 0.0 110.273 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.405 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 27.7 t-80 -83.93 167.37 17.03 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.784 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.0 m -58.2 -27.99 64.39 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.737 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 1.3 p30 -79.45 -10.5 59.82 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.848 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.31 -0.93 64.08 Favored Glycine 0 N--CA 1.496 2.693 0 C-N-CA 119.798 -1.191 . . . . 0.0 111.905 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.81 144.42 28.46 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.928 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.9 m -101.15 155.9 17.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.193 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -138.16 90.54 2.49 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.889 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 76' ' ' PHE . 2.1 tt -156.67 134.65 11.1 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' ND2' ' CZ ' ' A' ' 41' ' ' TYR . 9.7 p-10 -129.47 167.38 17.92 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.681 -0.807 . . . . 0.0 111.333 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' CD2' HD12 ' A' ' 78' ' ' LEU . 54.4 m95 -116.47 166.41 12.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.486 ' CZ ' ' ND2' ' A' ' 39' ' ' ASN . 24.5 m-85 -146.09 159.67 42.96 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.649 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 25.8 tp -151.14 132.7 14.78 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.297 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -134.11 155.2 50.48 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.67 -128.9 0.28 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.701 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.51 -53.25 6.43 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.22 42.88 0.34 Allowed Glycine 0 N--CA 1.496 2.683 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.324 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.16 176.98 5.01 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -62.29 153.35 75.97 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.62 143.21 98.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.774 1.649 . . . . 0.0 111.25 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.34 135.17 54.84 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.3 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.17 126.33 51.99 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.9 mm? -100.48 -48.75 4.44 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.103 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.67 HD13 ' HA ' ' A' ' 59' ' ' ARG . 18.6 mm -130.68 136.24 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.617 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 43.0 p90 -115.61 -10.37 11.87 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.165 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.4 mmtp -145.03 99.69 3.37 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.175 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.806 HG13 ' H ' ' A' ' 57' ' ' SER . 7.5 p 42.06 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 124.233 0.958 . . . . 0.0 113.13 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.806 ' H ' HG13 ' A' ' 56' ' ' VAL . 65.1 p -122.62 -24.85 4.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.341 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.6 OUTLIER -47.4 106.8 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.325 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.67 ' HA ' HD13 ' A' ' 53' ' ' ILE . 18.0 mtm-85 -78.62 159.65 27.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.695 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 61' ' ' SER . 84.7 t80 -82.26 158.0 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.438 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.2 p -64.53 85.65 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.651 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.06 -6.57 2.04 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.448 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.28 118.05 69.08 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.257 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.19 153.08 67.51 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 121.889 1.726 . . . . 0.0 111.84 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' HH21 ' A' ' 59' ' ' ARG . 5.4 m-20 -58.74 -7.72 1.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.594 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 84' ' ' GLU . 23.0 mtt180 -61.68 -28.96 69.77 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -99.21 130.65 45.53 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t -142.42 135.63 28.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.646 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.39 135.31 11.75 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.272 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.8 t -158.54 -177.93 6.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.604 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . 134.17 -178.13 18.61 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.5 t -89.77 -178.52 5.53 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.62 -15.59 53.95 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.459 -1.353 . . . . 0.0 110.111 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.8 p -119.7 17.34 12.76 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -153.1 123.94 7.36 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.158 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 38' ' ' LEU . 29.0 m-85 -133.79 130.81 38.52 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.625 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 21' ' ' ILE . 24.9 m -130.51 147.39 52.2 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.636 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.7 tt -105.79 96.42 6.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.96 140.16 30.04 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.455 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 71.4 mt -125.07 134.04 67.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.249 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 -62.26 1.71 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.671 -1.212 . . . . 0.0 111.558 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -128.86 107.83 9.95 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 13' ' ' VAL . 88.6 t -67.39 104.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.998 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' CD ' HH21 ' A' ' 66' ' ' ARG . 3.2 mt-10 -90.83 -164.48 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.341 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.29 -26.34 46.98 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.752 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -76.03 -31.12 58.71 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.3 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.53 -22.45 66.97 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 111' ' ' ILE . 64.9 mt -57.67 155.61 9.7 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.44 -149.22 19.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.372 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -116.31 138.71 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.318 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.669 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 15.7 m-85 -116.16 151.68 35.2 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.396 -0.921 . . . . 0.0 111.947 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -149.54 174.77 12.15 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.49 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.65 160.11 43.18 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.83 165.58 34.07 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.639 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.76 44.31 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.766 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.93 45.5 2.69 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.097 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.8 -46.05 3.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.468 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 2' ' ' VAL . 18.3 m-70 -106.24 161.42 14.55 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.307 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.7 p -124.83 131.79 24.19 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.3 Cg_endo -70.6 153.74 95.21 Favored 'Cis proline' 0 C--N 1.318 -1.042 0 C-N-CA 123.468 -1.472 . . . . 0.0 111.032 -1.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.63 131.5 40.53 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.644 1.562 . . . . 0.0 110.681 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.57 127.63 34.51 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.451 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -107.53 154.98 20.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.37 177.08 46.68 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.304 -1.427 . . . . 0.0 110.723 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.22 167.7 14.92 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.448 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.63 39.33 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.507 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.3 m -77.64 116.14 17.95 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.087 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.09 107.63 16.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.151 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.72 88.6 6.32 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -114.69 143.33 45.22 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.242 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 88' ' ' LEU . 15.6 mt -71.14 140.24 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HE2' ' N ' ' A' ' 113' ' ' ARG . 0.3 OUTLIER -69.63 177.71 2.86 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.58 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.478 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 CA-C-O 116.405 -1.76 . . . . 0.0 110.608 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 98' ' ' HIS . 61.0 t -75.55 150.72 6.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 118.806 -1.158 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 4' ' ' MET . 12.5 t -96.85 160.52 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.149 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.442 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -149.35 113.25 5.12 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.903 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -101.31 125.16 47.92 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.409 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.621 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -110.92 135.18 51.84 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.039 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.82 158.11 26.6 Favored Pre-proline 0 N--CA 1.49 1.54 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.826 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.5 Cg_endo -78.67 176.89 40.84 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.492 -1.461 . . . . 0.0 111.317 -1.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.7 mt -79.98 -40.51 27.81 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.538 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -132.08 150.89 52.04 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.802 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.6 tp -143.15 82.11 12.12 Favored Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.814 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.85 107.88 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.586 1.524 . . . . 0.0 110.041 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 11' ' ' LEU . 5.1 m -129.66 178.43 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.227 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -109.11 158.14 18.06 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.146 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.83 88.39 1.02 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.678 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.34 -10.77 1.53 Allowed Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -168.11 1.75 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.229 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -112.66 156.3 22.99 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -113.64 162.69 15.92 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.6 p -162.4 75.3 0.43 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.659 -0.816 . . . . 0.0 111.004 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 77' ' ' THR . 11.2 mt -80.21 121.01 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.979 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' THR . 18.2 t -89.0 157.25 18.43 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.621 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.6 m -160.18 108.52 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.561 -1.199 . . . . 0.0 109.311 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -113.27 155.91 24.26 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.096 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -127.71 139.49 52.66 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.012 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -53.42 -53.0 57.59 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -106.4 153.35 22.37 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.449 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' VAL . 1.4 p -63.4 122.06 15.32 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.257 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 29.6 mt -75.81 28.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.017 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' SER . 51.9 t -90.06 144.38 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.474 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.485 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 28.4 t-80 -96.5 169.2 10.06 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.506 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.41 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 1.4 t -67.22 -29.88 69.66 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.662 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.485 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -75.69 -14.52 60.35 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.349 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.75 -20.37 34.19 Favored Glycine 0 N--CA 1.497 2.702 0 C-N-CA 119.671 -1.252 . . . . 0.0 111.575 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -79.23 130.64 35.67 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.241 -0.983 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 m -106.03 155.11 19.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.065 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -128.37 138.42 52.35 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.761 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -165.14 166.36 19.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.847 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -163.41 149.1 11.47 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.118 179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.479 ' CD2' HD12 ' A' ' 78' ' ' LEU . 64.1 m95 -117.72 154.27 31.96 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -144.94 151.38 38.55 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.303 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 91' ' ' TYR . 17.8 tp -132.25 81.22 1.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.406 ' N ' ' CD ' ' A' ' 43' ' ' GLN . 3.1 mp0 -57.05 99.09 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.13 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HD3' ' N ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -101.51 158.3 16.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.082 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 44' ' ' LYS . . . -60.37 107.55 0.68 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.686 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.79 -43.32 2.87 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.265 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' O ' ' C ' ' A' ' 48' ' ' SER . 0.9 OUTLIER -79.6 11.36 3.16 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.88 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.531 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -30.37 -55.61 0.35 Allowed Pre-proline 0 N--CA 1.495 1.823 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.031 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 1.8 Cg_endo -68.43 87.05 0.42 Allowed 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 121.42 1.413 . . . . 0.0 111.135 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -153.1 156.11 38.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 52' ' ' LEU . 15.7 tp -134.28 152.68 51.94 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.806 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.657 ' H ' HD12 ' A' ' 51' ' ' LEU . 1.1 mp -122.11 -67.33 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.645 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 56' ' ' VAL . 5.5 mm -128.29 153.42 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.021 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 5.1 p90 -136.35 -65.98 0.55 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.48 73.49 5.03 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.954 -1.099 . . . . 0.0 110.227 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 53' ' ' ILE . 10.4 t 62.57 -74.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.927 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 55' ' ' LYS . 1.2 t -117.67 -8.78 10.85 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 1.7 m-80 -60.71 121.27 11.83 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' A' ' 65' ' ' ASP . 5.6 mtt-85 -97.15 161.13 13.96 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -86.38 152.93 22.31 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.278 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.1 t -55.52 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.14 -29.98 2.38 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.464 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 121.15 74.78 Favored Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.601 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.88 138.51 86.08 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.752 1.635 . . . . 0.0 111.641 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' A' ' 59' ' ' ARG . 2.6 t70 -54.48 -14.3 1.22 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HE ' ' N ' ' A' ' 66' ' ' ARG . 1.1 mmp_? -57.54 -19.15 23.21 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.699 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -100.16 130.47 46.3 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.309 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 p -139.82 121.24 15.05 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.295 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.91 133.4 11.37 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.224 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.2 140.94 35.97 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.83 154.36 12.75 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.461 -1.352 . . . . 0.0 110.66 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.7 m -91.28 -79.99 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.276 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.33 -34.72 0.1 OUTLIER Glycine 0 N--CA 1.498 2.772 0 C-N-CA 119.724 -1.227 . . . . 0.0 110.671 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.4 p -121.65 19.19 11.16 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -151.74 126.82 9.79 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.624 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -141.21 138.23 33.17 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 50.0 m -135.86 149.9 49.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.239 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 40' ' ' TRP . 7.1 tt -109.27 109.12 19.95 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.391 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 14.2 mttm -110.53 139.36 45.84 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.406 -0.918 . . . . 0.0 112.232 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -120.93 132.7 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.619 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.5 m -61.73 -56.41 19.87 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.764 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.37 103.34 6.39 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.78 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.6 t -70.01 129.66 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.437 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -109.23 -171.86 1.93 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.46 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.2 -41.4 63.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -62.51 -32.46 73.39 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -21.36 50.43 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.606 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.54 143.32 50.52 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.969 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.1 -155.59 26.28 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 90' ' ' ILE . 4.1 mt -114.18 114.74 47.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.425 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 42' ' ' LEU . 7.2 m-85 -88.56 152.76 21.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.494 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -148.61 165.7 30.52 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.598 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.92 152.96 31.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.829 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.6 t -156.34 178.98 9.69 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.028 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -132.53 142.77 49.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.5 p -115.28 22.67 13.09 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.561 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -43.85 60.2 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.985 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.472 ' CD2' HG21 ' A' ' 2' ' ' VAL . 90.9 m-70 -111.39 148.84 32.17 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER -118.85 142.16 31.36 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.971 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 99' ' ' VAL . 1.0 OUTLIER -70.09 162.99 83.88 Favored 'Cis proline' 0 C--N 1.319 -1.02 0 C-N-CA 123.984 -1.257 . . . . 0.0 111.972 -0.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.96 142.41 81.52 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.6 p -79.42 -61.62 1.95 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.981 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.467 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 88.1 t80 61.93 161.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 145.13 -165.7 27.71 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.383 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 107.9 -149.98 16.85 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.495 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.71 56.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 68.4 m -78.79 106.49 10.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.381 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -71.16 97.49 1.52 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.411 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tp -88.56 83.5 6.79 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.558 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -110.14 144.9 38.08 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.3 tt -64.61 159.38 3.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -55.92 -29.81 60.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.223 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 116.483 -1.722 . . . . 0.0 111.107 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.994 0.426 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.701 HG21 ' CD2' ' A' ' 98' ' ' HIS . 57.7 t -71.6 140.03 18.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.949 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.41 155.59 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.997 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mtt -145.54 114.1 6.76 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.007 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -100.11 129.26 46.13 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.532 HE22 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.7 140.98 37.92 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.51 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -163.84 145.16 7.12 Favored Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.16 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 107' ' ' THR . 9.5 Cg_endo -81.15 -176.51 17.83 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.8 -1.334 . . . . 0.0 111.165 -2.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.532 HD23 HE22 ' A' ' 6' ' ' GLN . 14.5 mt -85.19 -46.6 10.92 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.7 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.5 p -124.12 158.42 32.33 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.914 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 13' ' ' VAL . 1.2 tp -146.74 85.0 7.31 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.953 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -69.43 121.62 8.38 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.846 1.698 . . . . 0.0 110.225 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 11' ' ' LEU . 3.6 m -143.39 -170.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.181 -1.007 . . . . 0.0 112.06 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -132.15 161.9 32.21 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.456 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -71.08 87.9 0.77 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.186 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.21 30.68 0.1 OUTLIER Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -125.58 -176.33 3.57 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.083 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -114.82 138.84 50.29 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.645 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -114.64 157.86 22.53 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.298 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 2.7 m -155.44 91.24 1.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.836 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.521 HD12 HD22 ' A' ' 78' ' ' LEU . 5.9 mt -83.16 132.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.305 -0.958 . . . . 0.0 109.607 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 7' ' ' THR . 8.0 t -104.25 145.5 30.13 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.777 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -149.27 98.45 2.81 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.466 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.43 154.53 19.33 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.409 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.8 p -129.9 143.05 50.6 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.901 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -53.66 -71.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.482 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -82.08 152.24 26.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.3 p -66.52 131.45 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' C ' HG21 ' A' ' 97' ' ' THR . 26.8 mt -78.58 30.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.236 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.0 t -97.26 133.44 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.9 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -86.32 163.11 17.88 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.153 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -60.7 -24.62 65.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.028 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -76.5 -15.29 59.92 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.321 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.67 -10.04 41.36 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.634 -1.27 . . . . 0.0 111.499 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 8.8 m120 -89.25 141.21 28.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.983 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.0 m -109.37 157.49 18.85 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.497 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -137.46 108.87 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.172 -1.011 . . . . 0.0 112.491 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -154.81 128.63 8.71 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.261 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 28.0 m-20 -125.15 167.71 14.44 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.513 -0.875 . . . . 0.0 112.505 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.512 ' O ' HD12 ' A' ' 51' ' ' LEU . 57.5 m95 -124.09 152.14 43.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.438 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 92' ' ' PHE . 29.3 m-85 -135.34 156.37 49.05 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.282 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.464 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 15.4 tp -146.51 117.37 7.67 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.241 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -125.58 158.2 35.23 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.338 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -114.25 -147.28 0.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.128 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.42 -56.32 3.41 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.002 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.64 56.43 0.69 Allowed Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.847 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -131.64 162.89 29.32 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.691 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 m -70.96 124.45 91.04 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.04 158.48 29.69 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.87 1.714 . . . . 0.0 111.516 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -150.98 159.58 44.48 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.322 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' TRP . 45.0 tp -101.96 134.82 44.56 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.957 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 mt -102.72 -67.77 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.231 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -119.4 142.44 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.193 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.3 p90 -145.06 167.82 21.79 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.078 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER 60.85 15.37 5.92 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.461 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 55' ' ' LYS . 0.4 OUTLIER 78.58 5.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.681 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.27 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.501 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -44.11 128.39 5.86 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.661 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.565 HH21 ' N ' ' A' ' 65' ' ' ASP . 11.7 mtm-85 -97.29 146.31 25.26 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.165 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.81 159.32 34.53 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.639 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -58.04 122.28 12.66 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.43 -18.06 45.63 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.74 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.35 116.48 53.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.693 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.496 ' C ' HH21 ' A' ' 59' ' ' ARG . 1.1 Cg_endo -65.89 172.66 8.07 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.137 1.891 . . . . 0.0 112.423 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.565 ' N ' HH21 ' A' ' 59' ' ' ARG . 1.2 m-20 -78.05 -15.81 58.6 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -56.2 -27.15 53.63 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.321 -0.951 . . . . 0.0 110.169 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -96.66 118.99 34.31 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.286 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.9 p -128.03 91.21 3.23 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.924 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.51 127.62 8.8 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 t -160.96 178.37 9.44 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.58 -178.5 42.58 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.541 -1.314 . . . . 0.0 110.836 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -92.88 -85.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.039 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.2 -34.84 0.11 Allowed Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.57 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.8 p -124.17 6.6 8.5 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.42 118.36 16.31 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.817 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -133.61 153.13 51.91 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.429 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 16.1 m -154.2 145.89 23.32 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.83 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 21' ' ' ILE . 1.9 tt -96.71 99.62 11.21 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.587 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -91.1 122.58 33.87 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.247 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD12 ' HB3' ' A' ' 19' ' ' ALA . 45.0 mt -112.5 133.04 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 m -70.31 -71.86 0.22 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.842 -1.143 . . . . 0.0 112.665 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.81 102.45 9.11 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.518 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.5 t -63.7 131.47 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -117.05 -173.9 2.49 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.302 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.24 -25.36 61.59 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.72 -32.11 59.91 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.07 -31.74 70.29 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.182 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.1 mt -46.74 139.44 5.31 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.583 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.29 -150.72 22.8 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.436 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 90' ' ' ILE . 2.6 mp -122.09 121.38 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.463 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.464 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 29.9 m-85 -93.11 151.28 19.95 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.174 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 46.9 m-85 -143.23 164.32 30.52 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.192 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 14.4 p -147.26 151.48 36.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.191 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.9 p -157.22 157.3 34.07 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.178 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.57 146.96 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.444 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.5 p -126.14 27.9 6.18 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.504 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.479 HG21 ' C ' ' A' ' 29' ' ' LEU . 1.1 m -77.98 -33.87 51.2 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.171 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.701 ' CD2' HG21 ' A' ' 2' ' ' VAL . 74.0 m-70 -105.81 -43.56 4.86 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.583 -0.847 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.581 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.7 OUTLIER 66.45 140.12 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.574 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.581 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 0.9 OUTLIER -66.67 168.65 50.54 Favored 'Cis proline' 0 C--N 1.318 -1.029 0 C-N-CA 123.901 -1.291 . . . . 0.0 111.903 -0.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.24 134.56 46.02 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.172 1.915 . . . . 0.0 111.788 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 p -78.09 -57.39 3.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.715 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 80.2 t80 62.7 164.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.449 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 139.91 -157.57 25.4 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.65 -137.26 19.93 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.449 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 117.18 68.06 0.38 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.418 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 8' ' ' PRO . 12.1 m -78.31 114.89 17.62 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.274 -0.971 . . . . 0.0 109.713 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -77.39 111.33 12.97 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.682 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 89.39 2.98 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.775 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -121.45 144.55 48.62 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.1 tt -66.41 150.94 10.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.664 -0.815 . . . . 0.0 111.067 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -53.43 135.69 39.04 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.966 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 116.39 -1.767 . . . . 0.0 110.945 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 102' ' ' THR . 7.6 t -76.64 142.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.158 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.54 148.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.634 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mmt -134.26 104.97 6.4 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.627 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 m -100.49 129.71 46.47 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.31 147.38 32.77 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.281 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.72 7.73 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.806 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' O ' HG23 ' A' ' 107' ' ' THR . 12.1 Cg_endo -83.94 171.78 47.36 Favored 'Cis proline' 0 C--N 1.315 -1.195 0 C-N-CA 124.005 -1.248 . . . . 0.0 111.502 -0.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.758 ' H ' HD22 ' A' ' 9' ' ' LEU . 1.7 mm? -74.41 -42.43 59.23 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.01 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.2 p -125.96 146.05 50.03 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.101 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.3 tp -137.69 74.6 45.38 Favored Pre-proline 0 N--CA 1.49 1.57 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.48 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.37 117.94 5.12 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.536 1.491 . . . . 0.0 109.877 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 11' ' ' LEU . 6.3 m -139.4 -174.67 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -113.05 172.16 7.11 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.725 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.75 86.23 7.37 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.828 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.57 33.4 0.06 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.714 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -128.23 -173.7 3.02 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.097 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -114.47 137.28 52.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.984 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.79 166.77 11.48 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.641 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.7 p -162.23 76.83 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 77' ' ' THR . 19.1 mt -79.23 140.03 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.248 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.7 t -113.35 152.59 29.76 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.741 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.8 m -156.43 99.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 114.282 -1.326 . . . . 0.0 108.598 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HG2' ' HA ' ' A' ' 75' ' ' ASP . 9.9 mtm180 -110.02 152.63 25.67 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.943 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.5 p -118.64 150.65 39.34 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.317 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 t -58.5 -45.76 88.1 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.665 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.63 174.66 5.82 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.861 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.1 t -74.04 146.66 43.54 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.9 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.515 ' C ' HG21 ' A' ' 97' ' ' THR . 83.0 mt -101.09 30.51 4.08 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.78 131.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.571 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 152.54 37.66 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.012 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.9 t -45.8 -25.94 0.59 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.712 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -155.2 45.24 0.49 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.138 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -136.29 -136.14 3.51 Favored Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -176.45 3.95 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.074 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 137.22 36.17 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.031 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -117.78 105.36 11.89 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.833 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' CD2' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -145.14 143.12 30.19 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.346 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -134.7 154.72 51.43 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.247 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.522 ' O ' HD12 ' A' ' 51' ' ' LEU . 82.6 m95 -123.49 147.41 47.24 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.346 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -140.77 145.84 36.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.547 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.8 tp -130.67 115.54 16.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.87 138.05 54.55 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.749 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 -122.61 0.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.66 -39.92 12.9 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.316 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.44 68.83 0.1 OUTLIER Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.605 -1.284 . . . . 0.0 110.451 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.437 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -117.04 159.01 23.19 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.13 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -75.77 -56.43 1.75 Allowed Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.644 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 48' ' ' SER . 5.6 Cg_exo -56.92 113.57 1.53 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 121.565 1.51 . . . . 0.0 111.511 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.0 24.81 3.59 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 40' ' ' TRP . 22.5 tp -143.08 126.52 16.74 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.999 -0.681 . . . . 0.0 110.732 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.427 ' HA ' HG21 ' A' ' 63' ' ' VAL . 3.8 mp -107.8 -52.43 2.76 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.939 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 55' ' ' LYS . 2.0 mm -129.3 134.42 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.507 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -112.27 39.04 2.53 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.2 OUTLIER 179.22 -167.14 0.07 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.632 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' H ' ' HG3' ' A' ' 55' ' ' LYS . 27.5 t -76.82 -13.31 14.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.861 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.85 79.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.462 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.448 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -170.88 107.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.236 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 31.8 mtm180 -74.38 150.22 40.15 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -80.1 163.73 23.91 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.629 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -63.73 89.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.802 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.47 -28.54 2.32 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' A' ' 52' ' ' LEU . 49.8 t -70.4 116.93 50.05 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.061 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.94 148.49 76.01 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.104 1.869 . . . . 0.0 112.874 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 2.9 m-20 -57.8 -8.81 1.03 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.123 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -20.67 63.84 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.927 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.47 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 94.9 m-85 -105.51 119.67 39.7 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.708 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.9 p -125.51 107.4 10.59 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.68 139.01 14.3 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.198 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.6 p -156.2 146.12 21.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.082 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -173.63 168.71 41.68 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.68 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.5 p -94.44 -105.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.437 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.73 -33.72 1.26 Allowed Glycine 0 N--CA 1.496 2.659 0 C-N-CA 120.026 -1.083 . . . . 0.0 110.483 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.6 p -126.87 10.09 7.0 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.964 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 24' ' ' ARG . 11.9 t0 -136.68 130.65 32.46 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.071 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 70.0 m-85 -145.03 147.9 33.12 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.533 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 21' ' ' ILE . 53.3 m -149.8 133.14 16.49 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.656 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -93.74 114.8 27.15 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.468 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -113.66 145.21 41.66 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.825 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.439 HG12 ' CD1' ' A' ' 67' ' ' PHE . 67.3 mt -123.08 143.22 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.746 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -70.61 -57.76 4.39 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.617 -1.233 . . . . 0.0 111.547 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 82' ' ' ARG . 8.7 ptm180 -129.48 107.35 9.41 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.659 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.1 t -70.47 105.39 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.229 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.33 -163.03 1.0 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.223 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.86 -30.14 50.77 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.49 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -26.13 65.73 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.708 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.1 -21.9 62.16 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.49 137.46 48.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.294 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.78 -158.73 27.76 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.25 124.82 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.568 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CE1' HD13 ' A' ' 42' ' ' LEU . 17.6 m-85 -94.16 153.4 18.11 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.297 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -141.07 170.26 16.06 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.73 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.6 p -151.72 152.57 32.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.617 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.6 p -154.89 164.38 38.94 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.197 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 160.72 29.55 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.165 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -134.58 24.24 3.71 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.814 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.515 HG21 ' C ' ' A' ' 29' ' ' LEU . 17.1 m -79.92 -43.74 21.61 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.752 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -122.19 141.69 51.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.788 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 100' ' ' PRO . 3.2 t -95.98 141.47 23.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.496 ' HA ' ' CG1' ' A' ' 99' ' ' VAL . 9.3 Cg_endo -77.46 163.51 88.42 Favored 'Cis proline' 0 C--N 1.317 -1.102 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.193 -0.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 2.3 Cg_endo -67.87 117.43 4.89 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.029 1.819 . . . . 0.0 110.347 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 2' ' ' VAL . 20.8 p -90.39 104.25 16.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.992 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -86.34 150.39 24.36 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.18 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.05 170.72 42.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.1 -149.74 18.63 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.366 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.54 40.91 1.29 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.378 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 8' ' ' PRO . 95.8 m -79.23 106.42 11.25 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.47 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -71.86 112.93 8.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.221 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.61 80.25 1.45 Allowed 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.33 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.56 140.84 34.24 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.582 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.4 tt -71.8 150.48 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -54.92 128.9 35.48 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.111 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.082 -179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.078 0.466 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 98' ' ' HIS . 43.5 t -68.94 110.57 2.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.96 141.23 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.087 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 5.1 mtp -128.21 105.19 8.19 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.499 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.09 143.1 37.66 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.11 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.457 ' OE1' ' N ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -130.59 135.68 48.13 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.337 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.18 157.3 24.73 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.112 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' HG22 ' A' ' 7' ' ' THR . 10.1 Cg_endo -78.66 176.46 42.6 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.563 -1.432 . . . . 0.0 111.362 -1.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.744 HD22 ' N ' ' A' ' 9' ' ' LEU . 2.2 mm? -78.96 -44.35 22.63 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.619 -0.832 . . . . 0.0 109.161 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.3 p -128.09 144.4 51.11 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.627 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 tp -132.31 78.17 68.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.039 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.81 108.32 1.44 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 121.621 1.547 . . . . 0.0 110.231 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.91 -173.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.29 -0.964 . . . . 0.0 111.976 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -119.1 173.18 7.07 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.675 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -88.04 90.12 8.26 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.94 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.35 42.31 0.08 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.92 -1.133 . . . . 0.0 110.426 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -170.56 2.94 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.758 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -109.16 140.68 42.43 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.071 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 83' ' ' VAL . . . -108.95 159.24 16.98 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.75 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -157.43 88.56 1.01 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 77' ' ' THR . 4.0 mt -81.19 128.71 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.794 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.15 140.42 30.89 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.029 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.8 t -153.88 110.83 3.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.792 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.23 173.39 6.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.683 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 4' ' ' MET . 79.5 p -132.23 166.99 20.62 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.333 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -72.85 -50.85 21.44 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.94 161.01 17.5 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.359 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' VAL . 64.4 m -59.98 126.35 27.22 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.408 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 29' ' ' LEU . 76.6 mt -79.98 29.93 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' SER . 60.9 t -98.85 137.49 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.432 ' ND1' ' ND2' ' A' ' 33' ' ' ASN . 13.5 t-80 -86.43 171.05 11.43 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.556 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.4 t -74.0 -24.44 59.59 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' ND1' ' A' ' 31' ' ' HIS . 8.6 p30 -77.97 -29.74 49.91 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.477 -0.889 . . . . 0.0 111.446 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.02 43.89 0.65 Allowed Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.7 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -130.43 141.54 50.53 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.838 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.8 m -113.86 109.44 18.53 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.441 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -98.05 109.74 22.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.611 -0.836 . . . . 0.0 112.057 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -154.07 127.75 8.72 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.615 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.559 ' N ' HD23 ' A' ' 38' ' ' LEU . 12.9 p-10 -130.67 152.78 49.65 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.376 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.733 ' CD2' HD13 ' A' ' 78' ' ' LEU . 53.7 m95 -115.78 158.35 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 16.9 m-85 -137.14 156.01 48.89 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.596 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 91' ' ' TYR . 9.1 tp -140.6 127.03 19.99 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.13 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -131.64 155.92 46.73 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.474 -0.891 . . . . 0.0 111.036 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.0 -118.37 0.3 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.272 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.23 -90.06 0.07 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.616 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -124.53 38.62 2.32 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.327 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.96 -175.94 5.01 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.692 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.1 p -84.73 151.08 57.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.545 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.08 125.85 20.28 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.009 1.806 . . . . 0.0 111.836 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -107.38 137.9 44.57 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.383 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 54' ' ' TYR . 27.7 tp -103.13 133.91 47.44 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.337 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.3 mt -113.4 -49.65 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.81 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.563 HG13 HD11 ' A' ' 78' ' ' LEU . 6.1 mm -127.54 135.43 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.385 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.495 ' HB3' HD21 ' A' ' 51' ' ' LEU . 51.1 p90 -122.62 -11.25 8.27 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.567 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -142.22 88.57 2.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.376 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.684 HG13 ' N ' ' A' ' 57' ' ' SER . 1.5 p 45.26 -68.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 124.348 1.03 . . . . 0.0 113.537 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.684 ' N ' HG13 ' A' ' 56' ' ' VAL . 53.9 p -130.32 28.73 4.95 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 3.4 m-80 -103.78 111.55 24.11 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -75.87 152.23 37.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.649 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 33.4 t80 -88.78 167.18 13.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.03 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.425 ' N ' ' CD2' ' A' ' 60' ' ' PHE . 5.3 t -59.79 132.69 54.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.692 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.11 -17.46 56.9 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -73.58 117.69 62.82 Favored Pre-proline 0 N--CA 1.489 1.515 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.815 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.8 144.42 96.91 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.731 1.621 . . . . 0.0 111.667 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.99 -10.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.368 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -62.27 -19.92 63.75 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.973 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -104.54 122.69 46.1 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.254 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.13 121.32 13.83 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.469 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.41 147.78 17.49 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.881 -1.152 . . . . 0.0 110.41 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -161.35 161.1 30.33 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.672 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.5 173.45 44.65 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.7 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -91.21 -87.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.47 -34.76 0.11 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -120.95 17.86 11.75 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.572 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -155.01 126.2 7.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.986 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CG ' ' CD1' ' A' ' 38' ' ' LEU . 7.5 m-85 -141.56 153.53 44.9 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 21' ' ' ILE . 18.8 m -148.34 142.38 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.886 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.733 HD13 ' CD2' ' A' ' 40' ' ' TRP . 4.6 tp -101.83 115.09 29.78 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.065 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -111.17 151.11 28.58 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.635 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.9 mt -127.89 134.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.94 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.6 m -67.35 -49.9 62.12 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.84 103.64 5.94 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.814 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 19' ' ' ALA . 98.7 t -68.09 117.76 10.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.079 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -108.47 -177.93 3.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.81 -22.95 63.26 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -74.94 -42.93 56.73 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.68 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -60.03 -19.66 53.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 88' ' ' LEU . 73.4 mt -52.67 147.84 8.09 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.746 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.36 -160.42 25.07 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.14 151.54 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.046 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.562 ' CE1' HD13 ' A' ' 42' ' ' LEU . 13.3 m-85 -123.57 148.69 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.565 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -141.66 162.94 34.25 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.3 p -144.86 125.16 13.8 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.436 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 87.5 p -120.64 161.85 20.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.545 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.532 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -125.97 150.7 47.83 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.895 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.0 m -125.06 52.13 1.61 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.634 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.94 -50.08 3.11 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.353 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' H ' HE22 ' A' ' 95' ' ' GLN . 91.0 m-70 -112.51 163.38 14.54 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.269 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 100' ' ' PRO . 11.2 p -117.98 139.78 26.99 Favored Pre-proline 0 N--CA 1.49 1.54 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.484 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.519 ' HA ' HG23 ' A' ' 99' ' ' VAL . 7.0 Cg_endo -75.75 156.68 99.01 Favored 'Cis proline' 0 C--N 1.315 -1.201 0 C-N-CA 123.69 -1.379 . . . . 0.0 111.71 -0.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.04 120.19 7.37 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.977 1.784 . . . . 0.0 110.847 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.7 p -91.28 136.19 33.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.397 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -85.67 176.42 8.17 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.6 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.66 -161.95 37.85 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.654 -1.26 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 6' ' ' GLN . . . -87.98 -79.3 1.27 Allowed Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.832 -1.175 . . . . 0.0 111.307 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.89 95.09 0.15 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.423 HG21 HG23 ' A' ' 21' ' ' ILE . 95.2 m -92.29 117.33 29.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.561 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -85.51 114.53 22.6 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.318 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.4 93.42 4.59 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.802 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.8 139.18 52.02 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.007 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.6 tt -66.85 156.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -55.34 152.32 8.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.707 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.967 0.413 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.64 HG21 ' CD2' ' A' ' 98' ' ' HIS . 47.8 t -67.02 152.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.981 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 4' ' ' MET . 3.8 t -96.94 166.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.265 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -148.76 115.45 5.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.516 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.9 m -95.85 140.8 30.11 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.012 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.541 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 1.9 mm-40 -129.9 132.14 46.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.538 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -160.99 158.02 23.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.932 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 7' ' ' THR . 9.8 Cg_endo -79.69 175.1 46.49 Favored 'Cis proline' 0 C--N 1.31 -1.479 0 C-N-CA 123.429 -1.488 . . . . 0.0 110.538 -1.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.6 mm? -77.75 -43.96 29.2 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.801 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.7 m -126.14 146.05 50.1 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tp -136.09 78.03 47.72 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.338 -0.945 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.62 112.27 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.79 1.66 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.6 m -139.34 178.96 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.386 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -110.34 174.58 5.8 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.787 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 HD13 ' A' ' 111' ' ' ILE . 15.3 mt -85.95 87.73 7.46 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.77 52.72 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.629 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.5 179.38 8.85 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.75 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -100.49 141.31 33.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.455 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -113.37 165.76 12.13 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.132 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -159.55 91.42 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.591 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.687 ' O ' HG23 ' A' ' 77' ' ' THR . 25.9 mt -79.31 152.74 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 m -121.48 140.99 51.47 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.188 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.6 t -149.25 110.9 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.393 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.426 ' HE ' ' CG ' ' A' ' 75' ' ' ASP . 58.0 mtp180 -113.13 163.48 14.7 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.514 -0.874 . . . . 0.0 112.184 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.2 p -133.47 147.73 51.68 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.176 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.3 m -62.72 -41.05 98.96 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -116.94 159.26 22.72 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 p -70.68 129.58 39.51 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.53 34.41 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.126 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.9 t -82.72 147.74 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.58 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.429 ' HB3' HD21 ' A' ' 33' ' ' ASN . 3.6 t-80 -97.42 167.22 11.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.464 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.8 t -75.19 66.39 1.69 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.883 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 31' ' ' HIS . 0.4 OUTLIER -174.14 -30.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.837 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 31.55 1.15 Allowed Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.671 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 2.6 m-80 -132.47 132.71 43.0 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 56' ' ' VAL . 2.9 m -79.26 153.42 29.94 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.651 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -124.09 89.03 3.01 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.729 -0.789 . . . . 0.0 111.779 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.628 HD13 ' CD2' ' A' ' 76' ' ' PHE . 1.1 tt -155.37 134.49 12.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.181 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -129.42 150.15 50.9 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.044 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CE3' HD13 ' A' ' 78' ' ' LEU . 86.5 m95 -103.96 153.32 20.96 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.346 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -155.54 130.26 9.17 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.961 -1.096 . . . . 0.0 111.24 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 91' ' ' TYR . 13.8 tp -109.83 142.81 40.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.455 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.569 ' H ' HD12 ' A' ' 42' ' ' LEU . 8.1 tt0 -125.3 137.64 54.07 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.822 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -121.85 170.03 10.19 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.475 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.24 137.45 53.15 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.829 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 40.15 51.26 3.54 Favored Glycine 0 N--CA 1.497 2.726 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -130.42 158.68 39.23 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.369 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.76 158.68 77.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.843 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -60.28 150.35 80.54 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.884 1.723 . . . . 0.0 110.923 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.82 134.6 5.19 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.198 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 53' ' ' ILE . 13.5 tp -102.62 139.08 38.68 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.319 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 67' ' ' PHE . 1.1 tp -99.63 -62.47 1.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.586 ' O ' HD11 ' A' ' 51' ' ' LEU . 1.2 mm -126.25 149.46 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.015 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.567 ' HB3' HD21 ' A' ' 51' ' ' LEU . 42.6 p90 -137.99 160.8 38.36 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.358 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 71.03 -63.69 0.41 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 123.629 0.58 . . . . 0.0 110.133 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 57' ' ' SER . 7.0 p -172.39 -37.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.756 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 49.6 m -150.5 -25.64 0.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.657 -1.217 . . . . 0.0 113.016 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 34.8 m-80 -53.31 120.92 6.61 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.793 -1.163 . . . . 0.0 111.274 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' NH2' ' HA ' ' A' ' 65' ' ' ASP . 13.4 mtm180 -76.55 151.29 36.39 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.227 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -90.27 167.82 12.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.731 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 t -62.62 121.69 13.99 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 103.27 -8.96 53.55 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.62 113.8 58.13 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.342 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -66.0 155.39 69.78 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.129 1.886 . . . . 0.0 112.315 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' NH2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -57.39 -13.21 3.18 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.345 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -62.79 -18.29 62.47 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.895 -0.722 . . . . 0.0 112.026 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.487 ' CD1' HD21 ' A' ' 52' ' ' LEU . 63.9 m-85 -106.18 109.59 21.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.547 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.5 t -116.95 119.36 35.1 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.974 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -126.11 130.64 7.19 Favored Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.21 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.1 t -161.24 168.91 23.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.95 -177.7 48.56 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.028 -1.558 . . . . 0.0 111.398 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.9 t -91.26 -106.59 0.1 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.068 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.8 -35.15 0.86 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.022 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.2 p -124.3 16.85 9.06 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' CG ' ' HE ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -145.31 120.86 10.4 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.733 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.628 ' CD2' HD13 ' A' ' 38' ' ' LEU . 40.2 m-85 -133.6 144.67 49.42 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 21' ' ' ILE . 68.5 m -141.15 141.48 34.14 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.635 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.612 HD13 ' CE3' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -98.86 99.69 10.79 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.785 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -89.12 117.06 27.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.633 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 37.5 mt -104.56 138.11 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.935 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.4 m -73.41 -64.25 1.03 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.904 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -124.37 103.46 8.21 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.013 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.52 104.68 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.207 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -99.52 167.76 10.4 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.093 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 88' ' ' LEU . . . -55.29 -25.45 34.15 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.408 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -79.53 -37.39 36.66 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.506 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -5.24 25.13 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.312 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.615 HD11 HD11 ' A' ' 111' ' ' ILE . 85.0 mt -74.03 150.07 40.86 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.772 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.1 -149.42 21.55 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.299 -1.429 . . . . 0.0 111.202 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 mp -120.53 118.58 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.29 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.571 ' CE1' HD13 ' A' ' 42' ' ' LEU . 22.6 m-85 -92.76 154.15 18.47 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.862 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' CE1' ' HA2' ' A' ' 106' ' ' GLY . 97.5 m-85 -143.34 157.4 44.5 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.634 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.541 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 16.0 p -135.63 147.47 48.63 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.755 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -150.0 166.35 29.93 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.627 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.54 HE21 HG23 ' A' ' 102' ' ' THR . 1.7 pp0? -127.22 145.08 50.89 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.62 18.02 13.53 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.504 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.505 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -71.77 -42.34 67.28 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.536 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.64 ' CD2' HG21 ' A' ' 2' ' ' VAL . 44.0 m-70 -111.4 171.81 7.26 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.422 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 100' ' ' PRO . 98.9 t -138.81 140.85 28.58 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.574 ' HA ' HG13 ' A' ' 99' ' ' VAL . 1.6 Cg_endo -70.76 168.82 70.1 Favored 'Cis proline' 0 C--N 1.319 -1.025 0 C-N-CA 123.741 -1.358 . . . . 0.0 111.883 -0.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.88 156.99 54.9 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.935 1.757 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.54 HG23 HE21 ' A' ' 95' ' ' GLN . 26.7 p -89.58 -64.25 1.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.961 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 63.24 171.55 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.128 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.04 -156.92 19.82 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.652 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.54 -172.73 45.04 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.402 ' HA2' ' CE1' ' A' ' 92' ' ' PHE . . . 162.14 59.81 0.02 OUTLIER Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.064 -1.541 . . . . 0.0 111.005 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.1 m -77.28 109.51 11.23 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.876 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -78.07 132.03 37.56 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.569 -0.852 . . . . 0.0 111.003 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.481 HD23 HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -123.2 76.92 1.42 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.964 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -107.0 137.85 44.28 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.96 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 88' ' ' LEU . 18.9 mt -63.32 124.71 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.507 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.489 ' C ' ' HE3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -64.12 103.14 0.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.729 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 116.597 -1.668 . . . . 0.0 111.499 -179.928 . . . . . . . . 1 1 . 1 stop_ save_